0001493152-21-029915.txt : 20211126 0001493152-21-029915.hdr.sgml : 20211126 20211126130221 ACCESSION NUMBER: 0001493152-21-029915 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 75 FILED AS OF DATE: 20211126 DATE AS OF CHANGE: 20211126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glimpse Group, Inc. CENTRAL INDEX KEY: 0001854445 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371] IRS NUMBER: 812958271 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-261380 FILM NUMBER: 211450974 BUSINESS ADDRESS: STREET 1: 15 WEST 38TH ST, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-292-2685 MAIL ADDRESS: STREET 1: 15 WEST 38TH ST, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 S-1 1 forms-1.htm
0001854445 false P3Y 3 3 2 2026-06-30 0001854445 2021-07-01 2021-09-30 0001854445 2021-09-30 0001854445 2021-06-30 0001854445 2020-07-01 2020-09-30 0001854445 GGIC:SoftwareSercicesMember 2021-07-01 2021-09-30 0001854445 GGIC:SoftwareSercicesMember 2020-07-01 2020-09-30 0001854445 GGIC:SoftwareLicenseMember 2021-07-01 2021-09-30 0001854445 GGIC:SoftwareLicenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:CommonStockMember 2021-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001854445 us-gaap:RetainedEarningsMember 2021-06-30 0001854445 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001854445 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001854445 us-gaap:CommonStockMember 2021-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001854445 us-gaap:RetainedEarningsMember 2021-09-30 0001854445 us-gaap:CommonStockMember 2020-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001854445 us-gaap:RetainedEarningsMember 2020-06-30 0001854445 2020-06-30 0001854445 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001854445 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001854445 us-gaap:CommonStockMember 2020-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001854445 us-gaap:RetainedEarningsMember 2020-09-30 0001854445 2020-09-30 0001854445 2021-07-02 0001854445 2021-07-01 2021-07-02 0001854445 us-gaap:SubsequentEventMember 2021-11-01 2021-11-02 0001854445 us-gaap:SubsequentEventMember 2021-11-02 0001854445 GGIC:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:FourOtherCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OneCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0001854445 us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001854445 us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0001854445 2021-08-01 2021-08-31 0001854445 us-gaap:CustomerRelationshipsMember 2021-09-30 0001854445 us-gaap:CustomerRelationshipsMember 2021-07-01 2021-09-30 0001854445 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-09-30 0001854445 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-07-01 2021-09-30 0001854445 GGIC:Kabaq3DTechnologiesLLCMember 2021-08-01 2021-08-31 0001854445 GGIC:Kabaq3DTechnologiesLLCMember us-gaap:StockOptionMember 2021-08-01 2021-08-31 0001854445 GGIC:Kabaq3DTechnologiesLLCMember us-gaap:StockOptionMember 2021-08-31 0001854445 GGIC:KreatARLLCMember 2021-08-01 2021-08-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2019-12-01 2019-12-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2019-12-31 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:AdditionalInterestMember 2020-09-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-01-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-01-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-06-01 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:SecondYearOfNotesMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-03-01 2021-03-31 0001854445 us-gaap:IPOMember 2021-07-01 2021-09-30 0001854445 us-gaap:IPOMember 2021-09-30 0001854445 us-gaap:InvestorMember 2021-07-01 2021-09-30 0001854445 us-gaap:InvestorMember 2021-09-30 0001854445 us-gaap:InvestorMember 2020-07-01 2020-09-30 0001854445 us-gaap:InvestorMember 2020-09-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-07-01 2021-09-30 0001854445 us-gaap:CommonStockMember GGIC:AcquisitionMember 2021-07-01 2021-09-30 0001854445 us-gaap:CommonStockMember GGIC:LegacyAcquisitionObligationMember 2021-07-01 2021-09-30 0001854445 GGIC:LegacyAcquisitionObligationMember 2021-07-01 2021-09-30 0001854445 GGIC:VendorsMember 2021-07-01 2021-09-30 0001854445 GGIC:VendorsMember 2020-07-01 2020-09-30 0001854445 GGIC:ToSatisfyContingentLiabilitiesMember 2021-07-01 2021-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember srt:MaximumMember 2021-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-09-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001854445 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001854445 GGIC:BoardOptionExpenseMember 2021-07-01 2021-09-30 0001854445 GGIC:BoardOptionExpenseMember 2020-07-01 2020-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember GGIC:AdvisorsMember 2018-07-01 2019-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-07-01 2021-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-07-01 2020-09-30 0001854445 GGIC:StockOptionsMember 2021-07-01 2021-09-30 0001854445 GGIC:StockOptionsMember 2020-07-01 2020-09-30 0001854445 GGIC:WarrantsMember 2021-07-01 2021-09-30 0001854445 GGIC:WarrantsMember 2020-07-01 2020-09-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2021-07-01 2021-09-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2020-07-01 2020-09-30 0001854445 2018-06-30 0001854445 GGIC:OctoberTwoThousandTwentyOneToSeptemberTwoThousandTwentyTwoMember 2021-09-30 0001854445 us-gaap:SubsequentEventMember 2021-10-02 2021-10-31 0001854445 us-gaap:SubsequentEventMember GGIC:SecuritiesPurchaseAgreementMember 2021-11-01 2021-11-30 0001854445 us-gaap:SubsequentEventMember GGIC:SecuritiesPurchaseAgreementMember 2021-11-30 0001854445 2020-07-01 2021-06-30 0001854445 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareSercicesMember 2020-07-01 2021-06-30 0001854445 GGIC:SoftwareSercicesMember 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareLicenseMember 2020-07-01 2021-06-30 0001854445 GGIC:SoftwareLicenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:CommonStockMember 2019-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001854445 us-gaap:RetainedEarningsMember 2019-06-30 0001854445 2019-06-30 0001854445 us-gaap:CommonStockMember 2019-07-01 2020-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2020-06-30 0001854445 us-gaap:RetainedEarningsMember 2019-07-01 2020-06-30 0001854445 us-gaap:CommonStockMember 2020-07-01 2021-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2021-06-30 0001854445 us-gaap:RetainedEarningsMember 2020-07-01 2021-06-30 0001854445 2016-06-15 2021-06-30 0001854445 us-gaap:SubsequentEventMember 2021-07-02 0001854445 us-gaap:SubsequentEventMember 2021-07-01 2021-07-02 0001854445 GGIC:PaymentProtectionProgramOneMember 2019-07-01 2020-06-30 0001854445 GGIC:PaymentProtectionProgramTwoMember 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareServicesMember 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareLicenseAndSoftwareServiceMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredOverTimeMember 2020-07-01 2021-06-30 0001854445 GGIC:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:OtherCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:FourOtherCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:StockOptionsMember 2020-07-01 2021-06-30 0001854445 GGIC:StockOptionsMember 2019-07-01 2020-06-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2020-07-01 2021-06-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2019-07-01 2020-06-30 0001854445 us-gaap:InvestorMember 2020-07-01 2021-06-30 0001854445 us-gaap:InvestorMember 2019-07-01 2020-06-30 0001854445 us-gaap:InvestorMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2020-07-01 2021-06-30 0001854445 GGIC:NewConvertibleNotesPayableMember 2020-07-01 2021-06-30 0001854445 GGIC:ConvertibleNotesPayablesMember 2019-07-01 2020-06-30 0001854445 GGIC:VendorsMember 2020-07-01 2021-06-30 0001854445 GGIC:VendorsMember 2019-07-01 2020-06-30 0001854445 GGIC:ToSatisfyContingentLiabilitiesMember 2020-07-01 2021-06-30 0001854445 GGIC:ToSatisfyContingentLiabilitiesMember 2019-07-01 2020-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember srt:MaximumMember 2020-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember srt:MaximumMember 2021-04-30 0001854445 GGIC:EmployeesMember 2020-07-01 2021-06-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:CostOfSalesMember 2020-07-01 2021-06-30 0001854445 us-gaap:CostOfSalesMember 2019-07-01 2020-06-30 0001854445 GGIC:BoardOptionExpenseMember 2020-07-01 2021-06-30 0001854445 GGIC:BoardOptionExpenseMember 2019-07-01 2020-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-07-01 2021-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2019-07-01 2020-06-30 0001854445 GGIC:EarlyAdopterComMember 2021-06-30 0001854445 GGIC:EarlyAdopterComMember 2020-06-30 0001854445 GGIC:EarlyAdopterComMember 2020-07-01 2021-06-30 0001854445 GGIC:Kabaq3DTechnologiesLLCMember srt:ScenarioForecastMember 2021-08-01 2021-08-31 0001854445 GGIC:KreatARLLCMember srt:ScenarioForecastMember 2021-08-01 2021-08-31 0001854445 GGIC:EarlyAdopterComMember 2019-07-01 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2019-07-01 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:ExecutivesAndIndependentMembersMember 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:AdditionalInterestMember 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:FirstTwoYearsOfInteresPrepaymentMember 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:FirstTwoYearsOfInteresPrepaymentMember 2019-07-01 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember srt:MaximumMember 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember srt:MinimumMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:ThirdYearInterestMember 2020-07-01 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:ThirdYearInterestMember 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:FristYearOfInterestPrepaymentMember 2021-03-01 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember GGIC:SecondYearOfNotesMember 2021-03-31 0001854445 GGIC:PaycheckProtectionProgramMember 2020-05-01 2020-05-31 0001854445 GGIC:EconomicInjuryDisasterLoanMember 2020-05-01 2020-05-31 0001854445 GGIC:PaycheckProtectionProgramMember 2021-02-01 2021-02-28 0001854445 GGIC:PaycheckProtectionProgramMember 2021-02-28 0001854445 GGIC:JulyAndDecemberTwoThousandTwentyOneMember 2021-06-30 0001854445 GGIC:ThreeOfficersMember 2020-07-01 2021-06-30 0001854445 us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-07-02 0001854445 us-gaap:CommonStockMember us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 GGIC:PreOfferingCostsMember us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 us-gaap:AccountsPayableMember us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 us-gaap:IPOMember 2021-06-30 0001854445 us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 srt:ProFormaMember 2021-06-30 0001854445 us-gaap:SubsequentEventMember 2021-08-01 2021-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

As filed with the Securities and Exchange Commission on November 26, 2021

 

Registration No.       

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM S-1

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

  THE GLIMPSE GROUP, INC.  
  (Exact name of registrant as specified in its charter)  

 

Nevada   81-2958271
(State or other jurisdiction
of incorporation)
  (IRS Employer
Identification No.)

 

7371

Primary Standard Industrial Classification Code Number

 

15 West 38th St, 9th Fl

New York, NY 10018

917-292-2685

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Lyron Bentovim

President & Chief Executive Officer

The Glimpse Group, Inc.

15 West 38th St, 9th Fl

New York, NY 10018

917-292-2685

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

Darrin M. Ocasio, Esq.

Jay K. Yamamoto, Esq.

Sichenzia Ross Ference LLP

1185 Avenue of the Americas, 31st Floor

New York, New York 10036

Phone: (212) 930-9700

 

Approximate date of commencement of proposed sale of the securities to the public: From time to time after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer Non-accelerated filer
Accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.

 

CALCULATION OF REGISTRATION FEE

 

Title of Class of Securities to be Registered  Amount To
be Registered
   Proposed
Maximum
Aggregate
Price
Per Share (2)
   Proposed
Maximum
Aggregate
Offering
Price
   Amount of
Registration
Fee
 
                 
Common Stock $0.001 per share (1)   1,500,000   $13.67   $20,505,000   $1900.81 
Common Stock underlying warrants   750,000   $13.67   $10,252,500    950.41 
Total number of securities to be registered   2,250,000   $13.67   $30,757,500   $2,851.22 

 

(1) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this Registration Statement also covers any additional shares of common stock which may become issuable to prevent dilution from stock splits, stock dividends and similar events. Represent shares of The Glimpse Group, Inc. offered by selling stockholders.
   
(2) Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, using the average of the high and low prices as reported on the Nasdaq Capital Market on November 23, 2021.

 

The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

   
 

 

The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION DATED NOVEMBER 26, 2021

 

2,250,000 Shares of Common Stock Offered by the Selling Stockholders

 

This prospectus relates to the offering and resale by the selling stockholders identified herein of up to 2,250,000 shares of common stock issued or issuable to such selling stockholders including (i) 1,500,000 shares of our common stock, and (ii) 750,000 shares of common stock issuable upon the exercise of outstanding warrants, which were issued by us on November 2, 2021 pursuant to a Securities Purchase Agreement entered into on October 29, 2021 with seven institutional investors (the “October 2021 Private Placement”). Please see “Private Placement of Shares of Common Stock and Warrants” beginning on page 64 of this prospectus.

 

We will not receive any proceeds from the sale of shares of common stock by the selling stockholders. Upon the cash exercise of the warrants however, we will receive the exercise price of such warrants, for an aggregate of approximately $11.0 million.

 

The selling stockholders may sell all or a portion of the shares of common stock beneficially owned by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. Please see the section entitled “Plan of Distribution” on page 67 of this prospectus for more information. For information on the selling stockholders, see the section entitled “Selling Stockholders” on page 65 of this prospectus. We will bear all fees and expenses incident to our obligation to register the shares of common stock.

 

Our common stock is quoted on the Nasdaq Capital Market under the symbol “VRAR.” On November 23, 2021, the last reported sale price per share of our common stock was $13.28.

 

The selling stockholders will offer their shares at prevailing market prices or privately negotiated prices.

 

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, and, as such, may elect to comply with certain reduced public company reporting requirements for future filings. This prospectus complies with the requirements that apply to an issuer that is an emerging growth company.

 

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you make your investment decision.

 

Investing in our common stock involves a high degree of risk. See Risk Factorsbeginning on page 11 of this prospectus for a discussion of information that you should consider before investing in our securities.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

The date of this prospectus is for         , 2021

 

   
 

 

TABLE OF CONTENTS

 

  Page
   
About this Prospectus 1
Prospectus Summary 1
The Offering 10
Risk Factors 11
Special Note Regarding Forward-Looking Statements 24
Use of Proceeds 25
Dividends Policy 25
Our Business 25
Management’s Discussion and Analysis of Financial Condition and Results of Operations 37
Management 51
Executive and Director Compensation 57
Security Ownership of Certain Beneficial Owners and Management 59
Certain Relationships and Related Transactions 61
Description of Securities 61
Private Placement of Shares of Common Stock and Warrants 64
Selling Stockholders 65
Plan of Distribution 67
Legal Matters 68
Experts 69
Where You Can Find More Information 69
Index to Financial Statements F-1

 

i

 

 

ABOUT THIS PROSPECTUS

 

You may only rely on the information contained in this prospectus or that we have referred you to. We have not authorized anyone to provide you with different information. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities other than the common stock offered by this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any common stock in any circumstances in which such offer or solicitation is unlawful. Neither the delivery of this prospectus nor any sale made in connection with this prospectus shall, under any circumstances, create any implication that there has been no change in our affairs since the date of this prospectus. For investors outside the United States: Neither we nor the selling stockholders have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States.

 

Unless the context otherwise requires, references to “we,” “our,” “us,” “Glimpse Group”, or the “Company” in this prospectus mean The Glimpse Group, Inc.

 

PROSPECTUS SUMMARY

 

This summary highlights information contained elsewhere in this prospectus and does not contain all the information that you should consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including our financial statements and the related notes and the information set forth under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in each case included elsewhere in this prospectus.

 

Company Overview

 

We are a Virtual (“VR”) and Augmented (“AR”) Reality platform company, comprised of a diversified group of wholly-owned and operated VR and AR companies, providing enterprise-focused software, services and solutions. We believe that we offer significant exposure to the rapidly growing and potentially transformative VR and AR markets, while mitigating downside risk via our diversified model and ecosystem.

 

Our platform of VR/AR subsidiary companies, collaborative environment and diversified business model aims to simplify the challenges faced by companies in the emerging VR/AR industry, potentially improving each subsidiary company’s ability to succeed, while simultaneously providing investors an opportunity to invest directly into the emerging VR/AR industry via a diversified infrastructure.

 

Leveraging our platform, we strive to cultivate and manage the business operations of our VR/AR subsidiary companies, with the goal of allowing each underlying company to better focus on mission-critical endeavors, collaborate with the other subsidiary companies, reduce time to market, optimize costs, improve product quality and leverage joint go-to-market strategies. Subject to operational, market and financial developments and conditions, we intend to carefully add to our current portfolio of subsidiary companies via a combination of organic expansion and/or outside acquisition.

 

The VR/AR industry is an early-stage technology industry with nascent markets. We believe that this industry has significant growth potential across verticals, may be transformative and that our diversified platform and ecosystem create important competitive advantages. Our subsidiary companies currently target a wide array of industry verticals, including but not limited to: Corporate Training, Education, Healthcare, Branding/Marketing/Advertising, Retail, Financial Services, Food & Hospitality, Media & Entertainment, Architecture/Engineering/Construction (“AEC”) and Social VR support groups and therapy. We do not currently target direct-to-consumer (“B2C’) VR/AR software or services, only business-to-business (“B2B”) and business-to-business-to-consumer (“B2B2C”), and we are hardware agnostic.

 

1
 

 

The Glimpse Platform

 

We develop, commercialize and market innovative and proprietary VR/AR software products, solutions and intellectual property (“IP”). Our platform is currently comprised of eleven active wholly-owned subsidiary companies, each targeting different industry segments in a non-competitive, collaborative manner. Our experienced management and dynamic VR/AR entrepreneurs have deep domain expertise, providing the foundation for value-add-collaborations throughout our ecosystem.

 

Each of our subsidiary companies share operational, financial and IP infrastructure, facilitating shorter time-to-market, higher quality products, reduced development costs, fewer redundancies, significant go-to-market synergies and, ultimately, a higher potential for success for each subsidiary company. We believe that our collaborative platform is unique and necessary, especially given the early nature of the VR/AR industry. By offering technologies and solutions in various industry segments, we aim to reduce dependency on any one single subsidiary company, technology or industry segment.

 

We believe that three core tenets enhance our probability of success: (1) our ecosystem of VR/AR companies, (2) diversification and (3) profitable growth.

 

(1) Our ecosystem of VR/AR software and service companies provides significant benefits to each subsidiary company and our group as a whole. We believe that the most notable benefits are: (a) economies of scale, cost efficiencies and reduced redundancies; (b) cross company collaboration, deep domain expertise, IP and knowledge transfer; (c) superior product offerings; (d) faster time to market; (e) enhanced business development and sales synergies; and (f) multiple monetization paths. In an emerging industry that is lacking in infrastructure, we believe that our ecosystem provides a distinct competitive advantage relative to a single, standalone company in the industry.

 

(2) By design, we incorporate multiple aspects of diversity to reduce the risks associated with an early stage industry, create multiple monetization venues and improve the probabilities of success. There is no single point of failure or dependency. This is created through: (a) ownership of numerous wholly-owned subsidiary companies operating in different industry segments; (b) targeting large industries with clear VR/AR use-cases; (c) developing and utilizing various technologies and IP; (d) expanding to different geographic technology centers in a hub model under our umbrella; and (e) across industries, having a wide array of customers and potential acquirers/investors.

 

(3) From our inception, we have prioritized achieving operational cash flow neutrality early in our life. This was an important factor that drove our strategy to: (a) focus on enterprise software and services, only onboarding companies that are generating revenues or clearly could in the short term; (b) target solutions that are based on use cases that have a clear return on investment (“ROI”) and can be effectively developed from existing technologies and hardware; and (c) centralize costs to reduce inefficiencies. By targeting cash flow neutrality, our goal is to minimize dilution and support greater independence from capital markets, thereby increasing resiliency and maximizing upside potential.

 

As part of our platform, we provide a centralized corporate structure, which significantly reduces general and administrative costs (financial, operational, legal & IP), streamlines capital allocation and helps in coordinating business strategies. This allows our subsidiary company general managers to focus their time and effort almost exclusively on the core software, product and business development activities relating to their subsidiary.

 

Additionally, aligned economic incentives encourage cross-Company collaboration. All of our employees own equity in our Company. The leadership team of each subsidiary company, in addition to their equity ownership in Glimpse, also have an economic interest in their particular subsidiary company. This economic interest is negotiated with lead management of a subsidiary company upon their joining of our Company, and typically ranges between 5-10% of the total net sale proceeds of the subsidiary and includes a three-year vesting schedule. Thus, there is benefit to them not only when their subsidiary company succeeds but also when any of the other subsidiaries succeeds, and when Glimpse as a whole succeeds. We believe that this ownership mechanism is a strong driver of cross-pollination of ideas and fosters collaboration. While each subsidiary company owns its own IP, our parent company currently owns 100% of each subsidiary company. In addition, there will be perpetual licensing agreements between our subsidiary companies, so that if a subsidiary company is divested, then the remaining subsidiaries, if utilizing the IP of a divested subsidiary company, will continue to retain usage rights post-divestiture.

 

2
 

 

Active Glimpse Subsidiary Companies

 

  1. Kabaq 3D Technologies, LLC (dba QReal): Creation of lifelike photorealistic 3D interactive digital models and experiences in AR
  2. Adept Reality, LLC (dba Adept XR Learning): VR/AR solutions for higher education learning and corporate training
  3. KreatAR, LLC (dba PostReality): AR presentation tools for design, creation and collaboration
  4. D6 VR, LLC (D6): VR/AR data visualization and data-analysis tools and collaboration for Financial Services and other data intensive industries
  5. Immersive Health Group, LLC (IHG): VR/AR platform for evidence-based and outcome driven healthcare solutions
  6. Foretell Studios, LLC (dba Foretell Reality): Customizable social VR platform for behavioral health, support groups, collaboration and soft skills training
  7. Number 9, LLC (dba Pagoni VR): VR broadcasting solutions and environments for events, education, media & entertainment
  8. Early Adopter, LLC (EA): AR/VR solutions for K-12 education
  9. MotionZone, LLC (dba AUGGD): AR software and solutions for the Architecture, Engineering and Construction segments
 

10.

 

Glimpse Group Yazilim ve ARGE Ticaret Anonim Sirketi (Glimpse Turkey): a development center in Turkey, primarily developing and creating 3D models for QReal

  11. XR Terra, LLC (XR Terra): a developer and provider of teaching platforms utilized in coding software used in VR and AR programming

 

1. QReal

 

QReal is a software and services company that creates and distributes lifelike photorealistic 3D and AR content. This content is typically integrated in social media campaigns and e-commerce platforms with the goal of increasing sales, improving brand recognition, creating viral content and boosting e-commerce conversion. Current industry verticals include: food, fashion, apparel, architecture and automotive.

 

QReal offers both one-time content creation as well as monthly subscriptions. With a monthly subscription, QReal offers content management and digital distribution.

 

We recently opened a development center, Glimpse Turkey, that primarily creates 3D models for QReal.

 

2. Adept XR Learning

 

Adept XR Learning (“Adept”) provides higher education learning and corporate VR training solutions via its SaaS platform (“Elevate”) built around collaboration and multi-user learning across geographical areas. The platform provides users the unique ability to create multiple sessions of a corporate VR training experience, incorporating data visualization, computer graphics, blended real-life 360 videos, artificial intelligence, data and analytics.

 

Adept’s platform can be purchased as a Software as a Service (“SaaS”) subscription, software license or a white label solution.

 

3. PostReality

 

PostReality creates cloud-based, cost effective, SaaS solutions that enable businesses to rapidly create, edit, integrate and deploy AR experiences.

 

3
 

 

PostReality’s solutions are:

 

a) PostReality, a cloud-based, SaaS solution enabling users to easily create AR presentations via a drag-and-drop process and then view and share
b) XR Platform, a cloud-based, scalable and secure backend infrastructure designed for VR/AR companies, allowing for the incorporation of various functionalities, such as proprietary cloud image recognition technology, online storage, creation and management of subscription plans, invoicing and payments
c) Custom specialized AR applications, white label solutions and services

 

PostReality’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

4. D6

 

D6 is a comprehensive, VR-based, analysis, presentation and education software platform, designed specifically to provide insight into complex data sets, improve productivity and facilitate virtual collaboration. D6 targets data intensive industries, with an initial focus on Financial Services and Higher Education.

 

Key attributes of D6’s platform:

 

- Workspace of the Future: Without physical limitations and with essentially unlimited virtual monitor space, users can create customizable Data Rooms which can be used for traditional workflows and/or presentations.
- Collaboration: Collaborate and present in the virtual world, share virtual workspaces with clients and colleagues around the globe, presenting multi-dimensional data visualizations in both VR and AR.
- Visualization: Visualize and manipulate complex data in 3D space, deriving insights that are faster, more powerful, and more memorable. Instantly turn multi-variable data sets into intuitive, immersive displays.

 

D6’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

5. Immersive Health Group

 

Immersive Health Group (“IHG”) is a digital health platform company that leverages VR/AR technology to simplify and streamline complex healthcare challenges in scale.

 

IHG’s main software platform is ContinuumXR:

 

- ContinuumXR (“CXR”) provides a VR and AR software training platform, specifically designed for clinician and caregiver learning and practice. The platform is designed to improve quality of care, retain clinical talent and reduce turnover, reduce errors, and improve patient experiences.

 

IHG’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

6. Foretell Reality

 

Foretell Reality (“Foretell”) provides remote groups an immersive, engaging and safe space to meet and collaborate in customizable, distraction-free environments. Through its VR software platform, Foretell aims to enhance human communications and productivity by overcoming geographic and physical constraints.

 

Foretell offers an enterprise-grade and easy-to-use solution for meeting others in VR with rich environments and features. The Foretell platform is designed to support applications and use cases across multiple industries, including: VR Telemental Health (especially support groups and therapy), Corporate Collaboration and Soft Skills and Remote Learning. Foretell’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

4
 

 

7. Pagoni VR

 

Pagoni VR (“Pagoni”) provides immersive and interactive VR video broadcasting solutions to universities, enterprise, entertainment venues, sports venues and houses of worship. Pagoni’s main product, Chimera, enables real-time communications between a presenter and local and remote attendees in VR.

 

Pagoni’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

8. Early Adopter

 

Early Adopter (“EA”) provides immersive VR and AR EdTech solutions for K-12 schools and pediatric hospital programs, based on engaging inquiry-driven and game-based learning.

 

In response to the Covid-19 pandemic, EA created Common Room, a social AR SaaS app that allows users to interact as if they were with one another. Common Room can also be white labeled by schools and other third parties.

 

EA’s platform can be purchased as a SaaS subscription, software license, or a white label solution.

 

9. AUGGD

 

AUGGD provides AR software and services primarily for the Architecture, Engineering & Construction (AEC) industries. Its solutions seek to improve building quality, lower construction costs, provide clearer planning and impactful marketing.

 

Based historically in Australia and Europe, AUGGD is looking to expand in the US.

 

AUGGD’s solutions can be purchased as a SaaS subscription, software license, white label solution or service.

 

10. Glimpse Turkey

 

Glimpse Turkey specializes in utilizing photogrammetry tools in order to develop and create web optimized 3D models, primarily for QReal.

 

It is based in Turkey and is currently a development center.

 

11. XR Terra

 

XR Terra is a provider of VR/AR teaching, training and skills development through innovative programs and corporate partnerships.

 

Recent Business Developments

 

On July 1, 2021, we completed an initial public offering (“IPO”) of common stock and initial listing on the Nasdaq Capital Market under the symbol “VRAR”, at an initial public offering price of $7.00 per share. In conjunction with the IPO and the underwriter’s exercise of its over-allotment option, we sold 1,912,500 shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million.

 

In August 2021, we completed an acquisition of certain assets from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services to the Architecture, Engineering and Construction market segments. Initial consideration for the purchase was $0.75 million payable by the issuance of 77,264 shares of our common stock. Additional consideration in the form of our common stock shall be issued if certain future revenue growth targets are achieved.

 

In October 2021, we completed an acquisition of certain assets from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming. Initial consideration for the purchase is $0.60 million payable 50% in our common stock and 50% in cash. In October 2021, the Company paid $0.30 million cash and issued 33,877 shares of common stock to satisfy the purchase price. Additional consideration in the form of our common stock shall be issued if certain future revenue growth targets are achieved.

 

On November 2, 2021, we, pursuant to a securities purchase agreement, sold 1.50 million shares of common stock and warrants to purchase 0.75 million shares of common stock to certain institutional investors in a private placement. The warrants have an exercise price of $14.68 per share. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The gross proceeds to us from the private placement offering was approximately $13.6 million after deducting the placement agent’s fees and other offering expenses.

 

On November 11, 2021, the Company entered into a Master Services Agreement and Statement of Work with a leading global social media and metaverse company for a $1.0 million augmented reality software and services contract, which is expected to be delivered over the coming months.

 

On November 21, 2021, the Company was issued U.S. patent number 11189097 for presenting a simulated reality experience in a preset location.

 

The VR and AR (XR) Markets

 

Virtual Reality (VR) fully immerses the user in a digital environment via a head mounted display (“HMD”), where the user is blocked out of their immediate physical environment. Augmented Reality (AR) is a less immersive experience, where the user views their immediate physical environment with digital images overlaid, via a phone, tablet or a dedicated HMD such as smart glasses. While distinct, VR and AR are related, utilize some similar underlying technologies and are expected to become increasingly interconnected - combined they are often referred to as Immersive Technology (XR).

 

VR and AR are emerging technologies, and the markets for them are still nascent. We believe that XR technologies and solutions have the potential to fundamentally transform how people and businesses interact, further enabling remote work, education and commerce. XR is also expected to increasingly interconnect with other emerging technologies such as artificial intelligence, computer vision, big data, NFT and crypto currencies. Additionally, HMD and telecommunication (5G) advancements have been driving vast improvements in capabilities and ease of use, while significantly reducing headset cost. As a result, market adoption has accelerated and is expected to continue. Leading technology companies such as Facebook, Apple, Microsoft, Google, Samsung, Sony and HP have been at the forefront of VR/AR hardware development and software infrastructure, while also increasing integration of their products with AR and VR capabilities.

 

5
 

 

Since Facebook released its first VR headset as a consumer product in 2016 (after its $2B+ acquisition of Oculus), successive iterations of it, as well as others, have become significantly lighter, more comfortable, lower priced, with higher resolution and increasingly wireless/mobile. With a standalone mobile headset, users no longer need an expensive gaming computer to power the headset and they also do not have a wire tethered to that computer restricting movement. These advances have facilitated easier corporate procurement and integration. The accelerating rollout of 5G should enable further improvement in user experience since with 5G, remote processing and heavier, real time applications become possible without noticeable visual lag, allowing for lighter, smaller, more comfortable HMDs with longer battery life.

 

Based on Artillery Intelligence’s market forecasts, the VR and AR markets are forecasted to grow 31% in 2021 to over $9 billion, expanding at a 39% Compound Annual Growth Rate (CAGR) over the next three years, exceeding $35 billion by 2023. In particular, VR and AR enterprise software – the segment we are focused on – is projected to grow 59% in 2021 and expand at a 55% CAGR to more than $10 billion in 2023.

 

https:||www.sec.gov|Archives|edgar|data|1854445|000149315221023976|marketsize.jpg

 

Business Development and Sales

 

We utilize a hybrid approach to the sales and distribution of our software products and services.

 

At our subsidiary company level, each company has its own business development and sales team, the size of which depends on its stage of development. Each subsidiary company’s general manager is responsible for business development, and as the subsidiary gains market traction, its business development and sales team are expanded as needed.

 

Our subsidiary companies’ business development and sales teams are enhanced by the shared resources and influence of our ecosystem. Our management takes an active role in the business development activities of each subsidiary company and in the overall development and integration of sale strategies, goals and budgets. As an integral part of the business development and sales processes, each subsidiary company’s general manager is very familiar with the product offerings of other subsidiary companies and leverages those into his or her own efforts when appropriate. This leads to substantial cross marketing collaboration.

 

We believe that a subsidiary company’s ability to demonstrate to potential customers scale as part of our ecosystem of companies, combined with our subsidiary’s ability to offer its products and solutions as well as those of our other subsidiary companies in an integrated manner, represents a key competitive advantage. We believe our customers often view us as a “one-stop-shop” for all their VR/AR needs and an expert in the emerging VR/AR space.

 

6
 

 

We and our subsidiary companies continue to develop a shared partner ecosystem to further scale business and expand our solutions into new and existing target markets.

 

Competitive Environment

 

We believe that our competitors in the VR/AR industry are focused on two primary segments: VR/AR Hardware (headsets) and Software.

 

VR/AR Hardware (Headsets) (“Hardware”):

 

We do not develop any Hardware, and our software and service solutions are mostly compatible with any Hardware. We believe that Hardware development, commercialization and distribution are highly capital intensive and there is not yet large enough scale or mass adoption in the VR/AR industry to justify such expenditures for a smaller company. As such, there are relatively few participants on the Hardware side, some very large (for example: Facebook/Oculus, Microsoft, Samsung, Google, Apple, HTC, HP, Lenovo, Sony and Epson) and some much smaller (for example: Magic Leap, Pico, Valve and Vuzix). In general, Hardware cycles have been accelerating and performance improving, with simplified usability and reduced end-user costs. The more advanced, easier to use and cheaper the Hardware becomes, the higher the potential for the development of robust software applications and increased market adoption of VR/AR solutions.

 

VR/AR Software (“Software”):

 

In contrast to VR/AR Hardware, Software is highly fragmented with hundreds of VR/AR Software companies targeting different segments and solutions. Many are consumer oriented, whereas we are entirely enterprise focused (B2B, B2B2C). We believe that the AR/VR Software segment is currently far less competitive than traditional software markets, as most companies in the space tend to be early stage and often underfunded.

 

While competition is evolving and increasing, there is currently no dominant player in any particular VR/AR Software segment. We believe that we have the potential to become a leader in the VR/AR Software space in general and that each of our subsidiary companies has the potential to become a significant player in their particular industry sector.

 

As previously described, we believe that our structure, ecosystem and integrated capabilities create significant competitive advantages for each of our subsidiary companies, not available to other Software companies in the VR/AR space. By owning and operating a diverse set of VR/AR companies, we believe that we significantly improve each of our subsidiary company’s ability to succeed by addressing many of the challenges early stage companies face and expanding each’s opportunity set and capabilities.

 

We believe that there are a select number of earlier stage companies of approximately our size that provide VR/AR Software and could be viewed as potential competitors. In addition, several of the larger technology players provide general infrastructure VR/AR Software. In particular: ARCore from Google and ARKit from Apple, which enable AR functionality on smartphones and tablets; and Unity and Epic Unreal, which enable software languages used in VR and AR programing. We do not view these larger companies as competition, but rather as complementary to our business. We believe infrastructure software benefits us, and the industry at large, as they are not industry specific and enable companies like us to more effectively build industry specific solutions, thereby saving significant costs and development efforts.

 

Platform Expansion and Diversification Strategy

 

As described above in “Competitive Environment,” the VR/AR software and services industries are highly fragmented. There are numerous potential acquisition targets that, while having established a niche market position, product or technology, have limited resources and ability to pursue growth initiatives. We intend to leverage our position and relative scale in the industry in order to continue to add to our platform both earlier stage companies and technologies and, subject to the availability of capital and appropriate targets, more mature companies. Beyond the expected financial impact of each such potential addition, these could also enhance our ecosystem, technology, scale and competitive position. These potential acquisitions may be domestic or international. If there is sufficient scale in a certain geographic location (beyond our current NYC headquarters), then a new hub may be established in such location, with several subsidiary companies operating in that hub, under the overall Glimpse umbrella.

 

7
 

 

Strategic Divestitures

 

Each one of our subsidiary companies has the potential to be divested or spun off. Although the purpose of our platform is to grow and develop the ecosystem on which each of our subsidiaries can mature by benefitting from collaboration, each subsidiary company targets a specific industry vertical (i.e. Healthcare, Education, Corporate Training, etc.) and as such has a distinct set of potential acquirers or investors. If a subsidiary company is divested and the proceeds are substantive, then our intent is to distribute the majority of the net proceeds to our shareholder base, if such distribution would not jeopardize our growth and operations.

 

Intellectual Property

 

Our intellectual property is an integral part of our business strategy and practice. In accordance with industry practice, we protect our proprietary products, technology and competitive advantage through a combination of contractual provisions and trade secrets, patents, copyright and trademark laws in the United States and other jurisdictions where business is conducted.

 

As of the date of this disclosure and summarized in the table below, we have filed thirteen (13) patent applications, four (4) of which have been issued and one (1) allowed and registered with the United States Patent and Trademark Office (the “USPTO”).

 

Title of Invention   Subsidiary   Filing Date   Month Issued   Application Number   Docket Number   Confirmation Number   Expiration
                             
Issued Patent                      
                             
Interactive Mixed Reality System for a Real World Event   Pagoni VR   6/21/2018   Sep-19   16/014,956   P270977.US.02-503511-16   1537   6/21/2038
                             
Augmented Reality Geolocation Using Image Matching   KreatAR   8/22/2018   Dec-20   16/108,830   194445.001   3370   8/22/2038
                             
Immersive Display System with Adjustable Perspective   Pagoni VR   11/27/2018   Jul-20   16/201,863   194445.007   6423   11/27/2038
                             
System for Sharing User-Generated Content   Pagoni VR   6/12/2019   Aug-21   16/439,280   94445.00501   7323   6/12/2039
                             
Presenting a Simulated Reality Experience in a Present Location   Mezmos   6/14/2019   Nov-21   16/901,830   94445.01001   7386   6/14/2039
                             
Patent Applications                            
                             
Simulated Reality Data Representation System and Method   D6VR   2/2/2018                    
                             
Viewer Position Coordination in Simulated Reality   KreatAR   6/10/2019                    
                             
Virtual Reality System Cross Platform   Foretell Reality   4/23/2019                    
                             
Marker-Based Positioning of Simulated Reality   KreatAR   4/23/2019                    
                             
Presentation Interface and Immersion Platform   Pagoni VR   4/30/2019                    
                             
Simulated Reality Based Confidence Assessment   Adept Reality   6/6/2019                    
                             
Simulated Reality Risks Mitigation System   Adept Reality   7/19/2019                    
                             
Simulated Reality Adaptive User Space   Immersive Health Group   7/26/2019                    

 

8
 

 

We may continue to file for patents regarding various aspects of our products, services and technologies at a later date depending on the costs and timing associated with such filings. We may make investments to further strengthen our copyright protection going forward, although no assurances can be given that we will be successful in such patent and trademark protection endeavors. We seek to limit disclosure of our intellectual property by requiring employees, consultants, and partners with access to our proprietary information to execute confidentiality agreements and non-competition agreements (when applicable) and by restricting access to our proprietary information. Due to rapid technological change, we believe that establishing and maintaining an industry and technology advantage in factors such as the expertise and technological and creative skills of our personnel, as well as new services and enhancements to our existing services, are more important to our business and profitability than other available legal protections.

 

Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our services or to obtain and use information that we regard as proprietary. The laws of many countries do not protect proprietary rights to the same extent as the laws of the U.S. Litigation may be necessary in the future to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement. Any such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results and financial condition. There can be no assurance that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar services or products. Any failure by us to adequately protect our intellectual property could have a material adverse effect on our business, operating results and financial condition. See “Risk Factors—Risks Related to our Business.”

 

Business Cycles

 

Based on our history and information available to date, we have not been able to identify any seasonality of cycles within our business. Since VR/AR is an emerging industry, market and customer education are material and the length of the typical sales cycle can be between 3 and 18 months, depending on the size and complexity of the proposed solution and the customer’s level of understanding of the VR/AR space and prior experience.

 

Facilities

 

We are based in New York, New York. Our current facilities are leased and adequate to meet our ongoing needs. If we require additional space or expand geographically, we may seek additional facilities on commercially reasonable terms at such time. Due to Covid-19 constraints, since March 2020 our personnel have been working primarily on a remote basis, without detrimental effects. We returned to partial in person work in July 2021 and expect to continue as such for the foreseeable future, subject to Covid-19 developments.

 

We also lease a small office in Izmir, Turkey for the operations of Glimpse Turkey.

 

Employees

 

We currently have approximately 90 full time employees and consultants, primarily software developers, engineers and 3D artists.

 

Corporate Information

 

The Glimpse Group, Inc. was originally incorporated in the State of Nevada on June 15, 2016. Our principal business address is 15 West 38th St, 9th Fl, New York, NY 10018.

 

Information contained on our websites, including www.theglimpsegroup.com, shall not be deemed to be part of this prospectus or incorporated herein by reference and should not be relied upon by prospective investors for the purposes of determining whether to purchase the units offered hereunder.

 

9
 

 

THE OFFERING

 

Issuer   The Glimpse Group, Inc.
     
Securities Offered by the Selling Stockholders   1,500,000 shares of our common stock and 750,000 shares common stock issuable upon the exercise of warrants.
     
Trading Market   The common stock offered in this prospectus is quoted on the Nasdaq Capital Market under the symbol “VRAR”.
     
Common Stock Outstanding Before this Offering   12,069,839 shares
     
Common Stock Outstanding After this Offering   12,819,839 shares(1)
     
Use of Proceeds   We will not receive any of the proceeds from the sale of the shares of our common stock being offered for sale by the selling stockholders. Upon the exercise of the warrants for an aggregate of 750,000 shares of common stock by payment of cash however, we will receive the exercise price of the warrants, or an aggregate of approximately $11.0 million from the investors in the October 2021 Private Placement.
     
Plan of Distribution   The selling stockholders may sell all or a portion of the shares of common stock beneficially owned by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. Registration of the common stock covered by this prospectus does not mean, however, that such shares necessarily will be offered or sold. See “Plan of Distribution.
     
Risk Factors   Please read “Risk Factors” and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in the securities offered in this prospectus.
     
Emerging Growth Company under the JOBS Act   As a company with less than $1.07 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As an emerging growth company, we have elected to take advantage of reduced reporting requirements and are relieved of certain other significant requirements that are otherwise generally applicable to public companies. As an emerging growth company:

 

  we may present only two years of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations;
  we are exempt from the requirement to obtain an attestation and report from our auditors on whether we maintained effective internal control over financial reporting under the Sarbanes-Oxley Act;
  we are permitted to provide less extensive disclosure about our executive compensation arrangements; and
  we are not required to give our stockholders non-binding advisory votes on executive compensation or golden parachute arrangements.

 

    We may take advantage of these provisions until June 30, 2026 (the last day of the fiscal year following the fifth anniversary of our initial public offering) if we continue to be an emerging growth company. We would cease to be an emerging growth company if we have more than $1.07 billion in annual revenue, have more than $700 million in market value of our shares held by non-affiliates or issue more than $1.0 billion of non-convertible debt over a three-year period. We may choose to take advantage of some but not all of these reduced burdens. We have elected to provide two years of audited financial statements. Additionally, we have elected to take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act.

 

 

1 The number of shares of common stock shown above to be outstanding after this offering is based on 12,069,839 shares outstanding as of November 23, 2021 and assumes the exercise of the warrants into 750,000 shares of common stock.

 

10
 

 

RISK FACTORS

 

An investment in the Companys common stock involves a high degree of risk. In determining whether to purchase the Companys common stock, an investor should carefully consider all the material risks described below, together with the other information contained in this prospectus before deciding to purchase the Companys securities. An investor should only purchase the Companys securities if he or she can afford to suffer the loss of his or her entire investment.

 

RISKS RELATED TO OUR BUSINESS

 

The Company is an early stage technology company

 

We were incorporated on June 15, 2016 and are an early stage technology development company, comprised of a wholly-owned group of early stage companies in the VR and AR space. As such, we are subject to the risks associated with being an early stage company operating in an emerging industry, including, but not limited to, the risks set forth herein.

 

Health epidemics, including the current COVID-19 pandemic, have had, and could in the future have, an adverse impact on our business, operations, and the markets and communities in which we, our partners and customers operate. For example, sales cycles have generally lengthened and some customers have delayed purchase decisions.

 

Our business and operations could be adversely affected by health epidemics, including the current COVID-19 pandemic, impacting the markets and communities in which we, our partners and customers operate. The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption on both a nationwide and global level, as well as the ongoing effects on our business.

 

The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, and we may be unable to accurately forecast our revenue or financial results. Further, as many of our customers or partners experience downturns or uncertainty in their own business operations or revenue resulting from the spread of COVID-19, they may decrease or delay their spending, request pricing concessions or seek renegotiations of their contracts, any of which may result in decreased revenue for us. As a result of the COVID-19 pandemic, we have seen the length of our sale cycles generally increase and some of our customers have delayed purchase decisions. In addition, we may experience customer or strategic partner losses, including due to bankruptcy or our customers or strategic partners ceasing operations, which may result in an inability to collect receivables from these parties. A decline in revenue or the collectability of our receivables could harm our business.

 

In addition, in response to the initial outbreak of COVID-19, we required substantially all of our employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit our ability to operate the business effectively (we have since returned to non-remote, in-person office work, initially several days per week.). Decreased effectiveness and availability of our team could adversely affect our results due to slow-downs in our sales cycles and recruiting efforts, delays in our entry into customer contracts, delays in addressing performance issues, delays in product development, delays and inefficiencies among various operational aspects of our business, including our financial organization, or other decreases in productivity that could seriously harm our business. Furthermore, we may decide to postpone or cancel planned investments in our business in response to changes in our business as a result of the spread of COVID-19, which may impact our ability to attract and retain customers and our rate of innovation, either of which could harm our business. In addition, our facilities needs could evolve based on continuing changes and impact on work environments as a result of the COVID-19 pandemic, and we may not be able to alter our contractual commitments to accommodate such changes, which could cause us to incur additional costs or otherwise harm our business. More generally, the COVID-19 outbreak has adversely affected economies and financial markets globally, which could decrease technology spending and adversely affect demand for our platforms and solutions.

 

The global impact of COVID-19 continues to rapidly evolve, and we will continue to monitor the situation and the effects on our business and operations closely. We do not yet know the full extent of potential impacts on our business, operations or the global economy as a whole, particularly if the COVID-19 pandemic and related public health measures continue and persist for an extended period of time. Given the uncertainty, we cannot reasonably estimate the impact on our future results of operations, cash flows or financial condition. While the spread of COVID-19 may eventually be contained or mitigated, there is no guarantee that a future outbreak of this or any other widespread epidemics will not occur, or that the global economy will recover, either of which could harm our business.

 

We have incurred significant net losses since inception and anticipate that we will continue to incur net losses for the foreseeable future and may never achieve or maintain profitability.

 

Since inception, we have incurred significant net losses. As of September 30, 2021 and as of June 30, 2021, we had an accumulated deficit of approximately $23.8 million and $22.1 million, respectively. The net loss for the three months ended September 30, 2021 was approximately $1.7 million and for the fiscal year ended June 30, 2021 was approximately $6.1 million. To date, we have devoted our efforts towards securing financing, building and evolving our technology platform and creating an infrastructure that allows for the growth of such technology platform. In the past, the combination of operating losses, cash expected to be used to continue operating activities and uncertain conditions relating to additional capital raises and continued revenue growth created an uncertainty about the Company’s ability to continue as a going concern. Doubt about the Company’s ability to continue as a going concern was alleviated on our financial statements for the three months ended September 30, 2021 and for the year ended June 30, 2021, supported by funding raised in our July 2021 initial public offering and the October 2021 Private Placement, which are more fully described later in this filing. Net proceeds from those fundings were approximately $11.8 million and $13.6 million, respectively. We expect to continue to incur significant expenses and potential operating losses for the foreseeable future. We anticipate that our expenses will increase if, and as, we continue to:

 

  hire and retain additional sales, accounting and finance, marketing and engineering personnel;
     
  build out our product pipeline;
     
  add operational, financial and management information systems and personnel; and
     
  maintain, expand, protect and enforce our intellectual property portfolio.

 

11
 

 

To become profitable, we must continue to grow our revenue base and control expenditures. This will require us to be successful in a range of challenging activities, and our expenses will increase as we continue to develop and bring our current products, as well as new ones, to market. We may never succeed in any or all of these activities and, even if we do, we may never generate revenue that is significant or sufficient to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable or to sufficiently fund our operations through financing activity could potentially, again, create an uncertainty about the Company’s ability to continue as a going concern.

 

Based on our recent financing activity we believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for more than one year.

 

Based on our recent financing activity we believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for more than one year. Consequently, our financial statements have been prepared under the assumption that we will continue as a going concern. However, we have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. In the future, if we are unable to obtain sufficient funding to support our operations, we could be forced to delay, reduce or eliminate some or all of our development and growth initiatives, and our financial condition and results of operations will be materially and adversely affected and we may be unable to continue as a going concern. In the future, reports from our independent registered public accounting firm may also contain statements expressing substantial doubt about our ability to continue as a going concern. If we seek additional financing to fund our business activities in the future and there remains substantial doubt about our ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding to us on commercially reasonable terms or at all.

 

We may not be successful in raising additional capital necessary to meet expected increases in working capital needs. If we need additional funding for operations and we are unable to raise it, we may not be able to continue our business operations.

 

We expect our working capital needs to increase in the future as we continue to expand and enhance our operations. Our ability to raise additional funds through equity or debt financings or other sources will depend on the financial success of our current business and successful implementation of our key strategic initiatives, financial, economic and market conditions and other factors, some of which are beyond our control. No assurance can be given that we will be successful in raising the required capital at reasonable cost and at the required times, or at all. Further equity financings may have a dilutive effect on shareholders and any debt financing, if available, may require restrictions to be placed on our future financing and operating activities. If we require additional capital and are unsuccessful in raising that capital, we may not be able to continue our business operations and advance our growth initiatives, which could adversely impact our business, financial condition and results of operations.

 

Our market is competitive and dynamic. New competing products and services could be introduced at any time that could result in reduced profit margins and loss of market share.

 

The AR and VR industries are very dynamic, with new technology and services being introduced by a range of players, from larger established companies to start-ups, on a frequent basis. Our competitors may announce new products, services, or enhancements that better meet the needs of end-users or changing industry standards. Further, new competitors or alliances among competitors could emerge. Increased competition may cause price reductions, reduced gross margins and loss of market share, any of which could have a material adverse effect on our business, financial condition and results of operations.

 

Furthermore, the worldwide AR and VR markets are increasingly competitive. A number of companies developing AR and VR products and services compete for a limited number of customers. Some of our competitors in this market have substantially greater financial and other resources, larger research and development staffs, and more experience and capabilities in developing, marketing and distributing products. Ongoing pricing pressure could result in significant price erosion, reduced profit margins and loss of market share, any of which could have a material adverse effect on our business, results of operations, financial position and liquidity.

 

12
 

 

Our plans for growth will place significant demands upon our resources. If we are unsuccessful in achieving our plan for growth, our business could be harmed.

 

We are actively marketing our products domestically and internationally. The plan places significant demands upon managerial, financial, and human resources. Our ability to manage future growth will depend in large part upon several factors, including our ability to rapidly:

 

  build or leverage, as applicable, a network of business partners to create an expanding presence in the evolving marketplace for our products and services;
     
  build or leverage, as applicable, sales teams to keep end-users and business partners informed regarding the technical features, issues and key selling points of our products and services;

 

  attract and retain qualified technical personnel in order to continue to develop reliable and flexible products and provide services that respond to evolving customer needs;
     
  develop support capacity for end-users as sales increase, so that we can provide post-sales support without diverting resources from product development efforts; and
     
  expand our internal management and financial controls significantly, so that we can maintain control over our operations and provide support to other functional areas as the number of personnel and size increases.

 

Our inability to achieve any of these objectives could harm our business, financial condition and results of operations.

 

We have material customer concentration, with a limited number of customers accounting for a material portion of our 2021 revenues.

 

For the three months ended September 30, 2021 and the year ended June 30, 2021, our five largest customers, accounted for approximately 87% and 63% of our revenues, respectively. There are inherent risks whenever a large percentage of total revenues are concentrated with a limited number of customers. It is not possible for us to predict the future level of demand for our services that will be generated by these customers or the future demand for the products and services of these customers in the end-user marketplace. In addition, revenues from these customers may fluctuate from time to time based on the commencement and completion of projects, the timing of which may be affected by market conditions or other facts, some of which may be outside of our control. Further, some of our contracts with these customers permit them to terminate our services at any time (subject to notice and certain other provisions). If any of these customers experience declining or delayed sales due to market, economic or competitive conditions, we could be pressured to reduce the prices we charge for our services or we could lose a major customer. Any such development could have an adverse effect on our margins and financial position, and would negatively affect our revenues and results of operations and/or trading price of our common stock.

 

We anticipate our products and technologies will require ongoing research and development (“R&D”) and we may experience technical problems or delays and may not have the funds necessary to continue their development, which could lead our business to fail.

 

Our R&D efforts are subject to the risks typically associated with the development of new products and technologies based on emerging and innovative technologies, including, for example, unexpected technical problems or the possible insufficiency of funds for completing development of these products or technologies. If we experience technical problems or delays, further improvements in our products or technologies and the introduction of future products or technologies could be delayed, and we could incur significant additional expenses and our business may fail.

 

We anticipate that we may require additional funds to increase or sustain our current levels of expenditure for the R&D of new products and technologies, and to obtain and maintain patents and other intellectual property rights in these technologies, the timing and amount of which are difficult to forecast. Any funds we need may not be available on commercially reasonable terms or at all. If we cannot obtain the necessary additional capital when needed, we might be forced to reduce our R&D efforts which would materially and adversely affect our business. If we attempt to raise capital in an offering of shares of our common stock, preferred stock, convertible securities or warrants, our then-existing stockholders’ interests will be diluted.

 

13
 

 

Our success depends on our ability to anticipate technological changes and develop new and enhanced products and services.

 

The markets for our products and services are characterized by rapidly changing technology, evolving industry standards and increasingly sophisticated customer requirements. The introduction of products embodying new technology and the emergence of new industry standards can negatively impact the marketability of our existing products and can exert price pressures on existing products. It is critical to our success that we are able to anticipate and react quickly to changes in technology or in industry standards and to successfully develop, introduce, and achieve market acceptance of new, enhanced and competitive products and services on a timely basis and cost-effective basis. We invest substantial resources towards continued innovation; however, there can be no assurance that we will successfully develop new products and services or enhance and improve our existing products and services, that new products and services and enhanced and improved existing products and services will achieve market acceptance or that the introduction of new products and services or enhanced existing products and services by others will not negatively impact us. Our inability to develop products and services that are competitive in technology and price and that meet end-user needs could have a material adverse effect on our business, financial condition or results of operations.

 

Development schedules for technology products and services are inherently uncertain. We may not meet our products and/or services development schedules, and development costs could exceed budgeted amounts. Our business, results of operations, financial position and liquidity may be materially and adversely affected if the products or product enhancements that we develop are delayed or not delivered due to developmental problems, quality issues or component shortage problems, or if our products or product enhancements do not achieve market acceptance or are unreliable. We or our competitors will continue to introduce products embodying new technologies. In addition, new industry standards may emerge. Such events could render our existing products obsolete or not marketable, which would have a material adverse effect on our business, results of operations, financial position and liquidity.

 

We place significant decision making powers with our subsidiaries’ management, which presents certain risks that may cause the operating results of individual subsidiaries to vary.

 

We believe that our practice of placing significant decision making powers with each of our subsidiaries’ management is important to our successful growth and allows us to be responsive to opportunities and to our customers’ needs. However, this practice can make it difficult to coordinate procedures across our operations and presents certain risks, including the risk that we may be slower or less effective in our attempts to identify or react to problems affecting an important business issue, or that we would be slower to identify a misalignment between a subsidiary’s and our overall business strategy. Inconsistent implementation of corporate strategy and policies at the subsidiary level could materially and adversely affect our financial position, results of operations and cash flows and prospects.

 

The operating results of an individual subsidiary may differ from those of another subsidiary for a variety of reasons, including market size, customer base, competitive landscape, regulatory requirements and economic conditions affecting a particular industry vertical. As a result, certain of our subsidiaries may experience higher or lower levels of profitability and growth than other subsidiaries.

 

The failure to attract, hire, retain and motivate key personnel could have a significant adverse impact on our operations.

 

Our success depends on the retention and maintenance of key personnel, including members of senior management and our technical, sales and marketing teams. Achieving this objective may be difficult due to many factors, including competition for such highly skilled personnel; fluctuations in global economic and industry conditions; changes in our management or leadership; competitors’ hiring practices; and the effectiveness of our compensation programs. The loss of any of these key persons could have a material adverse effect on our business, financial condition or results of operations. Competition for qualified employees is particularly intense in the technology industry. Our failure to attract and to retain the necessary qualified personnel could seriously harm our operating results and financial condition. Competition for such personnel can be intense, and no assurance can be provided that we will be able to attract or retain highly qualified technical and managerial personnel in the future, which may have a material adverse effect on our future growth and profitability.

 

14
 

 

Our financial results may fluctuate substantially for many reasons, and past results should not be relied on as indications of future performance.

 

Our revenues and operating results may fluctuate from quarter to quarter and from year to year due to a combination of factors, including, but not limited to:

 

  varying size, timing and contractual terms of orders for our products and services, which may delay the recognition of revenue;
     
  competitive conditions in the industry, including strategic initiatives by us or our competitors, new products or services, product or service announcements and changes in pricing policy by us or our competitors;
     
  market acceptance of our products and services;
     
  our ability to maintain existing relationships and to create new relationships with customers and business partners;
     
  the discretionary nature of purchase and budget cycles of our customers and end-users;
     
  the length and variability of the sales cycles for our products;
     
  general weakening of the economy resulting in a decrease in the overall demand for our products and services or otherwise affecting the capital investment levels of businesses with respect to our products or services;
     
  timing of product development and new product initiatives;
     
  changes in customer mix;
     
  increases in the cost of, or limitations on, the availability of materials;
     
  changes in product mix; and
     
  increases in costs and expenses associated with the introduction of new products.

 

Further, the markets that we serve are volatile and subject to market shifts that we may be unable to anticipate. A slowdown in the demand for AR or VR products and services can have a significant adverse effect on the demand for our products and services in any given period. Our customers may cancel or delay purchase orders for a variety of reasons, including, but not limited to, the rescheduling of new product introductions, changes in our customers’ inventory practices or forecasted demand, general economic conditions affecting our customers’ markets, changes in our pricing or the pricing of our competitors, new product announcements by us or others, quality or reliability problems related to our products, or selection of competitive products as alternate sources of supply.

 

Thus, there can be no assurance that we will be able to reach profitability on a quarterly or annual basis. We believe that our revenue and operating results will continue to fluctuate, and that period-to-period comparisons are not necessarily indications of future performance. Our revenue and operating results may fail to meet the expectations of public market analysts or investors, which could have a material adverse effect on the price of our common stock. In addition, portions of our expenses are fixed and difficult to reduce if our revenues do not meet our expectations. These fixed expenses magnify the adverse effect of any revenue shortfall.

 

Our plans for implementing our business strategy and achieving profitability are based upon the experience, judgment and assumptions of our key management personnel, and available information concerning the communications and technology industries. If management’s assumptions prove to be incorrect, it could have a material adverse effect on our business, financial condition or results of operations.

 

15
 

 

Our centralized management will have significant discretion over directing our resources and if management does not allocate resources effectively, our business, financial condition or result of operations could be harmed.

 

Our centralized management has significant discretion over directing our resources to any and all of our subsidiary companies. As a consequence, it is possible that one or more of our subsidiary companies will not receive adequate capital or management resources. If a subsidiary company does not receive adequate capital or resources, it may not be able to commercialize its products and services, or if its products and services are already commercialized, it may not be able to keep such products and services competitive. Therefore, if we don’t allocate resources effectively, our business, financial condition or result of operations could be harmed.

 

Competitive pricing pressure may reduce our gross profits and adversely affect our financial results.

 

If we are unable to maintain our pricing due to competitive pressures or other factors, our margins will be reduced and our gross profits, business, results of operations, and financial condition would be adversely affected. The subscription prices for our software platforms, cloud modules, and professional services may decline for a variety of reasons, including competitive pricing pressures, discounts, anticipation of the introduction of new solutions by our competitors, or promotional programs offered by us or our competitors. Competition continues to increase in the market segments in which we operate, and we expect competition to further increase in the future.

 

Our future growth depends on our ability to attract, retain customers, and the loss of existing customers, or failure to attract new ones, could adversely impact our business and future prospects.

 

Once the platform is further developed, the size of our community of customers on our platforms is critical to our success. Our ability to achieve profitability in the future will depend, in large part, on our ability to add new customers, while retaining and even expanding offerings to existing customers. Our customers can generally decide to cease using our solutions at any time. While we have experienced customer growth, this growth may not continue at the same pace in the future or at all. In addition, it is possible that the ongoing effects of COVID-19 may have a deleterious effect on our customer growth in the future. Achieving growth in our customer base may require us to engage in increasingly sophisticated and costly sales and marketing efforts that may not result in additional customers. We may also need to modify our pricing model to attract and retain such customers. If we fail to attract new users or fail to maintain or expand existing relationships in a cost-effective manner, our business and future prospects may be materially and adversely impacted.

 

The continued operation of our business depends on the performance and reliability of the Internet, mobile networks, and other infrastructure that is not under our control.

 

Our business depends on the performance and reliability of the Internet, mobile networks, and other infrastructure that is not under our control. Disruptions in such infrastructure, including as the result of power outages, telecommunications delay or failure, security breach, or computer virus, as well as failure by telecommunications network operators to provide us with the bandwidth we need to provide our products and offerings, could cause delays or interruptions to our products, offerings, and platforms. Any of these events could damage our reputation, resulting in fewer users actively using our platforms, disrupt our operations, and subject us to liability, which could adversely affect our business, financial condition, and operating results.

 

If we do not make our platforms, including new versions or technology advancements, easier to use or properly train customers on how to use our platforms, our ability to broaden the appeal of our products and services and to increase our revenue could suffer.

 

In order to get full use of our platforms, users generally need training. We provide a variety of training and support services to our customers, and we believe we will need to continue to maintain and enhance the breadth and effectiveness of our training and support services as the scope and complexity of our platforms increase. If we do not provide effective training and support resources for our customers on how to efficiently and effectively use our platforms, our ability to grow our business will suffer, and our business and results of operations may be adversely affected. Additionally, when we announce or release new versions of our platforms or advancements in our technology, we could fail to sufficiently explain or train our customers on how to use such new versions or advancements or we may announce or release such versions prematurely. These failures on our part may lead to our customers being confused about use of our products or expected technology releases, and our ability to grow our business, results of operations, brand and reputation may be adversely affected.

 

16
 

 

Interruptions, performance problems or defects associated with our platforms may adversely affect our business, financial condition and results of operations.

 

Our reputation and ability to attract and retain customers and grow our business depends in part on our ability to operate our platforms at high levels of reliability, scalability and performance, including the ability of our existing and potential customers to access our platforms at any time and within an acceptable amount of time. Interruptions in the performance of our platforms, whether due to system failures, computer viruses or physical or electronic break-ins, could affect the availability of our platforms. We have experienced, and may in the future experience, disruptions, outages and other performance problems due to a variety of factors, including infrastructure changes, introductions of new functionality, human or software errors, capacity constraints due to an overwhelming number of customers accessing our platforms simultaneously, denial of service attacks or other security-related incidents.

 

It may become increasingly difficult to maintain and improve our performance, especially during peak usage times and as our customer base grows and our platforms becomes more complex. If our platforms are unavailable or if our customers are unable to access our platforms within a reasonable amount of time or at all, we may experience a loss of customers, lost or delayed market acceptance of our platforms, delays in payment to us by customers, injury to our reputation and brand, legal claims against us, significant cost of remedying these problems and the diversion of our resources. In addition, to the extent that we do not effectively address capacity constraints, upgrade our systems as needed and continually develop our technology and network architecture to accommodate actual and anticipated changes in technology, our business, financial condition and results of operations, as well as our reputation, may be adversely affected.

 

Further, the software technologies underlying our platforms are inherently complex and may contain material defects or errors, particularly when new products are first introduced or when new features or capabilities are released. We have from time to time found defects or errors in our platforms, and new defects or errors in our existing platforms or new products may be detected in the future by us or our users. We cannot assure you that our existing platforms and new products will not contain defects. Any real or perceived errors, failures, vulnerabilities, or bugs in our platforms could result in negative publicity or lead to data security, access, retention or other performance issues, all of which could harm our business. The costs incurred in correcting such defects or errors may be substantial and could harm our business. Moreover, the harm to our reputation and legal liability related to such defects or errors may be substantial and could similarly harm our business.

 

If we fail to timely release updates and new features to our platforms and adapt and respond effectively to rapidly changing technology, evolving industry standards, changing regulations, or changing customer needs, requirements or preferences, our platforms may become less competitive.

 

The markets in which we compete are subject to rapid technological change, evolving industry standards, and changing regulations, as well as changing customer needs, requirements and preferences. The success of our business will depend, in part, on our ability to adapt and respond effectively to these changes on a timely basis. Accordingly, our ability to increase our revenue depends in large part on our ability to maintain, improve and differentiate our existing platforms and introduce new functionality.

 

We must continue to improve existing features and add new features and functionality to our platforms in order to retain our existing customers and attract new ones. If the technology underlying our platforms become obsolete or do not address the needs of our customers, our business would suffer.

 

Revenue growth from our products depends on our ability to continue to develop and offer effective features and functionality for our customers and to respond to frequently changing data protection regulations, policies and end-user demands and expectations, which will require us to incur additional costs to implement. If we do not continue to improve our platforms with additional features and functionality in a timely fashion, or if improvements to our platforms are not well received by customers, our revenue could be adversely affected.

 

17
 

 

If we fail to deliver timely releases of our products that are ready for commercial use, release a new version, service, tool or update with material errors, or are unable to enhance our platforms to keep pace with rapid technological and regulatory changes or respond to new offerings by our competitors, or if new technologies emerge that are able to deliver competitive solutions at lower prices, more efficiently, more conveniently or more securely than our solutions, or if new operating systems, gaming platforms or devices are developed and we are unable to support our customers’ deployment of games and other applications onto those systems, platforms or devices, our business, financial condition and results of operations could be adversely affected.

 

We are an “emerging growth company,” and we cannot be certain if the reduced reporting and disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

 

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, or Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Pursuant to Section 107 of the JOBS Act, as an emerging growth company, we may choose to elect to use the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, which may make our common stock less attractive to investors. In addition, if we cease to be an emerging growth company, we will no longer be able to use the extended transition period for complying with new or revised accounting standards.

 

We will remain an emerging growth company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary of our initial public offering; (2) the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the date on which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4) the date we qualify as a “large accelerated filer,” with at least $700 million of equity securities held by non-affiliates.

 

We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. For example, if we do not adopt a new or revised accounting standard, our future results of operations may not be as comparable to the results of operations of certain other companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.

 

RISKS RELATED TO OUR ACQUISITION STRATEGY

 

We may be unable to obtain additional financing, if required, to fund the existing operations of the business, complete future acquisitions or to fund the development and commercialization of the companies, technologies, or intellectual property.

 

Our primary business strategy is to: 1) generate and increase revenues of existing subsidiary companies and 2) to further enhance our presence in the VR/AR market through the acquisition of additional VR/AR companies, technologies, or intellectual property. If our existing subsidiary companies do not achieve sufficient levels of revenue and profits, we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements to finance the operations of the business.

 

18
 

 

Additionally, there can be no assurance that we will be able to successfully identify, acquire or profitably manage such additional companies, technologies, or intellectual property or successfully integrate these, if any, into the Glimpse ecosystem without substantial costs, delays or other operational or financial problems. If potential acquisition targets are unwilling to accept our equity as the consideration for their businesses, then we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements to finance the acquisition transaction. If we complete a business combination, we may require additional financing to fund the operations or growth of an acquisition target. Further, acquisitions involve a number of other special risks, including possible adverse effects on our operating results, diversion of management’s attention, dependence on retention, hiring and training of key personnel, risks associated with unanticipated problems or legal liabilities, and realization of acquired intangible assets, some or all of which could have a material adverse effect on our business, financial condition and results of operations. In addition, there can be no assurance that the companies, technologies, or intellectual property acquired in the future, if any, will generate anticipated revenues and earnings. As a result, we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements. To the extent that we are unable to acquire additional companies, technologies, or intellectual property or integrate those successfully, our ability to generate and increase our revenues may be reduced significantly. As a result, we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements. As an early-stage company, we cannot assure that such financing will be available on acceptable terms, if at all.

 

With respect to our future acquisition strategy, no assurance can be made that we will have the funds necessary to make future acquisitions. To the extent that additional financing proves to be unavailable, that fact will likely have a negative impact on our business and we may be compelled to restructure the operations of the business or abandon a particular contemplated business combination.

 

If we fail to integrate any existing or acquired subsidiaries into the Glimpse ecosystem, we may not realize the anticipated benefits of the collaborative Glimpse ecosystem and the integration of any acquisitions, which could harm our business, financial condition or results of operations.

 

Even though Glimpse’s ecosystem provides a centralized corporate structure and the potential for cross company collaboration synergies, each subsidiary company has its own business development, technology development, sales team and general manager. Although we believe that the integration of our existing subsidiary companies has been a success, there is still continued risk that we may encounter difficulties related to continued integration of the existing subsidiary companies in the future. There is also the risk that the business development, sales team and general manager of a future acquired subsidiary are unsuccessful. Some of these risks are out of our control. Successfully integrating any acquired subsidiary may be more difficult, costly or time-consuming than we anticipate, or we may not otherwise realize any of the anticipated benefits of such acquisition. Any of the foregoing could adversely affect our business, financial condition or results of operations.

 

We have made a number of acquisitions in the past and we intend to make more acquisitions in the future. Our ability to identify complementary assets, products or businesses for acquisition and successfully integrate them could affect our business, financial condition and operating results.

 

In the future, we intend to continue to pursue acquisitions of assets, products or businesses that we believe are complementary to our existing business and/or to enhance our market position or expand our product portfolio. There is a risk that we will not be able to identify suitable acquisition candidates available for sale at reasonable prices, complete any acquisition, or successfully integrate any acquired product or business into our operations. We may face competition for acquisition candidates from other parties including those that have substantially greater available resources. Acquisitions may involve a number of other risks, including:

 

  diversion of management’s attention from other subsidiaries;
     
  disruption to our ongoing business;
     
  failure to retain key acquired personnel;
     
  difficulties in integrating acquired operations, technologies, products, or personnel;
     
  unanticipated expenses, events, or circumstances;
     
  assumption of disclosed and undisclosed liabilities; and

 

19
 

 

  inappropriate valuation of the acquired in-process R&D, or the entire acquired business.

 

If we do not successfully address these risks or any other problems encountered in connection with an acquisition, the acquisition could have a material adverse effect on our business, results of operations and financial condition. Problems with an acquired business could have a material adverse effect on our performance or our business as a whole. In addition, if we proceed with an acquisition, our available cash may be used to complete the transaction, diminishing our liquidity and capital resources, or shares may be issued which could cause significant dilution to existing shareholders.

 

RISKS RELATED TO OUR INTELLECTUAL PROPERTY

 

If we cannot obtain and maintain appropriate patent and other intellectual property rights protection for our technology, our business will suffer.

 

The value of our software and services is dependent on our ability to secure and maintain appropriate patent and other intellectual property rights protection. We intend to continue to pursue additional patent protection for our new software and technology. Although we own multiple patents covering our technology that have already been issued, we may not be able to obtain additional patents that we apply for, or that any of these patents, once issued, will give us commercially significant protection for our technology, or will be found valid if challenged. Moreover, we have not obtained patent protection for our technology in all foreign countries in which our products might be sold. In any event, the patent laws and enforcement regimes of other countries may differ from those of the United States as to the patentability of our personal display and related technologies and the degree of protection afforded.

 

Any patent or trademark owned by us may be challenged and invalidated or circumvented. Patents may not be issued from any of our pending or future patent applications. Any claims and issued patents or pending patent applications may not be broad or strong enough and may not be issued in all countries where our products can be sold or our technologies may not be licensed to provide meaningful protection against any commercial damage to us. Further, others may develop technologies that are similar or superior to our technologies, duplicate our technologies or design around the patents owned by us. Effective intellectual property protection may be unavailable or limited in certain foreign countries. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy or otherwise use aspects of our processes and devices that we regard as proprietary. Policing unauthorized use of our proprietary information and technology is difficult and our efforts to do so may not prevent misappropriation of our technologies. In the event that our intellectual property protection is insufficient to protect our intellectual property rights, we could face increased competition in the market for our products and technologies, which could have a material adverse effect on our business, financial condition and results of operations.

 

We may become engaged in litigation to protect or enforce our patent and other intellectual property rights or in International Trade Commission proceedings to abate the importation of goods that would compete unfairly with our products. In addition, we may have to participate in interference or reexamination proceedings before the US Patent and Trademark Office, or in opposition, nullification or other proceedings before foreign patent offices, with respect to our patents or patent applications. All of these actions would place our patents and other intellectual property rights at risk and may result in substantial costs to us as well as a diversion of management attention. Moreover, if successful, these actions could result in the loss of patent or other intellectual property rights protection for the key technologies on which our business strategy depends.

 

In addition, we rely in part on unpatented proprietary technology, and others may independently develop the same or similar technology or otherwise obtain access to our unpatented technology. To protect our trade secrets, know-how and other proprietary information, we require employees, consultants, financial advisors and strategic partners to enter into confidentiality agreements. These agreements may not provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use, misappropriation or disclosure of those trade secrets, know-how or other proprietary information. In particular, we may not be able to fully or adequately protect our proprietary information as we conduct discussions with potential strategic partners. If we are unable to protect the proprietary nature of our technology, it will harm our business.

 

20
 

 

Despite our efforts to protect our intellectual property rights, intellectual property laws afford us only limited protection. A third party could copy or otherwise obtain information from us without authorization. Accordingly, we may not be able to prevent misappropriation of our intellectual property or to deter others from developing similar products or services. Further, monitoring the unauthorized use of our intellectual property is difficult. Litigation may be necessary to enforce our intellectual property rights or to determine the validity and scope of the proprietary rights of others. Litigation of this type could result in substantial costs and diversion of resources, may result in counterclaims or other claims against us and could significantly harm our results of operations. In addition, the laws of some foreign countries do not protect our proprietary rights to the same extent as do the laws of the United States.

 

As is commonplace in technology companies, we employ individuals who were previously employed at other technology companies. To the extent our employees are involved in research areas that are similar to those areas in which they were involved at their former employers, we may be subject to claims that such employees or we have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of the former employers. Litigation may be necessary to defend against such claims. Litigation of this type could result in substantial costs to us and divert our resources.

 

We also depend on trade secret protection through confidentiality and license agreements with our employees, subsidiaries, licensees, licensors and others. We may not have agreements containing adequate protective provisions in every case, and the contractual provisions that are in place may not provide us with adequate protection in all circumstances. The unauthorized reproduction or other misappropriation of our intellectual property could diminish the value of our brand, competitive advantages or goodwill and result in decreased sales.

 

We may incur substantial costs or lose important rights as a result of litigation or other proceedings relating to our products, patents and other intellectual property rights.

 

In recent years, there has been significant litigation involving patents and other intellectual property rights in many technology-related industries. Until recently, patent applications were retained in secrecy by the US Patent and Trademark Office until and unless a patent was issued. As a result, there may be US patent applications pending of which we are unaware that may be infringed by the use of our technology or a part thereof, thus substantially interfering with the future conduct of our business. In addition, there may be issued patents in the United States or other countries that are pertinent to our business of which we are not aware. We and our customers could be sued by other parties for patent infringement in the future. Such lawsuits could subject us and them to liability for damages or require us to obtain additional licenses that could increase the cost of our products, which might have an adverse effect on our sales.

 

In addition, in the future we may assert our intellectual property rights by instituting legal proceedings against others. We may not be able to successfully enforce our patents in any lawsuits we may commence. Defendants in any litigation we may commence to enforce our patents may attempt to establish that our patents are invalid or are unenforceable. Any patent litigation could lead to a determination that one or more of our patents are invalid or unenforceable. If a third party succeeds in invalidating one or more of our patents, we may experience greater competition from such party and from others. Our ability to derive sales from products or technologies covered by these patents could be adversely affected.

 

Whether we are defending the assertion of third party intellectual property rights against our business as a result of the use of our technology, or we are asserting our own intellectual property rights against others, such litigation can be complex, costly, protracted and highly disruptive to our business operations by diverting the attention and energies of management and key technical personnel. As a result, the pendency or adverse outcome of any intellectual property litigation to which we are subject could disrupt business operations, require the incurrence of substantial costs and subject us to significant liabilities, each of which could severely harm our business.

 

Plaintiffs in intellectual property cases often seek injunctive relief. Any intellectual property litigation commenced against us could force us to take actions that could be harmful to our business and thus to our sales, including the following:

 

● discontinuing selling the products that incorporate or otherwise use technology that contains our allegedly infringing intellectual property;

 

21
 

 

● attempting to obtain a license to the relevant third party intellectual property, which may not be available on reasonable terms or at all; or

 

● attempting to redesign our products to remove our allegedly infringing intellectual property.

 

If we are forced to take any of the foregoing actions, we may be unable to sell products that incorporate our technology at a profit or at all. Furthermore, the measure of damages in intellectual property litigation can be complex, and is often subjective or uncertain. If we were to be found liable for infringement of proprietary rights of a third party, the amount of damages we might have to pay could be substantial and is difficult to predict. Decreased sales of our products incorporating our technology would adversely affect our results of operations. Any necessity to procure rights to the third party technology might cause us to negotiate the royalty terms of the third party license which could increase our cost of production or, in certain cases, terminate our ability to build some of our products entirely.

 

Our failure to renew, register or otherwise protect our trademarks could have a negative impact on the value of our brand names and our ability to use those names in certain geographical areas.

 

We believe our copyrights and trademarks are integral to our success. We rely on trademark, copyright and other intellectual property laws to protect our proprietary rights. If we fail to properly register and otherwise protect our trademarks, service marks and copyrights, we may lose our rights, or our exclusive rights, to them. In that case, our ability to effectively market and sell our products and services could suffer, which could harm our business.

 

RISKS RELATED TO OUR SECURITIES AND OTHER RISKS

 

Following our initial public offering, our stock price may be volatile, and the value of our common stock may decline.

 

We cannot predict the prices at which our common stock will trade. Factors that could cause fluctuations in the trading price of our common stock include the following:

 

  actual or anticipated fluctuations in our financial condition or results of operations;
     
  variance in our financial performance from expectations of securities analysts;
     
  changes in the pricing of the solutions on our platforms;
     
  changes in our projected operating and financial results;
     
  changes in laws or regulations applicable to our platforms;
     
  announcements by us or our competitors of significant business developments, acquisitions or new offerings;
     
  sales of shares of our common stock by us or our shareholders;
     
  significant data breaches, disruptions to or other incidents involving our platforms;
     
  our involvement in litigation;
     
  conditions or developments affecting the AR and VR industries;
     
  future sales of our common stock by us or our stockholders, as well as the anticipation of lock-up releases;
     
  changes in senior management or key personnel;
     
  the trading volume of our common stock;

 

22
 

 

  changes in the anticipated future size and growth rate of our market;
     
  general economic and market conditions; and
     
  other events or factors, including those resulting from war, incidents of terrorism, global pandemics or responses to these events.

 

Broad market and industry fluctuations, as well as general economic, political, regulatory and market conditions, may also negatively impact the market price of our common stock. In addition, technology stocks have historically experienced high levels of volatility. In the past, companies who have experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the target of this type of litigation in the future, which could result in substantial expenses and divert our management’s attention.

 

If securities or industry analysts do not publish research or publish unfavorable or inaccurate research about our business, the market price and trading volume of our common stock could decline.

 

The market price and trading volume of our common stock is heavily influenced by the way analysts interpret our financial information and other disclosures. We do not have control over these analysts. If few securities analysts commence coverage of us, or if industry analysts cease coverage of us, our stock price would be negatively affected. If securities or industry analysts do not publish research or reports about our business, downgrade our common stock, or publish negative reports about our business, our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our stock price to decline and could decrease the trading volume of our common stock.

 

We do not intend to pay dividends for the foreseeable future and, as a result, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.

 

We have never declared or paid any cash dividends on our capital stock, and, subject to the discretionary dividend policy described in Part II, Item 5 of this report, we do not intend to pay any cash dividends in the foreseeable future. Any determination to pay dividends in the future will be at the discretion of our board of directors. Accordingly, you may need to rely on sales of our common stock after price appreciation, which may never occur, as the only way to realize any future gains on your investment.

 

We expect to incur substantial costs as a result of operating as a public company, and our management is required to devote substantial time to compliance with our public company responsibilities and corporate governance practices.

 

As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company, which we expect to further increase after we are no longer an “emerging growth company.” The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of the Nasdaq Capital Market, and other applicable securities rules and regulations impose various requirements on public companies. Our management and other personnel devotes a substantial amount of time to compliance with these requirements. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time-consuming and costly.

 

An active trading market for our securities may not exist, which would adversely affect the liquidity and price of our securities.

 

The price of our securities may vary significantly due to results of operation, general market or economic conditions. Furthermore, an active trading market for our securities may not exist or be sustained. You may be unable to sell your securities unless a market can be established and sustained.

 

The requirements of being a public company may strain our resources and distract our management, which could make it difficult to manage our business, particularly after we are no longer an “emerging growth company.”

 

We are required to comply with various regulatory and reporting requirements, including those required by the SEC. Complying with these reporting and other regulatory requirements is time-consuming and results in increased costs to us and could have a negative effect on our results of operations, financial condition or business.

 

23
 

 

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) and the requirements of the Sarbanes-Oxley Act. These requirements may place a strain on our systems and resources. The Exchange Act requires that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal controls over financial reporting. To maintain and improve the effectiveness of our disclosure controls and procedures, we need to commit significant resources, hire additional staff and provide additional management oversight. We will be implementing additional procedures and processes for the purpose of addressing the standards and requirements applicable to public companies. Sustaining our growth also will require us to commit additional management, operational and financial resources to identify new professionals to join our firm and to maintain appropriate operational and financial systems to adequately support expansion. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on our results of operations, financial condition or business.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus contains forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. These forward-looking statements are based on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such statements.

 

In some cases, you can identify forward-looking statements by terminology, such as “expects”, “anticipates”, “intends”, “estimates”, “plans”, “potential”, “possible”, “probable”, “believes”, “seeks”, “may”, “will”, “should”, “could” or the negative of such terms or other similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this prospectus.

 

You should read this prospectus and the documents that we reference herein and have filed as exhibits to the registration statement, of which this prospectus is part, completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this prospectus is accurate as of the date on the front cover of this prospectus only. Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this prospectus, and particularly our forward-looking statements, by these cautionary statements.

 

24
 

 

USE OF PROCEEDS

 

We will not receive any of the proceeds from the sale of the shares of our common stock being offered for sale by the selling stockholders. Upon the exercise of the warrants for an aggregate of 750,000 shares of common stock assuming all payments are made by cash and there is no reliance on cashless exercise provisions, however, we will receive the exercise price of the warrants, or an aggregate of approximately $11.0 million, from the investors in the October 2021 Private Placement. We will bear all fees and expenses incident to our obligation to register the shares of common stock. Brokerage fees, commissions and similar expenses, if any, attributable to the sale of shares offered hereby will be borne by the selling stockholder.

 

There is no assurance the warrants will be exercised for cash. We intend to use such proceeds, if any, for general corporate and working capital purposes.

 

DIVIDENDS POLICY

 

We have never declared or paid cash dividends on our capital stock. Although we currently intend to retain all available funds and future earnings, if any, to fund the development and expansion of our business, we are committed, subject to the limitations on distributions under Nevada law, to pay certain distributions in the event (i) we sell the business of any of our subsidiaries; or (ii) we report consolidated net income on our fiscal year end audited financial statements. No assurances can be made that any such milestone will be achieved or if achieved that our Board of Directors will approve any distribution in connection therewith.

 

Distribution upon sale of business. In the event we sell all or substantially all of the business of any of our subsidiaries, whether by means of a merger, asset sale, stock sale or otherwise, for a price in excess of $10,000,000, we intend to distribute no less than 85% of the after-tax net proceeds for such sale. However, such distribution shall be subject to a determination by our Board of Directors that there exist no special circumstances that would prevent it from approving such distribution or the extent thereof. Such special circumstances could include, but not be limited to, the Company or any of its subsidiary companies contemplating or actively being engaged in a prospective acquisition or acquisitions that may require the use of such net proceeds, or other uses integral to the operations, growth or business development of any existing subsidiary company. Moreover, such distribution may be waived, in writing, by the holders of a majority of our securities holders entitled to vote, voting together as a single class.

 

Distribution of consolidated net income. In the event our annual audited financial statements report consolidated net income, we intend to distribute, within 90 days after completion of such audit, 10% of the consolidated net income for such fiscal year. However, such distribution shall be subject to a determination by our Board of Directors that there exist no special circumstances that would prevent it from approving such distribution or the extent thereof. Such special circumstances could include, but not be limited to, the Board of Directors determining that such distribution, which could have otherwise been reinvested into our existing businesses, would impair our ability to execute on our business strategy. Moreover, such distribution may be waived, in writing, by the holders of a majority of our securities holders entitled to vote, voting together as a single class.

 

Subject to the distribution intentions discussed above, any future determination regarding the declaration and payment of dividends, if any, will be subject to the limitations on distributions under Nevada law, will be at the discretion of our board of directors and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects, and other factors our board of directors may deem relevant. In addition, our ability to pay dividends may be restricted by any agreements we may enter into in the future.

 

OUR BUSINESS

 

The Glimpse Group, Inc. (together with its consolidated subsidiary companies, unless the context otherwise requires, referred to herein as “Glimpse Group,” “Glimpse,” “we,” “us,” “our,” or the “Company”) operates through eleven wholly-owned subsidiary companies.

 

History

 

The Glimpse Group, Inc. was incorporated on June 15, 2016, under the laws of the State of Nevada and is headquartered in New York, New York.

 

25
 

 

On July 6, 2021, the Company completed its initial public offering (“IPO”). In connection with the IPO, the Company’s common stock began trading on the Nasdaq Capital Market on and as of July 1, 2021. In conjunction with its IPO, the Company sold approximately 1.91 million shares of its common stock at $7.00 per share, raising approximately $11.82 million in net proceeds after fees and expenses.

 

On November 2, 2021, the Company closed the sale of 1.50 million shares of its common stock and warrants to purchase 0.75 million shares of common stock to certain institutional investors in a private placement. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The warrants have an exercise price of $14.68 per share and will expire five years from the date they can be exercised. The gross proceeds to the Company were approximately $13.6 million after deducting the placement agent’s fees and other offering expenses.

 

COMPANY OVERVIEW

 

We are a Virtual (“VR”) and Augmented (“AR”) Reality platform company, comprised of a diversified group of wholly-owned and operated VR and AR companies, providing enterprise-focused software, services and solutions. We believe that we offer significant exposure to the rapidly growing and potentially transformative VR and AR markets, while mitigating downside risk via our diversified model and ecosystem.

 

Our platform of VR/AR subsidiary companies, collaborative environment and diversified business model aims to simplify the challenges faced by companies in the emerging VR/AR industry, potentially improving each subsidiary company’s ability to succeed, while simultaneously providing investors an opportunity to invest directly into the emerging VR/AR industry via a diversified infrastructure.

 

Leveraging our platform, we strive to cultivate and manage the business operations of our VR/AR subsidiary companies, with the goal of allowing each underlying company to better focus on mission-critical endeavors, collaborate with the other subsidiary companies, reduce time to market, optimize costs, improve product quality and leverage joint go-to-market strategies. Subject to operational, market and financial developments and conditions, we intend to carefully add to our current portfolio of subsidiary companies via a combination of organic expansion and/or outside acquisition.

 

The VR/AR industry is an early-stage technology industry with nascent markets. We believe that this industry has significant growth potential across verticals, may be transformative and that our diversified platform and ecosystem create important competitive advantages. Our subsidiary companies currently target a wide array of industry verticals, including but not limited to: Corporate Training, Education, Healthcare, Branding/Marketing/Advertising, Retail, Financial Services, Food & Hospitality, Media & Entertainment, Architecture/Engineering/Construction (“AEC”) and Social VR support groups and therapy. We do not currently target direct-to-consumer (“B2C’) VR/AR software or services, only business-to-business (“B2B”) and business-to-business-to-consumer (“B2B2C”), and we are hardware agnostic.

 

The Glimpse Platform

 

We develop, commercialize and market innovative and proprietary VR/AR software products, solutions and intellectual property (“IP”). Our platform is currently comprised of eleven active wholly-owned subsidiary companies, each targeting different industry segments in a non-competitive, collaborative manner. Our experienced management and dynamic VR/AR entrepreneurs have deep domain expertise, providing the foundation for value-add-collaborations throughout our ecosystem.

 

Each of our subsidiary companies share operational, financial and IP infrastructure, facilitating shorter time-to-market, higher quality products, reduced development costs, fewer redundancies, significant go-to-market synergies and, ultimately, a higher potential for success for each subsidiary company. We believe that our collaborative platform is unique and necessary, especially given the early nature of the VR/AR industry. By offering technologies and solutions in various industry segments, we aim to reduce dependency on any one single subsidiary company, technology or industry segment.

 

We believe that three core tenets enhance our probability of success: (1) our ecosystem of VR/AR companies, (2) diversification and (3) profitable growth.

 

26
 

 

(1) Our ecosystem of VR/AR software and service companies provides significant benefits to each subsidiary company and our group as a whole. We believe that the most notable benefits are: (a) economies of scale, cost efficiencies and reduced redundancies; (b) cross company collaboration, deep domain expertise, IP and knowledge transfer; (c) superior product offerings; (d) faster time to market; (e) enhanced business development and sales synergies; and (f) multiple monetization paths. In an emerging industry that is lacking in infrastructure, we believe that our ecosystem provides a distinct competitive advantage relative to a single, standalone company in the industry.

 

(2) By design, we incorporate multiple aspects of diversity to reduce the risks associated with an early stage industry, create multiple monetization venues and improve the probabilities of success. There is no single point of failure or dependency. This is created through: (a) ownership of numerous wholly-owned subsidiary companies operating in different industry segments; (b) targeting large industries with clear VR/AR use-cases; (c) developing and utilizing various technologies and IP; (d) expanding to different geographic technology centers in a hub model under our umbrella; and (e) across industries, having a wide array of customers and potential acquirers/investors.

 

(3) From our inception, we have prioritized achieving operational cash flow neutrality early in our life. This was an important factor that drove our strategy to: (a) focus on enterprise software and services, only onboarding companies that are generating revenues or clearly could in the short term; (b) target solutions that are based on use cases that have a clear return on investment (“ROI”) and can be effectively developed from existing technologies and hardware; and (c) centralize costs to reduce inefficiencies. By targeting cash flow neutrality, our goal is to minimize dilution and support greater independence from capital markets, thereby increasing resiliency and maximizing upside potential.

 

As part of our platform, we provide a centralized corporate structure, which significantly reduces general and administrative costs (financial, operational, legal & IP), streamlines capital allocation and helps in coordinating business strategies. This allows our subsidiary company general managers to focus their time and effort almost exclusively on the core software, product and business development activities relating to their subsidiary.

 

Additionally, aligned economic incentives encourage cross-Company collaboration. All of our employees own equity in our Company. The leadership team of each subsidiary company, in addition to their equity ownership in Glimpse, also have an economic interest in their particular subsidiary company. This economic interest is negotiated with lead management of a subsidiary company upon their joining of our Company, and typically ranges between 5-10% of the total net sale proceeds of the subsidiary and includes a three-year vesting schedule. Thus, there is benefit to them not only when their subsidiary company succeeds but also when any of the other subsidiaries succeeds, and when Glimpse as a whole succeeds. We believe that this ownership mechanism is a strong driver of cross-pollination of ideas and fosters collaboration. While each subsidiary company owns its own IP, our parent company currently owns 100% of each subsidiary company. In addition, there will be perpetual licensing agreements between our subsidiary companies, so that if a subsidiary company is divested, then the remaining subsidiaries, if utilizing the IP of a divested subsidiary company, will continue to retain usage rights post-divestiture.

 

Active Glimpse Subsidiary Companies

 

  1. Kabaq 3D Technologies, LLC (dba QReal): Creation of lifelike photorealistic 3D interactive digital models and experiences in AR
  2. Adept Reality, LLC (dba Adept XR Learning): VR/AR solutions for higher education learning and corporate training
  3. KreatAR, LLC (dba PostReality): AR presentation tools for design, creation and collaboration
  4. D6 VR, LLC (D6): VR/AR data visualization and data-analysis tools and collaboration for Financial Services and other data intensive industries
  5. Immersive Health Group, LLC (IHG): VR/AR platform for evidence-based and outcome driven healthcare solutions
  6. Foretell Studios, LLC (dba Foretell Reality): Customizable social VR platform for behavioral health, support groups, collaboration and soft skills training
  7. Number 9, LLC (dba Pagoni VR): VR broadcasting solutions and environments for events, education, media & entertainment
  8. Early Adopter, LLC (EA): AR/VR solutions for K-12 education

 

27
 

 

  9. MotionZone, LLC (dba AUGGD): AR software and solutions for the Architecture, Engineering and Construction segments
  10. Glimpse Group Yazilim ve ARGE Ticaret Anonim Sirketi (Glimpse Turkey): a development center in Turkey, primarily developing and creating 3D models for QReal
  11. XR Terra, LLC (XR Terra): a developer and provider of teaching platforms utilized in coding software used in VR and AR programming

 

1. QReal

 

QReal is a software and services company that creates and distributes lifelike photorealistic 3D and AR content. This content is typically integrated in social media campaigns and e-commerce platforms with the goal of increasing sales, improving brand recognition, creating viral content and boosting e-commerce conversion. Current industry verticals include: food, fashion, apparel, architecture and automotive.

 

QReal offers both one-time content creation as well as monthly subscriptions. With a monthly subscription, QReal offers content management and digital distribution.

 

We recently opened a development center, Glimpse Turkey, that primarily creates 3D models for QReal.

 

2. Adept XR Learning

 

Adept XR Learning (“Adept”) provides higher education learning and corporate VR training solutions via its SaaS platform (“Elevate”) built around collaboration and multi-user learning across geographical areas. The platform provides users the unique ability to create multiple sessions of a corporate VR training experience, incorporating data visualization, computer graphics, blended real-life 360 videos, artificial intelligence, data and analytics.

 

Adept’s platform can be purchased as a Software as a Service (“SaaS”) subscription, software license or a white label solution.

 

3. PostReality

 

PostReality creates cloud-based, cost effective, SaaS solutions that enable businesses to rapidly create, edit, integrate and deploy AR experiences.

 

PostReality’s solutions are:

 

a) PostReality, a cloud-based, SaaS solution enabling users to easily create AR presentations via a drag-and-drop process and then view and share
b) XR Platform, a cloud-based, scalable and secure backend infrastructure designed for VR/AR companies, allowing for the incorporation of various functionalities, such as proprietary cloud image recognition technology, online storage, creation and management of subscription plans, invoicing and payments
c) Custom specialized AR applications, white label solutions and services

 

PostReality’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

4. D6 VR

 

D6 VR (“D6”) is a comprehensive, VR-based, analysis, presentation and education software platform, designed specifically to provide insight into complex data sets, improve productivity and facilitate virtual collaboration. D6 targets data intensive industries, with an initial focus on Financial Services and Higher Education.

 

Key attributes of D6’s platform:

 

- Workspace of the Future: Without physical limitations and with essentially unlimited virtual monitor space, users can create customizable Data Rooms which can be used for traditional workflows and/or presentations.

 

28
 

 

- Collaboration: Collaborate and present in the virtual world, share virtual workspaces with clients and colleagues around the globe, presenting multi-dimensional data visualizations in both VR and AR.
- Visualization: Visualize and manipulate complex data in 3D space, deriving insights that are faster, more powerful, and more memorable. Instantly turn multi-variable data sets into intuitive, immersive displays.

 

D6’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

5. Immersive Health Group

 

Immersive Health Group (“IHG”) is a digital health platform company that leverages VR/AR technology to simplify and streamline complex healthcare challenges in scale.

 

IHG’s main software platform is ContinuumXR:

 

- ContinuumXR (“CXR”) provides a VR and AR software training platform, specifically designed for clinician and caregiver learning and practice. The platform is designed to improve quality of care, retain clinical talent and reduce turnover, reduce errors, and improve patient experiences.

 

IHG’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

6. Foretell Reality

 

Foretell Reality (“Foretell”) provides remote groups an immersive, engaging and safe space to meet and collaborate in customizable, distraction-free environments. Through its VR software platform, Foretell aims to enhance human communications and productivity by overcoming geographic and physical constraints.

 

Foretell offers an enterprise-grade and easy-to-use solution for meeting others in VR with rich environments and features. The Foretell platform is designed to support applications and use cases across multiple industries, including: VR Telemental Health (especially support groups and therapy), Corporate Collaboration and Soft Skills and Remote Learning. Foretell’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

7. Pagoni VR

 

Pagoni VR (“Pagoni”) provides immersive and interactive VR video broadcasting solutions to universities, enterprise, entertainment venues, sports venues and houses of worship. Pagoni’s main product, Chimera, enables real-time communications between a presenter and local and remote attendees in VR.

 

Pagoni’s platform can be purchased as a SaaS subscription, software license or a white label solution.

 

8. Early Adopter

 

Early Adopter (“EA”) provides immersive VR and AR EdTech solutions for K-12 schools and pediatric hospital programs, based on engaging inquiry-driven and game-based learning.

 

In response to the Covid-19 pandemic, EA created Common Room, a social AR SaaS app that allows users to interact as if they were with one another. Common Room can also be white labeled by schools and other third parties.

 

EA’s platform can be purchased as a SaaS subscription, software license, or a white label solution.

 

9. AUGGD

 

AUGGD provides AR software and services primarily for the Architecture, Engineering & Construction (AEC) industries. Its solutions seek to improve building quality, lower construction costs, provide clearer planning and impactful marketing.

 

29
 

 

Based historically in Australia and Europe, AUGGD is looking to expand in the US.

 

AUGGD’s solutions can be purchased as a SaaS subscription, software license, white label solution or service.

 

10. Glimpse Turkey

 

Glimpse Turkey specializes in utilizing photogrammetry tools in order to develop and create web optimized 3D models, primarily for QReal.

 

It is based in Turkey and is currently a development center.

 

11. XR Terra

 

XR Terra is a provider of VR/AR teaching, training and skills development through innovative programs and corporate partnerships.

 

Recent Business Developments

 

Initial Public Offering

 

On July 1 ,2021, we completed the IPO of common stock and initial listing on the Nasdaq Capital Market under the symbol “VRAR”, at an initial public offering price of $7.00 per share. In conjunction with the IPO and the underwriter’s exercise of its over-allotment option, we sold 1,912,500 shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million.

 

AUGGD Asset Acquisition

 

In August 2021, we completed an acquisition of certain assets from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services to the Architecture, Engineering and Construction market segments. Initial consideration for the purchase was $0.75 million payable by the issuance of 77,264 shares of our common stock. Additional consideration in the form of our common stock shall be issued if certain future revenue growth targets are achieved.

 

XR Terra Asset Acquisition

 

In October 2021, we completed an acquisition of certain assets from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming. Initial consideration for the purchase is $0.60 million payable 50% in our common stock and 50% in cash. In October 2021, the Company paid $0.30 million cash and issued 33,877 shares of common stock to satisfy the purchase price. Additional consideration in the form of our common stock shall be issued if certain future revenue growth targets are achieved.

 

Private Placement

 

On November 2, 2021, the Company closed the sale of 1.5 million shares of its common stock and warrants to purchase 0.75 million shares of common stock to certain institutional investors in a private placement. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The warrants have an exercise price of $14.68 per share and will expire five years from the date they can be exercised. The gross proceeds to the Company were approximately $13.6 million after deducting the placement agent’s fees and other offering expenses.

 

The VR and AR (XR) Markets

 

Virtual Reality (VR) fully immerses the user in a digital environment via a head mounted display (“HMD”), where the user is blocked out of their immediate physical environment. Augmented Reality (AR) is a less immersive experience, where the user views their immediate physical environment with digital images overlaid, via a phone, tablet or a dedicated HMD such as smart glasses. While distinct, VR and AR are related, utilize some similar underlying technologies and are expected to become increasingly interconnected - combined they are often referred to as Immersive Technology (XR).

 

30
 

 

VR and AR are emerging technologies, and the markets for them are still nascent. We believe that XR technologies and solutions have the potential to fundamentally transform how people and businesses interact, further enabling remote work, education and commerce. XR is also expected to increasingly interconnect with other emerging technologies such as artificial intelligence, computer vision, big data, NFT and crypto currencies. Additionally, HMD and telecommunication (5G) advancements have been driving vast improvements in capabilities and ease of use, while significantly reducing headset cost. As a result, market adoption has accelerated and is expected to continue. Leading technology companies such as Facebook, Apple, Microsoft, Google, Samsung, Sony and HP have been at the forefront of VR/AR hardware development and software infrastructure, while also increasing integration of their products with AR and VR capabilities.

 

Since Facebook released its first VR headset as a consumer product in 2016 (after its $2B+ acquisition of Oculus), successive iterations of it, as well as others, have become significantly lighter, more comfortable, lower priced, with higher resolution and increasingly wireless/mobile. With a standalone mobile headset, users no longer need an expensive gaming computer to power the headset and they also do not have a wire tethered to that computer restricting movement. These advances have facilitated easier corporate procurement and integration. The accelerating rollout of 5G should enable further improvement in user experience since with 5G, remote processing and heavier, real time applications become possible without noticeable visual lag, allowing for lighter, smaller, more comfortable HMDs with longer battery life.

 

Based on Artillery Intelligence’s market forecasts, the VR and AR markets are forecasted to grow 31% in 2021 to over $9 billion, expanding at a 39% Compound Annual Growth Rate (CAGR) over the next three years, exceeding $35 billion by 2023. In particular, VR and AR enterprise software – the segment we are focused on – is projected to grow 59% in 2021 and expand at a 55% CAGR to more than $10 billion in 2023.

 

https:||www.sec.gov|Archives|edgar|data|1854445|000149315221023976|marketsize.jpg

 

Business Development and Sales

 

We utilize a hybrid approach to the sales and distribution of our software products and services.

 

31
 

 

At our subsidiary company level, each company has its own business development and sales team, the size of which depends on its stage of development. Each subsidiary company’s general manager is responsible for business development, and as the subsidiary gains market traction, its business development and sales team are expanded as needed.

 

Our subsidiary companies’ business development and sales teams are enhanced by the shared resources and influence of our ecosystem. Our management takes an active role in the business development activities of each subsidiary company and in the overall development and integration of sale strategies, goals and budgets. As an integral part of the business development and sales processes, each subsidiary company’s general manager is very familiar with the product offerings of other subsidiary companies and leverages those into his or her own efforts when appropriate. This leads to substantial cross marketing collaboration.

 

We believe that a subsidiary company’s ability to demonstrate to potential customers scale as part of our ecosystem of companies, combined with our subsidiary’s ability to offer its products and solutions as well as those of our other subsidiary companies in an integrated manner, represents a key competitive advantage. We believe our customers often view us as a “one-stop-shop” for all their VR/AR needs and an expert in the emerging VR/AR space.

 

We and our subsidiary companies continue to develop a shared partner ecosystem to further scale business and expand our solutions into new and existing target markets.

 

Competitive Environment

 

We believe that our competitors in the VR/AR industry are focused on two primary segments: VR/AR Hardware (headsets) and Software.

 

VR/AR Hardware (Headsets) (“Hardware”):

 

We do not develop any Hardware, and our software and service solutions are mostly compatible with any Hardware. We believe that Hardware development, commercialization and distribution are highly capital intensive and there is not yet large enough scale or mass adoption in the VR/AR industry to justify such expenditures for a smaller company. As such, there are relatively few participants on the Hardware side, some very large (for example: Facebook/Oculus, Microsoft, Samsung, Google, Apple, HTC, HP, Lenovo, Sony and Epson) and some much smaller (for example: Magic Leap, Pico, Valve and Vuzix). In general, Hardware cycles have been accelerating and performance improving, with simplified usability and reduced end-user costs. The more advanced, easier to use and cheaper the Hardware becomes, the higher the potential for the development of robust software applications and increased market adoption of VR/AR solutions.

 

VR/AR Software (“Software”):

 

In contrast to VR/AR Hardware, Software is highly fragmented with hundreds of VR/AR Software companies targeting different segments and solutions. Many are consumer oriented, whereas we are entirely enterprise focused (B2B, B2B2C). We believe that the AR/VR Software segment is currently far less competitive than traditional software markets, as most companies in the space tend to be early stage and often underfunded.

 

While competition is evolving and increasing, there is currently no dominant player in any particular VR/AR Software segment. We believe that we have the potential to become a leader in the VR/AR Software space in general and that each of our subsidiary companies has the potential to become a significant player in their particular industry sector.

 

As previously described, we believe that our structure, ecosystem and integrated capabilities create significant competitive advantages for each of our subsidiary companies, not available to other Software companies in the VR/AR space. By owning and operating a diverse set of VR/AR companies, we believe that we significantly improve each of our subsidiary company’s ability to succeed by addressing many of the challenges early stage companies face and expanding each’s opportunity set and capabilities.

 

32
 

 

We believe that there are a select number of earlier stage companies of approximately our size that provide VR/AR Software and could be viewed as potential competitors. In addition, several of the larger technology players provide general infrastructure VR/AR Software. In particular: ARCore from Google and ARKit from Apple, which enable AR functionality on smartphones and tablets; and Unity and Epic Unreal, which enable software languages used in VR and AR programing. We do not view these larger companies as competition, but rather as complementary to our business. We believe infrastructure software benefits us, and the industry at large, as they are not industry specific and enable companies like us to more effectively build industry specific solutions, thereby saving significant costs and development efforts.

 

Platform Expansion and Diversification Strategy

 

As described above in “Competitive Environment,” the VR/AR software and services industries are highly fragmented. There are numerous potential acquisition targets that, while having established a niche market position, product or technology, have limited resources and ability to pursue growth initiatives. We intend to leverage our position and relative scale in the industry in order to continue to add to our platform both earlier stage companies and technologies and, subject to the availability of capital and appropriate targets, more mature companies. Beyond the expected financial impact of each such potential addition, these could also enhance our ecosystem, technology, scale and competitive position. These potential acquisitions may be domestic or international. If there is sufficient scale in a certain geographic location (beyond our current NYC headquarters), then a new hub may be established in such location, with several subsidiary companies operating in that hub, under the overall Glimpse umbrella.

 

Strategic Divestitures

 

Each one of our subsidiary companies has the potential to be divested or spun off. Although the purpose of our platform is to grow and develop the ecosystem on which each of our subsidiaries can mature by benefitting from collaboration, each subsidiary company targets a specific industry vertical (i.e. Healthcare, Education, Corporate Training, etc.) and as such has a distinct set of potential acquirers or investors. If a subsidiary company is divested and the proceeds are substantive, then our intent is to distribute the majority of the net proceeds to our shareholder base, if such distribution would not jeopardize our growth and operations.

 

Intellectual Property

 

Our intellectual property is an integral part of our business strategy and practice. In accordance with industry practice, we protect our proprietary products, technology and competitive advantage through a combination of contractual provisions and trade secrets, patents, copyright and trademark laws in the United States and other jurisdictions where business is conducted.

 

As of the date of this disclosure and summarized in the table below, we have filed thirteen (13) patent applications, four (4) of which have been issued and one (1) allowed and registered with the United States Patent and Trademark Office (the “USPTO”).

 

33
 

 

Title of Invention   Subsidiary   Filing Date   Month Issued   Application Number   Docket Number   Confirmation Number   Expiration
                             
Issued Patent                      
                             
Interactive Mixed Reality System for a Real World Event   Pagoni VR   6/21/2018   Sep-19   16/014,956   P270977.US.02-503511-16   1537   6/21/2038
                             
Augmented Reality Geolocation Using Image Matching   KreatAR   8/22/2018   Dec-20   16/108,830   194445.001   3370   8/22/2038
                             
Immersive Display System with Adjustable Perspective   Pagoni VR   11/27/2018   Jul-20   16/201,863   194445.007   6423   11/27/2038
                             
System for Sharing User-Generated Content   Pagoni VR   6/12/2019   Aug-21   16/439,280   94445.00501   7323   6/12/2039
                             
Presenting a Simulated Reality Experience in a Present Location   Mezmos   6/14/2019   Nov-21   16/901,830   94445.01001   7386   6/14/2039
                             
Patent Applications                            
                             
Simulated Reality Data Representation System and Method   D6VR   2/2/2018                    
                             
Viewer Position Coordination in Simulated Reality   KreatAR   6/10/2019                    
                             
Virtual Reality System Cross Platform   Foretell Reality   4/23/2019                    
                             
Marker-Based Positioning of Simulated Reality   KreatAR   4/23/2019                    
                             
Presentation Interface and Immersion Platform   Pagoni VR   4/30/2019                    
                             
Simulated Reality Based Confidence Assessment   Adept Reality   6/6/2019                    
                             
Simulated Reality Risks Mitigation System   Adept Reality   7/19/2019                    
                             
Simulated Reality Adaptive User Space   Immersive Health Group   7/26/2019                    

 

34
 

 

We may continue to file for patents regarding various aspects of our products, services and technologies at a later date depending on the costs and timing associated with such filings. We may make investments to further strengthen our copyright protection going forward, although no assurances can be given that we will be successful in such patent and trademark protection endeavors. We seek to limit disclosure of our intellectual property by requiring employees, consultants, and partners with access to our proprietary information to execute confidentiality agreements and non-competition agreements (when applicable) and by restricting access to our proprietary information. Due to rapid technological change, we believe that establishing and maintaining an industry and technology advantage in factors such as the expertise and technological and creative skills of our personnel, as well as new services and enhancements to our existing services, are more important to our business and profitability than other available legal protections.

 

Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our services or to obtain and use information that we regard as proprietary. The laws of many countries do not protect proprietary rights to the same extent as the laws of the U.S. Litigation may be necessary in the future to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement. Any such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results and financial condition. There can be no assurance that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar services or products. Any failure by us to adequately protect our intellectual property could have a material adverse effect on our business, operating results and financial condition. See “Risk Factors—Risks Related to our Business.”

 

Business Cycles

 

Based on our history and information available to date, we have not been able to identify any seasonality of cycles within our business. Since VR/AR is an emerging industry, market and customer education are material and the length of the typical sales cycle can be between 3 and 18 months, depending on the size and complexity of the proposed solution and the customer’s level of understanding of the VR/AR space and prior experience.

 

Economic Dependence

 

Two customers accounted for approximately 70% (56% and 14%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2021. No other customer accounted for more than 10% of our revenues for the period. For the year ended June 30, 2021, one customer mentioned above accounted for approximately 27% of our revenues and a different customer from above accounted for another approximately 23% of our revenues. No other customer accounted for more than 10% of our revenues for the year ended June 30, 2021.

 

We operate in an early stage industry, and customers are exploring various options for AR and VR solutions and acting as early adopters of VR and AR solutions. As such, there is a high degree of variance on our source of revenues while customers are on-boarded and our software product and solutions are integrated, measured and digested. A customer that may account for a higher concentration of revenue in one period may not account for any revenue in subsequent periods. In some cases those customers could re-engage after they have evaluated our solutions and may or may not be a source of future revenue.

 

As such, customers that make up a significant portion of revenues in one period, often do not make up a significant portion in other periods. Given this dynamic, which has continued both prior and subsequent to the reported periods, we expect this variability in Customer Concentration to continue until such point in time when our revenue has reached larger scale, and with a larger portion of our revenues coming from Software Licenses/SaaS. While there has been consistent oscillation in Customer Concentration from period-to-period, a significant reduction in revenue from our larger customers could have a material negative impact on our operations.

 

35
 

 

Typically, customer contracts can be canceled at any time by the customer upon 30-90 day written notice (depending on the size of the contract). In such an event, the customer would owe the Company unpaid amounts up until the point of cancelation. We typically charge 25-50% of the contract value upfront and the amounts are usually not refundable, mitigating some of the contract cancellation risk. While it does happen on occasion, it is rare that a signed contract is canceled.

 

Facilities

 

We are based in New York, New York. Our current facilities are leased and adequate to meet our ongoing needs. If we require additional space or expand geographically, we may seek additional facilities on commercially reasonable terms at such time. Due to Covid-19 constraints, since March 2020 our personnel have been working primarily on a remote basis, without detrimental effects. We returned to partial in person work in July 2021 and expect to continue as such for the foreseeable future, subject to Covid-19 developments.

 

We also lease a small office in Izmir, Turkey for the operations of Glimpse Turkey.

 

Human Capital

 

We currently have approximately 90 full time employees and consultants, primarily software developers, engineers and 3D artists.

 

Corporate Information

 

Information contained on our websites, including www.theglimpsegroup.com, shall not be deemed to be part of this filing or incorporated herein by reference and should not be relied upon by prospective investors for the purposes of determining whether to invest in the Company.

 

Legal Proceedings

 

We are not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business or otherwise material to the financial condition of our business. None of our directors, officers or affiliates are involved in a proceeding adverse to our business or have a material interest adverse to our business.

 

Impact of COVID-19

 

In January 2020, an outbreak of a new strain of coronavirus, COVID-19, was identified in Wuhan, China. Through the first quarter of 2020, the disease became widespread around the world, and on March 11, 2020, the World Health Organization declared a pandemic. Our business and operations have been adversely affected by the COVID-19 pandemic, as have the markets in which our customers operate. The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.

 

In March 2020, we required substantially all of our employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit our ability to operate the business effectively. In the summer of 2021, we returned to non-remote, in-person office work, initially several days per week for our New York area based employees.

 

We continue to closely monitor the situation and the effects on our business and operations. While uncertainty remains, given the current state of the pandemic, our expected revenue growth and current cash balance, we do not expect the impact of COVID-19 on our business and operations to worsen going forward.

 

36
 

 

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS

 

You should read the following discussion and analysis of financial condition and results of operations in conjunction with our financial statements and related notes appearing elsewhere in this prospectus. In addition to historical information, the following discussion and analysis includes forward looking statements that involve risks, uncertainties and assumptions. Our actual results and the timing of events could differ materially from those anticipated in these forward looking statements as a result of a variety of factors, including those discussed in “Risk Factors” and elsewhere in this prospectus. See the discussion under “Special Note Regarding Forward Looking Statements” beginning on page 24 of this prospectus.

 

Significant Transactions

 

On July 1, 2021, we completed an initial public offering (“IPO”) of common stock and initial listing on the Nasdaq Capital Market under the symbol “VRAR”, at an initial public offering price of $7.00 per share. In conjunction with the IPO and the underwriter’s exercise of its over-allotment option, we sold 1,912,500 shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million.

 

In August 2021, we completed an acquisition of certain assets from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services to the Architecture, Engineering and Construction market segments. Initial consideration for the purchase was $0.75 million payable by the issuance of 77,264 shares of our common stock. Additional consideration in the form of our common stock shall be issued if certain future revenue growth targets are achieved.

 

In October 2021, we completed an acquisition of certain assets from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming. Initial consideration for the purchase is $0.60 million payable 50% in our common stock and 50% in cash. In October 2021, the Company paid $0.30 million cash and issued 33,877 shares of common stock to satisfy the purchase price. Additional consideration in the form of our common stock shall be issued if certain future revenue growth targets are achieved.

 

On November 2, 2021, we, pursuant to a securities purchase agreement, closed the sale of 1.50 million shares of common stock and warrants to purchase 0.75 million shares of common stock to certain institutional investors in a private placement. The warrants have an exercise price of $14.68 per share. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The gross proceeds to us from the private placement offering was approximately $13.6 million after deducting the placement agent’s fees and other offering expenses.

 

Overview

 

We are a Virtual (“VR”) and Augmented (“AR”) Reality platform company, comprised of a diversified group of wholly-owned and operated VR and AR companies, providing enterprise-focused software, services and solutions. We believe that we offer significant exposure to the rapidly growing and potentially transformative VR and AR markets, while mitigating downside risk via our diversified model and ecosystem.

 

37
 

 

We were incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016 and are headquartered in New York, New York. We currently own and actively operate eleven, wholly-owned subsidiary companies (“Subsidiary Companies”, “Subsidiaries”) as represented in the below organizational charts:

 

 

Impact of COVID-19

 

In January 2020, an outbreak of a new strain of coronavirus, COVID-19, was identified in Wuhan, China. Through the first quarter of 2020, the disease became widespread around the world, and on March 11, 2020, the World Health Organization declared a pandemic. Our business and operations have been adversely affected by the COVID-19 pandemic, as have the markets in which our customers operate. The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. While we demonstrated continued revenue growth in the three months ended September 30, 2021 and the year ended June 30, 2021, notwithstanding this growth, management believes growth could have been higher if not for the COVID-19 pandemic. As a result of the COVID-19 pandemic, we saw the length of our sale cycles generally increase by several months and some of our customers have put purchase decisions on hold, in particular customers in our hospital and education segments. While several of these delays have since materialized into contracts, it is yet to be determined whether outstanding delays are permanent. In other instances, customers have requested payment schedule extensions, but have eventually paid in full. We are encouraged by the passage of various U.S. Government assistance programs which may accelerate recovery, especially relating to hospitals and educational institutions.

 

Overall, our accounts receivable loss ratio was, and remains, nominal and revenue collection on signed and executed contracts has not been impacted. To date, we have not had to reduce headcount as a result of the COVID-19 pandemic. This is due to infusion of capital in May 2020 from a Paycheck Protection Program loan (PPP1) of approximately $548,000, an additional Paycheck Protection Program loan (PPP2) of approximately $623,000 in February 2021, and the overall performance of our business.

 

In March 2020, we required substantially all of our employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit our ability to operate the business effectively. In the summer of 2021, we returned to non-remote, in-person office work, initially several days per week for our New York area based employees.

 

We continue to closely monitor the situation and the effects on our business and operations. While uncertainty remains, given the current state of the pandemic, our expected revenue growth and current cash balance, we do not expect the impact of COVID-19 on our business and operations to worsen going forward.

 

38
 

 

The following information should be read in conjunction with our Consolidated Financial Statements and related notes contained in our Annual Report on Form 10-K.

 

Critical Accounting Policies and Estimates and Recent Accounting Pronouncements

 

Basis of Presentation

 

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). While our significant accounting policies are more fully described in our financial statements, we believe the following accounting policies are the most critical to aid in fully understanding and evaluating this management discussion and analysis.

 

Principles of Consolidation

 

The consolidated financial statements include the balances of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Accounting Estimates

 

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options and cost of goods sold.

 

Revenue Recognition

 

The Company adopted the new accounting standard, Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, (“ASC 606”) beginning on July 1, 2020 using the modified retrospective method for all open contracts and related amendments. The adoption did not result in an adjustment to the accumulated deficit as of September 30, 2021. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods. The adoption of ASC 606 did not have a material impact on reported sales to customers and net earnings (losses).

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract; and
  recognize revenue as the performance obligation is satisfied and collection is reasonably assured.

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.

 

39
 

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

Significant Judgments

 

The Company’s customer contracts may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generates revenue by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software License and SaaS, consisting primarily of VR and AR software licenses or SaaS.

 

Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.

 

Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

The Company currently generates its revenues primarily from customers in the United States.

 

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of September 30, 2021, no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the nascent industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

40
 

 

Recently Issued Pronouncements

 

Leases

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (Topic 842). The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company does not expect to adopt this standard prior to July 1, 2022. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Financial Instruments – Credit Losses

 

In June 2016, the Financial Accounting Standards Board (the “FASB”) issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates (Accounting Standards Codification – “ASC” 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. As an emerging growth company, the Company does not expect to adopt this standard prior to July 1, 2023.

 

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Results Of Operations For The Three Months Ended September 30, 2021 And 2020

 

The following table sets forth our results of operations for the three months ended September 30, 2021 and 2020:

 

   For the Three Months Ended September 30,   Change 
   2021   2020   $   % 
   (in millions)     
Revenue  $1.02   $0.26   $0.76    292%
Cost of Goods Sold   0.15    0.14    0.01    7%
Gross Profit   0.87    0.12    0.75    625%
Total Operating Expenses   2.27    1.36    0.91    67%
Loss from Operations before Other Income and Expense   (1.40)   (1.24)   (0.16)   13%
Other Income and Expense, net   (0.26)   (0.04)   (0.22)   550%
Net Loss  $(1.66)  $(1.28)  $(0.38)   30%

 

41
 

 

Revenues

 

  

For the Three Months Ended

September 30,

   Change 
   2021   2020   $   % 
   (in millions)     
Software Services  $0.80   $0.19   $0.61    321%
Software License/Software as a Service   0.22    0.07    0.15    214%
Total Revenue  $1.02   $0.26   $0.76    292%

 

Total revenue for the three months ended September 30, 2021 was approximately $1.02 million compared to approximately $0.26 million for the three months ended September 30, 2020, an increase of 292%. This growth was primarily due to the addition of new customers.

 

We break out our revenues into two main categories – Software Services and Software License.

 

  Software Services revenues are primarily comprised of VR/AR projects, services related to our software licenses and consulting retainers.
     
  Software License revenues are comprised of the sale of our internally developed VR/AR software as licenses or as software-as-a-service (“SaaS”).

 

For the three months ended September 30, 2021, Software Services revenue was approximately $0.80 million compared to approximately $0.19 million for the three months ended September 30, 2020, an increase of approximately 321%. This growth was primarily due to the addition of new customers.

 

For the three months ended September 30, 2021, Software License revenue was approximately $0.22 million compared to approximately $0.07 for the three months ended September 30, 2020, an increase of approximately 214%. As the VR and AR industries continue to mature, we expect our Software License revenue to continue to grow on an absolute basis and as an overall percentage of total revenue.

 

For the three months ended September 30, 2021, non-project revenue (i.e., VR/Software and services revenue only), was approximately $0.86 million compared to approximately $0.14 million for the three months ended September 30, 2020, an increase of approximately 514%. For the three months ended September 30, 2021, non-project revenue accounted for approximately 84% of total revenues compared to approximately 54% for the three months ended September 30, 2020.

 

Customer Concentration

 

Two customers accounted for approximately 70% (56% and 14%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2021. Four different customers accounted for approximately 53% (19%, 13%, 11% and 10%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2020.

 

We operate in an early stage industry, and customers are exploring various options for AR and VR solutions and acting as early adopters of VR and AR solutions. As such, there is a high degree of variance on our source of revenues while customers are on-boarded and our software product and solutions are integrated, measured and digested. A customer that may account for a higher concentration of revenue in one period may not account for any revenue in subsequent periods. In some cases those customers could re-engage after they have evaluated our solutions and may or may not be a source of future revenue. As such, customers that make up a significant portion of revenues in one period, often do not make up a significant portion in other periods. Given this dynamic, which has continued both prior and subsequent to the reported periods, we expect this variability in Customer Concentration to continue until such point in time when our revenue has reached larger scale, and with a larger portion of our revenues coming from Software Licenses/SaaS. Due to the consistent oscillation in Customer Concentration from period-to-period, we do not view Customer Concentration as a material issue at this time.

 

42
 

 

Gross Profit

 

  

For the Three Months Ended

September 30,

   Change 
   2021   2020   $   % 
   (in millions)     
Revenue  $1.02   $0.26   $0.76    292%
Cost of Goods Sold   0.15    0.14    0.01    7%
Gross Profit  $0.87   $0.12   $0.75    625%
Gross Profit Margin   85%   46%          

 

Gross profit was approximately 85% for the three months ended September 30, 2021 compared to approximately 46% for the three months ended September 30, 2020. The increase was driven by the increase in non-project revenue which produces higher margin and improved management of project revenue costs of goods sold.

 

Operating Expenses

 

Operating expenses for the three months ended September 30, 2021 were approximately $2.27 million compared to $1.36 million for the three months ended September 30, 2020, an increase of approximately 67%. This increase was driven by increased employee headcount to support growth and the incurrence of expenses specific to Glimpse being a publicly traded company.

 

Research and Development

 

Research and development expenses for the three months ended September 30, 2021 were approximately $0.99 million compared to $0.74 million for the three months ended September 30, 2020, an increase of approximately 34%. This reflects increased use of fulltime employee headcount. Going forward, we expect research and development costs to continue to increase as we continue to develop and commercialize our software products.

 

For the three months ended September 30, 2021, non-cash stock option expenses relating to research and development included approximately $0.35 million of employee compensation expenses, comprising approximately 35% of total research and development expenses. For the three months ended September 30, 2020, non-cash stock option expenses relating to research and development included approximately $0.40 million of employee compensation expenses, comprising approximately 54% of total research and development expenses. Over time, we expect non-cash stock options and common stock research and development expenses, as a percentage of the total related expenses, to continue to decrease as we utilize a larger portion of cash for compensation.

 

General and Administrative

 

General and administrative expenses for the three months ended September 30, 2021 were approximately $0.78 million compared to $0.34 million for the three months ended September 30, 2020, an increase of approximately 129%. The increase reflects additional headcount, related cash compensation and other expenses to build infrastructure to support the operations of a public company (i.e., public company directors & officers liability insurance, investor relation and public listing fees, additional legal and accounting fees, and additional independent board members).

 

For the three months ended September 30, 2021, non-cash stock option and common stock expenses relating to general and administrative expenses included approximately $0.22 million of employee, board of directors and other compensation expenses, comprising approximately 28% of total general and administrative expenses. For the three months ended September 30, 2020, non-cash stock option and common stock expenses relating to general and administrative expenses included approximately $0.14 million of employee, board of directors and other compensation expenses, comprising approximately 41% of total general and administrative expenses. Over time, we expect non-cash stock options and common stock general and administrative expenses, as a percentage of the total related expenses, to continue to decrease as we utilize a larger portion of cash for compensation.

 

43
 

 

Sales and Marketing

 

Sales and marketing expenses for the three months ended September 30, 2021 were approximately $0.50 million compared to $0.29 million for the three months ended September 30, 2020, an increase of approximately 72%. The increase was driven by an employee bonus related to year-to-date revenue milestones met during the current quarter and internal reallocations between operating functions. As our subsidiary companies continue to establish initial market traction and grow their revenue base, we expect to increase our business development and sales expenses.

 

For the three months ended September 30, 2021, non-cash stock option and common stock expenses relating to sales and marketing expenses included approximately $0.13 million of employee compensation expense, comprising approximately 26% of total sales and marketing expenses. For the three months ended September 30, 2020, non-cash stock option and common stock expenses relating to sales and marketing expenses included approximately $0.11 million of employee, vendor and fee compensation expenses, comprising approximately 38% of total sales and marketing expenses. This non-cash period-to-period decrease reflects cash bonus compensation representing a greater percentage of total sales and marketing expense.

 

Other Income and Expense, net

 

Other income and expense, net for the three months ended September 30, 2021, was an expense of $0.26 million as compared to an expense of $0.04 million during the prior period, an increase in expense of $0.22 million. This increase primarily reflects the $0.28 million non-cash loss on conversion of convertible notes to common stock as a result of the July 1, 2021 initial public offering, offset by a decrease of approximately $0.05 million in non-cash interest expense on the notes in the prior period.

 

Net Losses

 

We sustained a net loss of $1.66 million for the three months ended September 30, 2020 as compared to a net loss of $1.28 million for the prior period, a loss increase of $0.38 million or 30%. This reflects a period-over-period increase in revenue and related gross profit, offset by an increase in operating expenses and the incurrence of a non-cash loss on conversion of convertible notes to common stock as a result of the July 1, 2021 initial public offering and a decrease in non-cash interest expense.

 

Non-GAAP Financial Measures

 

The following discussion and analysis includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to, net income, operating income, and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of the Company nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP. Our management uses and relies on EBITDA and Adjusted EBITDA, which are non-GAAP financial measures. We believe that both management and shareholders benefit from referring to the following non-GAAP financial measures in planning, forecasting and analyzing future periods.

 

Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the described excluded items.

 

The Company defines Adjusted EBITDA as earnings (or loss) from continuing operations before the items in the table below. Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period-to-period after removing the impact of items of a non-operational nature that affect comparability.

 

44
 

 

We have included a reconciliation of our financial measures calculated in accordance with GAAP to the most comparable non-GAAP financial measures. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between the Company and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measures and the corresponding GAAP measures provided by each company under applicable SEC rules.

 

The following table presents a reconciliation of net loss to Adjusted EBITDA for the three months ended September 30, 2021 and 2020:

 

  

For the Three Months Ended

September 30,

 
   2021   2020 
   (in millions) 
Net loss  $(1.66)  $(1.28)
Interest expense, net   -    0.05 
Depreciation and amortization   0.03    0.01 
EBITDA (loss)   (1.63)   (1.22)
Stock based compensation expenses   0.72    0.70 
Stock based financing related expenses   0.28    - 
Public company expenses   0.18    - 
Acquisition related expenses   0.01    - 
Adjusted EBITDA (loss)  $(0.44)  $(0.52)

 

Adjusted EBITDA loss for the three months ended September 30, 2021 improved by $0.08 million, or approximately 15%, as compared to that of the three months ended September 30, 2020.

 

Results Of Operations For The Years Ended June 30, 2021 And 2020

 

Summary P&L:

 

  

For the Year Ended June 30,

   Change 
   2021   2020   $   % 
   (in millions) 
Revenue  $3.42   $1.95   $1.47    75%
Cost of Goods Sold   1.46    1.14    0.32    28%
Gross Profit   1.96    0.81    1.15    142%
Total Operating Expenses   6.67    5.73    0.94    16%
Loss from Operations before Other Income and Expense   (4.71)   (4.92)   0.21    -4%
Other Income and Expense, net   (1.38)   (0.07)   (1.31)   1871%
Net Loss  $(6.09)  $(4.99)  $(1.10)   22%

 

45
 

 

Revenue

 

  

For the Year Ended June 30,

   Change 
   2021   2020   $   % 
   (in millions) 
Software Services  $3.08   $1.78   $1.30    73%
Software License/Software as a Service   0.34    0.17    0.17    100%
Total Revenue  $3.42   $1.95   $1.47    75%

 

Total revenue for the year ended June 30, 2021 was approximately $3.42 million compared to approximately $1.95 million for the year ended June 30, 2020, an increase of approximately 75%. This growth was due to the addition of new customers and increased business with some of our existing customers.

 

We break out our revenues into two main categories – Software Services and Software License.

 

  Software Services revenues are primarily comprised of VR/AR projects, services related to our software licenses and consulting retainers.
     
  Software License revenues are comprised of the sale of our internally developed VR/AR software as licenses or as software-as-a-service (“SaaS”).

 

For the year ended June 30, 2021, Software Services revenue was approximately $3.08 million compared to approximately $1.78 million for the year ended June 30, 2020, an increase of approximately 73%. This growth was due to the addition of new customers and increased business with some of our existing customers.

 

For the year ended June 30, 2021, Software License revenue was approximately $0.34 million compared to approximately $0.17 for the for the year ended June 30, 2020, an increase of approximately 100%. As the VR and AR industries continue to mature, we expect our Software License revenue to continue to grow on an absolute basis and as an overall percentage of total revenue.

 

For the year ended June 30, 2021, non-project revenue (i.e. VR/AR software and services revenue only), was approximately $1.73 million compared to approximately $0.51 million for the year ended June 30, 2020, an increase of approximately 239%. For the year ended June 30, 2021, non-project revenue accounted for approximately 50.6% of total revenues compared to approximately 26.1% for the year ended June 30, 2020.

 

Cost of Revenue

 

Cost of revenue for the year ended June 30, 2021 was $1.46 million compared to $1.14 million for the year ended June 30, 2020, an increase of approximately 28%. Cost of revenue was driven by the increase in revenue and primarily attributable to internal staffing costs and, to a lesser degree, third-party expenses.

 

For the year ended June 30, 2021, our gross profit was approximately $1.96 million representing a gross profit margin of approximately 57%, compared to a gross profit of approximately $0.81 million representing a gross profit margin of approximately 42% for the year ended June 30, 2020. The increase in gross profit margin was primarily due to an increase in services and Software License revenue, improved project management and higher utilization of internal staff. Our cash-based gross profit margin, excluding stock option based cost of revenue expenses, was approximately 74% for the year ended June 30, 2021 compared to approximately 53% for the year ended June 30, 2020.

 

For the year ended June 30, 2021 and 2020, internal staffing was approximately $1.35 million (92% of total Cost of Revenue) and approximately $1.02 million (89% of total Cost of Revenue), respectively. As we expand our internal headcount of engineers, software developers and 3D artists we have had less of a need for more expensive external staffing – a benefit of increased scale in the business.

 

46
 

 

Operating Expenses

 

Operating expenses for the year ended June 30, 2021 were approximately $6.67 million compared to $5.73 million for the year ended June 30, 2020, an increase of approximately 16%, primarily due to increases in research and development and general and administrative expenses, partially offset by a decrease in sales and marketing expense.

 

Sales and Marketing

 

Sales and marketing expenses for the year ended June 30, 2021 were approximately $1.27 million compared to $1.46 million for the year ended June 30, 2020, a decrease of approximately 13%. The decrease was primarily due to reduced commission expenses and internal reallocations between operating functions. As our subsidiary companies continue to establish initial market traction and grow their revenue base, we expect to increase our business development and sales expenses.

 

For the year ended June 30, 2021, non-cash stock option and common stock expenses relating to sales and marketing included approximately $0.57 million of employee, vendor and fee compensation expenses, comprising approximately 45% of total sales and marketing expenses. For the year ended June 30, 2020, non-cash stock option and common stock expenses relating to sales and marketing included approximately $0.35 million of employee, vendor and fee compensation expenses, comprising approximately 24% of total sales and marketing expenses. This non-cash period-to-period increase was primarily due to the hiring of temporary staff, which were compensated with stock options only.

 

Research and Development

 

Research and development expenses for the year ended June 30, 2021 were approximately $3.18 million compared to $2.43 million for the year ended June 30, 2020, an increase of approximately 31%. Going forward, we expect research and development costs to continue to increase as we continue to develop and commercialize our software products.

 

For the year ended June 30, 2021, non-cash stock option expenses relating to research and development included approximately $1.38 million of employee compensation expenses, comprising approximately 43% of total research and development expenses. For the year ended June 30, 2020, non-cash stock option expenses relating to research and development included approximately $1.27 million of employee compensation expenses, comprising approximately 52% of total research and development expenses. Over time, we expect non-cash stock options and common stock research and development expenses, as a percentage of the total related expenses, to continue to decrease as we utilize a larger portion of cash in compensation.

 

General and Administrative

 

General and administrative expenses for the year ended June 30, 2021 were approximately $2.22 million compared to $1.84 million for the year ended June 30, 2020, an increase of approximately 21%. Increases in cash compensation, headcount and executive bonuses were offset by decreases in non-cash stock and option compensation and goodwill impairment.

 

For the year ended June 30, 2021, non-cash stock option and common stock expenses relating to general and administrative included approximately $0.70 million of employee, board of directors and other compensation expenses, comprising approximately 31.5% of total general and administrative expenses. For the year ended June 30, 2020, non-cash stock option and common stock expenses relating to general and administrative expenses included approximately $0.92 million of employee, board of directors and other compensation expenses, comprising approximately 50.0% of total general and administrative expenses. Over time, we expect non-cash stock options and common stock general and administrative expenses, as a percentage of the total related expenses, to continue to decrease as we utilize a larger portion of cash in compensation.

 

47
 

 

Other Income (Expenses)

 

Other income (expenses), net for the year ended June 30, 2021 consisted of other net expenses of approximately $1.38 million compared to other net expenses of approximately $0.07 million for the year ended June 30, 2020, an increase of greater than 1,000%. The increase was primarily due to non-cash expenses of approximately $1.25 million of accrued expenses relating to past acquisitions, triggered by the Company’s July 1, 2021 IPO, $0.52 million in non- cash expenses due to conversions of unsecured convertible promissory notes, and $0.18 million non-cash interest expense on the Company’s unsecured convertible promissory notes. These expenses were offset by non-cash income of approximately $0.55 million related to the full forgiveness of the Company’s Paycheck Protection Program (PPP1) loan.

 

Net loss

 

For the year ended June 30, 2021, we incurred a net loss from operations of approximately $4.71 million compared to a net loss of approximately $4.92 million for the year ended June 30, 2020, an improvement of approximately 4% year-over-year, primarily driven by increases in revenues and profit margins which outpaced an increase in operating expenses.

 

For the year ended June 30, 2021, we incurred a net loss of approximately $6.09 million compared to a net loss of approximately $4.99 million for the year ended June 30, 2020, a decline of approximately 22% year-over-year, primarily driven by an increase in other expenses which were primarily one time in nature.

 

48
 

 

Non-GAAP Financial Measures

 

The following table presents a reconciliation of net loss to Adjusted EBITDA for the years ended June 30, 2021 and 2020:

 

   For the Year Ended June 30, 
   2021   2020 
   (in millions) 
Net loss  $(6.09)  $(4.99)
Interest expense, net   0.17    0.07 
Depreciation and amortization   0.03    0.02 
EBITDA (loss)   (5.89)   (4.90)
Forgiveness of PPP1 Loan and other   (0.56)   - 
Stock based compensation expenses   3.08    2.66 
Stock based financing related expenses   0.52    - 
Stock based acquisition related expenses   1.35    0.12 
Goodwill impairment   -    0.14 
Adjusted EBITDA (loss)  $(1.50)  $(1.98)

 

Fiscal Year 2021 Adjusted EBITDA loss improved by $0.48 million, or 24%, compared to that of Fiscal Year 2020.

 

Off-Balance Sheet Arrangements

 

We have not entered into any off-balance sheet transactions, arrangements or other relationships with unconsolidated entities or other persons.

 

Liquidity and Capital Resources

 

  

For the Three Months Ended

September 30,

   Change 
   2021   2020   $   % 
   (in millions) 
Net cash used in operating activities  $(1.05)  $(0.16)  $(0.89)   -556%
Net cash used in investing activities   (0.02)   (0.02)   -    0%
Net cash provided by financing activities   11.87    0.01    11.86    118600%
Net increase (decrease) in cash and cash equivalents   10.80    (0.17)   10.97    6453%
Cash and cash equivalents, beginning of year   1.78    1.04    0.74    71%
Cash and cash equivalents, end of period  $12.58   $0.87   $11.71    1346%

 

Operating Activities

 

Net cash used in operating activities was $1.05 million for the three months ended September 30, 2021, compared to $0.16 million during the prior period, an increase of approximately $0.89 million. This primarily reflects an increase in net loss of approximately $0.38 million, a decrease in deferred revenue/deferred costs of approximately $0.38 million and one-time cash payments of approximately $0.49 million related to Glimpse becoming a public company; offset by the non-cash loss on conversion of convertible notes of approximately $0.28 million.

 

Investing Activities

 

During the three months ended September 30, 2021, net cash used in investing activities was approximately $0.02 million, consistent to the prior period.

 

49
 

 

Financing Activities

 

Cash flow provided from financing activities during the three months ended September 30, 2021 was $11.87 million, primarily reflecting the net proceeds from our IPO. Financing activities were negligible during the same period of the prior year.

 

   For the Year Ended June 30,   Change 
   2021   2020   $   % 
   (in millions) 
Net cash used in operating activities  $(1.21)  $(2.02)  $0.81    40%
Net cash used in investing activities   (0.03)   (0.03)   -    0%
Net cash provided by financing activities   1.97    1.89    0.08    4%
Net increase (decrease) in cash and cash equivalents   0.73    (0.16)   0.89    556%
Cash and cash equivalents, beginning of year   1.04    1.20    (0.16)   -13%
Cash and cash equivalents, end of period  $1.77   $1.04   $0.73    70%

 

Operating activities

 

Net cash used in operating activities for the year ended June 30, 2021 was approximately $1.21 million, compared to approximately $2.02 million for the year ended June 30, 2020, an improvement of approximately 40% driven by increased revenues and cash gross margins, along with increases in non-cash compensation expenses in lieu of cash payments. We expect net cash from operating activities to be negative in the coming periods, however it should continue to improve as our revenue increases and economies of scale improve.

 

Investing activities

 

Net cash used in investing activities was approximately $0.03 million for both years ended June 30, 2021 and 2020. In both years our investing activities were primarily comprised of purchases of computer equipment.

 

Financing activities

 

Net cash provided by financing activities for the year ended June 30, 2021 was approximately $1.97 million, comprised of: issuance of $1.475 million of unsecured Convertible Promissory Notes 2, a $0.624 million Paycheck Protection Program (“PPP2”) loan and approximately $0.346 million from the issuance of common stock to investors at $4.50 per share. These were partially offset by approximately $0.47 million in financing costs related to the IPO.

 

Net cash provided by financing activities for the year ended June 30, 2020 was approximately $1.89 million, primarily comprised of the issuance of approximately $1.33 million of unsecured Convertible Promissory Notes 1 and a $0.55 million Paycheck Protection Program (“PPP1”) loan.

 

Capital Resources

 

As of September 30, 2021 the Company had cash and cash equivalent balances of $12.6 million. In addition, on November 2, 2021, $13.6 million in net cash was raised from the sale of 1.50 million shares of common stock and warrants to purchase 0.75 million shares of common stock. As of November 15, 2021, the Company had cash and cash equivalent balances in excess of $25.0 million.

 

As of September 30, 2021 the Company had no outstanding debt obligation except for a $0.62 million Paycheck Protection Program 2 loan expected to be fully forgiven in the coming months.

 

As of September 30, 2021 the Company had no issued and outstanding preferred stock.

 

The Company believes that it is sufficiently funded to meet its operational plan and future obligations beyond the 12-month period from the date of this filing.

 

50
 

 

Recently Adopted Accounting Pronouncements

 

Please see Note 3 of our June 30, 2021 consolidated financial statements that describe the impact, if any, from the adoption of Recent Accounting Pronouncements.

 

Estimated Cash Requirements over the Next Twelve Months

 

We continue to strive to approach operational cash break-even from our existing operations. Our estimated cash operating expense requirements over the next 12 months for our existing operations is approximately $8.4 million. However, this amount does not take into account any incoming revenue collections or potential proceeds from investment capital, either of which may match or exceed this amount. In addition, our current cash balance significantly exceeds our operational cash requirements over the next 12 months. Lastly, over 80% of our costs are variable (headcount related) and, if needed, we have a high degree of flexibility to reduce costs as needed.

 

An element in our future growth strategy are potential acquisitions. Historically, the purchase price of our acquisitions was primarily equity based. Going forward, while equity is expected to continue to be a primary source of payment in any acquisition we may make, we may also utilize some portion of cash in an acquisition.

 

Emerging Growth Company Status

 

We are an “emerging growth company”, as defined in the JOBS Act, and, for as long as we continue to be an emerging growth company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to emerging growth companies, including, but not limited to, not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As an emerging growth company we can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We intend to avail ourselves of these options. Once adopted, we must continue to report on that basis until we no longer qualify as an emerging growth company.

 

We will cease to be an emerging growth company upon the earliest of: (i) the end of the fiscal year following the fifth anniversary of our initial public offering; (ii) the first fiscal year after our annual gross revenues are $1.07 billion or more; (iii) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities; or (iv) the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year. We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. If, as a result of our decision to reduce future disclosure, investors find our common stock less attractive, there may be a less active trading market for our common stock and the price of our common stock may be more volatile.

 

MANAGEMENT

 

The following table sets forth information for our executive officers and directors, their ages and position(s) with the Company.

 

Name   Age   Position
Executive Officers        
Lyron Bentovim   52   President, Chief Executive Officer and Chairman of the Board
Maydan Rothblum   48   Chief Operating Officer, Chief Financial Officer, Secretary, Treasurer, and Director
D.J. Smith   46   Chief Creative Officer and Director
Non-Executive Directors        
Sharon Rowlands   63   Independent Director and Chair of Compensation Committee
Jeff Enslin   55   Independent Director and Chair of Audit Committee
Lemuel Amen   56   Independent Director
Alexander Ruckdaeschel   49   Independent Director

 

Directors are elected and hold office until the next annual meeting of the stockholders of the Company and until their successors are elected. Officers are elected and serve at the discretion of the Board of Directors.

 

51
 

 

Executive Officers

 

Lyron Bentovim has been President and Chief Executive Officer since he co-founded the Company in 2016. From July 2014 to August 2015, Mr. Bentovim was Chief Operating Officer and Chief Financial Officer of Top Image Systems, a Nasdaq-listed company. From March 2013 to July 2014, Mr. Bentovim served as Chief Operating Officer and Chief Financial Officer of NIT Health and Chief Operating Officer and Chief Financial Officer and Managing Director at Cabrillo Advisors. From August 2009 until July 2012, Mr. Bentovim served as the Chief Operating Officer and Chief Financial Officer of Sunrise Telecom, Inc. a Nasdaq-listed company. Prior to Sunrise Telecom, Inc., from January 2002 to July 2009, Mr. Bentovim was a Portfolio Manager for Skiritai Capital LLC, an investment advisor. Prior to Skiritai Capital LLC, Mr. Bentovim served as the President, Chief Operating Officer and co-founder of WebBrix, Inc. Mr. Bentovim serves on the board of directors of Manhattan Bridge Capital, a Nasdaq-listed company, and has served on the board of directors of the following publicly traded companies: Blue Sphere, RTW Inc., Ault, Inc., Top Image Systems Ltd., Three-Five Systems Inc., Sunrise Telecom Inc., and Argonaut Technologies Inc. Additionally, Mr. Bentovim was a Senior Engagement Manager with strategy consultancies USWeb/CKS, Mitchell Madison Group LLC and McKinsey & Company Inc. Mr. Bentovim has an MBA from Yale School of Management and a law degree from the Hebrew University, Israel.

 

Maydan Rothblum has been Chief Operating Officer and Chief Financial Officer since he co-founded the Company in 2016 and a member of our board of directors since July 2021. From 2004 to 2016, Mr. Rothblum served as the co-founder, Managing Director and Chief Operating Officer of Sigma Capital Partners, a middle-market private equity firm focused on making negotiated investments directly onto the balance sheets of, primarily, small-to-mid sized publicly traded technology companies. In addition to his role as principal investor, Mr. Rothblum oversaw the fund’s portfolio, managed the fund’s day-to-day operations and financial reporting. Prior to working at Sigma Capital Partners, Mr. Rothblum held positions at Apax Partners, a global private equity fund, and Booz, Allen & Hamilton, a global strategic consultancy. Additionally, Mr. Rothblum served as an Engineer for the Israel Defense Forces. Mr. Rothblum holds an MBA from Columbia Business School and a BS in Industrial Engineering and Management from the Technion - Israel Institute of Technology.

 

D.J. Smith has been the Chief Creative Officer since he co-founded the company in 2016. Since June 2016, Mr. Smith has served as the co-founder and Organizer of NYVR Meetup. Prior to co-founding the Company, Mr. Smith served as the Senior Project Manager at Avison Young, where he managed construction and real estate development projects. From April 2016 to August 2020, Mr. Smith was the Founder of VRTech Consulting LLC, which provided consulting for real estate development projects and virtual reality. Mr. Smith holds a B.S. in Civil Engineering from Pennsylvania State University.

 

Sharon Rowlands has served as a member of our board of directors since October 2017. She has also served as Chair of the Company’s Compensation Committee since October 2018. She has been the Chief Executive Officer and President of Newfold Digital (previously Web.com) since 2019. She has served on the board of directors of Everbridge, Inc., a Nasdaq-listed company, since 2019. Additionally, she has served on the board of directors of Pegasystems Inc., a Nasdaq-listed company, since April 2016. She served as President of USA Today Network Marketing Solutions at Gannett Co., a Nasdaq-listed company, from October 2017 to January 2019. Previously, Ms. Rowlands served as the Chief Executive Officer and member of the Board of Directors of ReachLocal, Inc., a Nasdaq-listed company, from April 2014 to January 2019. From November 2011 to December 2013, she was the Chief Executive Officer and member of the Board of Directors of Altegrity, Inc. From October 2008 to November 2011, Ms. Rowlands was the Chief Executive Officer of Penton Media, Inc. From 1997 to 2008, Ms. Rowlands held a variety of roles including Chief Executive Officer from 2005 to 2008, at Thomson Financial Inc. Ms. Rowlands received her post graduate certificate in education from the University of London and her Bachelor of Arts in History from the University of Newcastle.

 

52
 

 

Jeff Enslin has served as a member our board of directors since July 2018. He has also served as Chair of the Company’s Audit Committee since October 2018. From 1995 to 2018, Mr. Enslin was a senior partner and senior portfolio manager at Caxton Associates LP, a macro-focused hedge fund. Mr. Enslin is the founder and managing member of Perimetre Capital LLC since 2018, where he actively manages a wide portfolio of early stage technology investments. Mr. Enslin has served on the Investment Committees at Lehigh University (2010 to 2019) and the Peddie School (2010 to present, Advisory Trustee). Mr. Enslin is an active mentor at both Creative Destruction Labs and Endless Frontier Labs. Mr. Enslin received his MBA in finance and international business from New York University’s Stern School of Business and his B.S. in Finance from Lehigh University.

 

Lemuel Amen has served as a member of our board of directors since May 2021. He is the Founder and Chairman of Altius Manufacturing Group, LLC, an equity growth management firm, and has held senior executive positions and led global business units for Electronic Data Systems (EDS) and 3M. Mr. Amen has served on the board of directors for a privately held technology firm, AbeTech Inc., since 2009, and on the board of advisors of a privately held industrial firm, Diversified Chemical Technology, Inc., since 2018. Additionally, Mr. Amen is an experienced board governance professional serving high-growth technology, industrial services, and application software firms. Prior board governance service positions include: Chairman of the board of directors for Viking Engineering and Development Inc. (2011 to 2017); board director and operating committee member for Bauer Welding & Metal Fabricators, Inc. (2013 to 2016); and board President and lead director for HighJump Software, Inc. (2005 to 2008). Mr. Amen served as Chairman for the Federal Reserve Bank of Minneapolis, Ninth District Advisory Council from 2012 to 2015. Additional governance and board director service post includes: University of Michigan – Dearborn, College of Business, Board of Advisors (2019 to present); State of Minnesota Governor’s Workforce Development Council (2016 to 2019); Ordway Center for the Performing Arts (2015 to 2018); Junior Achievement Worldwide Inc., Global Board of Directors (2003 to 2008); and Northwestern University, McCormick School of Engineering & Computer Science, Industrial Advisory Board (2000 to 2006). Mr. Amen earned his M.S. in Civil and Environmental Engineering from Northwestern University, and his B.S. in Mechanical Engineering at California State University-Northridge.

 

Alexander Ruckdaeschel has served as a member of our board of directors since July 2021. Mr. Ruckdaeschel has worked in the financial industry for over 20 years in the U.S. and Europe as a co-founder, partner and senior executive. Since 2012 and until recently, he served on the board of directors of Vuzix, a Nasdaq listed company and a leading supplier of smart glasses and AR technology products and services and was the Chairman of Vuzix’s compensation committee. Mr. Ruckdaeschel co-founded Herakles Capital Management and AMK Capital Advisors in 2008. He was also a partner with Alpha Plus Advisors and Nanostart AG, where he was the head of their U.S. group. Mr. Ruckdaeschel has significant experience in startup operations as the manager of DAC Nanotech-Fund and Biotech-Fund, and sits on several boards. Following service in the German military, Mr. Ruckdaeschel was a research assistant at Dunmore Management focusing on intrinsic value and identifying firms that were undervalued and had global scale potential.

 

Committees of Our Board of Directors

 

Our board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee. The composition and responsibilities of each of the committees of our board of directors are described below. Members serve on these committees until their resignation or until otherwise determined by our board of directors. Our board of directors may establish other committees as it deems necessary or appropriate from time to time.

 

Audit Committee

 

Our audit committee consists of Jeff Enslin, Lemuel Amen and Sharon Rowlands. The chair of our audit committee is Jeff Enslin. Our board of directors has determined that Jeff Enslin is an “audit committee financial expert” within the meaning of SEC regulations. Each member of our audit committee can read and understand fundamental financial statements in accordance with applicable requirements. In arriving at these determinations, our board of directors has examined each audit committee member’s scope of experience and the nature of their employment. The Board has affirmatively determined that each member of the Audit Committee meets the additional independence criteria applicable to audit committee members under Nasdaq and SEC rules.

 

The primary purpose of our audit committee is to provide assistance to the board of directors in fulfilling its oversight responsibility to the shareholders and others relating to (1) the integrity of the Company’s financial statements, (2) the effectiveness of the Company’s internal control over financial reporting, (3) the Company’s compliance with legal and regulatory requirements, and (4) the independent auditor’s qualifications and independence. Specific responsibilities of our audit committee include:

 

  Reviewing and reassessing the charter at least annually and obtaining the approval of the board of directors;
     
  Reviewing and discussing quarterly and annual audited financial statements;
     
  Discussing the Company’s policies on risk assessment and risk management;
     
  Discussing with the independent auditor the overall scope and plans for their audit, including the adequacy of staffing and budget or compensation; and
     
  Reviewing and approving related party transactions;

 

53
 

 

Our Audit Committee previously operated under a written charter, adopted by our board of directors on November 21, 2018. On April 14, 2021, the Board approved the adoption of our Amended and Restated Audit Committee Charter. Our Audit Committee now operates under the Amended and Restated Audit Committee Charter. Our Audit Committee will review and reassess the adequacy of the written charter on an annual basis.

 

Compensation Committee

 

Our compensation committee consists of Sharon Rowlands, Lemuel Amen and Jeff Enslin. The chair of our compensation committee is Sharon Rowlands. The Board has affirmatively determined that each member of the Compensation Committee meets the additional independence criteria applicable to compensation committee members under Nasdaq and SEC rules.

 

The primary purpose of our compensation committee is to discharge the responsibilities of our board of directors with respect to all forms of compensation for the Company’s executive officers and to administer the Company’s equity incentive plan for employees. Specific responsibilities of our compensation committee include:

 

  Reviewing and overseeing the Company’s overall compensation philosophy, and overseeing the development and implementation of compensation programs aligned with the Company’s business strategy;
     
  Determining the form and amount of compensation to be paid or awarded to the Chief Executive Officer (“CEO”) and all other executive officers of the Company;
     
  Annually reviewing and approving all matters related to CEO compensation;
     
  Reviewing, adopting, amending, and terminating incentive compensation and equity plans, severance agreements, profit sharing plans, bonus plans, change-of-control protections, and any other compensatory arrangements for our executive officers and other senior management; and
     
  Reviewing and establishing general policies relating to compensation and benefits of our employees, including our overall compensation philosophy.

 

Our Compensation Committee previously operated under a written charter, adopted by our board of directors on November 21, 2018. On April 14, 2021, the Board approved the adoption of our Amended and Restated Compensation Committee Charter. Our Compensation Committee now operates under the Amended and Restated Compensation Committee Charter. Our Compensation Committee will review and reassess the adequacy of the written charter on an annual basis.

 

Nominating and Corporate Governance Committee

 

The members of our Nominating and Corporate Governance Committee are Jeff Enslin, Lemuel Amen and Sharon Rowlands. Jeff Enslin will serve as the chairperson of the committee. The Nominating and Corporate Governance Committee’s responsibilities include:

 

  identifying individuals qualified to become board members;
     
  recommending to our board of directors the persons to be nominated for election or appointed as directors and to each board committee;
     
  reviewing and recommending to our board of directors corporate governance principles, procedures and practices, and reviewing and recommending to our board of directors proposed changes to our corporate governance principles, procedures and practices from time to time; and
     
  reviewing and making recommendations to our board of directors with respect to the composition, size and needs of our board of directors.

 

54
 

 

Our Nominating and Corporate Governance Committee operates under a written charter, adopted by our board of directors on April 14, 2021, Our Nominating and Corporate Governance Committee will review and reassess the adequacy of the written charter on an annual basis.

 

Code of Ethics

 

On April 14, 2021, our board of directors adopted our Code of Ethics and Business Conduct. The code of ethics codifies the business and ethical principles that govern all aspects of our business.

 

Director or Officer Involvement in Certain Legal Proceedings

 

To our knowledge, (i) no director or executive officer has been a director or executive officer of any business which has filed a bankruptcy petition or had a bankruptcy petition filed against it during the past ten years; (ii) no director or executive officer has been convicted of a criminal offense or is the subject of a pending criminal proceeding during the past ten years; (iii) no director or executive officer has been the subject of any order, judgment or decree of any court permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities during the past ten years; and (iv) no director or officer has been found by a court to have violated a federal or state securities or commodities law during the past ten years.

 

Board Leadership Structure and Role in Risk Oversight

 

Although we have not adopted a formal policy on whether the Chairman and Chief Executive Officer positions should be separate or combined, in the past we determined that it was in the best interests of the Company and its shareholders to combine these roles.

 

Our Board of Directors receives and reviews periodic reports from management, auditors, legal counsel, and others, as considered appropriate regarding our Company’s assessment of risks. Our Board of Directors focuses on the most significant risks facing our Company and our Company’s general risk management strategy and ensures that risks undertaken by us are consistent with the Board’s appetite for risk. While the Board oversees our Company’s risk management, management is responsible for day-to-day risk management processes. We believe this division of responsibilities is the most effective approach for addressing the risks facing our Company and that our board leadership structure and role in risk oversight is effective.

 

Director Compensation

 

Because we are still in the development stage, our directors do not receive any cash compensation other than reimbursement for expenses incurred during the performance of their duties or their separate duties as officers of the Company.

 

55
 

 

The following table sets forth information concerning equity-based compensation for the fiscal year ending June 30, 2021 of our directors serving at such time who are not also named executive officers.

 

Name  Fiscal Year   Fees Earned ($)   Option Options (1)   Stock Awards ($)   All Other Compensation ($)   Total 
                         
Sharon Rowlands  2021    -   $86,093    -    -   $86,093 
                              
Jeffrey Enslin  2021    -   $86,093    -    -   $86,093 
                              
Lemuel Amen  2021    -   $55,021    -    -   $55,021 

 

(1) The amounts disclosed represent the aggregate grant date fair value of stock options granted to our named directors during Fiscal Year 2021 under the 2016 The Glimpse Group Incentive Plan. The assumptions used to compute the fair value are disclosed in Note 6 to our audited financial statements for Fiscal Year 2021. Such grant date fair values do not take into account any estimated forfeitures related to service-vesting conditions. These amounts do not reflect the actual economic value that will be realized by the named director upon the vesting of the stock options, the exercise of the stock options, or the sale of common stock acquired under such stock options.

 

Risk Management

 

The Company does not believe risks arising from its compensation policies and practices for its employees are reasonably likely to have a material adverse effect on the Company.

 

Director Independence

 

The Board evaluates the independence of each nominee for election as a director of our Company in accordance with the Listing Rules (the “Nasdaq Listing Rules”) of the Nasdaq Stock Market LLC (“Nasdaq”). Pursuant to these rules, a majority of our Board must be “independent directors” within the meaning of the Nasdaq Listing Rules, and all directors who sit on our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee must also be independent directors.

 

The Nasdaq definition of “independence” includes a series of objective tests, such as the director or director nominee is not, and was not during the last three years, an employee of Glimpse or our Subsidiaries and has not received certain payments from, or engaged in various types of business dealings with us. In addition, as further required by the Nasdaq Listing Rules, the Board has made a subjective determination as to each independent director that no relationships exist, which, in the opinion of the Board, would interfere with such individual’s exercise of independent judgment in carrying out his or her responsibilities as a director. In making these determinations, the Board reviewed and discussed information provided by the directors with regard to each director’s business and personal activities as they may relate to the Company and its management.

 

As a result, the Board has affirmatively determined that each of Sharon Rowlands, Lemuel Amen, Jeff Enslin and Alexander Ruckdaeschel, are independent in accordance with the Nasdaq listing rules. The Board has also affirmatively determined that all members of our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee are independent directors.

 

No family relationships exist between any of our officers or directors.

 

56
 

 

EXECUTIVE COMPENSATION

 

The following is a summary of the compensation we paid for each of the last three years ended June 30, 2020, 2019 and 2018, respectively, to our Executive Officers.

 

Name and Principal Position  Fiscal Year   Salary   Bonus   Stock Awards ($)   Option Award   Non-Equity Incentive Plan Compensation ($)   Non-Qualified Deferred Compensation Earnings ($)   All Other Compensation ($)   Total 
Lyron Bentovim  2021   $119,061   $225,000    -   $116,202    -    -    -   $460,263 
President & CEO  2020   $113,000    -    -   $151,857    -    -    -   $264,857 
   2019   $120,000    -    -   $109,633    -    -    -   $229,633 
                                             
Maydan  2021   $116,500   $175,000    -   $90,355    -    -    -   $381,855 
Rothblum  2020   $113,000    -    -   $118,773    -    -    -   $231,773 
CFO & COO  2019   $120,000    -    -   $84,340    -    -    -   $204,340 
                                             
David J Smith  2021   $94,000    -    -   $95,217    -    -    -   $189,217 
CCO  2020   $92,000    -    -   $79,834    -    -    -   $171,834 
   2019   $96,000    -    -   $67,464    -    -    -   $163,464 

 

Lyron Bentovim

 

On May 13, 2021, we entered into an executive employment agreement with Mr. Lyron Bentovim. Mr. Bentovim is one of our co-founders and has been the Company’s President and Chief Executive Officer since its inception. Pursuant to Mr. Bentovim’s employment agreement, he will continue to serve as our President and Chief Executive Officer. Mr. Bentovim’s employment agreement shall continue until terminated by either the Company or Mr. Bentovim. Pursuant to Mr. Bentovim’s employment agreement, he will receive an annual base salary of $250,000, of which $120,000 shall be paid in cash and $130,000 shall be paid in stock options. As a result of the Company’s listing on a national exchange, the going forward base salary shall be paid in cash only. In addition, Mr. Bentovim will be eligible to receive performance bonuses as determined by the Compensation Committee. Mr. Bentovim’s executive employment agreement entitles him to participate in the Company’s benefit plans, at our expense, and a severance payment in the amount of 12 months of his base salary in the event of his termination by us without cause or his resignation for good reason, as such terms are defined in the executive employment agreement. The agreement contains customary provisions relating to intellectual property assignment, confidentiality and non-compete.

 

Maydan Rothblum

 

On May 13, 2021, we entered into an executive employment agreement with Mr. Maydan Rothblum. Mr. Rothblum is one of our co-founders and has been the Company’s Chief Financial Officer and Chief Operating Officer since its inception. Pursuant to Mr. Rothblum’s employment agreement, he will continue to serve as our Chief Financial Officer and Chief Operating Officer. Mr. Rothblum’s employment agreement shall continue until terminated by either the Company or Mr. Rothblum. Pursuant to Mr. Rothblum’s employment agreement, he will receive an annual base salary of $220,000, of which $120,000 shall be paid in cash and $100,000 shall be paid in stock options. As a result of the Company’s listing on a national exchange, the going forward base salary shall be paid in cash only. In addition, Mr. Rothblum will be eligible to receive performance bonuses as determined by the Compensation Committee. Mr. Rothblum’s executive employment agreement entitles him to participate in the Company’s benefit plans, at our expense, and a severance payment in the amount of 12 months of his base salary in the first year of the employment agreement, 9 months in the second year of the employment agreement and 6 months in the third year of the employment agreement and thereafter, all in the event of his termination by us without cause or his resignation for good reason, as such terms are defined in the executive employment agreement. The agreement contains customary provisions relating to intellectual property assignment, confidentiality and non-compete.

 

57
 

 

David J. Smith

 

On May 13, 2021, we entered into an executive employment agreement with Mr. David J. Smith. Mr. Smith is one of our co-founders and has been the Company’s Chief Creative Officer since its inception. Pursuant to Mr. Smith’s employment agreement, he will continue to serve as our Chief Creative Officer. Mr. Smith’s employment agreement shall continue until terminated by either the Company or Mr. Smith. Pursuant to Mr. Smith’s employment agreement, he will receive an annual base salary of $200,000, of which $96,000 shall be paid in cash and $104,000 shall be paid in Company stock options. As a result of the Company’s listing on a national exchange, the going forward base salary shall be paid in cash only. In addition, Mr. Smith will be eligible to receive performance bonuses as determined by the Compensation Committee. Mr. Smith’s executive employment agreement entitles him to participate in the Company’s benefit plans, at our expense, and a severance payment in the amount of 12 months of his base salary in the first year of the employment agreement, 9 months in the second year of the employment agreement and 6 months in the third year of the employment agreement and thereafter, all in the event of his termination by us without cause or his resignation for good reason, as such terms are defined in the executive employment agreement. The agreement contains customary provisions relating to intellectual property assignment, confidentiality and non-compete.

 

Equity Incentive Plan

 

In October 2016, our majority shareholders approved our Equity Incentive Plan, as amended (the “Plan”), to be administered by our compensation committee. Pursuant to the Plan, we are authorized to grant options and other equity awards to employees of the Company or any subsidiary, non-employee directors or key consultants to the Company, or a subsidiary, and any person who has been offered employment by the Company or a subsidiary, provided that such prospective employee may not receive any payment or exercise any right relating to an Award until such person has commenced employment with the Company or a subsidiary (together, the “Eligible Persons”) The purchase price of each share of common stock purchasable under an award issued pursuant to the Plan, shall be determined by our compensation committee, in its sole discretion, at the time of grant, but shall not be less than 100% of the fair market of such share of common stock on the date the award is granted, subject to adjustment. Our compensation committee shall also have sole authority to set the terms of all awards at the time of grant.

 

Pursuant to the Plan, a maximum of 10,000,000 shares of our common stock shall be set aside and reserved for issuance. In addition, subject to adjustment as provided in the Plan, the share reserve will automatically increase on January 1 of each calendar year, for the period beginning on January 1, 2022 and ending on (and including) January 1, 2030 (each, an “Evergreen Date”) in an amount equal to five percent (5%) of the total number of shares of the Company’s common stock outstanding on December 31st immediately preceding the applicable Evergreen Date (the “Evergreen Increase”). Notwithstanding the foregoing, the Board may act prior to the Evergreen Date of a given year to provide that there will be no Evergreen Increase for such year, or that the Evergreen Increase for such year will be a lesser number of shares of the Company’s common stock than would otherwise occur pursuant to the preceding sentence. Any shares of Stock delivered under the Plan shall consist of authorized and unissued shares or treasury shares.

 

Under the Plan, an Eligible Person may be granted options, stock appreciation rights, restricted stock, phantom stock, sale phantom stock, stock granted as a bonus, a performance award, other stock-based awards or an annual incentive award, together with any related right or interest.

 

The term of each award under the Plan shall be for such period as may be determined by the compensation committee, subject to the express limitations set forth in the Plan.

 

Unless earlier terminated by action of the Board of Directors, the Plan will remain in effect until such time as no shares of common stock remains available for delivery under the Plan and the Company has no further rights or obligations under the Plan with respect to outstanding awards under the Plan.

 

58
 

 

Outstanding Equity Awards as of November 17, 2021

 

The following table discloses information regarding outstanding equity awards granted or accrued as of November 17, 2021, for our named executive officers.

 

Outstanding Equity Awards
   Option Awards  Stock Awards 
Name  Number of Securities Underlying Unexercised Options (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Option Exercise Price   Option Expiration Date  Number of Shares or Units of Stock that have not Vested (#)   Market Value of Shares or Units of Stock that have not Vested ($) 
Lyron Bentovim   32,508    -   $4.00   9/1/2028   -    - 
    10,836    -   $4.00   9/1/2029   -    - 
    28,896    -   $4.50   1/1/2030   -    - 
    2,333    -   $4.50   5/1/2030   -    - 
    1,167    -   $4.50   7/1/2030   -    - 
    14,448    -   $4.50   1/1/2031   -    - 
                             
Maydan Rothblum   250,000    -   $2.50   6/20/2027   -    - 
    25,008    -   $4.00   9/1/2028   -    - 
    8,336    -   $4.00   9/1/2029   -    - 
    22,224    -   $4.50   1/1/2030   -    - 
    2,333    -   $4.50   5/1/2030   -    - 
    1,167    -   $4.50   7/1/2030   -    - 
    11,112    -   $4.50   1/1/2031   -    - 
                             
D.J. Smith   20,004    -   $4.00   9/1/2028   -    - 
    6,668    -   $4.00   9/1/2029   -    - 
    14,232    -   $4.50   1/1/2030   -    - 
    1,333    -   $4.50   5/1/2030   -    - 
    667    -   $4.50   7/1/2030   -    - 
    889    -   $4.50   11/20/2030   -    - 
    11,556    -   $4.50   1/1/2031   -    - 

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table provides information about shares of common stock beneficially owned based on 12,069,839 shares of common stock issued and outstanding as November 23, 2021 by:

 

  each director;
     
  each officer named in the summary compensation table;
     
  each person owning of record or known by us, based on information provided to us by the persons named below, to own beneficially at least 5% of our common stock; and
     
  all directors and executive officers as a group.

 

59

 

 

Name of Beneficial Owner  Common Stock Beneficially Owned     Percentage of Common Stock Owned 
         
Directors and Officers:          
           
Lyron L. Bentovim          
President, Chief Executive Officer
and Chairman of the Board
     1,119,008(1)   9.20%
           
Maydan Rothblum          
Chief Operating Officer, Chief Financial          
Officer, Secretary and Treasurer     793,708(2)   6.41%
           
D.J. Smith          
Chief Creative Officer and Director     1,057,647(3)   8.72%
           
Sharon Rowlands          
Director and Chair of Compensation Committee     200,621(4)   1.65%
           
Jeff Enslin          
Director and Chair of Audit Committee     429,642(5)   3.46%
           
Lemuel Amen          
Director     14,352(6)   0.12%
           
Alexander Ruckdaeschel          
Director     5,886(7)   0.05%
           
All officers and directors (7 persons)   3,620,864    27.83%
           
Beneficial owners of more than 5%          
           
VRTech Consulting LLC(8)   1,002,298    8.30%
           
Darklight Partners LLC(9)   1,001,945    8.30%
           
Braden Ferrari(10)   691,331    5.73%
           
Kissa Capital LLC(11)   898,038    7.44%

 

(1) Includes: 1,028,820 shares of common stock, of which 1,001,945 shares are owned by Darklight Partners LLC (an entity owned and managed by Mr. Bentovim) and fully vested options to purchase 90,188 shares of common stock.
(2) Includes: 473,528 shares of common stock and fully vested options to purchase 320,180 shares of common stock. An additional 3,528 shares of common stock are held by Mr. Rothblum’s mother.  
(3) Includes: 1,002,298 shares of common stock owned by VRTech Consulting LLC (an entity owned and managed by Mr. Smith) and fully vested options to purchase 55,349 shares of common stock.  
(4) Includes: 83,163 shares of common stock, 113,754 fully vested options and 3,704 options that vest within 60 days
(5) Includes: 91,774 shares owned by Perimetre Capital, LLC (an entity owned and managed by Mr. Enslin), 334,164 fully vested option and 3,704 option that vest within 60 days   
(6) Represents 10,764 fully vested options and 3,588 options that vest within 60 days   
(7) Represents 3,882 fully vested options and 2,004 options that vest within 60 days  
(8) VRTech Consulting LLC is an entity owned and managed by Mr. Smith, our Chief Creative Officer and Director.
(9) Darklight Partners LLC is an entity owned and managed by Mr. Bentovim, our President, Chief Executive Officer and Chairman.
(10) Includes: 686,039 shares of common stock owned by Gilded Conquest LLC (an entity owned and managed by Braden Ferrari and having an address of 199 Lincoln Ave, Portsmouth, NH 03801). Mr. Ferrari is a Managing Director of EF Hutton, a division of Benchmark Investments, Inc., formerly known as Kingswood Capital Markets, a division of Benchmark Investments, LLC.  
(11) Kissa Capital LLC is an entity managed by Ariel Imas and having an address of 1775 York Avenue, New York, NY 10128. Mr. Imas is a Managing Director of EF Hutton, a division of Benchmark Investments, LLC, formerly known as Kingswood Capital Markets, a division of Benchmark Investments, LLC.  

 

60
 

 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

 

Other than as set forth below, since inception, there have been no related party transactions in which the amount involved in the transaction exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets as of the year-end for the last two completed fiscal years, and to which any of our directors, executive officers or beneficial holders of more than 5% of our capital stock, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.

 

We may encounter business arrangements or transactions with businesses and other organizations in which one of our directors or executive officers, significant stockholders or their immediate families is a participant and the amount exceeds $120,000. We refer to these transactions as related party transactions. Related party transactions have the potential to create actual or perceived conflicts of interest between Glimpse and its directors, officers and significant stockholders or their immediate family members.

 

DESCRIPTION OF SECURITIES

 

The rights of our stockholders are governed by Nevada law, our Articles of Incorporation, as amended, and our Bylaws. The following briefly summarizes the material terms of our common stock.

 

Common Stock

 

The Company is authorized to issue 300,000,000 shares of common stock, par value $0.001 per share. As of September 30, 2021, 10,291,638 shares of common stock were issued and outstanding. As of October 13, 2021, there were approximately 4,300 stockholders of our common stock.

 

Dividend Rights

 

The holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available at the times and in the amounts that our board of directors may determine.

 

Voting Rights

 

Each holder of our common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Our articles of incorporation provide that there is no cumulative voting for directors permitted.

 

61
 

 

Preemptive or Similar Rights

 

Our common stock is not entitled to preemptive rights to acquire additional securities issued by the Company.

 

Liquidation Rights

 

Upon our liquidation, dissolution, or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock outstanding at that time after payment of other claims of creditors.

 

Preferred Stock

 

The Company is authorized to issue 20,000,000 shares of preferred stock, par value $0.001 per share. As of September 30, 2021, no shares of preferred stock were issued and outstanding.

 

Preferred Stock

 

The preferred stock may be issued at any time or from time to time, in any one or more series, and any such series shall be comprised of such number of shares and may have such designations, preferences, limitations and relative or other rights thereof, including but not limited to: (a) the rate and manner of payments of dividends, if any; (b) whether shares may be redeemed and, if so, the redemption price and terms and conditions of redemption; (c) the amount payable upon shares in the event of liquidation, dissolution, or other winding-up of the Company; (d) sinking fund provisions, if any, for the redemption or purchase of shares; (e) the terms and conditions, if any, on which shares may be converted or exchanged; (f) voting rights, if any; and (g) any other rights and preferences of such shares, to the fullest extent permitted by the laws of the State of Nevada.

 

Prior to the issuance of any shares of a series, but after the adoption by the Board of Directors of the resolution of such series, the appropriate officers of the Company shall file such documents with the State of Nevada as may be required by law.

 

Potential Effects of Authorized but Unissued Stock

 

We have shares of common stock available for future issuance without stockholder approval. We may utilize these additional shares for a variety of corporate purposes, including future public offerings to raise additional capital, to facilitate corporate acquisitions or payment as a dividend on the capital stock.

 

The existence of unissued and unreserved common stock and preferred stock may enable our Board to issue shares to persons friendly to current management or to issue preferred stock with terms that could render more difficult or discourage a third-party attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise, thereby protecting the continuity of our management. In addition, our Board has the discretion to determine designations, rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences of each series of preferred stock, all to the fullest extent permissible under the Nevada Revised Statutes and subject to any limitations set forth in our articles of incorporation. The purpose of authorizing the Board to issue preferred stock and to determine the rights and preferences applicable to such preferred stock is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing desirable flexibility in connection with possible financings, acquisitions and other corporate purposes, could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from acquiring, a majority of our outstanding voting stock.

 

62
 

 

Limitations of Director Liability and Indemnification of Directors, Officers and Employees

 

Our articles of incorporation limits the liability of directors to the maximum extent permitted by Nevada law. Nevada law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors.

 

Our bylaws provide that we will indemnify our directors and officers to the fullest extent permitted by law, and may indemnify employees and other agents. Our bylaws also provide that we are obligated to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding.

 

We also maintain customary directors’ and officers’ liability insurance.

 

Our bylaws, subject to the provisions of Nevada Law, contain provisions which allow the corporation to indemnify any person against liabilities and other expenses incurred as the result of defending or administering any pending or anticipated legal issue in connection with service to us if it is determined that person acted in good faith and in a manner which he or she reasonably believed was in the best interest of the corporation. Insofar as indemnification for liabilities arising under the Securities Act of 1933 as amended, or the Securities Act, may be permitted to our directors, officers and controlling persons, we have been advised that in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

 

The limitation of liability and indemnification provisions in our bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful, might provide a benefit to us and our stockholders. Our results of operations and financial condition may be harmed to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.

 

At present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.

 

Requirements for Advance Notification of Stockholder Nominations and Proposals

 

Our bylaws establish advance notice procedures with respect to stockholder proposals and nomination of candidates for election as directors.

 

Limits on Special Meetings

 

Special meetings may be called for any purpose and at any time only by (i) the Board, (ii) the Chairman of the Board, (iii) the Chief Executive Officer, (iv) the President or (v) stockholders following receipt by the Secretary of the Company of a written request for a special meeting in proper form from the record holders of shares of common stock of the Corporation representing at least 15% of the outstanding common stock of the Company if such special meeting request complies with Section 2 of the Company’s bylaws.

 

Election and Removal of Directors

 

Our Board is elected annually by our stockholders. The exact number of directors shall be fixed from time to time by the Board pursuant to resolution adopted by a majority of the full Board. Directors are elected by a plurality of the votes of shares of our capital stock present in person or represented by proxy at a meeting and entitled to vote in the election of directors. Each director shall hold office until a successor is duly elected and qualified or until his or her earlier death, resignation or removal.

 

Newly created directorships resulting from any increase in the number of directors or any vacancies in the Board resulting from death, resignation, retirement, disqualification, removal from office or any other cause may be filled, so long as there is at least one remaining director, only by the Board, provided that a quorum is then in office and present, or by a majority of the directors then in office, if less than a quorum is then in office, or by the sole remaining director. Directors elected to fill a newly created directorship or other vacancies shall hold office until such director’s successor has been duly elected and qualified or until his or her earlier death, resignation or removal as hereinafter provided.

 

63
 

 

Any director may be removed from office at any time for cause, at a meeting called for that purpose, but only by the affirmative vote of the holders of at least 66-2/3% of the voting power of all outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class.

 

Our articles of incorporation and bylaws do not provide for cumulative voting in the election of directors.

 

Amendments to Our Governing Documents

 

Our articles of incorporation may be altered, amended or repealed, in whole or in part, or amendments may be adopted pursuant to the Nevada Revised Statutes.

 

The bylaws may be altered, amended or repealed, in whole or in part, or new by-laws may be adopted by: (i) the affirmative vote of the holders of not less than a majority of the combined voting power of the then outstanding shares of all classes and series of capital stock of the Corporation entitled generally to vote on the election of the directors of the Corporation, voting together as a single class, or (ii) by a majority of the whole Board.

 

Exclusive Forum For Certain Lawsuits

 

Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the state or federal courts located within the state of Nevada, shall, to the fullest extent permitted by law, be the sole and exclusive forum for any (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation’s stockholders, (iii) an action asserting a claim arising pursuant to any provision of the NRS, or (iv) any action asserting a claim governed by the internal affairs doctrine. Notwithstanding the foregoing, the provisions of this paragraph will not apply to actions arising under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

 

Listing

 

Our common stock is currently quoted on the Nasdaq Capital Market under the symbol “VRAR”.

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our common stock in this offering is ClearTrust, LLC. Their address is 16540 Pointe Village Dr Suite 205, Lutz, FL 33558.

 

PRIVATE PLACEMENT OF SHARES OF COMMON STOCK AND WARRANTS

 

On October 29, 2021, we entered into a securities purchase agreement (the “Purchase Agreement”) with several institutional investors pursuant to which the we sold to the investors in a private placement (i) 1,500,000 shares of common stock (the “Shares”), (ii) immediately exercisable common stock warrants to purchase up to 555,000 shares of common stock (the “Immediately Exercisable Warrants”), and (iii) warrants to purchase up to 195,000 shares of common stock (the “Common Warrants”), which Common Warrants are exercisable six (6) months after the closing of the October 2021 Private Placement (the Common Warrants together with the Immediately Exercisable Warrants, the “Warrants”). The combined purchase price for one Share and Warrant was $10.00. The Warrants have an exercise price of $14.63 per share of common stock, subject to adjustment as set forth in the Warrants.

 

The investors may exercise the Warrants on a cashless basis if the shares of common stock underlying the Warrants (the “Warrant Shares”) are not then registered pursuant to an effective registration statement. The investors have contractually agreed to restrict their ability to exercise the Warrants such that the number of shares of the Company’s common stock held by the Investors and any of their affiliates after such exercise does not exceed the Beneficial Ownership Limitation set forth in the Warrants which may not exceed initially 4.99% of the Company’s then issued and outstanding shares of common stock.

 

64
 

 

In connection with the Purchase Agreement, we entered into a registration rights agreement (the “Registration Rights Agreement”) with the investors. Pursuant to the Registration Rights Agreement, we will be required to file a resale registration statement (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) to register for resale the Shares and the Warrant Shares by November 26, 2021, and to have such Registration Statement declared effective within 45 days after the date of the Purchase Agreement, or 75 days of the Purchase Agreement in the event the Registration Statement is “fully” reviewed by the SEC. We will be obligated to pay certain liquidated damages to the investor if we fail to file the resale registration statement when required, fail to cause the Registration Statement to be declared effective by the SEC when required, or if we fail to maintain the effectiveness of the Registration Statement.

 

Pursuant to a Placement Agent Agreement (the “Placement Agent Agreement”), dated as of October 28, 2021, by and between the Company and EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), we engaged EF Hutton to act as our exclusive placement agent in connection with the offering. Pursuant to the Placement Agent Agreement, we agreed to pay EF Hutton a cash fee of 8.0% of the gross proceeds we received under the Purchase Agreement. We also agreed to pay EF Hutton and investors up to $100,000 for fees and expenses including “road show”, diligence, and reasonable legal fees and disbursements for EF Hutton’s counsel. Additionally, we agreed to grant EF Hutton a right of first refusal following the closing of the October 2021 Private Placement, whereby EF Hutton shall have an irrevocable right of first refusal (the “Right of First Refusal”) until July 1, 2022, to act as sole investment banker, sole book-runner, and/or sole placement agent, at EF Hutton’s sole discretion, for each and every future public and private equity and debt offering, including all equity linked financing.

 

SELLING STOCKHOLDERS

 

The common stock being offered by the selling stockholders are those previously issued to the investors in the October 2021 Private Placement and those issuable to the investors upon exercise of the Warrants. For additional information regarding the issuances of those shares of common stock and Warrants see “Private Placement of Shares of Common Stock and Warrants” above. We are registering the shares of common stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and Warrants, the selling stockholders have not had any material relationship with us within the past three years.

 

The table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock by the selling stockholders. The second column lists the number of shares of common stock beneficially owned by each of the selling stockholders, based on its ownership of the shares of common stock and warrants, as of November 23, 2021, assuming exercise of the Warrants held by the selling stockholders on that date, without regard to any limitations on exercises. As of November 23, 2021, 12,069,839 shares of the Company’s common stock were issued and outstanding.

 

The third column lists the shares of common stock being offered by this prospectus by the selling stockholders.

 

This prospectus generally covers the resale of the sum of (i) the number of shares of common stock issued to the investors in the October 29, 2021 Private Placement as described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related Warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.

 

Under the terms of the Warrants, the investors may not exercise the Warrants to the extent such exercise would cause such investor, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of the Warrants which have not been exercised (the “Beneficial Ownership Limitation”). The selling stockholder may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

 

65
 

 

Name of Selling Stockholder 

Number of

shares of

Common

Stock

Owned

Prior to

Offering

  

Maximum

Number of

shares of

Common

Stock to be

Sold

Pursuant to

this

Prospectus

  

Number

of shares

of

Common

Stock

Owned

After

Offering

 
Alpha Capital Anstalt c/o LH Financial Services(1)    324,767(2)   300,000    24,767 
3i, LP(3)    300,000(4)   300,000    0 
Bigger Capital Fund, LP(5)   150,000(6)   150,000    0 
Brio Capital Master Fund Ltd.(7)    300,000(8)   300,000    0 
District 2 Capital Fund LP(9)   150,000(10)   150,000    0
Ionic Ventures, LLC(11)    600,000(12)   600,000    0 
Leviston Resources LLC(13)   450,000(14)   450,000    0 

 

(1) The shares reflected as beneficially owned by Alpha Capital Anstalt (“Alpha”) and Nicola Feuerstein has the power to direct the vote and disposition of the securities held by Alpha. The business address of Alpha is Lettstrasse 32, 9490 Vaduz, Principality of Liechtenstein.
(2) The number of shares includes 100,000 shares of common stock issuable upon exercise of Immediately Exercisable Warrants and Common Warrants, both of which are subject to certain beneficial ownership limitations.
(3) The business address of 3i, LP is 140 Broadway, 38th Floor, New York, NY 10005. 3i, LP’s principal business is that of a private investor. Maier Joshua Tarlow is the manager of 3i Management, LLC, the general partner of 3i, LP, and has sole voting control and investment discretion over securities beneficially owned directly or indirectly by 3i Management, LLC and 3i, LP. Mr. Tarlow disclaims any beneficial ownership of the securities beneficially owned directly by 3i, LP and indirectly by 3i Management, LLC.
(4) The number of shares includes 100,000 shares of common stock issuable upon exercise of Immediately Exercisable Warrants and Common Warrants, both of which are subject to certain beneficial ownership limitations.
(5) The shares are directly held by Bigger Capital Fund, LP, and may be deemed to be indirectly beneficially owned by: Michael Bigger. Michael Bigger disclaims beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. The business address for Bigger Capital Fund, LP is 11700 West Charleston Blvd. #170-659, Las Vegas, NV, 89135.
(6) The number of shares includes 50,000 shares of common stock issuable upon exercise of Immediately Exercisable Warrants and Common Warrants, both of which are subject to certain beneficial ownership limitations.
(7) The shares are directly held by Brio Capital Master Fund Ltd. (“Brio”), and may be deemed to be indirectly beneficially owned by: Shaye Hirsch. Shaye Hirsch disclaims beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. The business address for Brio is 100 Merrick Rd, Suite 401M, Rockville Centre, NY 11570.
(8) The number of shares includes 100,000 shares of common stock issuable upon exercise of Immediately Exercisable Warrants and Common Warrants, both of which are subject to certain beneficial ownership limitations.
(9) The shares are directly held by District 2 Capital Master Fund LP (“District 2”), and may be deemed to be indirectly beneficially owned by: Michael Bigger and Eric Schlanger. Michael Bigger and Eric Schlanger each disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. The business address for District 2 is 175 West Carver, Huntington, NY 11743.

 

66
 

 

(10) The number of shares includes 50,000 shares of common stock issuable upon exercise of Immediately Exercisable Warrants and Common Warrants, both of which are subject to certain beneficial ownership limitations.
(11) The shares are directly held by Ionic Ventures, LLC (“Ionic”). Brendan O’Neil and Keith Coulston are the managers of Ionic and may also be deemed to have investment discretion and voting power over the shares that it holds. Mr. O’Neil and Mr. Coulston each disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. The business address for Ionic is 3053 Fillmore St., Suite 256, San Francisco, CA 94123.
(12) The number of shares includes 200,000 shares of common stock issuable upon exercise of Immediately Exercisable Warrants and Common Warrants, both of which are subject to certain beneficial ownership limitations.
(13) The shares are directly held by Leviston Resources, LLC (“Leviston”), and may be deemed to be indirectly beneficially owned by: Roman Rogol. Roman Rogol disclaims beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. The business address for Leviston is 1225 Ave, Ponce de Leon, PH 855, San Juan, PR 00907.
(14) The number of shares includes 150,000 shares of common stock issuable upon exercise of Immediately Exercisable Warrants and Common Warrants, both of which are subject to certain beneficial ownership limitations.

 

PLAN OF DISTRIBUTION

 

The Selling Stockholders (the “Selling Stockholders”) of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the Nasdaq Capital Markets or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. Each Selling Stockholder may use any one or more of the following methods when selling securities: The selling stockholders will offer their shares at prevailing market prices or privately negotiated prices.

 

  ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
     
  block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;
     
  purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
     
  an exchange distribution in accordance with the rules of the applicable exchange;
     
  privately negotiated transactions;
     
  settlement of short sales;
     
  in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;
     
  through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
     
  a combination of any such methods of sale; or
     
  any other method permitted pursuant to applicable law.

 

67
 

 

The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the “Securities Act”), if available, rather than under this prospectus.

 

Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2440.

 

In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

 

The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each of the Selling Stockholders have informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.

 

The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.

 

We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

 

Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling Stockholder or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).

 

LEGAL MATTERS

 

The validity of the securities being offered by this prospectus has been passed upon for us by Sichenzia Ross Ference LLP, New York, New York. Sichenzia Ross Ference LLP or certain members or employees of Sichenzia Ross Ference LLP have been issued common stock of the Company.

 

68
 

 

EXPERTS

 

The consolidated financial statements of The Glimpse Group, Inc. as of and for the years ended June 30, 2021 and 2020 appearing in this prospectus, have been audited by Hoberman & Lesser CPA’s, LLP, as set forth in its report thereon, included herein. Such consolidated financial statements are included herein in reliance upon such report given on the authority of such firm as experts in accounting and auditing.

 

WHERE YOU CAN FIND MORE INFORMATION

 

Federal securities laws require us to file information with the SEC concerning our business and operations. Accordingly, we file annual, quarterly, and special reports, and other information with the Commission. The SEC maintains a web site (http://www.sec.gov) at which you can read or download our reports and other information.

 

We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities being offered hereby. As permitted by the rules and regulations of the SEC, this prospectus does not contain all the information set forth in the registration statement and the exhibits and schedules thereto. For further information with respect to the Company and the securities offered hereby, reference is made to the registration statement, and such exhibits and schedules. The registration statement may be accessed at the SEC’s web site.

 

69
 

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

THE GLIMPSE GROUP, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

For the Three Months Ended September 30, 2021 and 2020

(UNAUDITED)

 

  Page
Index to Consolidated Financial Statements (Unaudited) F-1
Consolidated Balance Sheets F-2
Consolidated Statements of Operations F-3
Consolidated Statements of Stockholders’ Equity (Deficit) F-4
Consolidated Statements of Cash Flows F-5
Notes to Consolidated Financial Statements F-6 - F-20

 

THE GLIMPSE GROUP, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended June 30, 2021 and 2020

 

  Page
Index to Consolidated Financial Statements F-21
Independent Auditor’s Report F-22
Consolidated Balance Sheets F-23
Consolidated Statements of Operations F-24
Consolidated Statements of Stockholders’ Deficit F-25
Consolidated Statements of Cash Flows F-26
Notes to Consolidated Financial Statements F-27 - F-44

 

F-1

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED BALANCE SHEETS

 

         
  As of
September 30, 2021
(Unaudited)
   As of
June 30, 2021
(Audited)
 
ASSETS        
Cash and cash equivalents  $12,567,632   $1,771,929 
Accounts receivable   599,879    626,244 
Deferred costs   45,981    29,512 
Pre-offering costs   -    470,136 
Prepaid expenses and other current assets   533,782    281,047 
Total current assets   13,747,274    3,178,868 
           
Other assets   80,000    - 
Equipment, net   53,513    42,172 
Intangible assets, net   479,167    - 
Goodwill   250,000    - 
Total assets  $14,609,954   $3,221,040 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Accounts payable  $112,687   $381,510 
Accrued liabilities   136,975    168,745 
Accrued bonuses   288,388    440,357 
Accrued legacy acquisition expense   500,000    1,250,000 
Deferred revenue   114,055    98,425 
Total current liabilities   1,152,105    2,339,037 
           
Long term liabilities          
Paycheck Protection Program (PPP 2) loan   623,828    623,828 
Convertible promissory notes, net   -    1,429,953 
Total liabilities   1,775,933    4,392,818 
Commitments and contingencies   -     -  
Stockholders’ Equity (Deficit)          
Preferred Stock, par value $0.001 per share, 20 million shares authorized; 0 shares issued and outstanding   -    - 
Common Stock, par value $0.001 per share, 300 million shares authorized; 10,291,638 and 7,579,285 issued and outstanding   10,292    7,580 
Additional paid-in capital   36,595,898    20,936,050 
Accumulated deficit   (23,772,169)   (22,115,408)
Total stockholders’ equity (deficit)   12,834,021    (1,171,778)
Total liabilities and stockholders’ equity (deficit)  $14,609,954   $3,221,040 

  

The accompanying notes are an integral part of these consolidated financial statements.

 

F-2

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   For the Three Months Ended   For the Three Months Ended 
   September 30, 2021   September 30, 2020 
Revenue          
Software services  $804,718   $187,652 
Software license/software as a service   217,815    72,275 
Total Revenue   1,022,533    259,927 
Cost of goods sold   145,387    137,124 
Gross Profit   877,146    122,803 
Operating expenses:          
Research and development expenses   989,384    736,750 
General and administrative expenses   779,729    335,998 
Sales and marketing expenses   504,687    289,476 
Total operating expenses   2,273,800    1,362,224 
Net loss from operations before other income (expense)   (1,396,654)   (1,239,421)
           
Other income (expense)          
Other income   -    10,000 
Interest income   19,623    534 
Interest expense   -    (48,437)
Loss on conversion of convertible notes   (279,730)   - 
Total other expense, net   (260,107)   (37,903)
Net Loss  $(1,656,761)  $(1,277,324)
           
Basic and diluted net loss per share  $(0.17)  $(0.18)
Weighted-average shares used to compute basic and diluted net loss per share   9,967,821    7,039,928 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021

(Unaudited)

 

                     
   Common Stock   Additional
Paid-In
   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance as of July 1, 2021   7,579,285   $7,580   $20,936,050   $(22,115,408)  $(1,171,778)
Common stock issued in Initial Public Offering, net   1,912,500    1,913    11,819,451    -    11,821,364 
Common stock issued for convertible note conversion   324,150    324    1,605,852    -    1,606,176 
Common stock issued for acquisition   77,264    77    749,923    -    750,000 
Common stock issued for legacy acquisition obligation   375,000    375    749,625    -    750,000 
Common stock issued to vendors for compensation   6,045    6    65,389    -    65,395 
Common stock issued for exercise of options   17,394    17    45,683    -    45,700 
Stock option-based compensation expense   -    -    536,524    -    536,524 
Stock option-based board of directors expense   -    -    87,401    -    87,401 
Net loss   -    -    -    (1,656,761)   (1,656,761)
Balance as of September 30, 2021   10,291,638   $10,292   $36,595,898   $(23,772,169)  $12,834,021 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ (DEFICIT)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2020

(Unaudited)

 

   Common Stock   Additional
Paid-In
   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance as of July 1, 2020   7,035,771   $7,036   $15,710,996   $(16,023,721)  $(305,689)
Sales of common stock to investors   2,423    2    10,818    -    10,820 
Common stock issued to vendors for compensation   6,667    7    29,993    -    30,000 
Stock option-based compensation expense   -    -    772,635    -    772,635 
Stock option-based board of directors expense   -    -    41,532    -    41,532 
Net loss   -    -    -    (1,277,324)   (1,277,324)
Balance as of September 30, 2020   7,044,861   $7,045   $16,565,974   $(17,301,045)  $(728,026)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

           
  For the Three Months Ended
September 30, 2021
   For the Three Months Ended
September 30, 2020
 
Cash flows from operating activities:        
Net loss  $(1,656,761)  $(1,277,324)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization and depreciation   27,718    5,907 
Amortization of paid-in kind common stock interest on convertible notes   -    54,039 
Stock option based compensation for employees and board of directors   653,615    689,813 
Issuance of common stock to vendors as compensation   62,034    15,000 
Loss on conversion of convertible notes   279,730    - 
Changes in operating assets and liabilities:          
Accounts receivable   26,365    135,460 
Pre-offering costs   470,136    - 
Prepaid expenses and other current assets   (381,856)   (81,909)
Deferred costs   (17,185)   (124,155)
Other assets   (80,000)   - 
Accounts payable   (268,823)   (52,343)
Accrued liabilities   (31,770)   (18,680)
Accrued bonus   (151,969)   (6,000)
Deferred revenue   15,630    499,650 
Net cash used in operating activities   (1,053,136)   (160,542)
Cash flow from investing activities:          
Purchases of equipment   (18,225)   (15,004)
Net cash used in investing activities   (18,225)   (15,004)
Cash flows from financing activities:          
Proceeds from initial public offering, net   11,821,364    - 
Proceeds from issuance of common equity to investors   -    10,820 
Proceeds from exercise of stock options   45,700    - 
Net cash provided by financing activities   11,867,064    10,820 
           
Net change in cash and cash equivalents   10,795,703    (164,726)
Cash and cash equivalents, beginning of year   1,771,929    1,034,846 
Cash and cash equivalents, end of period  $12,567,632   $870,120 
           
Non-cash Investing and Financing activities:          
Common stock issued for asset acquisition  $750,000   $- 
Conversion of convertible promissory notes into common stock  $1,606,176   $- 
Issuance of warrants in connection with initial public offering  $522,360   $- 
Issuance of common stock for satisfaction of legacy acquisition liability  $750,000   $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

NOTE 1. DESCRIPTION OF BUSINESS

 

The Glimpse Group, Inc. (“Glimpse”) is a Virtual (VR) and Augmented (AR) Reality company, comprised of a diversified portfolio of VR and AR software and services companies. Glimpse’s ten wholly-owned operating subsidiaries (“Subsidiary Companies” or “Subsidiaries”) are: Adept Reality, LLC (dba Adept XR Learning), Kabaq 3D Technologies, LLC (dba QReal), KreatAR, LLC (dba PostReality), D6 VR, LLC, Immersive Health Group, LLC, Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), Early Adopter, LLC, and MotionZone, LLC (dba AUGGD) and one subsidiary in Turkey, Glimpse Group Yazılım ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”). In addition, the Company has one inactive subsidiary company, In-It VR, LLC (dba Mezmos), and with the operating Subsidiaries collectively comprise the “Company” or “Glimpse”. Glimpse was incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016.

 

A new subsidiary company was established in October 2021. See Note 11.

 

Glimpse’s robust VR/AR ecosystem, collaborative environment and business model simplify the many challenges faced by companies in an emerging industry. Glimpse cultivates and manages business operations while providing a strong network of professional relationships, thereby allowing the subsidiary company entrepreneurs to maximize their time and resources in pursuit of mission-critical endeavors, reducing time to market, optimizing costs, improving product quality and leveraging joint go-to-market strategies, while simultaneously providing investors an opportunity to invest directly into the VR/AR industry via a diversified platform.

 

The Company completed an initial public offering (“IPO”) of its common stock on the Nasdaq Capital Market Exchange (“Nasdaq”) on July 1, 2021, under the ticker VRAR. See Note 7.

 

On November 2, 2021 the Company completed a securities purchase agreement (“SPA”) for the sale of additional common stock to certain institutional investors. See Note 11.

 

NOTE 2. LIQUIDITY AND CAPITAL RESOURCES

 

The Company incurred a loss of $1.66 million during the three months ended September 30, 2021, compared to a loss of $1.28 million during the three months ended September 30, 2020. The loss was incurred as the Company funded operational expenses, primarily research and development, general and administrative, and sales and marketing costs.

 

On July 1, 2021 the Company completed an IPO in which, as a result of the sale of its common shares at $7.00 per share, it raised approximately $13.4 million in gross proceeds and $11.8 million in net proceeds after fees and expenses. See Note 7. Furthermore, on November 2, 2021 the Company completed a SPA whereby it sold additional common shares that resulted in approximately $13.6 million in net proceeds after fees and expenses. See Note 11.

 

The Company expects to continue to generate net losses for the foreseeable future as it makes investments to grow its business. Management believes that the Company’s existing balances of cash and cash equivalents, which are approximately $26 million following the SPA (see Note 11), will be sufficient to meet its anticipated cash requirements for at least twelve months from the date that these financial statements are issued. However, should the Company’s current cash and cash equivalents not be sufficient to support the development of its business to the point at which it has positive cash flows from operations, the Company plans to meet its future needs for additional capital through equity and/or debt financings. Equity financings may include sales of common stock. Such financing may not be available on terms favorable to the Company or at all. If the Company is unable to obtain adequate financing or financing on terms satisfactory to it when required, the Company’s ability to continue to support its business growth, scale its infrastructure, develop product enhancements and to respond to business challenges could be significantly impaired.

 

F-6

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2021 and the results of operations and cash flows for the three months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the three months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2022 or for any subsequent periods. The consolidated balance sheet at June 30, 2021 has been derived from the audited consolidated financial statements at that date.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations.

 

These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended June 30, 2021.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Accounting Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options, cost of goods sold and allocation of the purchase price of assets relating to business combinations.

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash and deposits in bank checking accounts with immediate access and cash equivalents that represent highly liquid investments.

 

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of September 30, 2021 and June 30, 2021 no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

F-7

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Customer Concentration and Credit Risk

 

Two customers accounted for approximately 70% (56% and 14%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2021. Four different customers accounted for approximately 53% (19%, 13%, 11% and 10%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2020.

 

One customer accounted for approximately 76% of the Company’s accounts receivable at September 30, 2021. The same customer, and along with a different customer, accounted for approximately 71% (57% and 14%, respectively) of the Company’s accounts receivable at June 30, 2021.

 

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

 

Equipment, net

 

Equipment is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.

 

The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.

 

Business Combinations

 

The results of a business acquired in a business combination are included in the Company’s consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business generally being recorded at their estimated fair values as of the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill.

 

The Company performs valuations of assets acquired and liabilities assumed and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired and liabilities assumed may require management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenues, costs and cash flows.

 

Intangibles, net

 

Intangibles represent the allocation of a portion of an asset acquisition purchase price (see Note 4). Intangibles are stated at allocated cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the related assets.

 

Goodwill

 

The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded goodwill related to an asset acquisition, see Note 4.

 

F-8

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.

 

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
     
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured.

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue for the three months ended September 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

F-9

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.

 

Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

Timing of Revenue

 

The timing of revenue recognition for the three months ended September 30, 2021 and 2020 was as follows:

 

       
   For the Three Months Ended 
   September 30, 
   2021   2020 
Products transferred at a point in time  $955,751   $193,175 
Products and services transferred over time   66,782    66,752 
Total Revenue  $1,022,533   $259,927 

 

Remaining Performance Obligations

 

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.

 

For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

 

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.

 

For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.

 

For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

 

F-10

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Deferred revenue is comprised mainly of software project contract performance obligations not completed.

 

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of September 30, 2021, the Company had approximately $1.20 million in unfulfilled performance obligations.

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for the Company since its IPO. Prior to its IPO, expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.

 

F-11

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the three months ended September 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.

 

Earnings Per Share

 

Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s financial statements.

 

NOTE 4. ASSET ACQUISTION

 

In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC (dba AUGGD), completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services. Over time, the acquisition may facilitate the Company’s endeavors in the Architecture, Engineering and Construction (“AEC”) market segments.

 

F-12

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Initial consideration for the purchase was $0.75 million payable in Company common stock. In August 2021, the Company issued 77,264 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company recorded the purchase price allocation as follows:

 

   As of September 30, 2021
   Value ($)   Useful Life
(Years)
Intangible Assets        
Customer Relationships  $250,000   3
Technology   250,000   3
Less: Accumulated Amortization   (20,833)   
Intangible Assets, net  $479,167    
         
Goodwill  $250,000   N/A

 

The goodwill recognized in connection with the acquisition is primarily attributable to new markets access and is expected to be deductible for tax purposes.

 

The results of operations of AUGGD have been included in the Company’s consolidated financial statements from the date of acquisition and did not have a material impact on the Company’s consolidated financial statements.

 

NOTE 5. CONTINGENT ACQUISITION LIABILITY

 

Kabaq 3D Technologies, LLC

 

The Company’s November 2016 acquisition of assets relating to the acquisition of Kabaq 3D Technologies, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met and the Company incurred $750,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition liability on the Company’s balance sheet at June 30, 2021. This obligation was satisfied in August 2021 through the issuance of common stock in settlement of 375,000 stock options at $2.00 per share.

 

KreatAR, LLC

 

The Company’s October 2016 acquisition of assets relating to the acquisitions of KreatAR, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met. In connection therewith, the Company incurred $500,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition liability on the Company’s balance sheet at June 30, 2021.

 

NOTE 6. DEBT

 

Convertible Promissory Notes 1

 

In December 2019 the Company raised $1.33 million by the issuance of unsecured Convertible Promissory Notes with a three-year term (the “Note 1” or “Notes 1”), primarily from existing Company investors.

 

The Notes 1 bore an interest rate of 10% per annum.

 

The Notes 1 were convertible by a Note 1 holder at any time during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion.

 

F-13

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Interest expense on the Notes 1 was approximately $48,500 for the three months ended September 30, 2020, representing amortization of the original issue discount and prepaid interest for the period.

 

Primarily in January 2021, Note 1 holders converted approximately $1.21 million of principal into approximately 0.30 million shares of common stock at a revised (to encourage early conversion) conversion price of $4.00/share.

 

The holders of the remaining unconverted Notes 1, equating to approximately $117,000 (net of original discount of approximately $8,000) of outstanding principal at June 30, 2021, amended their Notes 1 to allow for auto conversion upon the Company’s potential IPO event at a conversion price of $4.25/share. As per the amendment, the residual Notes 1 converted upon the IPO and no further obligations existed. See Note 7.

 

The Company recorded a loss on conversion of the remaining Notes 1 of approximately $18,000 at time of the IPO, representing unamortized original issue discount and prepaid interest.

 

Convertible Promissory Notes 2

 

In March 2021, the Company raised $1.48 million by the issuance of unsecured Convertible Promissory Notes with a two-year term (the “Notes 2”), to several investors.

 

The Notes 2 bore an interest rate of 10% per annum.

 

The Notes 2 were convertible by a note holder at any time during the term into common stock of the Company at a fixed price of $5.00/share, or 295,000 shares of common stock upon full conversion. Notes 2 had a maturity date of March 5, 2023. All outstanding amounts at the time of the Company’s IPO automatically converted at $5.00/share in the aggregate. Convertible Notes 2 totaled approximately $1.313 million (net of original issue discount of approximately $162,000) at June 30, 2021. The Notes 2 converted upon the IPO and no further obligations existed. See Note 7.

 

The Company recorded a loss on conversion of the Notes 2 of approximately $262,000 at time of the IPO, representing unamortized original issue discount and prepaid interest.

 

NOTE 7. EQUITY

 

Initial Public Offering (“IPO”)

 

On July 1 ,2021, the Company completed an IPO of common stock on the Nasdaq under the symbol “VRAR”, at a price of $7.00 per share.

 

The Company sold approximately 1.91 million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million.

 

In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase 87,500 shares of common stock at $7.00 per share. The warrant cannot be exercised prior to December 30, 2021, and expires in June 2026. The warrant is valued at approximately $520,000 based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 129% expected volatility, 0.87% risk-free rate and 0% expected dividend yield.

 

As stated in Note 6, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through the issuance of 324,150 shares of common stock. A loss of approximately $280,000 was recorded on this conversion at the time of the IPO.

 

F-14

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Common Stock Issued

 

Common stock sold to Investors

 

During the three months ended September 30, 2021, the Company sold approximately 1.91 million shares of common stock to investors at the IPO at a price of $7.00 per share, for total net proceeds of approximately $11.82 million.

 

During the three months ended September 30, 2020, the Company sold approximately 2,400 shares of common stock to investors at a price of $4.50 per share, for total net proceeds of approximately $10,800.

 

Common stock issued to Investors

 

During the three months ended September 30, 2021, in connection with the conversion of convertible promissory notes and in conjunction with the IPO, the Company issued 324,150 shares of common stock (see Note 6).

 

Common stock issued for Acquisition

 

During the three months ended September 30, 2021 the Company issued approximately 77,000 shares of common stock, valued at $0.75 million, as consideration for the acquisition of certain assets (see Note 4).

 

Common stock issued for Legacy Acquisition Obligation

 

During the three months ended September 30, 2021 the Company issued 375,000 shares of common stock to satisfy a legacy acquisition obligation of $750,000 (see Note 5). This was accomplished by settling outstanding stock options the acquiree had been granted at $2.00 per share.

 

Common stock issued to Vendors

 

During the three months ended September 30, 2021 and 2020, the Company issued approximately 6,000 and 6,700 shares of common stock, respectively, to various vendors for services performed and recorded share-based compensation of approximately $65,000 and $30,000, respectively (of which approximately $3,000 and $15,000 was unrecognized in the periods, respectively).

 

Common stock issued for Exercise of options

 

During the three months ended September 30, 2021, the Company issued approximately 17,000 shares of common stock upon exercise of the respective option grants, and realized cash proceeds of approximately $46,000.

 

Employee Stock-Based Compensation

 

The Company’s 2016 Equity Incentive Plan (the “Plan”), as amended, has 10 million common shares reserved for issuance. As of September 30, 2021, there were 5.64 million shares available for issuance under the Plan.

 

The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.

 

F-15

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table: 

 

   Three Months Ended
September 30, 2021
   Three Months Ended
September 30, 2020
 
Weighted average expected terms (in years)   5.4    5.1 
Weighted average expected volatility   146.1%   117.3%
Weighted average risk-free interest rate   0.9%   0.3%
Expected dividend yield   0.0%   0.0%

 

The grant date fair value, for options granted during the three months ended September 30, 2021 and 2020 was approximately $0.61 million and $0.40 million, respectively.

 

The following is a summary of the Company’s stock option activity for the three months ended September 30, 2021 and 2020:

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2021   4,740,910   $3.40    8.5   $7,893,467 
Options Granted   94,666    7.11    9.9    423,923 
Options Exercised   (392,394)   2.14    7.2    (3,720,795)
Options Forfeited / Cancelled   (82,838)   4.61    9.5    (563,393)
Outstanding at September 30, 2021   4,360,344   $3.58    8.6   $16,283,017 
Exercisable at September 30, 2021   4,143,324   $3.47    8.5   $15,852,955 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2020   4,092,593   $3.19    8.4   $5,553,916 
Options Granted   108,324    4.50    9.9    - 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (16,809)   4.33    9.4    (2,828)
Outstanding at September 30, 2020   4,184,108   $3.22    8.4   $5,469,339 
Exercisable at September 30, 2020   3,840,479   $3.14    8.4   $5,337,626 

 

F-16

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

The Company’s stock option-based expense for the three months ended September 30, 2021 and 2020 consisted of the following:

 

SCHEDULE OF STOCK OPTION-BASED EXPENSE 

   Three Months Ended
September 30, 2021
   Three Months Ended
September 30, 2020
 
Stock option-based expense :          
Research and development expenses  $347,597   $403,912 
General and administrative expenses   66,643    98,163 
Sales and marketing expenses   127,992    99,300 
Cost of goods sold   22,764    45,687 
Board option expense   88,619    42,751 
Total  $653,615   $689,813 

 

During the year ended June 30, 2019, certain Company advisors received approximately $320,000 worth of Company stock options with an exercise price of $5.25/share and a three-year term, for potential services to be performed over a three-year period. Of the $320,000, $29,000 and $58,000 was categorized as a prepaid expense at September 30, 2021 and June 30, 2021, respectively. During the three months ended September 30, 2021 and 2020, the Company recognized approximately $29,000 for each period, as general and administration expense.

 

At September 30, 2021, total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $1.06 million and is expected to be recognized over a weighted average period of 1.85 years. At September 30, 2020, total unrecognized compensation expense related to stock options was approximately $1.19 million and was recognized over a weighted average period of 0.83 years.

 

The intrinsic value of stock options at September 30, 2021 was computed using a fair market value of the common stock of $7.29/share, as compared to $4.50/share at September 30, 2020.

 

NOTE 8. EARNINGS PER SHARE

 

The following table presents the computation of basic and diluted net loss per common share:

 

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE 

   Three Months Ended September 30, 2021   Three Months Ended September 30, 2020 
Numerator:          
Net loss  $(1,656,761)  $(1,277,324)
Denominator:          
Weighted-average common shares outstanding
for basic and diluted net loss per share
   9,967,821    7,039,928 
Basic and diluted net loss per share  $(0.17)  $(0.18)

 

F-17

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

 

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES 

   At September 30, 2021   At September 30, 2020 
Stock Options   4,360,344    4,184,108 
Warrants   87,500    - 
Convertible Notes   -    296,111 
Total   4,447,844    4,480,219 

 

NOTE 9. PROVISION FOR INCOME TAXES

 

There was no current or deferred income tax provision for the three months ended September 30, 2021 and 2020.

 

The Company’s deferred tax assets as of September 30 2021 and 2020 consist of the following:

 

   As of September 30,   As of September 30, 
   2021   2020 
Deferred tax assets:          
Net-operating loss carryforward  $4,269,910   $2,961,194 
Stock-based compensation   586,042    394,742 
Total Deferred Tax Assets   4,855,952    3,355,936 
Valuation allowance   (4,855,952)   (3,355,936)
Deferred Tax Asset, Net  $-   $- 

 

The Company maintains a valuation allowance on deferred tax assets due to the uncertainty regarding the ability to utilize these deferred tax assets in the future. At September 30, 2021, the Company had potential utilizable aggregate gross net operating loss carryforwards (“NOLs”) of approximately $12.35 million. NOLs for the periods ending June 30, 2018 and prior in the amount of approximately $2.86 million begin to expire in 2037. NOLs subsequent to June 30, 2018 have no expiration.

 

Section 382 of the U.S. Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. The Company has not completed a Section 382 analysis of the NOL carryforwards. Consequently, the Company’s NOL carryforwards may be subject to annual limitations under Section 382.

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. As a result of the uncertainly in the realization of the Company’s deferred tax assets, the Company has provided a valuation allowance for the full amount of the deferred tax assets at September 30, 2021 and September 30, 2020.

 

The Company’s valuation allowance during the three months ended September 30, 2021 and 2020 increased by approximately $0.40 million and $0.20 million, respectively.

 

F-18

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:

 

SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE

   For the Three Months Ended September 30,   For the Three Months Ended September 30, 
   2021   2020 
Statutory Federal Income Tax Rate   21.00%   21.00%
State and Local Taxes, Net of Federal Tax Benefit   (13.56)%   (13.56)%
Stock Based Compensation Expense (ISO)   10.61%   19.15%
Change in Valuation Allowance   (18.05)%   (26.59)%
Income Taxes Provision (Benefit)   0.00    0.00 

 

Upon completion of its 2021 U.S. income tax return in 2022, the Company may identify additional remeasurement adjustments. The Company will continue to assess its provision for income taxes as future guidance is issued, but does not currently anticipate significant revisions will be necessary.

 

NOTE 10. COMMITMENTS AND CONTINGENCIES

 

Operating Lease

 

The Company has an office space lease expiring, as amended, on December 31, 2022. To secure the initial lease, the Company paid a $75,000 security deposit.

 

Rent expense was approximately $86,000 and $72,000 for the three months ended September 30, 2021 and 2020, respectively. There is approximately $309,000 due on the lease for the October 2021-September 2022 period and approximately $75,000 due thereafter for the remaining lease term.

 

Potential Future Distributions Upon Divestiture or Sale

 

Upon a divestiture or sale of a subsidiary company, the Company is contractually obligated to distribute up to 10% of the net proceeds from such divestiture or sale to the senior management team of the divested subsidiary company. Currently, there were no active discussions pertaining to a potential divestiture or sale of any of the Company’s subsidiaries.

 

COVID-19

 

The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.

 

From March 2020 through June 2021, the Company had required substantially all of its employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit the Company’s ability to operate its business effectively. Commencing July 2021, the Company has tentatively required employees to return to the office several days a week.

 

We continue to closely monitor the situation and the effects on our business and operations. While uncertainty remains, given the current state of the pandemic, our expected revenue growth and current cash balance, we do not expect the impact of COVID-19 on our business and operations to worsen going forward.

 

F-19

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

NOTE 11. SUBSEQUENT EVENTS

 

ASSET ACQUISTION

 

In October 2021, the Company, through its newly formed and wholly owned subsidiary company, XR Terra, LLC, completed an acquisition of certain assets, as defined, from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming.

 

Initial consideration for the purchase is $0.60 million payable 50% in Company common stock and 50% in cash. In October 2021, the Company paid $0.30 million cash and issued 33,877 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through September 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company is currently determining its purchase price allocation between customer list, intellectual property and goodwill.

 

SECURITIES PURCHASE AGREEMENT (“SPA”)

 

In November 2021, the Company entered into a SPA to sell $15.0 million worth of its common stock and warrants to certain institutional investors in a private placement.

 

Under the terms of the SPA, the Company sold 1.50 million shares of its common stock and warrants to purchase 0.75 million shares of common stock. The warrants have an exercise price of $14.68 per share. The warrants will expire five years from the date they can be exercised. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The gross proceeds to the Company from the registered direct offering were approximately $13.6 million after deducting the placement agent’s fees and other estimated offering expenses.

 

F-20

 

  

THE GLIMPSE GROUP, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

  Page
Index to Consolidated Financial Statements F-21
Independent Auditor’s Report F-22
Consolidated Balance Sheets F-23
Consolidated Statements of Operations F-24
Consolidated Statements of Stockholders’ Deficit F-25
Consolidated Statements of Cash Flows F-26
Notes to Consolidated Financial Statements F-27 - F-44

 

F-21

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of The Glimpse Group, Inc.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of The Glimpse Group, Inc. (the “Company”) as of June 30, 2021 and 2020, and the related consolidated statements of operations, stockholders’ deficit and cash flows for each of the years in the two-year period ended June 30, 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the two-year period ended June 30, 2021, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

 

We have served as the Company’s auditor since 2019.

 

New York NY

September 28, 2021

 

MGI Worldwide is a network of independent audit, tax, accounting and consulting firms. MGI Worldwide does not provide any services and its member firms are not an international partnership. Each member firm is a separate entity and neither MGI Worldwide nor any member firm accepts responsibility for the activities, work, opinions or services of any other member firm. For more information visit www.mgiworld.com/legal  

  

F-22

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED BALANCE SHEETS

 

   As of
June 30, 2021
   As of
June 30, 2020
 
ASSETS          
Cash and cash equivalents  $1,771,929   $1,034,846 
Accounts receivable   626,244    214,673 
Deferred costs   29,512    237,745 
Pre-offering costs   470,136    - 
Prepaid expenses and other current assets   281,047    468,747 
Total current assets   3,178,868    1,956,011 
           
Equipment, net   42,172    41,224 
Total assets  $3,221,040   $1,997,235 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Accounts payable  $381,510   $121,508 
Accrued liabilities   168,745    118,634 
Accrued bonuses   440,357    - 
Accrued legacy acquisition expense   1,250,000    - 
Deferred revenue   98,425    330,362 
Total current liabilities   2,339,037    570,504 
           
Long term liabilities          
Paycheck Protection Program (PPP 1) loan   -    548,885 
Paycheck Protection Program (PPP 2) loan   623,828    - 
Convertible promissory notes, net   1,429,953    1,183,535 
Total liabilities   4,392,818    2,302,924 
Commitments and contingencies          
Stockholders’ Deficit          
 Preferred Stock, par value $0.001 per share, 20 million shares
 authorized; 0 shares issued and outstanding
   -    - 
 Common Stock, par value $0.001 per share, 300 million shares
 authorized; 7,579,285 and 7,035,771 issued and outstanding
   7,580    7,036 
 Additional paid-in capital   20,936,050    15,710,996 
 Accumulated deficit   (22,115,408)   (16,023,721)
Total stockholders’ deficit   (1,171,778)   (305,689)
 Total liabilities and stockholders’ deficit  $3,221,040   $1,997,235 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-23

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   For the Year Ended   For the Year Ended 
   June 30, 2021   June 30, 2020 
Revenue          
Software services  $3,082,528   $1,777,447 
Software license/software as a service   338,967    167,868 
Total Revenue   3,421,495    1,945,315 
Cost of goods sold   1,461,210    1,137,193 
Gross Profit   1,960,285    808,122 
Operating expenses:          
Research and development expenses   3,183,055    2,430,752 
General and administrative expenses   2,220,811    1,835,147 
Sales and marketing expenses   1,267,088    1,462,701 
Total operating expenses   6,670,954    5,728,600 
Net loss from operations before other income (expense)   (4,710,669)   (4,920,478)
           
Other income (expense)          
 Forgiveness of Paycheck Protection Program (PPP1) loan   548,885    - 
 Other income   10,000    - 
 Interest income   6,202    8,583 
 Interest expense   (180,641)   (81,455)
 Loss on conversion of convertible notes   (515,464)   - 
 Legacy acquisition expense   (1,250,000)   - 
Total other expense, net   (1,381,018)   (72,872)
Net Loss  $(6,091,687)  $(4,993,350)
           
Basic and diluted net loss per share  $(0.84)  $(0.72)
Weighted-average shares used to compute basic and diluted net loss per share   7,259,249    6,923,506 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-24

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE YEARS ENDED JUNE 30, 2021 and 2020

 

   Shares             
   Common Stock   Additional Paid-In   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance as of July 1, 2019   6,860,246   $6,861   $12,497,228   $(11,030,371)  $1,473,718 
Sale of common stock to investors   1,556    1    6,999    -    7,000 
Common stock issued to convertible promissory note holders for prepaid interest   57,234    57    257,837    -    257,894 
Common stock issued to convertible promissory note holders as additional consideration   44,506    45    173,726    -    173,771 
Common stock issued to satisfy contingent liability   20,390    20    91,735    -    91,755 
Common stock issued to employees as compensation   28,158    28    126,683    -    126,711 
Common stock issued to vendors for compensation   23,681    24    101,475    -    101,499 
Stock option-based compensation expense   -    -    2,288,258    -    2,288,258 
Stock option-based board of directors expense   -    -    167,055    -    167,055 
Net loss   -    -    -    (4,993,350)   (4,993,350)
Balance as of June 30, 2020   7,035,771    7,036    15,710,996    (16,023,721)   (305,689)
Sales of common stock to investors   76,891    77    345,933    -    346,010 
Common stock issued for convertible note conversion   332,063    332    1,486,727    -    1,487,059 
Common stock issued to satisfy contingent liability   13,435    13    67,162    -    67,175 
Common stock issued to employees for compensation   18,553    19    92,746    -    92,765 
Common stock issued to convertible promissory note holders for prepaid interest   29,500    30    147,471    -    147,501 
Common stock issued to convertible promissory note holders as additional consideration   44,250    44    192,347    -    192,391 
Common stock issued to vendors for compensation   28,822    29    134,387    -    134,416 
Stock option-based compensation expense   -    -    2,576,058    -    2,576,058 
Stock option-based board of directors expense   -    -    182,223    -    182,223 
Net loss   -    -    -    (6,091,687)   (6,091,687)
Balance as of June 30, 2021   7,579,285   $7,580   $20,936,050   $(22,115,408)  $(1,171,778)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-25

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

  

For the Year Ended

June 30, 2021

  

For the Year Ended

June 30, 2020

 
Cash flows from operating activities:          
Net loss  $(6,091,687)  $(4,993,350)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   27,054    20,222 
Amortization of paid-in kind common stock interest on convertible notes   180,642    81,456 
Impairment of goodwill   -    139,754 
Stock option based compensation for employees and board of directors   2,945,487    2,550,521 
Issuance of common stock to vendors as compensation   134,416    101,499 
Issuance of common stock to employees to satisfy contingent liability   92,765    91,755 
Issuance of common stock for additional cost to satisfy contingent liability   20,217    39,311 
Loss on conversion of convertible notes   515,464    - 
Forgiveness of Paycheck Protection Program (PPP 1) loan   (548,885)   - 
Changes in operating assets and liabilities:          
Accounts receivable   (411,571)   (86,805)
Prepaid expenses and other current assets   (25,933)   (52,058)
Deferred costs   136,925    14,164 
Accounts payable   260,002    79,183 
Accrued liabilities   97,068    (72,360)
Accrued bonus   440,357    - 
Accrued legacy acquisition expense   1,250,000    - 
Deferred revenue   (231,937)   62,433 
Net cash used in operating activities   (1,209,616)   (2,024,275)
Cash flow from investing activities:          
Purchases of equipment   (28,003)   (32,660)
Net cash used in investing activities   (28,003)   (32,660)
Cash flows from financing activities:          
Proceeds from Paycheck Protection Program (PPP 1) loan   -    548,885 
Proceeds from Paycheck Protection Program (PPP 2) loan   623,828    - 
Proceeds from convertible promissory notes 1   -    1,332,500 
Proceeds from convertible promissory notes 2   1,475,000    - 
Proceeds from issuance of common equity to investors   346,010    7,000 
Pre-offering costs incurred   (470,136)   - 
Net cash provided by financing activities   1,974,702    1,888,385 
           
Net change in cash and cash equivalents   737,083    (168,550)
Cash and cash equivalents, beginning of year   1,034,846    1,203,396 
Cash and cash equivalents, end of period  $1,771,929   $1,034,846 
           
Non-cash Investing and Financing activities:          
Conversion of convertible promissory notes 1 into common stock  $1,487,059   $- 
Forgiveness of Paycheck Protection Program (PPP 1) loan  $548,885   $- 
Common stock issued to convertible Note 2 holders as additional consideration  $192,347   $- 
Common stock issued to convertible Note 1 holders as additional consideration  $-   $173,771 
Common stock issued for interest paid-in kind on convertible notes  $147,471   $257,894 
Issuance of common stock for satisfaction of contingent liability  $46,958   $87,400 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-26

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

  

NOTE 1. DESCRIPTION OF BUSINESS

 

The Glimpse Group, Inc. (“Glimpse”) is a Virtual (VR) and Augmented (AR) Reality company, comprised of a diversified portfolio of VR and AR software and services companies. Glimpse’s nine wholly-owned operating subsidiaries (“Subsidiary Companies” or “Subsidiaries”) are: Adept Reality, LLC (dba Adept XR Learning), Kabaq 3D Technologies, LLC (dba QReal), KreatAR, LLC (dba PostReality), D6 VR, LLC, Immersive Health Group, LLC, Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), and Early Adopter, LLC and one subsidiary in Turkey, Glimpse Group Yazilim ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”). In addition, the Company has two inactive subsidiary companies: In-It VR, LLC (dba Mezmos) and MotionZone, LLC (collectively, the “Company” or “Glimpse”). Glimpse was incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016.

 

Glimpse’s robust VR/AR ecosystem, collaborative environment and business model simplify the many challenges faced by companies in an emerging industry. Glimpse cultivates and manages business operations while providing a strong network of professional relationships, thereby allowing the subsidiary company entrepreneurs to maximize their time and resources in pursuit of mission-critical endeavors, reducing time to market, optimizing costs, improving product quality and leveraging joint go-to-market strategies, while simultaneously providing investors an opportunity to invest directly into the VR/AR industry via a diversified platform.

 

The Company completed an initial public offering (“IPO”) of its common stock on the Nasdaq Capital Market Exchange (“Nasdaq”) on July 1, 2021, under the ticker VRAR. See Note 13.

 

Summary of Glimpse’s Active Subsidiary Companies:

 

Kabaq 3D Technologies, LLC (dba QReal): Creating and displaying photorealistic 3D, AR, interactive digital models.

 

Adept Reality, LLC (dba Adept XR Learning): VR/AR corporate training solutions.

 

KreatAR, LLC (dba PostReality): AR presentation tools for design, creation and collaboration.

 

D6 VR, LLC: VR/AR data-analysis and collaboration for financial services and other data intensive industries.

 

Immersive Health Group, LLC (IHG): VR/AR solutions for the healthcare industry.

 

Foretell Studios, LLC (dba Foretell Reality): Social VR multi-person spaces, collaboration and group interaction for enterprise and support groups.

 

Number 9, LLC (dba Pagoni VR): VR/AR broadcasting solutions and environments for events, education, media and entertainment.

 

Early Adopter, LLC (EA): AR/VR solutions for K-12 education.

 

Glimpse Group Yazilim ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”): primarily develops and creates 3D models for QReal

 

NOTE 2. LIQUIDITY AND CAPITAL RESOURCES

 

The Company incurred a loss of $6.09 million during the year ended June 30, 2021, compared to a loss of $4.99 million during the year ended June 30, 2020. The loss was incurred as the Company funded operational expenses, primarily research and development, general and administrative, sales and marketing, and to satisfy legacy acquisitions costs.

 

F-27

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Net cash used in operating activities was $1.21 million during the year ended June 30, 2021, compared to $2.02 million during the year ended June 30, 2020. The Company has raised approximately $8.88 million through the issuance of common share and convertible debt financings since inception through June 30, 2021, of which approximately $1.82 million was raised during the year ended June 30, 2021 from the sale of common stock as disclosed in Note 6 and the issuance of convertible promissory notes as disclosed in Note 9.

 

The combination of operating losses since inception, cash expected to be used in operating activities in the future, uncertain conditions relating to additional capital raises and continued revenue growth had created uncertainty about the Company’s ability to continue as a going concern.

 

The Company had $1.77 million of cash as of June 30, 2021 compared to $1.03 million as of June 30, 2020. On July 1, 2021 the Company completed an IPO through Nasdaq in which, as a result of the sale of its common shares at $7.00 per share, it raised approximately $13.4 million in gross proceeds and $11.8 million in net proceeds after fees and expenses. See Note 13.

 

The Company generated $3.42 million of revenues during the year ended June 30, 2021, compared to $1.95 million during the year ended June 30, 2020. In addition, as disclosed in Note 9, during the year ended June 30, 2020 the Company received a $0.549 million Paycheck Protection Program 1 (“PPP 1”) loan and an additional $0.624 million Paycheck Protection Program 2 (“PPP 2”) loan in February 2021.

 

As of the date that this financial statement was issued, the Company’s cash position was approximately $13 million, contracted revenue backlog to be collected over the short term exceeded $1.5 million and the Company’s shares were traded on Nasdaq post its July 1, 2021 IPO. As such, the Company believes that it is sufficiently funded to meet its operational plan and future obligations beyond the 12-month period from the date that these financial statements were issued.

 

Given the above, doubt about the company’s ability to continue as a going concern was alleviated and the accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern.

 

While Management believes it will be able to continue to grow the Company’s revenue base, there is no assurance. In parallel, Management continually monitors its capital structure and operating plans and evaluates various potential funding alternatives that may be needed in order to finance the Company’s research and development activities, general and administrative expenses and growth strategy. These alternatives include raising funds through public equity or debt markets. Although there is no assurance that, if needed, the Company will be successful with its fundraising initiatives, the Company has been successful historically in raising equity capital and Management believes that its Nasdaq listing significantly increases its ability to access capital going forward.

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements.

 

F-28

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Accounting Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options and cost of goods sold.

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash and deposits in bank checking accounts or money market funds with immediate access.

 

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
     
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company adopted the new accounting standard, Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, (“ASC 606”) beginning on July 1, 2020 using the modified retrospective method for all open contracts and related amendments. The adoption did not result in an adjustment to the accumulated deficit as of June 30, 2020. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods. The adoption of ASC 606 did not have a material impact on reported sales to customers and net earnings (losses).

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured

 

F-29

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue for the years ended June 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.

 

Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

As detailed in the Company’s Consolidated Statement of Operations, the following is a disaggregation of the Company’s revenue by major source for the years ended June 30, 2021 and 2020:

 

   For the Years Ended 
   June 30, 
   2021   2020 
Software Services  $3,082,528   $1,777,447 
Software License and Software as a Service   338,967    167,868 
Total Revenue  $3,421,495   $1,945,315 

 

F-30

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Timing of Revenue

 

As the Company began adopting ASC 606 in July 2020, the timing of revenue recognition for periods prior to the adoption is not required:

 

   For the Year Ended 
   June 30, 2021 
Products transferred at a point in time  $2,967,586 
Products and services transferred over time   453,909 
Total Revenue  $3,421,495 

 

Remaining Performance Obligations

 

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.

 

For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

 

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.

 

For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.

 

For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

 

Deferred revenue is comprised mainly of software project contract performance obligations not completed.

 

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of June 30, 2021, the Company had approximately $1.23 million in unfulfilled performance obligations.

 

F-31

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Prior to the adoption of ASC 606 at July 1, 2020, the Company’s revenue recognition was as follows:

 

Software Service Revenue

 

The Company generates software related revenues from services performed for: Virtual and Augmented Reality projects, consulting retainers, and ongoing website maintenance and support. Software service revenue generated from Virtual and Augmented Reality projects is recognized after delivery of the project has occurred, when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured. Any unrecognized portion of project revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets. Deferred costs include cash and equity based payroll costs, and may include payments to vendors. Software service revenue generated from consulting retainers is typically billed in advance for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, services have been performed, and collection is reasonably assured. Software service revenue generated from ongoing website maintenance and support services is typically billed in arrears for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured.

 

Software License and Software as a Service Revenue

 

The Company derives revenue from software as-a-service subscriptions and software licenses. Upon delivery of the software to customers, revenue is recognized ratably over the term of the contract or arrangement. The unrecognized portion of this revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets.

 

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of June 30, 2021 and June 30, 2020 no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

Customer Concentration and Credit Risk

 

Two customers accounted for approximately 49% (26% and 23%, respectively) of the Company’s total gross revenues during the year ended June 30, 2021. One different customer accounted for approximately 13% of the Company’s total gross revenues during the year ended June 30, 2020.

 

Two customers accounted for approximately 71% (57% and 14%, respectively) of the Company’s accounts receivable at June 30, 2021. Four different customers accounted for approximately 96% (35%, 35%, 14% and 12%, respectively) of the Company’s accounts receivable at June 30, 2020.

 

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

 

Equipment, net

 

Equipment is stated at cost less accumulated depreciation (see Note 4). Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.

 

The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

F-32

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.

 

The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the years ended June 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.

 

Goodwill

 

The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded a goodwill impairment during the fiscal year ended June 30, 2020 (see Note 8). There was no Goodwill at June 30, 2021 and 2020.

 

Earnings Per Share

 

Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.

 

F-33

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.

 

Recently Issued Pronouncements

 

Leases

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (Topic 842). The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company does not expect to adopt this standard prior to July 1, 2022. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Financial Instruments – Credit Losses

 

In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates (ASC 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

F-34

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

NOTE 4. EQUIPMENT, NET

 

Equipment, primarily comprised of computers and hardware, consisted of the following:

 

      Useful Life (Years)      Useful Life (Years) 
   As of June 30, 2021   As of June 30, 2020 
   Value ($)   Useful Life (Years)   Value ($)   Useful Life (Years) 
Equipment  $96,963    3   $105,239    3 
Less: accumulated depreciation   (54,791)        (64,015)     
Balance  $42,172        $41,224      

 

Depreciation expense was $27,054 and $20,222 during the years ended June 30, 2021 and 2020, respectively.

 

NOTE 5. EARNINGS PER SHARE

 

The following table presents the computation of basic and diluted net loss per common share:

 

       
   Year Ended
June 30, 2021
   Year Ended
June 30, 2020
 
Numerator:          
Net loss  $(6,091,687)  $(4,993,350)
Denominator:          
Weighted-average common shares outstanding for basic and diluted net loss per share   7,259,249    6,923,506 
Basic and diluted net loss per share  $(0.84)  $(0.72)

 

Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

 

 

   At
June 30, 2021
   At
June 30, 2020
 
Stock Options   4,740,910    4,092,593 
Convertible Notes   324,150    296,111 
Total   5,065,060    4,388,704 

 

F-35

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

NOTE 6. EQUITY

 

Common Stock and Preferred Stock

 

As of June 30, 2021, the Company had authorized 300 million shares of common stock, $0.001 par value per share and 20 million shares of preferred stock; 7.58 million and 7.04 million shares of common stock were issued and outstanding as of June 30, 2021 and 2020, respectively. 0 shares of preferred stock were issued and outstanding as of June 30, 2021 and 2020, respectively.

 

Sale of Common Stock

 

Common stock sold to Investors

 

During the years ended June 30, 2021 and 2020, the Company sold approximately 76,900 and 1,600 shares of common stock to investors at a price of $4.50/share, for total proceeds of approximately $346,000 and $7,000, respectively.

 

On July 1, 2021 the Company sold 1,912,500 shares of common stock in an initial public offering at a price of $7.00/share. See Note 13.

 

Common stock issued to Investors

 

During the year ended June 30, 2021, in connection with the conversion of convertible promissory notes the Company issued approximately 332,000 shares of common stock (see Note 9).

 

During the years ended June 30, 2021 and 2020, in connection with the issuance of convertible promissory notes, the Company issued approximately 74,000 and 102,000 shares of common stock, respectively (see Note 9).

 

Common stock issued to Vendors

 

During the years ended June 30, 2021 and 2020, the Company issued approximately 28,800 and 23,700 shares of common stock, respectively, to various vendors for services performed and recorded share-based compensation of approximately $134,400 and $101,500, respectively.

 

Common stock issued to satisfy Contingent Liabilities

 

During the year ended June 30, 2021 the Company issued approximately 13,000 shares of common stock to satisfy a contingent liability related to a prior acquisition with a fair market value of approximately $67,000 (see Note 7).

 

During the year ended June 30, 2020 the Company issued approximately 20,000 shares of common stock to satisfy a contingent liability related to a prior acquisition with a fair market value of approximately $92,000 (see Note 7).

 

Employee Stock-Based Compensation

 

In October 2016, the Company’s Board of Directors and its stockholders adopted The Glimpse Group, Inc. 2016 Equity Incentive Plan (the “Plan”).

 

Under the Plan, the Company grants stock options at exercise prices generally equal to the fair value of the common stock on the grant date. These options generally expire ten years after the grant date and vest, depending on the optionee, over a varying period of continuous service following the vesting commencement date of such option (ranging from zero to three years), unless the optionee’s continuous service with the Company is terminated earlier. Stock-based compensation expense is recognized evenly over the requisite service period.

 

F-36

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The Plan is administered by the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), who determine the recipients and the terms of the awards granted, subject to the approval of the Company’s Board of Directors. The Plan provides that awards granted may be options, restricted stock, restricted stock units or other stock based awards (collectively the “Awards”). Stock option awards may be either incentive stock options or nonqualified options. The Awards may be granted to eligible employees, directors, service providers, consultants and advisers.

 

As of June 30, 2020 an aggregate of up to 5 million shares of common stock were reserved for issuance under the Plan, with 0.91 million available for issuance.

 

In January and April 2021, the Company amended its 2016 Equity Incentive Plan (the “Plan”), increasing the amount of common shares reserved for issuance from 5 million to 10 million. As of June 30, 2021, there were 5.26 million shares available for issuance under the Plan.

 

In addition, the share reserve will automatically increase on January 1 of each calendar year, for the period beginning on January 1, 2022 and ending on (and including) January 1, 2030 (each, an “Evergreen Date”) in an amount equal to five percent (5%) of the total number of shares of the Company’s common stock outstanding on December 31st immediately preceding the applicable Evergreen Date (the “Evergreen Increase”). Notwithstanding the foregoing, the Board may act prior to the Evergreen Date of a given year to provide that there will be no Evergreen Increase for such year, or that the Evergreen Increase for such year will be a lesser number of shares of the Company’s common stock than would otherwise occur pursuant to the aforementioned. Any shares of stock delivered under the Plan shall consist of authorized and unissued shares or treasury shares. There were no other significant changes to the incentive plan.

 

The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.

 

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table:

 

       
   Year Ended
June, 2021
   Year Ended
June, 2020
 
Weighted average expected terms (in years)   5.3    5.3 
Weighted average expected volatility   126.6%   117.3%
Weighted average risk-free interest rate   0.5%   1.4%
Expected dividend yield   0%   0%

 

The grant date fair value, for options granted during the year ended June 30, 2021 was approximately $2.94 million.

 

The grant date fair value, for options granted during the year ended June 30, 2020 was approximately $2.70 million.

 

F-37

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The following is a summary of the Company’s stock option activity for the years ended June 30, 2021 and 2020:

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2019   3,408,452   $2.97    8.5   $3,721,339 
Options Granted   766,455    4.26    9.5    182,328 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (82,314)   3.84    9.6    (53,977)
Outstanding at June 30, 2020   4,092,593   $3.19    8.4   $5,553,916 
Exercisable at June 30, 2020   3,581,514   $3.06    8.3   $5,365,512 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2020   4,092,593   $3.19    8.4   $5,553,916 
Options Granted   766,419    4.66    9.7    383,210 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (118,102)   4.28    8.9    (89,956)
Outstanding at June 30, 2021   4,740,910   $3.40    8.5   $7,893,467 
Exercisable at June 30, 2021   4,346,734   $3.29    8.4   $7,659,692 

 

The Company’s stock option-based expense for the years ended June 30, 2021 and 2020 consisted of the following:

 

   Year Ended
June 30, 2021
   Year Ended
June 30, 2020
 
Stock option-based expense :          
Research and development expenses  $1,381,168   $1,266,911 
General and administrative expenses  $373,506    570,765 
Sales and marketing expenses  $477,561    293,226 
Cost of goods sold  $526,156    236,825 
Board option expense  $187,096    182,794 
Total  $2,945,487   $2,550,521 
           

 

During the year ended June 30, 2019, certain Company advisors received $0.31 million worth of Company stock options with an exercise price of $5.25/share and a three-year term, for potential services to be performed over a three-year period. Of the $0.31 million, $0.06 million and $0.17 million was categorized as a prepaid expense at June 30, 2021 and 2020, respectively. During the years ended June 30, 2021 and 2020, the Company recognized approximately $116,000 for each period, as general and administration expense.

 

At June 30, 2021, total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $1.50 million and is expected to be recognized over a weighted average period of 1.1 years. At June 30, 2020, total unrecognized compensation expense related to stock options was approximately $1.62 million and was expected to be recognized over a weighted average period of 1.02 years.

 

The intrinsic value of stock options as of June 30, 2021 was computed using a fair market value of the common stock of $5.00/share, as compared to $4.50/share as of June 30, 2020.

 

F-38

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

NOTE 7. CONTINGENT ACQUISITION LIABILITY

 

Early Adopter, LLC

 

In connection with the Company’s April 2018 asset acquisition of Early Adopter.Com (“EA”), the Company expected to pay additional contingent amounts, based on EA’s annual revenues (“contingent performance bonus”) as measured and paid in each of the first three anniversary dates after the closing of the acquisition, paid by the issuance of the Company’s common stock at a fixed price of $3.25/share.

 

At June 30, 2020, the total estimated contingent acquisition liability was approximately $47,000 due for the third anniversary, which is included in accrued liabilities. During the year ended June 30, 2021, the Company issued approximately 32,000 shares of common stock in final payment of all contingent liabilities related to the EA acquisition and recorded share-based expense of approximately $96,800. There are no further obligations relating to the EA acquisition.

 

Kabaq 3D Technologies, LLC

 

The Company’s November 2016 acquisition of assets relating to the acquisition of Kabaq 3D Technologies, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met and the Company incurred $750,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition expense on the Company’s statement of operations for the year ended June 30, 2021. At June 30, 2020, no expense was accrued because the likelihood of the Company going public and reaching the volume threshold was not probable at that time.

 

KreatAR, LLC

 

The Company’s October 2016 acquisition of assets relating to the acquisitions of KreatAR, LLC (and related entity LocateAR) contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met. In connection therewith, the Company incurred $500,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition expense on the Company’s statement of operations for the year ended June 30, 2021. At June 30, 2020, no expense was accrued because the likelihood of the Company going public and reaching the volume threshold was not probable at that time.

 

NOTE 8. GOODWILL

 

Due to a significant decline in EA’s business, unsuccessful VR/AR product commercialization efforts and negative future growth prospects, the goodwill related to the EA acquisition was determined to be impaired and written down to $0 as of June 30, 2020. During the year ended June 30, 2020, general and administrative expense included approximately $140,000 for the impairment of goodwill. The Company has no other goodwill.

 

NOTE 9. DEBT

 

Convertible Promissory Notes 1

 

During the year ended June 30, 2020, the Company raised $1.33 million by the issuance of unsecured Convertible Promissory Notes with a three-year term (the “Note 1” or “Notes 1”), primarily from existing Company investors. The Notes 1 included participation by the Company’s executives and independent members of the Company’s Board in the amount of $0.2 million. The Note 1 holders received approximately 45,000 shares of common stock (at $4.50/share) in the aggregate, with a relative value of $170,000 at the time of issuance. As of June 30, 2020, the remaining original issue discount on the Notes was approximately $149,000, which was to be amortized over the remaining term of the Notes.

 

F-39

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Additional interest expense for the amortization of the original issue discount amounted to approximately $96,900 for the year ended June 30, 2020.

 

The Notes 1 bore an interest rate of 10% per annum. The first two years of interest were prepaid with the issuance of the Company’s common stock (at $4.50/share), for an issuance of approximately 57,000 shares of common stock with a fair value of approximately $258,000.

 

The Notes 1 were convertible by a Note 1 holder at any time during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion.

 

During the year ended June 30, 2021, Note 1 holders converted approximately $1.21 million of principal into approximately 0.30 million shares of common stock at a revised conversion price of $4.00/share. The original contracted conversion price was $4.50/share. In order to encourage early conversion, two years before the maturity of the Convertible Notes 1, the Company reduced the conversion price to $4.00/share.

 

In addition to the reduced conversion price, the Note holders who converted received the third year interest (10%) on the Notes, totaling approximately $122,000, as additional consideration to convert early which was paid in the Company’s common stock, amounting to approximately 30,000 shares. In the aggregate, a loss of approximately $515,500 was recognized during the year ended June 30, 2021, reflecting the reduction of the Notes conversion price from $4.50/share to $4.00/share, the issuance of Year 3 Interest (10%) paid in common stock (at $4.00/share instead of $4.50/share), and the write-off of the remaining related pre-paid interest and original issue discount expenses.

 

The holders of the remaining unconverted Convertible Notes 1, equating to approximately $117,000 (net of original discount of approximately $8,000) of outstanding principal at June 30, 2021, amended their Notes 1 to allow for auto conversion upon the Company’s potential IPO event at a conversion price of $4.25/share. As per the amendment, the residual Notes 1 converted upon the IPO. See Note 13.

 

Convertible Promissory Notes 2

 

In March 2021, the Company raised $1.475 million by the issuance of unsecured Convertible Promissory Notes with a two-year term (the “Notes 2”), to several investors. The Notes 2 holders received approximately 44,000 shares of common stock (at $5.00/share) in the aggregate, with a relative fair value of approximately $192,000 at the time of issuance. Accordingly, the original issue discount on the Notes 2 will be amortized over its term.

 

The Notes 2 bear an interest rate of 10% per annum. The first year of interest was prepaid with the issuance of the Company’s common stock (at $5.00/share), for an issuance of 29,500 shares of common stock with a fair value of $147,500. During the second year of the Notes 2, interest will be paid monthly in the Company’s common stock (at a fixed price of $5.00/share) on any unpaid principal outstanding.

 

The Notes 2 are convertible by a note holder at any time during the term into common stock of the Company at a fixed price of $5.00/share, or 295,000 shares of common stock upon full conversion. Notes 2 have a maturity date of March 5, 2023. All outstanding amounts at the time of the Company’s IPO automatically converted at $5.00/share in the aggregate. Convertible Notes 2 totaled approximately $1.313 million (net of original issue discount of approximately $162,000) at June 30, 2021. The Notes 2 converted upon the IPO. See Note 13.

 

F-40

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

SBA Paycheck Protection Program Loans/EIDL

 

In May 2020, the Company received a Paycheck Protection Program 1 (“PPP1”) loan from the Small Business Administration (“SBA”) in the amount of $0.55 million. The Company utilized the PPP 1 loan proceeds in full towards payroll and rent in accordance with the SBA guidelines. Pursuant to SBA guidelines, the Company’s PPP1 loan was fully forgiven in February 2021. In conjunction with the PPP1 loan, the Company also received an Economic Injury Disaster Loan (“EIDL”) advance of $0.01 million. As per the SBA guidelines, EIDL advances do not need to be repaid.

 

In February 2021, the Company received a second Paycheck Protection Program 2 (“PPP2”) loan in the amount of $0.62 million. Similar to the PPP1 loan, the Company expects to utilize the loan proceeds in full toward payroll and rent in accordance with SBA guidelines. The PPP2 loan bears a fixed interest rate of 1% per annum and is due in February 2026. Pursuant to SBA guidelines, the Company expects to apply for full forgiveness of its PPP2 loan in fiscal year 2022.

 

NOTE 10. PROVISION FOR INCOME TAXES

 

There was no current or deferred income tax provision for the years ended June 30, 2021 and 2020.

 

The Company’s deferred tax assets as of June 30, 2021 and 2020 consist of the following:

 

   As of   As of 
   June 30, 2021   June 30, 2020 
Deferred tax assets:          
Net-operating loss carryforward  $3,923,012   $2,811,156 
Stock-based compensation   536,265    348,013 
Total Deferred Tax Assets   4,459,277    3,159,169 
Valuation allowance   (4,459,277)   (3,159,169)
Deferred Tax Asset, Net  $-   $- 

 

The Company maintains a valuation allowance on deferred tax assets due to the uncertainty regarding the ability to utilize these deferred tax assets in the future. At June 30, 2021, the Company had potential utilizable aggregate gross net operating loss carryforwards (“NOLs”) of approximately $11.35 million. NOLs for the periods ending June 30, 2018 and prior ($2.86 million) begin to expire in 2037. NOLs for the years ending June 30, 2021, 2020 and 2019 ($8.49 million), in accordance with changes to the U.S. Internal Revenue Code, have no expiration.

 

Section 382 of the U.S. Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. The Company has not completed a Section 382 analysis of the NOL carryforwards. Consequently, the Company’s NOL carryforwards may be subject to annual limitations under Section 382.

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. As a result of the uncertainly in the realization of the Company’s deferred tax assets, the Company has provided a valuation allowance for the full amount of the deferred tax assets at June 30, 2021 and June 30, 2020.

 

F-41

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The Company’s valuation allowance during the years ended June 30, 2021 and 2020 increased by approximately $1.30 million and $1.00 million, respectively.

 

The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:

SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE 

   For the Year Ended   For the Year Ended 
   June 30, 2021   June 30, 2020 
Statutory Federal Income Tax Rate   (21.00)%   (21.00)%
State and Local Taxes, Net of Federal Tax Benefit   (13.56)%   (13.56)%
Stock Based Compensation Expense (ISO)   13.20%   14.50%
Change in Valuation Allowance   21.36%   20.06%
Income Taxes Provision (Benefit)   0.00    0.00 

 

Upon completion of its 2021 U.S. income tax return in 2022, the Company may identify additional remeasurement adjustments. The Company will continue to assess its provision for income taxes as future guidance is issued, but do not currently anticipate significant revisions will be necessary.

 

NOTE 11. FOREIGN OPERATIONS

 

In March 2021, the Company established Glimpse Turkey to support the operations of Kabaq 3D Technologies (dba QReal). Operations consist primarily of 3D modeler and artist employees. Glimpse Turkey has no revenue, long-term obligations or operating leases and all salaries are denominated in US dollars.

 

In August 2021, the Company completed an asset acquisition which included certain assets, as defined, in Australia. See Note 13.

 

NOTE 12. COMMITMENTS AND CONTINGENCIES

 

Operating Lease

 

The Company entered into a 2-year lease commencing January 1, 2020 and ending on December 31, 2021. To secure the new lease, the Company paid a $75,000 security deposit.

 

Rent expense was approximately $296,000 and $247,000 for the years ended June 30, 2021 and 2020, respectively. There is approximately $180,000 due on the lease for the July-December 2021 period, prior to any potential discounts.

 

Officers’ Employment Agreements

 

In May 2021, the Company entered into employment agreements with its three corporate officers. The agreements provide for base salary (including increases linked to Company revenue thresholds), performance bonus, incentive bonus (including those based on capital raising thresholds), equity incentives, benefits and severance (including confidentiality and non-compete). The employment agreements will continue until terminated by either the Company or the respective officers. The Company accrued approximately $426,000 of bonuses at June 30, 2021 related to these agreements resulting from the IPO and other met thresholds, as defined. The statement of operations for the year ended June 30, 2021 (the year the employment agreements were executed) includes salary, stock option and the aforementioned bonus expenses for the three officers of approximately $1.03 million.

 

F-42

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Potential Future Distributions Upon Divestiture or Sale

 

Upon a divestiture or sale of a subsidiary company, the Company is contractually obligated to distribute up to 10% of the net proceeds from such divestiture or sale to the senior management team of the divested subsidiary company. Currently, there were no active discussions pertaining to a potential divestiture or sale of any of the Company’s subsidiaries.

 

COVID-19

 

The Company’s business and operations have been adversely affected by the COVID-19 pandemic, as have the markets in which our customers operate. The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.

 

From March 2020 through June 2021, the Company had required substantially all of its employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit the Company’s ability to operate its business effectively. Commencing July 2021, the Company has tentatively required employees to return to the office several days a week.

 

The Company continues to closely monitor the situation and the effects on its business and operations. The Company does not yet know the full extent of potential impacts on its business and operations. Given the uncertainty, the Company cannot reasonably estimate the impact on its future results of operations, cash flows or financial condition.

 

NOTE 13. SUBSEQUENT EVENTS

 

Initial Public Offering (“IPO”)

 

On July 1 ,2021, the Company completed an IPO of common stock on the NASDAQ under the symbol “VRAR”, at a price of $7.00 per share.

 

The Company sold approximately 1.91 million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million. Professional fees and listing expenses of approximately $0.47 million were included in pre-offering costs, of which $0.309 million was included in accounts payable on the balance sheet at June 30, 2021.

 

In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase 87,500 shares of common stock at $7.00 per share. The warrant cannot be exercised prior to December 30, 2021, and expires in June 2026.

 

As stated in Note 9, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through issuance of 324,150 shares of commons stock.

 

F-43

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The following is a condensed balance sheet reflecting the proforma effect of the IPO on the June 30, 2021 balance sheet.

  

   As Reported at
June 30, 2021
   Proforma for IPO 
Cash and cash equivalents  $1,771,929   $13,728,429 
Other current assets   1,406,939    833,296 
Equipment, net   42,172    42,172 
Total assets  $3,221,040   $14,603,897 
           
Total current liabilities  $2,339,037   $2,004,037 
Convertible promissory notes, net   1,429,953    - 
Other long term liability   623,828    623,828 
Total liabilities   4,392,818    2,627,865 
Total stockholders’ equity (deficit)   (1,171,778)   11,976,032 
Total liabilities and stockholders’ equity (deficit)  $3,221,040   $14,603,897 

 

ASSET ACQUISTION

 

In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC, completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services. Over time, the acquisition may facilitate the Company’s endeavors in the Architecture, Engineering and Construction (“AEC”) market segments.

 

Initial consideration for the purchase is $0.75 million payable in Company common stock. In August 2021, the Company issued 77,264 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company is currently determining its purchase price allocation between customer list, intellectual property and goodwill.

 

F-44

 

 

PART IIINFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13. Other Expenses of Issuance and Distribution.

 

The following table sets forth all expenses to be paid by the registrant in connection with the issuance and distribution of the securities to be registered, other than underwriting discounts and commissions. All amounts shown are estimates except for the SEC registration fee:

 

SEC registration fee  $2,851.22 
Legal fees and expenses  115,000.00 
Accounting fees and expenses  5,000.00 
Placement agent accountable expense reimbursement  100,000.00 
Total  $222,851.22 

 

Item 14. Indemnification of Directors and Officers.

 

Neither our Articles of Incorporation nor Bylaws prevent us from indemnifying our officers, directors and agents to the extent permitted under the Nevada Reserve Statutes (“NRS”). NRS provides that a corporation shall indemnify any director, officer, employee or agent of a corporation against expenses, including attorneys’ fees, actually and reasonably incurred by him in connection with any defense to the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in NRS or in defense of any claim, issue or matter therein.

 

Item 15. Recent Sales of Unregistered Securities.

 

None

 

Item 16. Exhibits and Financial Statement Schedules.

 

3.1   Articles of Incorporation, incorporated by reference to Exhibit 3.1 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
3.2   Amended and Restated Bylaws, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
5.1*   Opinion of Sichenzia Ross Ference LLP
10.1   Amended and Restated 2016 Incentive Plan, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.2   Limited Liability Company Agreement of Number 9, LLC entered into by the Company, effective as of February 13, 2018, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.3   Assignment of Technology, Patent, & Intellectual Property Agreement dated as of May 1, 2019, between the Company, Adept Reality, LLC and Aquinas Learning, Inc. , incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.4   Limited Liability Company Agreement of Adept Reality, LLC (f.k.a. Glimpse Group Consulting, LLC) entered into by the Company, effective as of May 3, 2017, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.5   Limited Liability Company Agreement of D6 VR, LLC (f.k.a. Dataview VR, LLC) (f.k.a. Marketview VR, LLC) entered into by the Company, effective as of August 8, 2017, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.

 

II-1
 

 

10.6   Economics Interests Agreement dated as of March 30, 2017 by and between the Company, D6 VR, LLC (f.k.a Dataview VR, LLC) (f.k.a. Marketview VR, LLC), and Andy Maggio, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.7   Economics Interests Agreement dated as of March 30, 2017 by and between the Company, D6 VR, LLC (f.k.a Dataview VR, LLC) (f.k.a. Marketview VR, LLC), and Brennan McTernan, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.8   Master Acquisition Agreement, dated as of April 1, 2018, among the Company, Early Adopter LLC, Early Adopter and Jay Van Buren, Lynn Van Buren, Marjorie Van Buren, Valerie Eakes-Kann, Joe Unander, and Christopher Gaughan, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.9   Bill of Sale entered into on April 1, 2018 by and between Early Adopter, and Jay Van Buren, Lynn Van Buren, Marjorie Van Buren, Valerie Eakes-Kann, Joe Unander, and Christopher Gaughan and Early Adopter, LLC, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.10   Limited Liability Company Agreement of Early Adopter, LLC entered into by the Company, effective as of April 1, 2018, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.

10.11

 

 

Master Acquisition Agreement dated as of October 31, 2016, by and between the Company, Crafty Games, LLC and Foretell Studios, LLC (f.k.a. Dire Studios, LLC) , incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.

10.12   Bill of Sale entered into on October 31, 2016 by and between Crafty Games, LLC and Foretell Studios, LLC (f.k.a. Dire Studios, LLC) , incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.13   Right of First Refusal Agreement dated as of December 30, 2019 by and between The Company and Membit Inc., incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.14   Limited Liability Company Agreement of Immersive Health Group, LLC entered into by the Company, effective as of October 13, 2017, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.15   Limited Liability Company Agreement of KabaQ 3D Technologies, LLC entered into by the Company, effective as of May 30, 2017, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.16   Master Acquisition Agreement dated as of November 8, 2016, among the Company, KabaQ 3D Food Technologies, LLC and Alper Guler, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.17   Bill of Sale entered into on November 8, 2016 by and between the Company, KabaQ Food Technologies, LLC and Alper Guler, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.18   Master Development Agreement dated as of July 14, 2017 by and between Pandora Reality LLC and KabaQ 3D Technologies, LLC, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.19   Agreement entered into as of June 12, 2017 by and among the Company, KabaQ 3D Food Technologies, LLC, Alper Guler and Caner Soyer, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.20   Master Acquisition Agreement dated as of October 28, 2016 among the Company, PresentAR and LocateAR and Liron Lerman, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.21   Limited Liability Company Agreement of Kreatar LLC entered into by the Company, effective as of May 30, 2017, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.22   Bill of Sale entered into on October 28, 2016 by and between the Company, PresentAR and LocateAR and Liron Lerman, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.

 

II-2
 

 

10.23   Amendment to Master Acquisition Agreement II dated as of November 12, 2018 by and between the Company and Liron Lerman, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.24   Technology & Intellectual Property Assignability Agreement dated as of March 29, 2018 among the Company, LocateAR, LLC and Kreatar, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.25   Employment Agreement dated May 13, 2021 by and between the Company and Lyron Bentovim, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.26   Employment Agreement dated May 13, 2021 by and between the Company and Maydan Rothblum, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.27   Employment Agreement dated May 13, 2021 by and between the Company and David J. Smith, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.28   Form of Series A Round Subscription Agreement, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.29   Form of Seed Round Subscription Agreement, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.30   Form of Interim Round Subscription Agreement, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.31   Form of Convertible Note I Promissory Note, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.32   Form of Convertible Note II Securities Purchase Agreement, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.33   Form of Convertible Note II Promissory Note, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
10.34   Placement Agent Agreement dated October 28, 2021, incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 3, 2021.
10.35   Form of Securities Purchase Agreement incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on November 3, 2021.
10.36   Form of Immediately Exercisable Warrants incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on November 3, 2021.
10.37   Form of Warrants Exercisable after Six Months incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on November 3, 2021.
10.38   Form of Registration Rights Agreement incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on November 3, 2021.
14.1   Code of Ethics, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
21.1*   List of Subsidiaries
23.1*   Consent of Hoberman & Lesser CPA’s LLP
23.2*   Consent of Sichenzia Ross Ference LLP (included in exhibit 5.1)
24.1   Power of Attorney (included in signature page to this registration statement)

  

* Filed herewith

 

Item 17. Undertakings.

 

(a) The undersigned registrant hereby undertakes:

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

II-3
 

 

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);

 

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

 

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

 

(2) That, for the purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of the securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(4) That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

(5) For the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

 

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

 

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

 

(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

II-4
 

 

(b) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities, other than the payment by the registrant of expenses incurred and paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding, is asserted by such director, officer or controlling person in connection with the securities being registered hereby, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

(c) The undersigned Registrant hereby undertakes that it will:

 

(1) for determining any liability under the Securities Act, treat the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under Rule 424(b)(1), or (4) or 497(h) under the Securities Act as part of this registration statement as of the time the Commission declared it effective.

 

(2) for determining any liability under the Securities Act, treat each post-effective amendment that contains a form of prospectus as a new registration statement for the securities offered in the registration statement, and that offering of the securities at that time as the initial bona fide offering of those securities.

 

II-5
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Manhattan, State of New York, on November 26, 2021.

 

  The Glimpse Group, Inc.
   
  By: /s/ Lyron Bentovim
    Lyron Bentovim
   

Chief Executive Officer and Chairman

(Principal Executive Officer)

     
  By: /s/ Maydan Rothblum
    Maydan Rothblum
   

Chief Financial Officer and Director

(Principal Financial and Accounting Officer)

 

Each person whose signature appears below constitutes and appoints Lyron Bentovim and/or Maydan Rothblum his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him and in his name, place and stead, and in any and all capacities, to sign for him and in him name in the capacities indicated below any and all amendments (including post-effective amendments) to this registration statement (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated below:

 

Date   Name and Title   Signature
         
November 26, 2021   Lyron Bentovim   /s/ Lyron Bentovim
    President Chief Executive Officer & Chairman    
         
November 26, 2021   Maydan Rothblum   /s/ Maydan Rothblum
    Chief Financial Officer, Chief Operating Officer, Secretary, Treasurer & Director    
         
November 26, 2021   D.J. Smith   /s/ D.J. Smith
    Chief Creative Officer & Director    
         
November 26, 2021   Sharon Rowlands   /s/ Sharon Rowlands
    Director    
         
November 26, 2021   Jeff Enslin   /s/ Jeff Enslin
    Director    
         
November 26, 2021   Lemuel Amen   /s/ Lemuel Amen
    Director    
         
November 26, 2021   Alexander Ruckdaeschel   /s/ Alexander Ruckdaeschel
    Director    

 

II-6

 

EX-5.1 2 ex5-1.htm

 

Exhibit 5.1

 

 

November 26, 2021

 

The Glimpse Group, Inc.

15 West 38th St, 9th Fl

New York, NY 10018

 

  RE: The Glimpse Group, Inc. – Registration Statement on Form S-1

 

Ladies and Gentlemen:

 

We have acted as counsel to The Glimpse Group, Inc., a Nevada corporation (the “Company”). As such, we have participated in the preparation of the Company’s registration statement on Form S-1 (the “Registration Statement”) relating to the registration under the United States Securities Act of 1933, as amended (the “Securities Act”), of the offering for resale by the selling stockholders listed therein of up to an aggregate of 2,250,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), consisting of (i) 1,500,000 shares of Common Stock (the “Resale Shares”), and (ii) 750,000 shares of Common Stock issuable upon the exercise of outstanding warrants originally issued to EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) in an October 2021 private placement (the “October Warrants”).

 

As counsel to the Company, we have examined copies of the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), such corporate records, instruments, and other documents relating to the Company and such matters of law as we have considered necessary or appropriate for the purpose of rendering this opinion. In such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, and the conformity to authentic originals of all documents submitted to us as copies.

 

Based on the foregoing, and subject to the assumptions, limitations and qualifications set forth herein, we are of the opinion that the Resale Shares are, and the Common Stock underlying the October Warrants, when paid for and issued pursuant to the terms of the applicable warrants, will be, duly authorized, legally issued, fully paid and non-assessable. The October Warrants are legally and validly binding obligations of the Company.

 

We are admitted to the Bar in the State of New York. We express no opinion as to the laws of any jurisdiction other than the laws of the State of New York except with respect to the Nevada Revised Statutes.

 

We consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of our name in the Registration Statement under the caption “Legal Matters”. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission.

 

  Very truly yours,
   
  /s/ Sichenzia Ross Ference LLP
   
Sichenzia Ross Ference LLP

 

1185 Avenue of the Americas | 31st Floor | New York, NY | 10036

T (212) 930 9700 | F (212) 930 9725 | WWW.SRF.LAW

 

 

EX-21.1 3 ex21-1.htm

 

Exhibit 21.1

 

Subsidiaries of the Registrant

 

Name of Subsidiary   Incorporation State
Adept Reality, LLC (dba Adept Reality Learning)   Nevada
Kabaq 3D Technologies, LLC (dba QReal)   Nevada
KreatAR, LLC (dba PostReality)   Nevada
Foretell Studios, LLC (dba Foretell Reality)   Nevada
In-It, VR LLC (dba Mezmos, in-active)   Nevada
D6 VR, LLC   Nevada
Immersive Health Group, LLC   Nevada
Number 9, LLC (dba Pagoni VR)   Nevada
Early Adopter, LLC   Nevada
MotionZone, LLC (dba Auggd)   Nevada
Glimpse Group Yazilim ve ARGE Ticaret Anonim Sirketi (Glimpse Turkey)   Turkey
XR Terra, LLC   Nevada

 

 

 

 

EX-23.1 4 ex23-1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the use in this registration statement on Form S-1 of our report dated September 28, 2021, relating to the consolidated financial statements of The Glimpse Group, Inc. as of June 30, 2021 and 2020, and for the years then ended appearing in the prospectus, which is part of this registration statement. We also consent to the reference to us under the heading “Experts” in such prospectus.

 

/s/ Hoberman & Lesser CPA’s, LLP

 

November 26, 2021

New York, New York

  

 

 

GRAPHIC 5 ex5-1_001.jpg begin 644 ex5-1_001.jpg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end GRAPHIC 6 forms-1_001.jpg begin 644 forms-1_001.jpg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end GRAPHIC 7 forms-1_002.jpg begin 644 forms-1_002.jpg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end GRAPHIC 8 forms-1_003.jpg begin 644 forms-1_003.jpg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end GRAPHIC 9 image_002.jpg begin 644 image_002.jpg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end GRAPHIC 10 image_003.jpg begin 644 image_003.jpg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end GRAPHIC 11 image_004.jpg begin 644 image_004.jpg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end GRAPHIC 12 image_005.jpg begin 644 image_005.jpg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ggic-20210930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ASSET ACQUISTION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CONTINGENT ACQUISITION LIABILITY link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - EQUITY link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - PROVISION FOR INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - GOODWILL link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - FOREIGN OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - ASSET ACQUISTION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - PROVISION FOR INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SUBSEQUENT EVENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - SCHEDULE OF TIMING REVENUE RECOGNITION (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SCHEDULE OF ASSET ACQUISITION (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - ASSET ACQUISTION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - CONTINGENT ACQUISITION LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - DEBT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF STOCK OPTION-BASED EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - PROVISION FOR INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 14 ggic-20210930_cal.xml XBRL CALCULATION FILE EX-101.DEF 15 ggic-20210930_def.xml XBRL DEFINITION FILE EX-101.LAB 16 ggic-20210930_lab.xml XBRL LABEL FILE Product and Service [Axis] Software Sercices [Member] Software License [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Customer [Axis] Two Customers [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer One [Member] Customer Two [Member] Four Other Customers [Member] Accounts Receivable [Member] Other Customer One [Member] Other Customer Two [Member] Other Customer Three [Member] Other Customer Four [Member] One Customers [Member] Timing of Transfer of Good or Service [Axis] Transferred at Point in Time [Member] Transferred over Time [Member] Finite-Lived Intangible Assets by Major Class [Axis] Customer Relationships [Member] Technology-Based Intangible Assets [Member] Business Acquisition [Axis] Kabaq3D Technologies, LLC [Member] Financial Instrument [Axis] Equity Option [Member] KreatAR LLC [Member] Debt Instrument [Axis] Convertible Notes Payable [Member] Scenario [Axis] Additional Interest [Member] Sale of Stock [Axis] IPO [Member] Second Year Of Notes [Member] Title of Individual [Axis] Investor [Member] Acquisition [Member] Legacy Acquisition Obligation [Member] Vendors [Member] To Satisfy Contingent Liabilities [Member] Plan Name [Axis] 2016 Equity Incentive Plan [Member] Statistical Measurement [Axis] Maximum [Member] Income Statement Location [Axis] Research and Development Expense [Member] General and Administrative Expense [Member] Selling and Marketing Expense [Member] Cost of Sales [Member] Board Option Expense [Member] Advisors [Member] Antidilutive Securities [Axis] Stock Options [Member] Warrants [Member] Convertible Debt Securities [Member] Award Date [Axis] October Two Thousand Twenty One To September Two Thousand Twenty Two [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] Payment Protection Program One [Member] Payment Protection Program Two [Member] SoftwareServicesMember Software License and Software as a Service [Member] Other Customers [Member] New Convertible Promissory Notes [Member] Convertible Promissory Notes [Member] [Default Label] Employees [Member] Early Adopter.Com [Member] Forecast [Member] Executives And Independent Members [Member] First Two Years Of Interes Prepayment [Member] Minimum [Member] Third Year Interest [Member] Frist Year Of Interest Prepayment [Member] Paycheck Protection Program [Member] Economic Injury Disaster Loan [Member] July And December Two Thousand Twenty One [Member] Three Officers [Member] Liability Class [Axis] Pre Offering Costs [Member] Accounts Payable [Member] Pro Forma [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Cash and cash equivalents Accounts receivable Deferred costs Pre-offering costs Prepaid expenses and other current assets Total current assets Other assets Equipment, net Intangible assets, net Goodwill Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Accounts payable Accrued liabilities Accrued bonuses Accrued legacy acquisition expense Deferred revenue Total current liabilities Long term liabilities Paycheck Protection Program (PPP 1) loan Paycheck Protection Program (PPP 2) loan Convertible promissory notes, net Total liabilities Commitments and contingencies Stockholders’ Equity (Deficit)  Preferred Stock, par value $0.001 per share, 20 million shares  authorized; 0 shares issued and outstanding  Common Stock, par value $0.001 per share, 300 million shares  authorized; 7,579,285 and 7,035,771 issued and outstanding  Additional paid-in capital  Accumulated deficit Total stockholders’ deficit  Total liabilities and stockholders’ deficit Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement [Table] Statement [Line Items] Revenue Total Revenue Cost of goods sold Gross Profit Operating expenses: Research and development expenses General and administrative expenses Sales and marketing expenses Total operating expenses Net loss from operations before other income (expense) Other income (expense)  Forgiveness of Paycheck Protection Program (PPP1) loan  Other income  Interest income  Interest expense  Loss on conversion of convertible notes  Legacy acquisition expense Total other expense, net Net Loss Basic and diluted net loss per share Weighted-average shares used to compute basic and diluted net loss per share Beginning balance, value Beginning Balance, Shares Sales of common stock to investors Sales of common stock to investors, Shares Common stock issued in Initial Public Offering, net Common stock issued in Initial Public Offering net, shares Common stock issued for convertible note conversion Common stock issued for convertible note conversion, Shares Common stock issued for acquisition Common stock issued for acquisition, shares Common stock issued for legacy acquisition obligation Common stock issued for legacy acquisition obligation, shares Common stock issued to vendors for compensation Common stock issued to vendors for compensation, Shares Common stock issued for exercise of options Common stock issued for exercise of options, shares Stock option-based compensation expense Stock option-based board of directors expense Net loss Ending balance, value Ending Balance, Shares Common stock issued to convertible promissory note holders for prepaid interest Common stock issued to convertible promissory note holders for prepaid interest, Shares Common stock issued to convertible promissory note holders as additional consideration Common stock issued to convertible promissory note holders as additional consideration, Shares Common stock issued to satisfy contingent liability Common stock issued to satisfy contingent liability, Shares Common stock issued to employees for compensation Common stock issued to employees for compensation, Shares Common stock issued to employees as compensation Common stock issued to employees as compensation, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Amortization and depreciation Depreciation Amortization of paid-in kind common stock interest on convertible notes Impairment of goodwill Stock option based compensation for employees and board of directors Issuance of common stock to vendors as compensation Issuance of common stock to employees to satisfy contingent liability Issuance of common stock for additional cost to satisfy contingent liability Loss on conversion of convertible notes Forgiveness of Paycheck Protection Program (PPP 1) loan Changes in operating assets and liabilities: Accounts receivable Pre-offering costs Prepaid expenses and other current assets Deferred costs Other assets Accounts payable Accrued liabilities Accrued bonus Accrued legacy acquisition expense Deferred revenue Net cash used in operating activities Cash flow from investing activities: Purchases of equipment Net cash used in investing activities Cash flows from financing activities: Proceeds from initial public offering, net Proceeds from issuance of common equity to investors Proceeds from exercise of stock options Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of period Non-cash Investing and Financing activities: Issuance of common stock for satisfaction of contingent liability Conversion of convertible promissory notes 1 into common stock Issuance of warrants in connection with initial public offering Issuance of common stock for satisfaction of legacy acquisition liability Proceeds from Paycheck Protection Program (PPP 1) loan Proceeds from Paycheck Protection Program (PPP 2) loan Proceeds from convertible promissory notes 1 Proceeds from convertible promissory notes 2 Pre-offering costs incurred Non-cash Investing and Financing activities: Forgiveness of Paycheck Protection Program (PPP 1) loan Common stock issued to convertible Note 2 holders as additional consideration Common stock issued to convertible Note 1 holders as additional consideration Common stock issued for interest paid-in kind on convertible notes Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF BUSINESS Liquidity And Capital Resources LIQUIDITY AND CAPITAL RESOURCES Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Combination and Asset Acquisition [Abstract] ASSET ACQUISTION CONTINGENT ACQUISITION LIABILITY Debt Disclosure [Abstract] DEBT Equity [Abstract] EQUITY Earnings Per Share [Abstract] EARNINGS PER SHARE Income Tax Disclosure [Abstract] PROVISION FOR INCOME TAXES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Property, Plant and Equipment [Abstract] EQUIPMENT, NET Goodwill and Intangible Assets Disclosure [Abstract] GOODWILL Foreign Operations FOREIGN OPERATIONS Basis of presentation Principles of Consolidation Use of Accounting Estimates Cash and Cash Equivalents Accounts Receivable Customer Concentration and Credit Risk Equipment, net Business Combinations Intangibles, net Goodwill Fair Value of Financial Instruments Revenue Recognition Employee Stock-Based Compensation Research and Development Costs Income Taxes Earnings Per Share Recently Issued Pronouncements SCHEDULE OF TIMING REVENUE RECOGNITION SCHEDULE OF DISAGGREGATION OF REVENUE SCHEDULE OF ASSET ACQUISITION SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS SUMMARY OF STOCK OPTION ACTIVITY SCHEDULE OF STOCK OPTION-BASED EXPENSE SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES SCHEDULE OF DEFERRED TAX ASSETS SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE SCHEDULE OF EQUIPMENT, NET SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT Subsequent Event [Table] Subsequent Event [Line Items] Net loss Share issued price per share Gross proceeds from issuance initial public offering Net proceeds from issuance initial public offering Cash and Cash Equivalents, at Carrying Value Net cash used in operating activities Net cash used in operating activities Proceeds from issuance of common stock and convertible debt Proceeds from issuance of common stock Cash Revenues Proceeds from PPP loan Cash position Contracted revenue backlog Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Total revenue Schedule of Product Information [Table] Product Information [Line Items] Allowance for doubtful accounts receivable Concentration risk percentage Unfulfilled performance obligations Tax benefit settlement description Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Acquired Finite-Lived Intangible Assets [Line Items] Technology Intangible assets useful life (years) Accumulated amortization Goodwill Purchase of assets consideration value Common stock purchase price Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Additional acquisition cost Shares issued Shares issued price per share Business acqusition, share price Contingent acquisition liability Stock issued during peirod shares acquisitions Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Proceeds from issuance of unsecured debt Debt instrument maturity date, description Debt instrument interest rate percentage Debt interest payment description Debt conversion converted instrument shares Original issue discount on notes Stock issued during period value Debt instrument conversion price per share Convertible promissory notes Loss on conversion of convertible notes Debt instrument maturity date Debt instrument term Debt instrument face amount Gain loss on debt Proceeds from debt Weighted average expected terms (in years) Weighted average expected volatility Weighted average risk-free interest rate Expected dividend yield Options Outstanding, Beginning balance Weighted Average Exercise Price, Outstanding, Beginning balance Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning Intrinsic Value, Outstanding Beginning balance Options, Granted Weighted Average Exercise Price, Options Granted Weighted Average Remaining Contractual Term (Yrs), Options Granted Intrinsic Value, Options Granted Options, Exercised Weighted Average Exercise Price, Options Exercised Weighted Average Remaining Contractual Term (Yrs), Options Exercised Intrinsic Value, Options Exercised Options, Forfeited/Cancelled Weighted Average Exercise Price, Options Forfeited/Cancelled Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled Intrinsic Value, Options Forfeited/Cancelled Options Outstanding, Ending balance Weighted Average Exercise Price, Outstanding, Ending balance Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending Intrinsic Value, Outstanding Ending balance Options Exercisable, Ending balance Weighted Average Exercise Price, Exercisable, Ending balance Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending Intrinsic Value, Exercisable Ending balance Options, Exercised Intrinsic Value, Options Forfeited/Cancelled Total Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Shares Issued, Price Per Share Proceeds from Issuance or Sale of Equity Stock issued during period shares for services Warrant exercisable description Stock issued during period shares Proceeds from sale of common stock Legacy acquisition obligation Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based compensation expense Unrecognized Share based compensation Aggregate number of common stock shares reserved for future issuance Stock available for issuance Options granted, fair value Stock options granted during period value Stock options exercise price per share Stock based compensation description Prepaid expenses General and administration expense Unrecognized compensation expense to employees and vendors Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Stock options intrinsic value per share Common stock shares authorized Common stock par value per share Preferred stock shares authorized Common stock shares issued Common stock shares outstanding Preferred stock shares issued Preferred stock shares outstanding Stock options granted during period value Stock options exercise period Weighted-average common shares outstanding for basic and diluted net loss per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Potentially dilutive securities Net-operating loss carryforward Stock-based compensation Total Deferred Tax Assets Valuation allowance Deferred Tax Asset, Net Statutory Federal Income Tax Rate State and Local Taxes, Net of Federal Tax Benefit Stock Based Compensation Expense (ISO) Change in Valuation Allowance Income Taxes Provision (Benefit) Statutory Federal Income Tax Rate State and Local Taxes, Net of Federal Tax Benefit Change in Valuation Allowance Operating loss carry forwards, net Operating loss carry forwards expiration date Valuation allowance Net operating loss carryforwards no expiration Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Lease Expiration Date Security deposit Rent expense Lease payments Lease payments due thereafter Maximum distribution percentage of net proceeds from divestiture Lease term Lease commencing date Accrued bonuses Bonus expenses Stock purchase percentage Stock Repurchased During Period, Value Stock Repurchased During Period, Shares Proceeds from sale of stock Sale of stock, shares Warrants to purchase shares Number of warrants to purchase per share Warrants and Rights Outstanding, Term Proceeds from warrants exercise Sale of stock, price per share Professional fees and listing expenses Number of warrants to purchase Warrants expires date Conversion of stock, shares issued Equipment Property, Plant and Equipment, Useful Life Less: accumulated depreciation Balance Depreciation expense Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill impairment Other current assets Property, Plant and Equipment, Net Total assets Total current liabilities Convertible promissory notes, net Other long term liability Total liabilities Total stockholders' equity (deficit) Total liabilities and stockholders' equity (deficit) Liquidity and capital resources disclosure text block. Accrued legacy acquisition expense. Long term loans payable one. Foreign operations text block. Loss on conversion of convertible notes. Proceeds from issuance of common stock and convertible debt. Issuance of common stock for additional cost to satisfy contingent liability. Issuance of common stock to employee as compensation to satisfy contingent liability. Proceeds from subscription receivable. Common stock issued for interest paid in kind on convertible notes. Common stock issued as additional consideration with convertible notes. Common stock issued to convertible note1 holders as additional consideration. Forgiveness of Paycheck Protection Program PPP loan. Gross proceeds from issuance initial public offering. Payment Protection Program Two Member. Software Services [Member] Software License and Software as a Service [Member] unfulfilled performance obligations. Two Customers [Member] Customer One [Member] Customer Two [Member] Other Customers [Member] Four other customer member. Other customer one member. Other customer two member. Other customer three member. Other customer four member. Stock options member. New Convertible Promissory Notes [Member] Convertible Promissory Notes [Member] Vendors Member. To Satisfy Contingent Liabilities Member. 2016 Equity Incentive Plan Member. Employees [Member] Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term. Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited/Cancelled Weighted Average Remaining Contractual Term. Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractua lTerm. Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term. Intrinsic Value, Options Granted. Intrinsic Value, Options Forfeited/Cancelled. Kabaq3D Technologies, LLC member. Software sercices member. Software license member. Payment protection program one member. Board option expense member. Advisors Member. Early Adopter.Com member. KreatAR LLC member. Executives and Independent Members [Member] First Two Years of Interest Prepayment [Member] Third Year Interest [Member] Paycheck Protection Program [Member] Economic Injury Disaster Loan [Member] First Year of Interest Prepayment [Member] Second Year of Notes [Member] Operating loss carry forwards expiration date. Stock-based compensation. Lease commencing date. July-December 2021 [Member] Maximum distribution percentage of net proceeds from divestiture. Professional fees and listing expenses. Pre Offering Costs [Member] Bonus expenses. Three Officers. Net operating loss carryforwards no expiration. Additional Interest [Member] Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Assets, Current Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Accounts Receivable IncreaseDecreaseInPreOfferingCosts Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deferred Charges IncreaseDecreaseInOtherAssets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities ChangeInAccruedLegacyAcquisitionExpense Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations PreofferingCostsIncurred Property, Plant and Equipment, Policy [Policy Text Block] Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] NetCashProvidedByUsedInOperatingsActivities Intangible Assets, Net (Excluding Goodwill) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture Deferred Tax Assets, Valuation Allowance Accrued Bonuses Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment EX-101.PRE 17 ggic-20210930_pre.xml XBRL PRESENTATION FILE XML 18 forms-1_htm.xml IDEA: XBRL DOCUMENT 0001854445 2021-07-01 2021-09-30 0001854445 2021-09-30 0001854445 2021-06-30 0001854445 2020-07-01 2020-09-30 0001854445 GGIC:SoftwareSercicesMember 2021-07-01 2021-09-30 0001854445 GGIC:SoftwareSercicesMember 2020-07-01 2020-09-30 0001854445 GGIC:SoftwareLicenseMember 2021-07-01 2021-09-30 0001854445 GGIC:SoftwareLicenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:CommonStockMember 2021-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001854445 us-gaap:RetainedEarningsMember 2021-06-30 0001854445 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001854445 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001854445 us-gaap:CommonStockMember 2021-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001854445 us-gaap:RetainedEarningsMember 2021-09-30 0001854445 us-gaap:CommonStockMember 2020-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001854445 us-gaap:RetainedEarningsMember 2020-06-30 0001854445 2020-06-30 0001854445 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001854445 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001854445 us-gaap:CommonStockMember 2020-09-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001854445 us-gaap:RetainedEarningsMember 2020-09-30 0001854445 2020-09-30 0001854445 2021-07-02 0001854445 2021-07-01 2021-07-02 0001854445 us-gaap:SubsequentEventMember 2021-11-01 2021-11-02 0001854445 us-gaap:SubsequentEventMember 2021-11-02 0001854445 GGIC:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:FourOtherCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OtherCustomerFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001854445 GGIC:OneCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001854445 GGIC:TwoCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0001854445 us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001854445 us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0001854445 2021-08-01 2021-08-31 0001854445 us-gaap:CustomerRelationshipsMember 2021-09-30 0001854445 us-gaap:CustomerRelationshipsMember 2021-07-01 2021-09-30 0001854445 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-09-30 0001854445 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-07-01 2021-09-30 0001854445 GGIC:Kabaq3DTechnologiesLLCMember 2021-08-01 2021-08-31 0001854445 GGIC:Kabaq3DTechnologiesLLCMember us-gaap:StockOptionMember 2021-08-01 2021-08-31 0001854445 GGIC:Kabaq3DTechnologiesLLCMember us-gaap:StockOptionMember 2021-08-31 0001854445 GGIC:KreatARLLCMember 2021-08-01 2021-08-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2019-12-01 2019-12-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2019-12-31 0001854445 GGIC:AdditionalInterestMember us-gaap:ConvertibleNotesPayableMember 2020-09-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-01-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-01-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-06-01 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-03-31 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-03-31 0001854445 GGIC:SecondYearOfNotesMember us-gaap:ConvertibleNotesPayableMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember us-gaap:IPOMember 2021-03-01 2021-03-31 0001854445 us-gaap:IPOMember 2021-07-01 2021-09-30 0001854445 us-gaap:IPOMember 2021-09-30 0001854445 us-gaap:InvestorMember 2021-07-01 2021-09-30 0001854445 us-gaap:InvestorMember 2021-09-30 0001854445 us-gaap:InvestorMember 2020-07-01 2020-09-30 0001854445 us-gaap:InvestorMember 2020-09-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-07-01 2021-09-30 0001854445 GGIC:AcquisitionMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001854445 GGIC:LegacyAcquisitionObligationMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001854445 GGIC:LegacyAcquisitionObligationMember 2021-07-01 2021-09-30 0001854445 GGIC:VendorsMember 2021-07-01 2021-09-30 0001854445 GGIC:VendorsMember 2020-07-01 2020-09-30 0001854445 GGIC:ToSatisfyContingentLiabilitiesMember 2021-07-01 2021-09-30 0001854445 srt:MaximumMember GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-09-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2020-09-30 0001854445 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001854445 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001854445 GGIC:BoardOptionExpenseMember 2021-07-01 2021-09-30 0001854445 GGIC:BoardOptionExpenseMember 2020-07-01 2020-09-30 0001854445 GGIC:AdvisorsMember GGIC:TwoThousandSixteenEquityIncentivePlanMember 2018-07-01 2019-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-07-01 2021-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-09-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-07-01 2020-09-30 0001854445 GGIC:StockOptionsMember 2021-07-01 2021-09-30 0001854445 GGIC:StockOptionsMember 2020-07-01 2020-09-30 0001854445 GGIC:WarrantsMember 2021-07-01 2021-09-30 0001854445 GGIC:WarrantsMember 2020-07-01 2020-09-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2021-07-01 2021-09-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2020-07-01 2020-09-30 0001854445 2018-06-30 0001854445 GGIC:OctoberTwoThousandTwentyOneToSeptemberTwoThousandTwentyTwoMember 2021-09-30 0001854445 us-gaap:SubsequentEventMember 2021-10-02 2021-10-31 0001854445 us-gaap:SubsequentEventMember GGIC:SecuritiesPurchaseAgreementMember 2021-11-01 2021-11-30 0001854445 us-gaap:SubsequentEventMember GGIC:SecuritiesPurchaseAgreementMember 2021-11-30 0001854445 2020-07-01 2021-06-30 0001854445 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareSercicesMember 2020-07-01 2021-06-30 0001854445 GGIC:SoftwareSercicesMember 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareLicenseMember 2020-07-01 2021-06-30 0001854445 GGIC:SoftwareLicenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:CommonStockMember 2019-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001854445 us-gaap:RetainedEarningsMember 2019-06-30 0001854445 2019-06-30 0001854445 us-gaap:CommonStockMember 2019-07-01 2020-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2020-06-30 0001854445 us-gaap:RetainedEarningsMember 2019-07-01 2020-06-30 0001854445 us-gaap:CommonStockMember 2020-07-01 2021-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2021-06-30 0001854445 us-gaap:RetainedEarningsMember 2020-07-01 2021-06-30 0001854445 2016-06-15 2021-06-30 0001854445 us-gaap:SubsequentEventMember 2021-07-02 0001854445 us-gaap:SubsequentEventMember 2021-07-01 2021-07-02 0001854445 GGIC:PaymentProtectionProgramOneMember 2019-07-01 2020-06-30 0001854445 GGIC:PaymentProtectionProgramTwoMember 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareServicesMember 2019-07-01 2020-06-30 0001854445 GGIC:SoftwareLicenseAndSoftwareServiceMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredOverTimeMember 2020-07-01 2021-06-30 0001854445 GGIC:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001854445 GGIC:OtherCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:FourOtherCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:OtherCustomerFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001854445 GGIC:StockOptionsMember 2020-07-01 2021-06-30 0001854445 GGIC:StockOptionsMember 2019-07-01 2020-06-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2020-07-01 2021-06-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2019-07-01 2020-06-30 0001854445 us-gaap:InvestorMember 2020-07-01 2021-06-30 0001854445 us-gaap:InvestorMember 2019-07-01 2020-06-30 0001854445 us-gaap:InvestorMember 2021-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2020-07-01 2021-06-30 0001854445 GGIC:NewConvertibleNotesPayableMember 2020-07-01 2021-06-30 0001854445 GGIC:ConvertibleNotesPayablesMember 2019-07-01 2020-06-30 0001854445 GGIC:VendorsMember 2020-07-01 2021-06-30 0001854445 GGIC:VendorsMember 2019-07-01 2020-06-30 0001854445 GGIC:ToSatisfyContingentLiabilitiesMember 2020-07-01 2021-06-30 0001854445 GGIC:ToSatisfyContingentLiabilitiesMember 2019-07-01 2020-06-30 0001854445 srt:MaximumMember GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-06-30 0001854445 srt:MaximumMember GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-04-30 0001854445 GGIC:EmployeesMember 2020-07-01 2021-06-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2019-07-01 2020-06-30 0001854445 us-gaap:CostOfSalesMember 2020-07-01 2021-06-30 0001854445 us-gaap:CostOfSalesMember 2019-07-01 2020-06-30 0001854445 GGIC:BoardOptionExpenseMember 2020-07-01 2021-06-30 0001854445 GGIC:BoardOptionExpenseMember 2019-07-01 2020-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-07-01 2021-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2019-07-01 2020-06-30 0001854445 GGIC:EarlyAdopterComMember 2021-06-30 0001854445 GGIC:EarlyAdopterComMember 2020-06-30 0001854445 GGIC:EarlyAdopterComMember 2020-07-01 2021-06-30 0001854445 srt:ScenarioForecastMember GGIC:Kabaq3DTechnologiesLLCMember 2021-08-01 2021-08-31 0001854445 srt:ScenarioForecastMember GGIC:KreatARLLCMember 2021-08-01 2021-08-31 0001854445 GGIC:EarlyAdopterComMember 2019-07-01 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2019-07-01 2020-06-30 0001854445 GGIC:ExecutivesAndIndependentMembersMember us-gaap:ConvertibleNotesPayableMember 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2020-06-30 0001854445 GGIC:AdditionalInterestMember us-gaap:ConvertibleNotesPayableMember 2020-06-30 0001854445 GGIC:FirstTwoYearsOfInteresPrepaymentMember us-gaap:ConvertibleNotesPayableMember 2020-06-30 0001854445 GGIC:FirstTwoYearsOfInteresPrepaymentMember us-gaap:ConvertibleNotesPayableMember 2019-07-01 2020-06-30 0001854445 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-06-30 0001854445 srt:MaximumMember us-gaap:ConvertibleNotesPayableMember 2021-03-31 0001854445 srt:MinimumMember us-gaap:ConvertibleNotesPayableMember 2021-06-30 0001854445 GGIC:ThirdYearInterestMember us-gaap:ConvertibleNotesPayableMember 2020-07-01 2021-03-31 0001854445 GGIC:ThirdYearInterestMember us-gaap:ConvertibleNotesPayableMember 2021-03-31 0001854445 GGIC:FristYearOfInterestPrepaymentMember us-gaap:ConvertibleNotesPayableMember 2021-03-01 2021-03-31 0001854445 GGIC:SecondYearOfNotesMember us-gaap:ConvertibleNotesPayableMember 2021-03-31 0001854445 GGIC:PaycheckProtectionProgramMember 2020-05-01 2020-05-31 0001854445 GGIC:EconomicInjuryDisasterLoanMember 2020-05-01 2020-05-31 0001854445 GGIC:PaycheckProtectionProgramMember 2021-02-01 2021-02-28 0001854445 GGIC:PaycheckProtectionProgramMember 2021-02-28 0001854445 GGIC:JulyAndDecemberTwoThousandTwentyOneMember 2021-06-30 0001854445 GGIC:ThreeOfficersMember 2020-07-01 2021-06-30 0001854445 us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-07-02 0001854445 us-gaap:CommonStockMember us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 GGIC:PreOfferingCostsMember us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 us-gaap:AccountsPayableMember us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 us-gaap:IPOMember 2021-06-30 0001854445 us-gaap:IPOMember 2020-07-01 2021-06-30 0001854445 srt:ProFormaMember 2021-06-30 0001854445 us-gaap:SubsequentEventMember 2021-08-01 2021-08-31 iso4217:USD shares iso4217:USD shares pure 0001854445 false P3Y P3Y P3Y P2Y 2026-06-30 S-1 THE GLIMPSE GROUP, INC. NV 81-2958271 15 West 38th St 9th Fl New York NY 10018 917 292-2685 Non-accelerated Filer true true false 12567632 1771929 599879 626244 45981 29512 470136 533782 281047 13747274 3178868 80000 53513 42172 479167 250000 -0 14609954 3221040 112687 381510 136975 168745 288388 440357 500000 1250000 114055 98425 1152105 2339037 623828 623828 1429953 1775933 4392818 0.001 0.001 20000000 20000000 0 0 0 0 0.001 0.001 300000000 300000000 10291638 10291638 7579285 7579285 10292 7580 36595898 20936050 -23772169 -22115408 12834021 -1171778 14609954 3221040 804718 187652 217815 72275 1022533 259927 145387 137124 877146 122803 989384 736750 779729 335998 504687 289476 2273800 1362224 -1396654 -1239421 10000 19623 534 48437 -279730 -260107 -37903 -1656761 -1277324 -0.17 -0.18 9967821 7039928 7579285 7580 20936050 -22115408 -1171778 1912500 1913 11819451 11821364 324150 324 1605852 1606176 77264 77 749923 750000 375000 375 749625 750000 6045 6 65389 65395 17394 17 45683 45700 536524 536524 87401 87401 -1656761 -1656761 10291638 10292 36595898 -23772169 12834021 7035771 7036 15710996 -16023721 -305689 2423 2 10818 10820 6667 7 29993 30000 772635 772635 41532 41532 -1277324 -1277324 7044861 7045 16565974 -17301045 -728026 -1656761 -1277324 27718 5907 54039 653615 689813 62034 15000 -279730 -26365 -135460 -470136 381856 81909 -17185 -124155 80000 -268823 -52343 -31770 -18680 -151969 -6000 15630 499650 -1053136 -160542 18225 15004 -18225 -15004 11821364 10820 45700 11867064 10820 10795703 -164726 1771929 1034846 12567632 870120 750000 1606176 522360 750000 <p id="xdx_804_eus-gaap--NatureOfOperations_zUxHNHwryad7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 1. <span id="xdx_82D_zO2qS6Ygfwqb">DESCRIPTION OF BUSINESS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Glimpse Group, Inc. (“Glimpse”) is a Virtual (VR) and Augmented (AR) Reality company, comprised of a diversified portfolio of VR and AR software and services companies. Glimpse’s ten wholly-owned operating subsidiaries (“Subsidiary Companies” or “Subsidiaries”) are: Adept Reality, LLC (dba Adept XR Learning), Kabaq 3D Technologies, LLC (dba QReal), KreatAR, LLC (dba PostReality), D6 VR, LLC, Immersive Health Group, LLC, Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), Early Adopter, LLC, and MotionZone, LLC (dba AUGGD) and one subsidiary in Turkey, Glimpse Group Yazılım ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”). In addition, the Company has one inactive subsidiary company, In-It VR, LLC (dba Mezmos), and with the operating Subsidiaries collectively comprise the “Company” or “Glimpse”. Glimpse was incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A new subsidiary company was established in October 2021. See Note 11.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Glimpse’s robust VR/AR ecosystem, collaborative environment and business model simplify the many challenges faced by companies in an emerging industry. Glimpse cultivates and manages business operations while providing a strong network of professional relationships, thereby allowing the subsidiary company entrepreneurs to maximize their time and resources in pursuit of mission-critical endeavors, reducing time to market, optimizing costs, improving product quality and leveraging joint go-to-market strategies, while simultaneously providing investors an opportunity to invest directly into the VR/AR industry via a diversified platform.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company completed an initial public offering (“IPO”) of its common stock on the Nasdaq Capital Market Exchange (“Nasdaq”) on July 1, 2021, under the ticker VRAR. See Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On November 2, 2021 the Company completed a securities purchase agreement (“SPA”) for the sale of additional common stock to certain institutional investors. See Note 11.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_801_ecustom--LiquidityAndCapitalResourcesDisclosureTextBlock_zfy1mn4BwV9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 2. <span id="xdx_821_z7FWWuaPjZX6">LIQUIDITY AND CAPITAL RESOURCES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company incurred a loss of $<span id="xdx_903_eus-gaap--NetIncomeLoss_iN_pn4n6_di_c20210701__20210930_zzQXq5UdHOq9" title="Net loss">1.66</span> million during the three months ended September 30, 2021, compared to a loss of $<span id="xdx_903_eus-gaap--NetIncomeLoss_iN_pn4n6_di_c20200701__20200930_zuCKjLuos4Mi" title="Net loss">1.28</span> million during the three months ended September 30, 2020. The loss was incurred as the Company funded operational expenses, primarily research and development, general and administrative, and sales and marketing costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2021 the Company completed an IPO in which, as a result of the sale of its common shares at $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210702_z0hNqOCH06R7" title="Share issued price per share">7.00</span> per share, it raised approximately $<span id="xdx_901_ecustom--GrossProceedsFromIssuanceInitialPublicOffering_pn5n6_c20210701__20210702_zSd73GrK1I68" title="Gross proceeds from issuance initial public offering">13.4</span> million in gross proceeds and $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20210701__20210702_zI6JK1JzkzQf" title="Net proceeds from issuance initial public offering">11.8</span> million in net proceeds after fees and expenses. See Note 7. Furthermore, on November 2, 2021 the Company completed a SPA whereby it sold additional common shares that resulted in approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20211101__20211102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3yF5EaxVT52" title="Net proceeds from issuance initial public offering">13.6</span> million in net proceeds after fees and expenses. See Note 11.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company expects to continue to generate net losses for the foreseeable future as it makes investments to grow its business. Management believes that the Company’s existing balances of cash and cash equivalents, which are approximately $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn6n6_c20211102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zw3OOSReNu67">26</span> million following the SPA (see Note 11), will be sufficient to meet its anticipated cash requirements for at least twelve months from the date that these financial statements are issued. However, should the Company’s current cash and cash equivalents not be sufficient to support the development of its business to the point at which it has positive cash flows from operations, the Company plans to meet its future needs for additional capital through equity and/or debt financings. Equity financings may include sales of common stock. Such financing may not be available on terms favorable to the Company or at all. If the Company is unable to obtain adequate financing or financing on terms satisfactory to it when required, the Company’s ability to continue to support its business growth, scale its infrastructure, develop product enhancements and to respond to business challenges could be significantly impaired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> -1660000 -1280000 7.00 13400000 11800000 13600000 26000000 <p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zmehVBejUhvi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 3. <span id="xdx_829_zdy9j7OAUer8">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zYFFVUrV6K2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_86D_zCsG9yeTzf44">Basis of presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2021 and the results of operations and cash flows for the three months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the three months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2022 or for any subsequent periods. The consolidated balance sheet at June 30, 2021 has been derived from the audited consolidated financial statements at that date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zFGfd5CTrJQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86F_zfp6MDK59Bni">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zaDoNtnUoYN2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86E_zzJr8uc9YYsb">Use of Accounting Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options, cost of goods sold and allocation of the purchase price of assets relating to business combinations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zF8YMpdn2JNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_861_zwBghVMZP4Zg">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents consist of cash and deposits in bank checking accounts with immediate access and cash equivalents that represent highly liquid investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zV9Hl7ci6jfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_861_zZQoqOZfcY07">Accounts Receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of September 30, 2021 and June 30, 2021 <span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20210930_zL8iBfX7Ee0f" title="Allowance for doubtful accounts receivable"><span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20210630_zy67SRMkjrkd" title="Allowance for doubtful accounts receivable">no</span></span> allowance for doubtful accounts was recorded as all amounts were considered collectible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zOhaVCfHYGHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86B_z4ow51XMVjFi">Customer Concentration and Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Two customers accounted for approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOpHI55FBMSe" title="Concentration risk percentage">70</span>% (<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zYiyuoGLB2Zb" title="Concentration risk percentage">56</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNYuH7ooojpf" title="Concentration risk percentage">14</span>%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2021. Four different customers accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--FourOtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJVciU0PUygj" title="Concentration risk percentage">53</span>% (<span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUrA9GBahyVj" title="Concentration risk percentage">19</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zpiB8yXacRfk" title="Concentration risk percentage">13</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6QkNTbjSGKh" title="Concentration risk percentage">11</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRjnpXOsdMS1" title="Concentration risk percentage">10</span>%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">One customer accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zKJQ3Yqz3bM7" title="Concentration risk percentage">76</span>% of the Company’s accounts receivable at September 30, 2021. The same customer, and along with a different customer, accounted for approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20210630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6t8FTFFeZf8">71</span>% (<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z606isv7Q1Hf">57</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFZbZvApmc5l">14</span>%, respectively) of the Company’s accounts receivable at June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zZAsPgRtZLr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zgZfc0bxgp43">Equipment, net</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--BusinessCombinationsPolicy_zHv6sY3FaQZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_zhjqe9xl27M3">Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The results of a business acquired in a business combination are included in the Company’s consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business generally being recorded at their estimated fair values as of the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company performs valuations of assets acquired and liabilities assumed and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired and liabilities assumed may require management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenues, costs and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z4kQrM6Qlkx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_862_zfsrhqf599F8">Intangibles, net</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangibles represent the allocation of a portion of an asset acquisition purchase price (see Note 4). Intangibles are stated at allocated cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the related assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zLrLpltLcMgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_860_z8uW1lOY8K53">Goodwill</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded goodwill related to an asset acquisition, see Note 4.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zgqOCKiIhLx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zH5U0YgPheFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_z8JapkPS0vQ4">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Nature of Revenues</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reports its revenues in two categories:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Software Services: Virtual and Augmented Reality projects, solutions and consulting services.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">allocate the transaction price to performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">recognize revenue as the performance obligation is satisfied;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">determine that collection is reasonably assured.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Significant Judgments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company generated revenue for the three months ended September 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses &amp; SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Timing of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfTimingRevenueRecognitionTableTextBlock_zmhHtZJG5wuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The timing of revenue recognition for the three months ended September 30, 2021 and 2020 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zTuifwKCHjHl" style="display: none">SCHEDULE OF TIMING REVENUE RECOGNITION</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"> </td><td style="display: none; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20210701__20210930_z4nXSApgRiDd" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">2021</td><td style="display: none; padding-bottom: 1pt; font-weight: bold"> </td><td style="display: none; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20200701__20200930_zR5D6AAhvCsh" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">2020</td><td style="display: none; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_z3u39nPHMSd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Products transferred at a point in time</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">955,751</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">193,175</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zHZz7VzwJpV6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Products and services transferred over time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">66,782</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">66,752</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,022,533</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">259,927</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p id="xdx_8A0_zLLEqFfOT8Ui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred revenue is comprised mainly of software project contract performance obligations not completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of September 30, 2021, the Company had approximately $<span id="xdx_90B_ecustom--UnfulfilledPerformanceObligations_pn4n6_c20210701__20210930_zAeiKo3PxJ56" title="Unfulfilled performance obligations">1.20</span> million in unfulfilled performance obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z71y8J8jxb86" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86B_zxLxMJ9mzt6f">Employee Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for the Company since its IPO. Prior to its IPO, expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z0dHdsw2npR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zCznZrnZWUIk">Research and Development Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zms5Hh4kPRud" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_zcihVAjfV3Rc">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is <span id="xdx_904_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210701__20210930_ziiz3wJO7fmb" title="Tax benefit settlement description">greater than 50%</span> likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, <i>Income Taxes</i>, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the three months ended September 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zqAcLX4OKgL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86F_zx1rV6Qe9Aai">Earnings Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z0xLbfNGgYIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zYMzqxFCslbi">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s financial statements.</span></p> <p id="xdx_850_zAzmA6oDfCvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zYFFVUrV6K2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span id="xdx_86D_zCsG9yeTzf44">Basis of presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2021 and the results of operations and cash flows for the three months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the three months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2022 or for any subsequent periods. The consolidated balance sheet at June 30, 2021 has been derived from the audited consolidated financial statements at that date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zFGfd5CTrJQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86F_zfp6MDK59Bni">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zaDoNtnUoYN2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86E_zzJr8uc9YYsb">Use of Accounting Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options, cost of goods sold and allocation of the purchase price of assets relating to business combinations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zF8YMpdn2JNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_861_zwBghVMZP4Zg">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents consist of cash and deposits in bank checking accounts with immediate access and cash equivalents that represent highly liquid investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zV9Hl7ci6jfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_861_zZQoqOZfcY07">Accounts Receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of September 30, 2021 and June 30, 2021 <span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20210930_zL8iBfX7Ee0f" title="Allowance for doubtful accounts receivable"><span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20210630_zy67SRMkjrkd" title="Allowance for doubtful accounts receivable">no</span></span> allowance for doubtful accounts was recorded as all amounts were considered collectible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 0 0 <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zOhaVCfHYGHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86B_z4ow51XMVjFi">Customer Concentration and Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Two customers accounted for approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOpHI55FBMSe" title="Concentration risk percentage">70</span>% (<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zYiyuoGLB2Zb" title="Concentration risk percentage">56</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNYuH7ooojpf" title="Concentration risk percentage">14</span>%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2021. Four different customers accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--FourOtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJVciU0PUygj" title="Concentration risk percentage">53</span>% (<span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUrA9GBahyVj" title="Concentration risk percentage">19</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zpiB8yXacRfk" title="Concentration risk percentage">13</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6QkNTbjSGKh" title="Concentration risk percentage">11</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20200930__srt--MajorCustomersAxis__custom--OtherCustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRjnpXOsdMS1" title="Concentration risk percentage">10</span>%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">One customer accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zKJQ3Yqz3bM7" title="Concentration risk percentage">76</span>% of the Company’s accounts receivable at September 30, 2021. The same customer, and along with a different customer, accounted for approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20210630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6t8FTFFeZf8">71</span>% (<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z606isv7Q1Hf">57</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFZbZvApmc5l">14</span>%, respectively) of the Company’s accounts receivable at June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 0.70 0.56 0.14 0.53 0.19 0.13 0.11 0.10 0.76 0.71 0.57 0.14 <p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zZAsPgRtZLr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zgZfc0bxgp43">Equipment, net</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--BusinessCombinationsPolicy_zHv6sY3FaQZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_zhjqe9xl27M3">Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The results of a business acquired in a business combination are included in the Company’s consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business generally being recorded at their estimated fair values as of the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company performs valuations of assets acquired and liabilities assumed and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired and liabilities assumed may require management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenues, costs and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z4kQrM6Qlkx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_862_zfsrhqf599F8">Intangibles, net</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangibles represent the allocation of a portion of an asset acquisition purchase price (see Note 4). Intangibles are stated at allocated cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the related assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zLrLpltLcMgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_860_z8uW1lOY8K53">Goodwill</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded goodwill related to an asset acquisition, see Note 4.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zgqOCKiIhLx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zH5U0YgPheFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_z8JapkPS0vQ4">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Nature of Revenues</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reports its revenues in two categories:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Software Services: Virtual and Augmented Reality projects, solutions and consulting services.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">allocate the transaction price to performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">recognize revenue as the performance obligation is satisfied;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">determine that collection is reasonably assured.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Significant Judgments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company generated revenue for the three months ended September 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses &amp; SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Timing of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfTimingRevenueRecognitionTableTextBlock_zmhHtZJG5wuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The timing of revenue recognition for the three months ended September 30, 2021 and 2020 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zTuifwKCHjHl" style="display: none">SCHEDULE OF TIMING REVENUE RECOGNITION</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"> </td><td style="display: none; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20210701__20210930_z4nXSApgRiDd" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">2021</td><td style="display: none; padding-bottom: 1pt; font-weight: bold"> </td><td style="display: none; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20200701__20200930_zR5D6AAhvCsh" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">2020</td><td style="display: none; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_z3u39nPHMSd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Products transferred at a point in time</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">955,751</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">193,175</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zHZz7VzwJpV6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Products and services transferred over time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">66,782</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">66,752</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,022,533</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">259,927</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p id="xdx_8A0_zLLEqFfOT8Ui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred revenue is comprised mainly of software project contract performance obligations not completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of September 30, 2021, the Company had approximately $<span id="xdx_90B_ecustom--UnfulfilledPerformanceObligations_pn4n6_c20210701__20210930_zAeiKo3PxJ56" title="Unfulfilled performance obligations">1.20</span> million in unfulfilled performance obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfTimingRevenueRecognitionTableTextBlock_zmhHtZJG5wuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The timing of revenue recognition for the three months ended September 30, 2021 and 2020 was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zTuifwKCHjHl" style="display: none">SCHEDULE OF TIMING REVENUE RECOGNITION</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"> </td><td style="display: none; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20210701__20210930_z4nXSApgRiDd" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">2021</td><td style="display: none; padding-bottom: 1pt; font-weight: bold"> </td><td style="display: none; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20200701__20200930_zR5D6AAhvCsh" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">2020</td><td style="display: none; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_z3u39nPHMSd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Products transferred at a point in time</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">955,751</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">193,175</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zHZz7VzwJpV6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Products and services transferred over time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">66,782</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">66,752</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,022,533</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">259,927</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"/></p> 955751 193175 66782 66752 1022533 259927 1200000 <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z71y8J8jxb86" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86B_zxLxMJ9mzt6f">Employee Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for the Company since its IPO. Prior to its IPO, expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_z0dHdsw2npR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zCznZrnZWUIk">Research and Development Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zms5Hh4kPRud" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_zcihVAjfV3Rc">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is <span id="xdx_904_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210701__20210930_ziiz3wJO7fmb" title="Tax benefit settlement description">greater than 50%</span> likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, <i>Income Taxes</i>, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the three months ended September 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> greater than 50% <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zqAcLX4OKgL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86F_zx1rV6Qe9Aai">Earnings Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z0xLbfNGgYIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_868_zYMzqxFCslbi">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s financial statements.</span></p> <p id="xdx_803_eus-gaap--AssetAcquisitionTextBlock_zTGCWRZ5Bvhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 4. <span id="xdx_82F_zApzID8pAYal">ASSET ACQUISTION</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC (dba AUGGD), completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services. Over time, the acquisition may facilitate the Company’s endeavors in the Architecture, Engineering and Construction (“AEC”) market segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Initial consideration for the purchase was $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pn4n6_c20210801__20210831_zEugW5OqqA35" title="Purchase of assets consideration value">0.75</span> million payable in Company common stock. In August 2021, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_pid_c20210801__20210831_zZiZOtqrEHyj" title="Common stock purchase price">77,264</span> shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company recorded the purchase price allocation as follows:</span></p> <p id="xdx_89C_eus-gaap--AssetAcquisitionContingentConsiderationTableTextBlock_zCTSBMTD8Ugg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BC_zW6VU7zTylp9" style="display: none">SCHEDULE OF ASSET ACQUISITION</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of September 30, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Useful Life<br/> (Years)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer Relationships</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_znRR1OUwhPX9" style="width: 16%; text-align: right" title="Customer relationships"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z3tOt3kxsbb6" title="Intangible assets useful life (years)">3</span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Technology</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zbnylF7rqlkk" style="text-align: right" title="Technology"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z3mxDp1s5HDk" title="Intangible assets useful life (years)">3</span></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated Amortization</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20210930_zGal3vn1a327" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif">(20,833</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Intangible Assets, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20210930_zYIoYXVtgGJg" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif">479,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20210930_zuy6kdpGsIZk" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">N/A</span></td></tr> </table> <p id="xdx_8A5_z7J9CP6URLJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The goodwill recognized in connection with the acquisition is primarily attributable to new markets access and is expected to be deductible for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The results of operations of AUGGD have been included in the Company’s consolidated financial statements from the date of acquisition and did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 750000 77264 <p id="xdx_89C_eus-gaap--AssetAcquisitionContingentConsiderationTableTextBlock_zCTSBMTD8Ugg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BC_zW6VU7zTylp9" style="display: none">SCHEDULE OF ASSET ACQUISITION</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of September 30, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Useful Life<br/> (Years)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer Relationships</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_znRR1OUwhPX9" style="width: 16%; text-align: right" title="Customer relationships"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z3tOt3kxsbb6" title="Intangible assets useful life (years)">3</span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Technology</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zbnylF7rqlkk" style="text-align: right" title="Technology"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z3mxDp1s5HDk" title="Intangible assets useful life (years)">3</span></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated Amortization</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20210930_zGal3vn1a327" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif">(20,833</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Intangible Assets, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20210930_zYIoYXVtgGJg" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"><span style="font-family: Times New Roman, Times, Serif">479,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_c20210930_zuy6kdpGsIZk" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif">250,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">N/A</span></td></tr> </table> 250000 P3Y 250000 P3Y -20833 479167 250000 <p id="xdx_806_eus-gaap--BusinessCombinationDisclosureTextBlock_z0TiRJDU5Oe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 5. <span><span id="xdx_826_z9XXyYkQ8Ec4">CONTINGENT ACQUISITION LIABILITY</span></span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Kabaq 3D Technologies, LLC</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s November 2016 acquisition of assets relating to the acquisition of Kabaq 3D Technologies, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met and the Company incurred $<span id="xdx_901_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_pp0p0_c20210801__20210831__us-gaap--BusinessAcquisitionAxis__custom--Kabaq3DTechnologiesLLCMember_zZIe99hsHO8j" title="Additional acquisition cost">750,000</span> of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition liability on the Company’s balance sheet at June 30, 2021. This obligation was satisfied in August 2021 through the issuance of common stock in settlement of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210801__20210831__us-gaap--BusinessAcquisitionAxis__custom--Kabaq3DTechnologiesLLCMember__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zasdMW5271q8" title="Shares issued">375,000</span> stock options at $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20210831__us-gaap--BusinessAcquisitionAxis__custom--Kabaq3DTechnologiesLLCMember__us-gaap--FinancialInstrumentAxis__us-gaap--StockOptionMember_zCoDNYwm6Cjf" title="Shares issued price per share">2.00</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>KreatAR, LLC</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s October 2016 acquisition of assets relating to the acquisitions of KreatAR, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met. In connection therewith, the Company incurred $<span id="xdx_900_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_pp0p0_c20210801__20210831__us-gaap--BusinessAcquisitionAxis__custom--KreatARLLCMember_zogo9T4oiuai">500,000</span> of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition liability on the Company’s balance sheet at June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 750000 375000 2.00 500000 <p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zkPI5j0kSDh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 6. <span id="xdx_829_zYqutsRV1vge">DEBT</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Convertible Promissory Notes 1</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019 the Company raised $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_c20191201__20191231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zMMBQBlqDyt1" title="Proceeds from issuance of unsecured debt">1.33</span> million by the issuance of unsecured Convertible Promissory Notes with a <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDateDescription_c20191201__20191231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zZ71wg8qUeA" title="Debt instrument term, description">three-year</span> term (the “Note 1” or “Notes 1”), primarily from existing Company investors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 1 bore an interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20191231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zyxFMzSGWVT9" title="Debt instrument interest rate percentage">10</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 1 were convertible by a Note 1 holder at any time <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20191201__20191231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z1yTNuMTfVXg" title="Debt interest payment description">during the term into common stock of the Company at a fixed price of $4.50/share, or approximately <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20191201__20191231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zp5PTXlUPSx9" title="Debt conversion converted instrument shares">295,000</span> shares of common stock upon full conversion</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Interest expense on the Notes 1 was approximately $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200930__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--AdditionalInterestMember_zqMQFAeLMpXk" title="Original issue discount on notes">48,500</span> for the three months ended September 30, 2020, representing amortization of the original issue discount and prepaid interest for the period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Primarily in January 2021, Note 1 holders converted approximately $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn4n6_c20210101__20210131__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zFr6Vb3yvhw3" title="Stock issued during period value">1.21</span> million of principal into approximately <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pn4n6_c20210101__20210131__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z7jCL2XH2YO1">0.30</span> million shares of common stock at a revised (to encourage early conversion) conversion price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20210131__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zxgdOgGpmue8">4.00</span>/share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The holders of the remaining unconverted Notes 1, equating to approximately $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zkv46qf1PAEh" title="Convertible promissory notes">117,000</span> (net of original discount of approximately $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zqhbzWED45g5" title="Original issue discount on notes">8,000</span>) of outstanding principal at June 30, 2021, amended their Notes 1 to allow for auto conversion upon the Company’s potential IPO event at a conversion price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zYJBTjlhIILe" title="Debt instrument conversion price per share">4.25</span>/share. As per the amendment, the residual Notes 1 converted upon the IPO and no further obligations existed. See Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recorded a loss on conversion of the remaining Notes 1 of approximately $<span id="xdx_901_ecustom--LossOnConversionOfConvertibleNotes_c20210601__20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zv52OhV7Q2c2" title="Loss on conversion of convertible notes">18,000</span> at time of the IPO, representing unamortized original issue discount and prepaid interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Convertible Promissory Notes 2</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In March 2021, the Company raised $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zmY2YZ5qUC52" title="Proceeds from issuance of unsecured debt">1.48</span> million by the issuance of unsecured Convertible Promissory Notes with a <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDateDescription_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zf7gSnE2TiKb" title="Debt instrument term, description">two-year term</span> (the “Notes 2”), to several investors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 2 bore an interest rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zWLD7tCXBJAe" title="Debt instrument interest rate percentage">10</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 2 were convertible by a note holder at any time during the term into common stock of the Company at a fixed price of $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1T0MSnXrzO4">5.00</span>/share, or <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zC2agz6rW284" title="Debt conversion converted instrument shares">295,000</span> shares of common stock upon full conversion. Notes 2 had a maturity date of <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zacq5UwBBCx8" title="Debt instrument maturity date">March 5, 2023</span>. All outstanding amounts at the time of the Company’s IPO automatically converted at $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--SecondYearOfNotesMember_zvidDlNzb2u6" title="Share issued price per share">5.00</span>/share in the aggregate. Convertible Notes 2 totaled approximately $<span id="xdx_90A_eus-gaap--ConvertibleNotesPayable_iI_pn3n6_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--SecondYearOfNotesMember_ziSY68syAlnf" title="Convertible promissory notes">1.313</span> million (net of original issue discount of approximately $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--SecondYearOfNotesMember_zLyz3UaaWHp4" title="Original issue discount on notes">162,000</span>) at June 30, 2021. The Notes 2 converted upon the IPO and no further obligations existed. See Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recorded a loss on conversion of the Notes 2 of approximately $<span id="xdx_908_ecustom--LossOnConversionOfConvertibleNotes_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zBaQX4ARW2s6" title="Loss on conversion of convertible notes">262,000</span> at time of the IPO, representing unamortized original issue discount and prepaid interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 1330000 three-year 0.10 during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion 295000 48500 1210000 300000 4.00 117000 8000 4.25 18000 1480000 two-year term 0.10 5.00 295000 2023-03-05 5.00 1313000 162000 262000 <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zWQ9MEz3huVa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 7. <span id="xdx_820_zd8kYWgfQYbl">EQUITY</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial Public Offering (“IPO”)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1 ,2021, the Company completed an IPO of common stock on the Nasdaq under the symbol “VRAR”, at a price of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210702_ztlKhIYBEsg2">7.00</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company sold approximately <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn4n6_c20210701__20210702_zBeGPOsVCL37" title="Shares issued">1.91</span> million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn4n6_c20210701__20210702_zzFi88L9YrMh">11.82</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210701__20210930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zo2VumONxFy9">87,500</span> shares of common stock at $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z949C2iVrnCl">7.00</span> per share. The warrant cannot be exercised prior to December 30, 2021, and expires in June 2026. <span id="xdx_902_ecustom--WarrantExercisableDescription_c20210701__20210930_zSaEigkztfw1" title="Warrant exercisable description">The warrant is valued at approximately $520,000 based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 129% expected volatility, 0.87% risk-free rate and 0% expected dividend yield.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As stated in Note 6, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through the issuance of <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210701__20210930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zCY6TNGQVFcl" title="Shares Issued For Convertable Promisary note">324,150</span> shares of common stock. A loss of approximately $<span id="xdx_903_ecustom--LossOnConversionOfConvertibleNotes_c20210701__20210930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zZ87vb3hZbsa" title="Loss on conversion of convertible notes">280,000</span> was recorded on this conversion at the time of the IPO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Common Stock Issued</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock sold to Investors</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2021, the Company sold approximately <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn4n6_c20210701__20210930__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zAtdeTcSctFk" title="Shares issued">1.91</span> million shares of common stock to investors at the IPO at a price of $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210930__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zXjXLxjMriVl">7.00</span> per share, for total net proceeds of approximately $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn4n6_c20210701__20210930__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z4VSL3C3tAU5" title="Proceeds from sale of common stock">11.82</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2020, the Company sold approximately <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20200930__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zQSDGfFDw5A7">2,400</span> shares of common stock to investors at a price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20200930__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zCnQY9rSC3uh">4.50</span> per share, for total net proceeds of approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20200701__20200930__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zQc2YergkqY1" title="Proceeds from sale of common stock">10,800</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued to Investors</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2021, in connection with the conversion of convertible promissory notes and in conjunction with the IPO, the Company issued <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210701__20210930__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zxGREX7LWVsl">324,150</span> shares of common stock (see Note 6).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued for Acquisition</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2021 the Company issued approximately <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--AcquisitionMember_z6LSaWd4ii8e">77,000</span> shares of common stock, valued at $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn4n6_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--AcquisitionMember_zhZkQzYeJlb3">0.75</span> million, as consideration for the acquisition of certain assets (see Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued for Legacy Acquisition Obligation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2021 the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--BusinessAcquisitionAxis__custom--LegacyAcquisitionObligationMember_zPxH3jCAYvx6">375,000 </span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of common stock to satisfy a legacy acquisition obligation of $<span id="xdx_901_ecustom--LeagacyAcquisitionObligation_c20210701__20210930_zpxkyKfth0Zj" title="Legacy acquisition obligation">750,000</span></span> <span style="font: 10pt Times New Roman, Times, Serif">(see Note 5). This was accomplished by settling outstanding stock options the acquiree had been granted at $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930__us-gaap--BusinessAcquisitionAxis__custom--LegacyAcquisitionObligationMember_zi5Qz0PA5jfj">2.00 </span></span><span style="font: 10pt Times New Roman, Times, Serif">per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued to Vendors</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2021 and 2020, the Company issued approximately <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210701__20210930__srt--TitleOfIndividualAxis__custom--VendorsMember_zeiOg71dKiCl" title="Stock issued during period shares for services">6,000</span> and <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20200930__srt--TitleOfIndividualAxis__custom--VendorsMember_zBrH6oeRvK5h" title="Stock issued during period shares for services">6,700</span> shares of common stock, respectively, to various vendors for services performed and recorded share-based compensation of approximately $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__custom--VendorsMember_zkXvYK4Yeii" title="Share-based compensation expense">65,000</span> and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200701__20200930__srt--TitleOfIndividualAxis__custom--VendorsMember_z8nIZntSwcxf" title="Share-based compensation expense">30,000</span>, respectively (of which approximately $<span id="xdx_908_ecustom--UnrecognizedShareBasedCompensation_pp0p0_c20210701__20210930__srt--TitleOfIndividualAxis__custom--VendorsMember_zTeYlR2YzUdb" title="Unrecognized Share based compensation">3,000</span> and $<span id="xdx_900_ecustom--UnrecognizedShareBasedCompensation_pp0p0_c20200701__20200930__srt--TitleOfIndividualAxis__custom--VendorsMember_z7cNU8RrAGlh" title="Unrecognized Share based compensation">15,000</span> was unrecognized in the periods, respectively).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued for Exercise of options</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2021, the Company issued approximately <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210930__srt--StatementScenarioAxis__custom--ToSatisfyContingentLiabilitiesMember_zfy4Qrcn8Ao7" title="Shares issued">17,000</span> shares of common stock upon exercise of the respective option grants, and realized cash proceeds of approximately $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210701__20210930__srt--StatementScenarioAxis__custom--ToSatisfyContingentLiabilitiesMember_zUqin1Fnt4q7" title="Stock issued during period value">46,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Employee Stock-Based Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s 2016 Equity Incentive Plan (the “Plan”), as amended, has <span id="xdx_908_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pn6n6_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zAQd4Ey4bRx6">10</span> million common shares reserved for issuance. As of September 30, 2021, there were <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pn4n6_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zIJxShjZNVDf" title="Stock available for issuance">5.64</span> million shares available for issuance under the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z7QJhkHqCYCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B4_z7fBNOvwUQPd" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20210701__20210930_z2TCgdgIMZek" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended <br/> September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20200701__20200930_zDLMikifgUo" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended <br/> September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average expected terms (in years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210701__20210930_zebAMzre8En5" title="Weighted average expected terms (in years)">5.4</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200701__20200930_zXkxIdJtZRek">5.1</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_zFR11igGr8Gf" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Weighted average expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">146.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">117.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_403_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_zBh1BxVvqdV4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Weighted average risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_zqzY6w0Aawt6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p id="xdx_8AC_zGRSDTwbVKU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The grant date fair value, for options granted during the three months ended September 30, 2021 and 2020 was approximately $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_pn4n6_c20210701__20210930_zLbPxVq7EU9" title="Options granted, fair value">0.61</span> million and $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_pn4n6_c20200701__20200930_z7pg5mqty6pb" title="Options granted, fair value">0.40</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zCtgE9wOYhHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following is a summary of the Company’s stock option activity for the three months ended September 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/><span id="xdx_8BE_z8mW58OMjBJ4" style="display: none">SUMMARY OF STOCK OPTION ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at July 1, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210701__20210930_zcf42gnGzHI2" style="width: 11%; text-align: right" title="Options Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">4,740,910</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210701__20210930_zS9mMdEWgZO4" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">3.40</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning"><span title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zkz4sHyeK6Rc" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.5</span></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210701__20210930_zuILNGe1QAaa" style="width: 11%; text-align: right" title="Intrinsic Value, Outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif">7,893,467</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210701__20210930_zHlxIsF07FQ2" style="text-align: right" title="Options, Granted"><span style="font-family: Times New Roman, Times, Serif">94,666</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zvVPexpZMfYj" style="text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font-family: Times New Roman, Times, Serif">7.11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20210701__20210930_zGVvmge1KVj" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.9</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1_pp0p0_c20210701__20210930_zWWSJPec41ng" style="text-align: right" title="Intrinsic Value, Options Granted"><span style="font-family: Times New Roman, Times, Serif">423,923</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210701__20210930_zctBeF87VX22" style="text-align: right" title="Options, Exercised"><span style="font-family: Times New Roman, Times, Serif">(392,394</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210701__20210930_zFQhF2pZrbF6" style="text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font-family: Times New Roman, Times, Serif">2.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_dtY_c20210701__20210930_zxCpVq1l8xfa" title="Weighted Average Remaining Contractual Term (Yrs), Options Exercised">7.2</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedInPeriodFairValue1_iN_pp0p0_di_c20210701__20210930_zY6GQiaNleNa" style="text-align: right" title="Intrinsic Value, Options Exercised"><span style="font-family: Times New Roman, Times, Serif">(3,720,795</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210701__20210930_zY5Ch1mTyiha" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(82,838</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210701__20210930_zKsAWgIAJEze" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">4.61</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20210701__20210930_zyyuDiXIbMt4" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">9.5</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_iN_pp0p0_di_c20210701__20210930_zWvQ3TQkX5Lg" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(563,393</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210701__20210930_zDSJJiwxX6m8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,360,344</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210701__20210930_zozEjwzNqzC1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.58</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210701__20210930_zSmHxz6Y7Cvg" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.6</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210701__20210930_zloACRC5oVJi" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Outstanding Ending balance"><span style="font-family: Times New Roman, Times, Serif">16,283,017</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20210930_zCljvalWtxd9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,143,324</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20210930_z8ShwsCXfCo4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zC5NqLWnnGab" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.5</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20210930_z0u3ywcRGFej" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font-family: Times New Roman, Times, Serif">15,852,955</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at July 1, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20200930_zwSWZPo7YPHc" style="width: 11%; text-align: right" title="Options Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">4,092,593</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20200930_zY5EJpIclhDa" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">3.19</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20200930_zGvtA9Ywqke7" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.4</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20200701__20200930_zGiBCAUHAJp1" style="width: 11%; text-align: right" title="Intrinsic Value, Outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif">5,553,916</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200701__20200930_zbrMudIwIQu5" style="text-align: right" title="Options, Granted"><span style="font-family: Times New Roman, Times, Serif">108,324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200701__20200930_zBbLzrstB0F2" style="text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font-family: Times New Roman, Times, Serif">4.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20200701__20200930_z2DVcHOEVLPf" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.9</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200701__20200930_z5iiBn4583xa" style="text-align: right" title="Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20200930_z2LMfrpT0bx2" style="text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200701__20200930_zB8fIZEDGsn5" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(16,809</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200701__20200930_zFJSvbfCJqfb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">4.33</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20200701__20200930_zDVA5CJNYqm1" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">9.4</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_iN_pp0p0_di_c20200701__20200930_zkX0ArK6FxJ7" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(2,828</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20200930_zyXbnCI48Nw5" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,184,108</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20200930_zzvfJVR40Nd6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200701__20200930_z4wtUG77e7Rg" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.4</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20200701__20200930_zOF3Mp4Tx3F5" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Outstanding Ending balance"><span style="font-family: Times New Roman, Times, Serif">5,469,339</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20200930_zQwhWzn3Kwt7" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3,840,479</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20200930_zjv7wuTOWiQ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20200701__20200930_zqDpeuZqNkb2" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.4</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20200930_zkSxu2ZUeBLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font-family: Times New Roman, Times, Serif">5,337,626</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zgCj9EtnxGKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zyCSO03Fxe0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s stock option-based expense for the three months ended September 30, 2021 and 2020 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B8_zWyPJAgftJ7i">SCHEDULE OF STOCK OPTION-BASED EXPENSE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20210701__20210930_znQrHFaQGS0d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20200701__20200930_zHRGcjiMyJHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended<br/> September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock option-based expense :</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_z1hyKuM4Xgal" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">347,597</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,912</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zWLaNFZRLIXf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,643</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,163</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zPM0Jva1nDS7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">127,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">99,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zvbwCDQUdyTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost of goods sold</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,764</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,687</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__custom--BoardOptionExpenseMember_zcQgjxBoidN9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Board option expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">88,619</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42,751</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_zvzSZeZR9IB5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,615</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">689,813</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_zhbkNWrGhtkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended June 30, 2019, certain Company advisors received approximately $<span id="xdx_903_ecustom--StockGrantedDuringPeriodValueSharebasedCompensationNet_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_zVNeYUxkIDp8" title="Stock options granted during period value">320,000</span> worth of Company stock options with an exercise price of $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_z1ewKjkt4Tnh" title="Stock options exercise price per share">5.25</span>/share and a <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_zvzQ7i2FZxs3">three-year term, for potential services to be performed over a three-year</span> period. Of the $<span id="xdx_906_ecustom--StockGrantedDuringPeriodValueSharebasedCompensationNet_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_z0f1PEh1zyTe">320,000</span>, $<span id="xdx_902_eus-gaap--PrepaidExpenseCurrent_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zMKpKjpWG7f3" title="Prepaid expenses">29,000</span> and $<span id="xdx_907_eus-gaap--PrepaidExpenseCurrent_iI_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zuE5rZaBoId8" title="Prepaid expenses">58,000</span> was categorized as a prepaid expense at September 30, 2021 and June 30, 2021, respectively. During the three months ended September 30, 2021 and 2020, the Company recognized approximately $<span id="xdx_901_eus-gaap--GeneralAndAdministrativeExpense_pp0p0_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zKaEaxxxqi13" title="General and administration expense">29,000</span> for each period, as general and administration expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At September 30, 2021, total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $<span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn4n6_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_z1ubKs26nW5i" title="Unrecognized compensation expense to employees and vendors">1.06</span> million and is expected to be recognized over a weighted average period of <span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zco1unZS4Hi3">1.85</span> years. At September 30, 2020, total unrecognized compensation expense related to stock options was approximately $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn4n6_c20200930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zuclhKQgQWu7" title="Unrecognized compensation expense to employees and vendors">1.19</span> million and was recognized over a weighted average period of <span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_z8r0R3pdrjo3">0.83</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The intrinsic value of stock options at September 30, 2021 was computed using a fair market value of the common stock of $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zjcoSxczOjQc" title="Stock options intrinsic value per share"><span>7.29</span></span>/share, as compared to $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zUvmsWAiJlwb" title="Stock options intrinsic value per share">4.50</span>/share at September 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 7.00 1910000 11820000 87500 7.00 The warrant is valued at approximately $520,000 based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 129% expected volatility, 0.87% risk-free rate and 0% expected dividend yield. 324150 280000 1910000 7.00 11820000 2400 4.50 10800 324150 77000 750000 375000 750000 2.00 6000 6700 65000 30000 3000 15000 17000 46000 10000000 5640000 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z7QJhkHqCYCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B4_z7fBNOvwUQPd" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20210701__20210930_z2TCgdgIMZek" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended <br/> September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20200701__20200930_zDLMikifgUo" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended <br/> September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average expected terms (in years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210701__20210930_zebAMzre8En5" title="Weighted average expected terms (in years)">5.4</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200701__20200930_zXkxIdJtZRek">5.1</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_zFR11igGr8Gf" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Weighted average expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">146.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">117.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_403_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_zBh1BxVvqdV4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Weighted average risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_zqzY6w0Aawt6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> P5Y4M24D P5Y1M6D 1.461 1.173 0.009 0.003 0.000 0.000 610000 400000 <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zCtgE9wOYhHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following is a summary of the Company’s stock option activity for the three months ended September 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/><span id="xdx_8BE_z8mW58OMjBJ4" style="display: none">SUMMARY OF STOCK OPTION ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at July 1, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210701__20210930_zcf42gnGzHI2" style="width: 11%; text-align: right" title="Options Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">4,740,910</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210701__20210930_zS9mMdEWgZO4" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">3.40</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning"><span title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zkz4sHyeK6Rc" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.5</span></span></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210701__20210930_zuILNGe1QAaa" style="width: 11%; text-align: right" title="Intrinsic Value, Outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif">7,893,467</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210701__20210930_zHlxIsF07FQ2" style="text-align: right" title="Options, Granted"><span style="font-family: Times New Roman, Times, Serif">94,666</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210701__20210930_zvVPexpZMfYj" style="text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font-family: Times New Roman, Times, Serif">7.11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20210701__20210930_zGVvmge1KVj" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.9</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1_pp0p0_c20210701__20210930_zWWSJPec41ng" style="text-align: right" title="Intrinsic Value, Options Granted"><span style="font-family: Times New Roman, Times, Serif">423,923</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210701__20210930_zctBeF87VX22" style="text-align: right" title="Options, Exercised"><span style="font-family: Times New Roman, Times, Serif">(392,394</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210701__20210930_zFQhF2pZrbF6" style="text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font-family: Times New Roman, Times, Serif">2.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_dtY_c20210701__20210930_zxCpVq1l8xfa" title="Weighted Average Remaining Contractual Term (Yrs), Options Exercised">7.2</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedInPeriodFairValue1_iN_pp0p0_di_c20210701__20210930_zY6GQiaNleNa" style="text-align: right" title="Intrinsic Value, Options Exercised"><span style="font-family: Times New Roman, Times, Serif">(3,720,795</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210701__20210930_zY5Ch1mTyiha" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(82,838</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210701__20210930_zKsAWgIAJEze" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">4.61</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20210701__20210930_zyyuDiXIbMt4" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">9.5</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_iN_pp0p0_di_c20210701__20210930_zWvQ3TQkX5Lg" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(563,393</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210701__20210930_zDSJJiwxX6m8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,360,344</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210701__20210930_zozEjwzNqzC1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.58</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210701__20210930_zSmHxz6Y7Cvg" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.6</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20210701__20210930_zloACRC5oVJi" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Outstanding Ending balance"><span style="font-family: Times New Roman, Times, Serif">16,283,017</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20210930_zCljvalWtxd9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,143,324</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20210930_z8ShwsCXfCo4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20210701__20210930_zC5NqLWnnGab" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.5</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20210930_z0u3ywcRGFej" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font-family: Times New Roman, Times, Serif">15,852,955</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at July 1, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20200930_zwSWZPo7YPHc" style="width: 11%; text-align: right" title="Options Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">4,092,593</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20200930_zY5EJpIclhDa" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">3.19</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20200930_zGvtA9Ywqke7" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.4</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20200701__20200930_zGiBCAUHAJp1" style="width: 11%; text-align: right" title="Intrinsic Value, Outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif">5,553,916</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200701__20200930_zbrMudIwIQu5" style="text-align: right" title="Options, Granted"><span style="font-family: Times New Roman, Times, Serif">108,324</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200701__20200930_zBbLzrstB0F2" style="text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font-family: Times New Roman, Times, Serif">4.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20200701__20200930_z2DVcHOEVLPf" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.9</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200701__20200930_z5iiBn4583xa" style="text-align: right" title="Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20200930_z2LMfrpT0bx2" style="text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200701__20200930_zB8fIZEDGsn5" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(16,809</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200701__20200930_zFJSvbfCJqfb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">4.33</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20200701__20200930_zDVA5CJNYqm1" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">9.4</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_iN_pp0p0_di_c20200701__20200930_zkX0ArK6FxJ7" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif">(2,828</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20200930_zyXbnCI48Nw5" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">4,184,108</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20200930_zzvfJVR40Nd6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.22</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200701__20200930_z4wtUG77e7Rg" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.4</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20200701__20200930_zOF3Mp4Tx3F5" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Outstanding Ending balance"><span style="font-family: Times New Roman, Times, Serif">5,469,339</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable at September 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20200930_zQwhWzn3Kwt7" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3,840,479</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20200930_zjv7wuTOWiQ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif">3.14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20200701__20200930_zqDpeuZqNkb2" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.4</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20200930_zkSxu2ZUeBLi" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font-family: Times New Roman, Times, Serif">5,337,626</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 4740910 3.40 P8Y6M 7893467 94666 7.11 P9Y10M24D 423923 392394 2.14 P7Y2M12D 3720795 82838 4.61 P9Y6M 563393 4360344 3.58 P8Y7M6D 16283017 4143324 3.47 P8Y6M 15852955 4092593 3.19 P8Y4M24D 5553916 108324 4.50 P9Y10M24D 16809 4.33 P9Y4M24D 2828 4184108 3.22 P8Y4M24D 5469339 3840479 3.14 P8Y4M24D 5337626 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zyCSO03Fxe0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s stock option-based expense for the three months ended September 30, 2021 and 2020 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B8_zWyPJAgftJ7i">SCHEDULE OF STOCK OPTION-BASED EXPENSE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20210701__20210930_znQrHFaQGS0d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended<br/> September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20200701__20200930_zHRGcjiMyJHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended<br/> September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock option-based expense :</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_z1hyKuM4Xgal" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">347,597</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">403,912</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zWLaNFZRLIXf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,643</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,163</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zPM0Jva1nDS7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">127,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">99,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zvbwCDQUdyTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost of goods sold</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,764</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,687</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__custom--BoardOptionExpenseMember_zcQgjxBoidN9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Board option expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">88,619</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42,751</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_zvzSZeZR9IB5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,615</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">689,813</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 347597 403912 66643 98163 127992 99300 22764 45687 88619 42751 653615 689813 320000 5.25 three-year term, for potential services to be performed over a three-year 320000 29000 58000 29000 1060000.00 P1Y10M6D 1190000 P0Y9M29D 7.29 4.50 <p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zmdmoUwCTvD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 8. <span id="xdx_82A_zDBdYrMPCutf">EARNINGS PER SHARE</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_znZIckl0v0S8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table presents the computation of basic and diluted net loss per common share:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B6_zBNvAPT8eT4k">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20210701__20210930_zjXj4ByZUJ6i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20200701__20200930_zgu154Bjv208" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_zfJzsYwXIzOj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; width: 56%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,656,761</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,277,324</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted-average common shares outstanding <br/> for basic and diluted net loss per share</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,967,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,039,928</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.17</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.18</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p id="xdx_8A2_z2knGuCg7JZg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zB9XyJtqOjZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B8_zfrhgBbxW6z9">SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210701__20210930_z6QN8NInpqeh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 9pt Times New Roman, Times, Serif">At September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20200701__20200930_zUz1UtuOFrjl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 9pt Times New Roman, Times, Serif">At September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zbfpv6gHwb19" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif">Stock Options</span></td><td style="width: 2%"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="width: 22%; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,360,344</span></td><td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="width: 22%; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,184,108</span></td><td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zkikNgdAts81" style="vertical-align: bottom; background-color: White"> <td><span style="font: 9pt Times New Roman, Times, Serif">Warrants</span></td><td><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">87,500</span></td><td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0857"> </span></span></td><td style="text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_ziv41klckLdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif">Convertible Notes</span></td><td style="padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0859"> </span></span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">296,111</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font: 9pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,447,844</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,480,219</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zpy9mEHQ0QCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_899_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_znZIckl0v0S8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table presents the computation of basic and diluted net loss per common share:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B6_zBNvAPT8eT4k">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20210701__20210930_zjXj4ByZUJ6i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20200701__20200930_zgu154Bjv208" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_zfJzsYwXIzOj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; width: 56%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,656,761</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,277,324</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Weighted-average common shares outstanding <br/> for basic and diluted net loss per share</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,967,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,039,928</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareBasicAndDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.17</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.18</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> -1656761 -1277324 9967821 7039928 -0.17 -0.18 <p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zB9XyJtqOjZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B8_zfrhgBbxW6z9">SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210701__20210930_z6QN8NInpqeh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 9pt Times New Roman, Times, Serif">At September 30, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20200701__20200930_zUz1UtuOFrjl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 9pt Times New Roman, Times, Serif">At September 30, 2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zbfpv6gHwb19" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif">Stock Options</span></td><td style="width: 2%"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="width: 22%; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,360,344</span></td><td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="width: 22%; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,184,108</span></td><td style="width: 1%; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zkikNgdAts81" style="vertical-align: bottom; background-color: White"> <td><span style="font: 9pt Times New Roman, Times, Serif">Warrants</span></td><td><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">87,500</span></td><td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0857"> </span></span></td><td style="text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_ziv41klckLdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif">Convertible Notes</span></td><td style="padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0859"> </span></span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">296,111</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font: 9pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,447,844</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: 9pt Times New Roman, Times, Serif">4,480,219</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 9pt Times New Roman, Times, Serif"> </span></td></tr> </table> 4360344 4184108 87500 296111 4447844 4480219 <p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zf2BjcnrAibk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 9. <span id="xdx_825_z4bQ6d8ORcPl">PROVISION FOR INCOME TAXES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There was no current or deferred income tax provision for the three months ended September 30, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zPElVvtmHJRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s deferred tax assets as of September 30 2021 and 2020 consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/><span id="xdx_8B5_zIWXrJQ7PiT5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20210930_z4yaSShrMP42" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20200930_zjCGUO6ntn76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net-operating loss carryforward</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,269,910</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,961,194</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsStockbasedCompensation_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">586,042</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">394,742</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Deferred Tax Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,855,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,355,936</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zgtGbwACFGJe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,855,952</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,355,936</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred Tax Asset, Net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0881">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_z5joO3F2HXug" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains a valuation allowance on deferred tax assets due to the uncertainty regarding the ability to utilize these deferred tax assets in the future. At September 30, 2021, the Company had potential utilizable aggregate gross net operating loss carryforwards (“NOLs”) of approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pn4n6_c20210930_zYr4ykkYoUke" title="Operating loss carry forwards, net">12.35</span> million. <span id="xdx_900_ecustom--OperatingLossCarryForwardsExpirationDateDescription_c20210701__20210930_zfF3bjMSGX5e" title="Operating loss carry forwards expiration date">NOLs for the periods ending June 30, 2018 and prior in the amount of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn4n6_c20180630_zRtctnlykBT5">2.86</span> million begin to expire in 2037</span>. NOLs subsequent to June 30, 2018 have no expiration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Section 382 of the U.S. Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. The Company has not completed a Section 382 analysis of the NOL carryforwards. Consequently, the Company’s NOL carryforwards may be subject to annual limitations under Section 382.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. As a result of the uncertainly in the realization of the Company’s deferred tax assets, the Company has provided a valuation allowance for the full amount of the deferred tax assets at September 30, 2021 and September 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s valuation allowance during the three months ended September 30, 2021 and 2020 increased by approximately $<span id="xdx_90A_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn4n6_c20210701__20210930_zUqE0PS8ZWPj" title="Valuation allowance">0.40</span> million and $<span id="xdx_900_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn4n6_c20200701__20200930_zEAjgBpstgE6" title="Valuation allowance">0.20</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zjkGpop1SaW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8BF_zjyeAqW0YgC">SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months Ended September 30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months Ended September 30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory Federal Income Tax Rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210701__20210930_zsuwfYjafS6h" style="width: 17%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font-family: Times New Roman, Times, Serif">21.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20200701__20200930_zKQqAZz5mxoe" style="width: 17%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font-family: Times New Roman, Times, Serif">21.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">State and Local Taxes, Net of Federal Tax Benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_iN_pid_dpi_uPure_c20210701__20210930_zoJfMHkJCO9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_iN_pid_dpi_uPure_c20200701__20200930_zS9oC3rbFEB1" style="text-align: right" title="State and Local Taxes, Net of Federal Tax Benefit"><span style="font-family: Times New Roman, Times, Serif">(13.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock Based Compensation Expense (ISO)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_c20210701__20210930_zruZhow7aIw6" style="text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font-family: Times New Roman, Times, Serif">10.61</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_c20200701__20200930_zv2gBpTK92j2" style="text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font-family: Times New Roman, Times, Serif">19.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in Valuation Allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_uPure_c20210701__20210930_zWytlwt8PsKh" style="border-bottom: Black 1pt solid; text-align: right" title="Change in Valuation Allowance"><span style="font-family: Times New Roman, Times, Serif">(18.05</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_uPure_c20200701__20200930_zTiFEih28cb1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in Valuation Allowance"><span style="font-family: Times New Roman, Times, Serif">(26.59</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Income Taxes Provision (Benefit)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20210701__20210930_zKhdVKzQTZA" style="border-bottom: Black 2.5pt double; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20200701__20200930_zpqBQYpVTO4j" style="border-bottom: Black 2.5pt double; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_ziPSVdXflMj4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon completion of its 2021 U.S. income tax return in 2022, the Company may identify additional remeasurement adjustments. The Company will continue to assess its provision for income taxes as future guidance is issued, but does not currently anticipate significant revisions will be necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zPElVvtmHJRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s deferred tax assets as of September 30 2021 and 2020 consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/><span id="xdx_8B5_zIWXrJQ7PiT5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20210930_z4yaSShrMP42" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20200930_zjCGUO6ntn76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net-operating loss carryforward</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,269,910</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,961,194</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredTaxAssetsStockbasedCompensation_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">586,042</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">394,742</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Deferred Tax Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,855,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,355,936</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zgtGbwACFGJe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,855,952</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,355,936</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred Tax Asset, Net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0881">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 4269910 2961194 586042 394742 4855952 3355936 4855952 3355936 12350000 NOLs for the periods ending June 30, 2018 and prior in the amount of approximately $2.86 million begin to expire in 2037 2860000 400000 200000 <p id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zjkGpop1SaW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8BF_zjyeAqW0YgC">SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months Ended September 30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months Ended September 30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Statutory Federal Income Tax Rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210701__20210930_zsuwfYjafS6h" style="width: 17%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font-family: Times New Roman, Times, Serif">21.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20200701__20200930_zKQqAZz5mxoe" style="width: 17%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font-family: Times New Roman, Times, Serif">21.00</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">State and Local Taxes, Net of Federal Tax Benefit</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_iN_pid_dpi_uPure_c20210701__20210930_zoJfMHkJCO9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_iN_pid_dpi_uPure_c20200701__20200930_zS9oC3rbFEB1" style="text-align: right" title="State and Local Taxes, Net of Federal Tax Benefit"><span style="font-family: Times New Roman, Times, Serif">(13.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock Based Compensation Expense (ISO)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_c20210701__20210930_zruZhow7aIw6" style="text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font-family: Times New Roman, Times, Serif">10.61</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_c20200701__20200930_zv2gBpTK92j2" style="text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font-family: Times New Roman, Times, Serif">19.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Change in Valuation Allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_uPure_c20210701__20210930_zWytlwt8PsKh" style="border-bottom: Black 1pt solid; text-align: right" title="Change in Valuation Allowance"><span style="font-family: Times New Roman, Times, Serif">(18.05</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_uPure_c20200701__20200930_zTiFEih28cb1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in Valuation Allowance"><span style="font-family: Times New Roman, Times, Serif">(26.59</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Income Taxes Provision (Benefit)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20210701__20210930_zKhdVKzQTZA" style="border-bottom: Black 2.5pt double; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20200701__20200930_zpqBQYpVTO4j" style="border-bottom: Black 2.5pt double; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.2100 0.2100 0.1356 0.1356 0.1061 0.1915 0.1805 0.2659 0.0000 0.0000 <p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zUCLC4tpznp5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 10. <span id="xdx_823_znL9QjIVLyzb">COMMITMENTS AND CONTINGENCIES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Operating Lease</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company has an office space lease expiring, as amended, on <span id="xdx_906_eus-gaap--LeaseExpirationDate1_dd_c20210701__20210930_zWYvByltoxac" title="Lease Expiration Date">December 31, 2022</span>. To secure the initial lease, the Company paid a $<span id="xdx_905_eus-gaap--SecurityDeposit_iI_pp0p0_c20210930_zLNzWDZ1YqTa" title="Security deposit">75,000</span> security deposit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Rent expense was approximately $<span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_pp0p0_c20210701__20210930_zz8xWx051jXg" title="Rent expense">86,000</span> and $<span id="xdx_901_eus-gaap--LeaseAndRentalExpense_pp0p0_c20200701__20200930_zHkIpBfnBQ18" title="Rent expense">72,000</span> for the three months ended September 30, 2021 and 2020, respectively. There is approximately $<span id="xdx_90A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20210930__us-gaap--AwardDateAxis__custom--OctoberTwoThousandTwentyOneToSeptemberTwoThousandTwentyTwoMember_zpdTWrJyZSc2" title="Lease payments">309,000</span> due on the lease for the October 2021-September 2022 period and approximately $<span id="xdx_907_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfter_iI_pp0p0_c20210930__us-gaap--AwardDateAxis__custom--OctoberTwoThousandTwentyOneToSeptemberTwoThousandTwentyTwoMember_zplW0wfb7xOg" title="Lease payments due thereafter">75,000</span> due thereafter for the remaining lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Potential Future Distributions Upon Divestiture or Sale</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon a divestiture or sale of a subsidiary company, the Company is contractually obligated to distribute up to <span id="xdx_906_ecustom--MaximumDistributionPercentageOfNetProceedsFromDivestiture_pid_dp_c20210701__20210930_zKdzAjpleb74" title="Maximum distribution percentage of net proceeds from divestiture">10</span>% of the net proceeds from such divestiture or sale to the senior management team of the divested subsidiary company. Currently, there were no active discussions pertaining to a potential divestiture or sale of any of the Company’s subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>COVID-19</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From March 2020 through June 2021, the Company had required substantially all of its employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit the Company’s ability to operate its business effectively. Commencing July 2021, the Company has tentatively required employees to return to the office several days a week.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We continue to closely monitor the situation and the effects on our business and operations. While uncertainty remains, given the current state of the pandemic, our expected revenue growth and current cash balance, we do not expect the impact of COVID-19 on our business and operations to worsen going forward.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(UNAUDITED)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">SEPTEMBER 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 2022-12-31 75000 86000 72000 309000 75000 0.10 <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zJe7UtjvMOQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 11. <span id="xdx_829_zXhYaalRLT99">SUBSEQUENT EVENTS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>ASSET ACQUISTION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In October 2021, the Company, through its newly formed and wholly owned subsidiary company, XR Terra, LLC, completed an acquisition of certain assets, as defined, from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Initial consideration for the purchase is $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pn4n6_c20211002__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKdTXn9g0WS7" title="Purchase of assets consideration value">0.60</span> million payable <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20211002__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCGO3p4IBCrc" title="Stock purchase percentage">50%</span> in Company common stock and <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20211002__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWDDSa7PyYl3">50%</span> in cash. In October 2021, the Company paid $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pn4n6_c20211002__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1AKuTL2wqJa">0.30</span> million cash and issued <span id="xdx_900_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20211002__20211031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1f89xE27P3g">33,877</span> shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through September 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company is currently determining its purchase price allocation between customer list, intellectual property and goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>SECURITIES PURCHASE AGREEMENT (“SPA”)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In November 2021, the Company entered into a SPA to sell $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20211101__20211130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zShfhkVHpQxh" title="Proceeds from sale of stock">15.0</span> million worth of its common stock and warrants to certain institutional investors in a private placement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Under the terms of the SPA, the Company sold <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pn4n6_c20211101__20211130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zA8LzWjsyvod" title="Sale of stock, shares">1.50</span> million shares of its common stock and warrants to purchase <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pn4n6_c20211130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zvwE9In3sepa" title="Warrants to purchase shares">0.75</span> million shares of common stock. The warrants have an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zsGYuXdAdUU8" title="Warrants price per share">14.68</span> per share. The warrants will expire <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20211130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6KJs3xnkGn5">five years</span> from the date they can be exercised. The purchase price for one share of common stock and half a corresponding warrant was $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20211130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zjxxw1XX9W6f">10.00</span>. The gross proceeds to the Company from the registered direct offering were approximately $<span id="xdx_902_eus-gaap--ProceedsFromWarrantExercises_pn5n6_c20211101__20211130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_ziEpR05NBmR8" title="Proceeds from warrants exercise">13.6</span> million after deducting the placement agent’s fees and other estimated offering expenses.</span></p> 600000 0.50 0.50 300000 33877 15000000.0 1500000 750000 14.68 P5Y 10.00 13600000 1771929 1034846 626244 214673 29512 237745 470136 281047 468747 3178868 1956011 42172 41224 3221040 1997235 381510 121508 168745 118634 440357 1250000 98425 330362 2339037 570504 548885 623828 1429953 1183535 4392818 2302924 0.001 0.001 20000000 20000000 0 0 0 0 0.001 0.001 300000000 300000000 7579285 7579285 7035771 7035771 7580 7036 20936050 15710996 -22115408 -16023721 -1171778 -305689 3221040 1997235 3082528 1777447 338967 167868 3421495 1945315 1461210 1137193 1960285 808122 3183055 2430752 2220811 1835147 1267088 1462701 6670954 5728600 -4710669 -4920478 548885 10000 6202 8583 180641 81455 -515464 -1250000 -1381018 -72872 -6091687 -4993350 -0.84 -0.72 7259249 6923506 6860246 6861 12497228 -11030371 1473718 1556 1 6999 7000 57234 57 257837 257894 44506 45 173726 173771 20390 20 91735 91755 28158 28 126683 126711 23681 24 101475 101499 2288258 2288258 167055 167055 -4993350 -4993350 7035771 7036 15710996 -16023721 -305689 76891 77 345933 346010 332063 332 1486727 1487059 13435 13 67162 67175 18553 19 92746 92765 29500 30 147471 147501 44250 44 192347 192391 28822 29 134387 134416 2576058 2576058 182223 182223 -6091687 -6091687 7579285 7580 20936050 -22115408 -1171778 -6091687 -4993350 27054 20222 180642 81456 139754 2945487 2550521 134416 101499 92765 91755 20217 39311 -515464 548885 411571 86805 25933 52058 -136925 -14164 260002 79183 97068 -72360 440357 -1250000 -231937 62433 -1209616 -2024275 28003 32660 -28003 -32660 548885 623828 1332500 1475000 346010 7000 470136 1974702 1888385 737083 -168550 1034846 1203396 1771929 1034846 1487059 548885 192347 173771 147471 257894 46958 87400 <p id="xdx_80D_eus-gaap--NatureOfOperations_z59gC3oMel1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 1. <span id="xdx_828_zfsthbRlX8Sj">DESCRIPTION OF BUSINESS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Glimpse Group, Inc. (“Glimpse”) is a Virtual (VR) and Augmented (AR) Reality company, comprised of a diversified portfolio of VR and AR software and services companies. Glimpse’s nine wholly-owned operating subsidiaries (“Subsidiary Companies” or “Subsidiaries”) are: Adept Reality, LLC (dba Adept XR Learning), Kabaq 3D Technologies, LLC (dba QReal), KreatAR, LLC (dba PostReality), D6 VR, LLC, Immersive Health Group, LLC, Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), and Early Adopter, LLC and one subsidiary in Turkey, Glimpse Group Yazilim ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”). In addition, the Company has two inactive subsidiary companies: In-It VR, LLC (dba Mezmos) and MotionZone, LLC (collectively, the “Company” or “Glimpse”). Glimpse was incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Glimpse’s robust VR/AR ecosystem, collaborative environment and business model simplify the many challenges faced by companies in an emerging industry. Glimpse cultivates and manages business operations while providing a strong network of professional relationships, thereby allowing the subsidiary company entrepreneurs to maximize their time and resources in pursuit of mission-critical endeavors, reducing time to market, optimizing costs, improving product quality and leveraging joint go-to-market strategies, while simultaneously providing investors an opportunity to invest directly into the VR/AR industry via a diversified platform.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company completed an initial public offering (“IPO”) of its common stock on the Nasdaq Capital Market Exchange (“Nasdaq”) on July 1, 2021, under the ticker VRAR. See Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Summary of Glimpse’s Active Subsidiary Companies</span>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Kabaq 3D Technologies, LLC (dba QReal)</span></i>: Creating and displaying photorealistic 3D, AR, interactive digital models.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Adept Reality, LLC (dba Adept XR Learning)</span></i>: VR/AR corporate training solutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">KreatAR, LLC (dba PostReality)</span></i>: AR presentation tools for design, creation and collaboration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">D6 VR, LLC</span></i>: VR/AR data-analysis and collaboration for financial services and other data intensive industries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Immersive Health Group, LLC (IHG)</span></i>: VR/AR solutions for the healthcare industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Foretell Studios, LLC (dba Foretell Reality)</span></i>: Social VR multi-person spaces, collaboration and group interaction for enterprise and support groups.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Number 9, LLC (dba Pagoni VR)</span></i>: VR/AR broadcasting solutions and environments for events, education, media and entertainment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Early Adopter, LLC (EA)</span></i>: AR/VR solutions for K-12 education.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Glimpse Group Yazilim ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”)</span>: </i>primarily develops and creates 3D models for QReal</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_809_ecustom--LiquidityAndCapitalResourcesDisclosureTextBlock_z8p7oY1CC5I8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 2. <span id="xdx_82F_zCIaerlsBmth">LIQUIDITY AND CAPITAL RESOURCES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company incurred a loss of $<span id="xdx_90E_eus-gaap--NetIncomeLoss_iN_pn4n6_di_c20200701__20210630_zenu4NHu8nji" title="Net loss">6.09</span> million during the year ended June 30, 2021, compared to a loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn4n6_di_c20190701__20200630_zeYVOqdPmmgl" title="Net loss">4.99</span> million during the year ended June 30, 2020. The loss was incurred as the Company funded operational expenses, primarily research and development, general and administrative, sales and marketing, and to satisfy legacy acquisitions costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net cash used in operating activities was $<span id="xdx_90A_ecustom--NetCashProvidedByUsedInOperatingsActivities_iN_pn4n6_di_c20200701__20210630_z4k7kOdSF2la" title="Net cash used in operating activities">1.21</span> million during the year ended June 30, 2021, compared to $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn4n6_di_c20190701__20200630_zLul5oV6l0S2" title="Net cash used in operating activities">2.02</span> million during the year ended June 30, 2020. The Company has raised approximately $<span id="xdx_902_ecustom--ProceedsFromIssuanceOfCommonStockAndConvertibleDebt_pn4n6_c20160615__20210630_zzyghj8mpLk1" title="Proceeds from issuance of common stock and convertible debt">8.88</span> million through the issuance of common share and convertible debt financings since inception through June 30, 2021, of which approximately $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn4n6_c20160615__20210630_zozJ7ezFwpx1" title="Proceeds from issuance of common stock">1.82</span> million was raised during the year ended June 30, 2021 from the sale of common stock as disclosed in Note 6 and the issuance of convertible promissory notes as disclosed in Note 9.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The combination of operating losses since inception, cash expected to be used in operating activities in the future, uncertain conditions relating to additional capital raises and continued revenue growth had created uncertainty about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company had $<span id="xdx_904_eus-gaap--Cash_iI_pn4n6_c20210630_zxvDw74ZzN1l" title="Cash">1.77</span> million of cash as of June 30, 2021 compared to $<span id="xdx_90C_eus-gaap--Cash_iI_pn4n6_c20200630_zLzoNWFwp9o" title="Cash">1.03</span> million as of June 30, 2020. On July 1, 2021 the Company completed an IPO through Nasdaq in which, as a result of the sale of its common shares at $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210702__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaSdxrxvOq28" title="Share issued price per share">7.00</span> per share, it raised approximately $<span id="xdx_901_ecustom--GrossProceedsFromIssuanceInitialPublicOffering_pn5n6_c20210701__20210702__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zppsvrT3trtg" title="Gross proceeds from issuance initial public offering">13.4</span> million in gross proceeds and $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20210701__20210702__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBR2GiWM1lSg" title="Net proceeds from issuance initial public offering">11.8</span> million in net proceeds after fees and expenses. See Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company generated $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn4n6_c20200701__20210630_zShh9CrS4Re6" title="Revenues">3.42</span> million of revenues during the year ended June 30, 2021, compared to $<span id="xdx_902_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn4n6_c20190701__20200630_zAVIk2x6IlRi" title="Revenues">1.95</span> million during the year ended June 30, 2020. In addition, as disclosed in Note 9, during the year ended June 30, 2020 the Company received a $<span id="xdx_904_eus-gaap--ProceedsFromBankDebt_pn3n6_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--PaymentProtectionProgramOneMember_z0TJO592PWfc" title="Proceeds from PPP loan">0.549</span> million Paycheck Protection Program 1 (“PPP 1”) loan and an additional $<span id="xdx_90E_eus-gaap--ProceedsFromBankDebt_pn3n6_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--PaymentProtectionProgramTwoMember_zfa7xRwURzjc" title="Proceeds from PPP loan">0.624</span> million Paycheck Protection Program 2 (“PPP 2”) loan in February 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of the date that this financial statement was issued, the Company’s cash position was approximately $<span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn6n6_c20210630_zZwpd6NQDG7" title="Cash position">13</span> million, contracted revenue backlog to be collected over the short term exceeded $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pn5n6_c20200701__20210630_zeAl6E2a6ESb" title="Contracted revenue backlog">1.5</span> million and the Company’s shares were traded on Nasdaq post its July 1, 2021 IPO. As such, the Company believes that it is sufficiently funded to meet its operational plan and future obligations beyond the 12-month period from the date that these financial statements were issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Given the above, doubt about the company’s ability to continue as a going concern was alleviated and the accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">While Management believes it will be able to continue to grow the Company’s revenue base, there is no assurance. In parallel, Management continually monitors its capital structure and operating plans and evaluates various potential funding alternatives that may be needed in order to finance the Company’s research and development activities, general and administrative expenses and growth strategy. These alternatives include raising funds through public equity or debt markets. Although there is no assurance that, if needed, the Company will be successful with its fundraising initiatives, the Company has been successful historically in raising equity capital and Management believes that its Nasdaq listing significantly increases its ability to access capital going forward.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> -6090000.00 -4990000 -1210000 -2020000.00 8880000 1820000 1770000 1030000.00 7.00 13400000 11800000 3420000 1950000 549000 624000 13000000 1500000 <p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zGMQskm25c09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 3. <span id="xdx_822_zzDLOtYMx3O3">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zULN36NFrW88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Basis of presentation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zZwCO3CoG8ul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Principles of Consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_ziFT4Vr1k5Me" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Use of Accounting Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options and cost of goods sold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zyadj7K5QtD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cash and Cash Equivalents</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents consist of cash and deposits in bank checking accounts or money market funds with immediate access.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zbUCnoMMDoa9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Nature of Revenues</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reports its revenues in two categories:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Software Services: Virtual and Augmented Reality projects, solutions and consulting services.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company adopted the new accounting standard, Accounting Standards Codification (“ASC”) 606, <i>Revenue from Contracts with Customers</i>, (“ASC 606”) beginning on July 1, 2020 using the modified retrospective method for all open contracts and related amendments. The adoption did not result in an adjustment to the accumulated deficit as of June 30, 2020. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods. The adoption of ASC 606 did not have a material impact on reported sales to customers and net earnings (losses).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">allocate the transaction price to performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">recognize revenue as the performance obligation is satisfied;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">determine that collection is reasonably assured</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Significant Judgments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company generated revenue for the years ended June 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses &amp; SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zQmV3G6zGHga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As detailed in the Company’s Consolidated Statement of Operations, the following is a disaggregation of the Company’s revenue by major source for the years ended June 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span style="background-color: white"><span id="xdx_8BF_zUEehthHDTse" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Years Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Software Services</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__srt--ProductOrServiceAxis__custom--SoftwareSercicesMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,082,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630__srt--ProductOrServiceAxis__custom--SoftwareServicesMember_zqJjLdjqP9s9" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">1,777,447</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Software License and Software as a Service</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__srt--ProductOrServiceAxis__custom--SoftwareLicenseAndSoftwareServiceMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">338,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630__srt--ProductOrServiceAxis__custom--SoftwareLicenseMember_zLauPGOFG0kc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">167,868</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,421,495</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630_zkmnxfQnv6Qd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">1,945,315</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zC6a86m5kwub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Timing of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_894_ecustom--ScheduleOfTimingRevenueRecognitionTableTextBlock_zJCsfBFdzTSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As the Company began adopting ASC 606 in July 2020, the timing of revenue recognition for periods prior to the adoption is not required:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_z6t0Pw3kLCXi" style="display: none">SCHEDULE OF TIMING REVENUE RECOGNITION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Year Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 71%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Products transferred at a point in time</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">2,967,586</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Products and services transferred over time</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">453,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200701__20210630_zPBHP0wucqkk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,421,495</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_z0laHJPHov9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred revenue is comprised mainly of software project contract performance obligations not completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of June 30, 2021, the Company had approximately $<span id="xdx_903_ecustom--UnfulfilledPerformanceObligations_pn4n6_c20200701__20210630_zwcSbH7ymWtj" title="Unfulfilled performance obligations">1.23</span> million in unfulfilled performance obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Prior to the adoption of ASC 606 at July 1, 2020, the Company’s revenue recognition was as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Software Service Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company generates software related revenues from services performed for: Virtual and Augmented Reality projects, consulting retainers, and ongoing website maintenance and support. Software service revenue generated from Virtual and Augmented Reality projects is recognized after delivery of the project has occurred, when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured. Any unrecognized portion of project revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets. Deferred costs include cash and equity based payroll costs, and may include payments to vendors. Software service revenue generated from consulting retainers is typically billed in advance for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, services have been performed, and collection is reasonably assured. Software service revenue generated from ongoing website maintenance and support services is typically billed in arrears for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Software License and Software as a Service Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company derives revenue from software as-a-service subscriptions and software licenses. Upon delivery of the software to customers, revenue is recognized ratably over the term of the contract or arrangement. The unrecognized portion of this revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zDAUNH9PnYti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Receivable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of June 30, 2021 and June 30, 2020 no allowance for doubtful accounts was recorded as all amounts were considered collectible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z4FusPZhNC2j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Customer Concentration and Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Two customers accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zE43Fi77m973" title="Concentration risk percentage">49%</span> (<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zrdhVuUobXfl" title="Concentration risk percentage">26%</span> and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVenouWpTyTa" title="Concentration risk percentage">23%</span>, respectively) of the Company’s total gross revenues during the year ended June 30, 2021. One different customer accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGbZB9WvdhD7" title="Concentration risk percentage">13%</span> of the Company’s total gross revenues during the year ended June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Two customers accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxfXPuQ7Pg88">71%</span> (<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCrwWq20K9M3">57%</span> and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0cBSIAUwm4g">14%</span>, respectively) of the Company’s accounts receivable at June 30, 2021. Four different customers accounted for approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--FourOtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCck2LiVL5Ob">96%</span> (<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzy8o5d9Ylo1">35%</span>, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_za3ObjjOmiE2">35%</span>, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkkY2LSmzLvi">14%</span> and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2f03sIrfin9">12%</span>, respectively) of the Company’s accounts receivable at June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_ziW2ij5putTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Equipment, net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment is stated at cost less accumulated depreciation (see Note 4). Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zh3KQG42bLe7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Employee Stock-Based Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--ResearchAndDevelopmentExpensePolicy_zrlbcXd196Se" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Research and Development Costs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zor3XBvyO5Yi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is <span id="xdx_90F_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200701__20210630" title="Tax benefit settlement description">greater than 50%</span> likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, <i>Income Taxes</i>, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the years ended June 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zsVbtux0rePk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Goodwill</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded a goodwill impairment during the fiscal year ended June 30, 2020 (see Note 8). There was <span id="xdx_90B_eus-gaap--Goodwill_iI_do_c20210630_zShacSgMZxXh" title="Goodwill"><span id="xdx_90C_eus-gaap--Goodwill_iI_do_c20200630_zEk6qn6hpOEh">no</span></span> Goodwill at June 30, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zxy82bOYhMa1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Earnings Per Share</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOkJnHmU6Uo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwPX37UN91ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Pronouncements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Leases</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases (Topic 842).</i> The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company does not expect to adopt this standard prior to July 1, 2022. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Financial Instruments – Credit Losses</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates (ASC 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Income Taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, <i>Income Taxes</i>. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zULN36NFrW88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Basis of presentation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zZwCO3CoG8ul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Principles of Consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_ziFT4Vr1k5Me" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Use of Accounting Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options and cost of goods sold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zyadj7K5QtD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Cash and Cash Equivalents</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents consist of cash and deposits in bank checking accounts or money market funds with immediate access.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zbUCnoMMDoa9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Nature of Revenues</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reports its revenues in two categories:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Software Services: Virtual and Augmented Reality projects, solutions and consulting services.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company adopted the new accounting standard, Accounting Standards Codification (“ASC”) 606, <i>Revenue from Contracts with Customers</i>, (“ASC 606”) beginning on July 1, 2020 using the modified retrospective method for all open contracts and related amendments. The adoption did not result in an adjustment to the accumulated deficit as of June 30, 2020. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods. The adoption of ASC 606 did not have a material impact on reported sales to customers and net earnings (losses).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">identify the contract with a customer;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">identify the performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">determine the transaction price;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">allocate the transaction price to performance obligations in the contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">recognize revenue as the performance obligation is satisfied;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">determine that collection is reasonably assured</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Significant Judgments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company generated revenue for the years ended June 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses &amp; SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zQmV3G6zGHga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As detailed in the Company’s Consolidated Statement of Operations, the following is a disaggregation of the Company’s revenue by major source for the years ended June 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span style="background-color: white"><span id="xdx_8BF_zUEehthHDTse" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Years Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Software Services</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__srt--ProductOrServiceAxis__custom--SoftwareSercicesMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,082,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630__srt--ProductOrServiceAxis__custom--SoftwareServicesMember_zqJjLdjqP9s9" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">1,777,447</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Software License and Software as a Service</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__srt--ProductOrServiceAxis__custom--SoftwareLicenseAndSoftwareServiceMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">338,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630__srt--ProductOrServiceAxis__custom--SoftwareLicenseMember_zLauPGOFG0kc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">167,868</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,421,495</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630_zkmnxfQnv6Qd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">1,945,315</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zC6a86m5kwub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Timing of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_894_ecustom--ScheduleOfTimingRevenueRecognitionTableTextBlock_zJCsfBFdzTSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As the Company began adopting ASC 606 in July 2020, the timing of revenue recognition for periods prior to the adoption is not required:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_z6t0Pw3kLCXi" style="display: none">SCHEDULE OF TIMING REVENUE RECOGNITION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Year Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 71%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Products transferred at a point in time</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">2,967,586</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Products and services transferred over time</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">453,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200701__20210630_zPBHP0wucqkk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,421,495</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_z0laHJPHov9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred revenue is comprised mainly of software project contract performance obligations not completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of June 30, 2021, the Company had approximately $<span id="xdx_903_ecustom--UnfulfilledPerformanceObligations_pn4n6_c20200701__20210630_zwcSbH7ymWtj" title="Unfulfilled performance obligations">1.23</span> million in unfulfilled performance obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Prior to the adoption of ASC 606 at July 1, 2020, the Company’s revenue recognition was as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Software Service Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company generates software related revenues from services performed for: Virtual and Augmented Reality projects, consulting retainers, and ongoing website maintenance and support. Software service revenue generated from Virtual and Augmented Reality projects is recognized after delivery of the project has occurred, when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured. Any unrecognized portion of project revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets. Deferred costs include cash and equity based payroll costs, and may include payments to vendors. Software service revenue generated from consulting retainers is typically billed in advance for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, services have been performed, and collection is reasonably assured. Software service revenue generated from ongoing website maintenance and support services is typically billed in arrears for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Software License and Software as a Service Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company derives revenue from software as-a-service subscriptions and software licenses. Upon delivery of the software to customers, revenue is recognized ratably over the term of the contract or arrangement. The unrecognized portion of this revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--DisaggregationOfRevenueTableTextBlock_zQmV3G6zGHga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As detailed in the Company’s Consolidated Statement of Operations, the following is a disaggregation of the Company’s revenue by major source for the years ended June 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span style="background-color: white"><span id="xdx_8BF_zUEehthHDTse" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Years Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Software Services</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__srt--ProductOrServiceAxis__custom--SoftwareSercicesMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,082,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630__srt--ProductOrServiceAxis__custom--SoftwareServicesMember_zqJjLdjqP9s9" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">1,777,447</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Software License and Software as a Service</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__srt--ProductOrServiceAxis__custom--SoftwareLicenseAndSoftwareServiceMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">338,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630__srt--ProductOrServiceAxis__custom--SoftwareLicenseMember_zLauPGOFG0kc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">167,868</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,421,495</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190701__20200630_zkmnxfQnv6Qd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Revenue"><span style="font: 10pt Times New Roman, Times, Serif">1,945,315</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 3082528 1777447 338967 167868 3421495 1945315 <p id="xdx_894_ecustom--ScheduleOfTimingRevenueRecognitionTableTextBlock_zJCsfBFdzTSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As the Company began adopting ASC 606 in July 2020, the timing of revenue recognition for periods prior to the adoption is not required:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_z6t0Pw3kLCXi" style="display: none">SCHEDULE OF TIMING REVENUE RECOGNITION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Year Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 71%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Products transferred at a point in time</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">2,967,586</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Products and services transferred over time</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20210630__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">453,909</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200701__20210630_zPBHP0wucqkk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font: 10pt Times New Roman, Times, Serif">3,421,495</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 2967586 453909 3421495 1230000 <p id="xdx_846_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zDAUNH9PnYti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Receivable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of June 30, 2021 and June 30, 2020 no allowance for doubtful accounts was recorded as all amounts were considered collectible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z4FusPZhNC2j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Customer Concentration and Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Two customers accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zE43Fi77m973" title="Concentration risk percentage">49%</span> (<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zrdhVuUobXfl" title="Concentration risk percentage">26%</span> and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVenouWpTyTa" title="Concentration risk percentage">23%</span>, respectively) of the Company’s total gross revenues during the year ended June 30, 2021. One different customer accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGbZB9WvdhD7" title="Concentration risk percentage">13%</span> of the Company’s total gross revenues during the year ended June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Two customers accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxfXPuQ7Pg88">71%</span> (<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCrwWq20K9M3">57%</span> and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_c20200701__20210630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0cBSIAUwm4g">14%</span>, respectively) of the Company’s accounts receivable at June 30, 2021. Four different customers accounted for approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--FourOtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCck2LiVL5Ob">96%</span> (<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzy8o5d9Ylo1">35%</span>, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_za3ObjjOmiE2">35%</span>, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkkY2LSmzLvi">14%</span> and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_c20190701__20200630__srt--MajorCustomersAxis__custom--OtherCustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2f03sIrfin9">12%</span>, respectively) of the Company’s accounts receivable at June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0.49 0.26 0.23 0.13 0.71 0.57 0.14 0.96 0.35 0.35 0.14 0.12 <p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_ziW2ij5putTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Equipment, net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment is stated at cost less accumulated depreciation (see Note 4). Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zh3KQG42bLe7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Employee Stock-Based Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--ResearchAndDevelopmentExpensePolicy_zrlbcXd196Se" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Research and Development Costs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zor3XBvyO5Yi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is <span id="xdx_90F_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200701__20210630" title="Tax benefit settlement description">greater than 50%</span> likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, <i>Income Taxes</i>, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the years ended June 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> greater than 50% <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zsVbtux0rePk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Goodwill</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded a goodwill impairment during the fiscal year ended June 30, 2020 (see Note 8). There was <span id="xdx_90B_eus-gaap--Goodwill_iI_do_c20210630_zShacSgMZxXh" title="Goodwill"><span id="xdx_90C_eus-gaap--Goodwill_iI_do_c20200630_zEk6qn6hpOEh">no</span></span> Goodwill at June 30, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0 0 <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zxy82bOYhMa1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Earnings Per Share</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOkJnHmU6Uo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwPX37UN91ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Pronouncements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Leases</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases (Topic 842).</i> The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company does not expect to adopt this standard prior to July 1, 2022. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Financial Instruments – Credit Losses</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates (ASC 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Income Taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, <i>Income Taxes</i>. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zqo55xCqQrmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 4. <span id="xdx_821_zJdy0tAx6cl8">EQUIPMENT, NET</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zb21ZfAuUPn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment, primarily comprised of computers and hardware, consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B8_zniptBWY10kl" style="display: none">SCHEDULE OF EQUIPMENT, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_490_20210630_zwlKa6tSUEXk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_496_20200630_zldvEC7T0Gq" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzQPF_zX6D7oyWRJk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font: 10pt Times New Roman, Times, Serif">Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">96,963</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630_zd6OgDSFesD9" title="Property, Plant and Equipment, Useful Life">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">105,239</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20190701__20200630_z9LdeWGoaLGh">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzQPF_zrj3CpSYNdt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less: accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(54,791</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(64,015</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzQPF_zXHGQnJAr5W1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">41,224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A9_zJxWfjvkECJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation expense was $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20200701__20210630_zYlIYIcoXqe5" title="Depreciation expense">27,054</span> and $<span id="xdx_903_eus-gaap--Depreciation_c20190701__20200630_pp0p0" title="Depreciation expense">20,222</span> during the years ended June 30, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zb21ZfAuUPn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment, primarily comprised of computers and hardware, consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B8_zniptBWY10kl" style="display: none">SCHEDULE OF EQUIPMENT, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_490_20210630_zwlKa6tSUEXk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_496_20200630_zldvEC7T0Gq" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value ($)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Useful Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzQPF_zX6D7oyWRJk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font: 10pt Times New Roman, Times, Serif">Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">96,963</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200701__20210630_zd6OgDSFesD9" title="Property, Plant and Equipment, Useful Life">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">105,239</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20190701__20200630_z9LdeWGoaLGh">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzQPF_zrj3CpSYNdt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less: accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(54,791</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(64,015</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzQPF_zXHGQnJAr5W1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">41,224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 96963 P3Y 105239 P3Y 54791 64015 42172 41224 27054 20222 <p id="xdx_80D_eus-gaap--EarningsPerShareTextBlock_zVOJOonBkXvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 5. <span id="xdx_82A_z5RGhMcDSpK6">EARNINGS PER SHARE</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zd6LYQ5LkBk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table presents the computation of basic and diluted net loss per common share:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BA_zYzQ3hijZj22" style="display: none">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_49F_20200701__20210630_zgWJTo2RAMV4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended <br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_49B_20190701__20200630_zL58IjuHeMN3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended<br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended <br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended<br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Numerator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLoss_pp0p0_z8kr4QdZ33I8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 56%; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(6,091,687</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(4,993,350</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Denominator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_zWP6lwhptC6f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average common shares outstanding for basic and diluted net loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,259,249</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,923,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasicAndDiluted_pid_z2F2szSDhYLe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Basic and diluted net loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(0.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(0.72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> <p id="xdx_8A3_ziVU69utGhw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zWxl8Lbl46if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_zRa9cFNZ2DA1" style="display: none">SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">At <br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">At <br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Stock Options</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zj7G6L6C8fma" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">4,740,910</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">4,092,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Convertible Notes</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_pdd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">324,150</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_pdd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">296,111</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20210630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">5,065,060</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20200630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">4,388,704</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A9_zu8YOkxhp0ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zd6LYQ5LkBk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table presents the computation of basic and diluted net loss per common share:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BA_zYzQ3hijZj22" style="display: none">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_49F_20200701__20210630_zgWJTo2RAMV4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended <br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_49B_20190701__20200630_zL58IjuHeMN3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended<br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended <br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended<br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Numerator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLoss_pp0p0_z8kr4QdZ33I8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 56%; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Net loss</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(6,091,687</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(4,993,350</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Denominator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_zWP6lwhptC6f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average common shares outstanding for basic and diluted net loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,259,249</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,923,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasicAndDiluted_pid_z2F2szSDhYLe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Basic and diluted net loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(0.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(0.72</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> </table> -6091687 -4993350 7259249 6923506 -0.84 -0.72 <p id="xdx_89B_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zWxl8Lbl46if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_zRa9cFNZ2DA1" style="display: none">SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">At <br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">At <br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Stock Options</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zj7G6L6C8fma" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">4,740,910</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">4,092,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Convertible Notes</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_pdd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">324,150</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20200630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_pdd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">296,111</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20210630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">5,065,060</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20200630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Potentially dilutive securities"><span style="font: 10pt Times New Roman, Times, Serif">4,388,704</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 4740910 4092593 324150 296111 5065060 4388704 <p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zHQxSpnuKiX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 6. <span id="xdx_828_zMl5GPVYZSd8">EQUITY</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Common Stock and Preferred Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2021, the Company had authorized <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pn6n6_c20210630_zMiRxvY2NyU4" title="Common stock shares authorized">300</span> million shares of common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210630_zxTTilVm41d6" title="Common stock par value per share">0.001</span> par value per share and <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pn6n6_c20210630_zHFnpdSfKnca" title="Preferred stock shares authorized">20</span> million shares of preferred stock; <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pn4n6_c20210630_zPR1Xh2KoD3a" title="Common stock shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pn4n6_c20210630_zjEUg1Qrn369" title="Common stock shares outstanding">7.58</span></span> million and <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pn4n6_c20200630_zSmBq7uS1kU3" title="Common stock shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pn4n6_c20200630_zB6ubz7RTmFk" title="Common stock shares outstanding">7.04</span></span> million shares of common stock were issued and outstanding as of June 30, 2021 and 2020, respectively. <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20210630_zxTRiDIiuPeg" title="Preferred stock shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20210630_zYBqaV8kiP1h" title="Preferred stock shares outstanding"><span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_c20200630_zQaFCXfH7IX4" title="Preferred stock shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20200630_zlYuKklrWjO7" title="Preferred stock shares outstanding">0</span></span></span></span> shares of preferred stock were issued and outstanding as of June 30, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Sale of Common Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock sold to Investors</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the years ended June 30, 2021 and 2020, the Company sold approximately <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zAQkqbWdNJj5" title="Shares issued">76,900</span> and <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zbLNyEc78NJj">1,600</span> shares of common stock to investors at a price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zcjTQOVcQDJ4">4.50</span>/share, for total proceeds of approximately $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20200701__20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pp0p0" title="Proceeds from sale of common stock">346,000</span> and $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20190701__20200630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_pp0p0" title="Proceeds from sale of common stock">7,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2021 the Company sold <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210701__20210702__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBbKncme7yZ">1,912,500</span> shares of common stock in an initial public offering at a price of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210702__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zbTsYKlDgJ9d">7.00</span>/share. See Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued to Investors</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended June 30, 2021, in connection with the conversion of convertible promissory notes the Company issued approximately <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20200701__20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z9Yr63BDQye2" title="Stock issued during period shares">332,000</span> shares of common stock (see Note 9).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the years ended June 30, 2021 and 2020, in connection with the issuance of convertible promissory notes, the Company issued approximately <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__us-gaap--DebtInstrumentAxis__custom--NewConvertibleNotesPayableMember_z0aMiKdUouie" title="Shares issued">74,000</span> and <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayablesMember_zjMpA7lfYVAe">102,000</span> shares of common stock, respectively (see Note 9).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued to Vendors</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the years ended June 30, 2021 and 2020, the Company issued approximately <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200701__20210630__srt--TitleOfIndividualAxis__custom--VendorsMember_pdd" title="Stock issued during period shares for services">28,800</span> and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20190701__20200630__srt--TitleOfIndividualAxis__custom--VendorsMember_pdd" title="Stock issued during period shares for services">23,700</span> shares of common stock, respectively, to various vendors for services performed and recorded share-based compensation of approximately $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20210630__srt--TitleOfIndividualAxis__custom--VendorsMember_pp0p0" title="Share-based compensation expense">134,400</span> and $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20190701__20200630__srt--TitleOfIndividualAxis__custom--VendorsMember_pp0p0" title="Share-based compensation expense">101,500</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Common stock issued to satisfy Contingent Liabilities</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended June 30, 2021 the Company issued approximately <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210630__srt--StatementScenarioAxis__custom--ToSatisfyContingentLiabilitiesMember_zYHSMbSPu7O8">13,000</span> shares of common stock to satisfy a contingent liability related to a prior acquisition with a fair market value of approximately $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200701__20210630__srt--StatementScenarioAxis__custom--ToSatisfyContingentLiabilitiesMember_zThFpWYz7zb6" title="Stock issued during period value">67,000</span> (see Note 7).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended June 30, 2020 the Company issued approximately <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__srt--StatementScenarioAxis__custom--ToSatisfyContingentLiabilitiesMember_zezVLooq0ELi" title="Shares issued">20,000</span> shares of common stock to satisfy a contingent liability related to a prior acquisition with a fair market value of approximately $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20190701__20200630__srt--StatementScenarioAxis__custom--ToSatisfyContingentLiabilitiesMember_pp0p0" title="Stock issued during period value">92,000</span> (see Note 7).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Employee Stock-Based Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In October 2016, the Company’s Board of Directors and its stockholders adopted The Glimpse Group, Inc. 2016 Equity Incentive Plan (the “Plan”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Under the Plan, the Company grants stock options at exercise prices generally equal to the fair value of the common stock on the grant date. These options generally expire ten years after the grant date and vest, depending on the optionee, over a varying period of continuous service following the vesting commencement date of such option (ranging from zero to three years), unless the optionee’s continuous service with the Company is terminated earlier. Stock-based compensation expense is recognized evenly over the requisite service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Plan is administered by the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), who determine the recipients and the terms of the awards granted, subject to the approval of the Company’s Board of Directors. The Plan provides that awards granted may be options, restricted stock, restricted stock units or other stock based awards (collectively the “Awards”). Stock option awards may be either incentive stock options or nonqualified options. The Awards may be granted to eligible employees, directors, service providers, consultants and advisers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020 an aggregate of up to <span id="xdx_90B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pn6n6_c20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zg3Z9wNwoL3l" title="Aggregate number of common stock shares reserved for future issuance">5</span> million shares of common stock were reserved for issuance under the Plan, with <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pn4n6_c20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zK5O6zXSu0n3" title="Stock available for issuance">0.91</span> million available for issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In January and April 2021, the Company amended its 2016 Equity Incentive Plan (the “Plan”), increasing the amount of common shares reserved for issuance from <span id="xdx_90B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pn6n6_c20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zxHChQ7krR9h">5</span> million to <span id="xdx_90E_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pn6n6_c20210430__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zdY79KbKHjJ8">10</span> million. As of June 30, 2021, there were <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pn4n6_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_z7MTv61S2Eci">5.26</span> million shares available for issuance under the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In addition, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20200701__20210630__srt--TitleOfIndividualAxis__custom--EmployeesMember" title="Stock based compensation description">the share reserve will automatically increase on January 1 of each calendar year, for the period beginning on January 1, 2022 and ending on (and including) January 1, 2030 (each, an “Evergreen Date”) in an amount equal to five percent (5%) of the total number of shares of the Company’s common stock outstanding on December 31st immediately preceding the applicable Evergreen Date (the “Evergreen Increase”).</span> Notwithstanding the foregoing, the Board may act prior to the Evergreen Date of a given year to provide that there will be no Evergreen Increase for such year, or that the Evergreen Increase for such year will be a lesser number of shares of the Company’s common stock than would otherwise occur pursuant to the aforementioned. Any shares of stock delivered under the Plan shall consist of authorized and unissued shares or treasury shares. There were no other significant changes to the incentive plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zZqv7NLMNHpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B9_zLlaCSpE3wx3" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_49E_20200701__20210630_z7QUQdoNouti" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended <br/> June, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_494_20190701__20200630_zzLuo4Q54s94" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended <br/> June, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended <br/> June, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended <br/> June, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Weighted average expected terms (in years)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200701__20210630_zspDvciFoI22" title="Weighted average expected terms (in years)">5.3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20190701__20200630_zWSWHXshX9X3">5.3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_zXuuGdrPaJdc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Weighted average expected volatility</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">126.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">117.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_zut77LN7OoL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Weighted average risk-free interest rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_zUK1YSx99LNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> </table> <p id="xdx_8AF_zjAM0fn3ic4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The grant date fair value, for options granted during the year ended June 30, 2021 was approximately $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20200701__20210630_z4LGhVX1PtQd" title="Options granted, fair value">2.94</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The grant date fair value, for options granted during the year ended June 30, 2020 was approximately $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20190701__20200630_zG1OOTXSGuX8">2.70</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z1ZnsxHyD366" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following is a summary of the Company’s stock option activity for the years ended June 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BD_zyZKqSw5FiGd" style="display: none">SUMMARY OF STOCK OPTION ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted Average</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Remaining</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Exercise</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Contractual</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Intrinsic</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at July 1, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190701__20200630_z3RUYUGiPrI5" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options Outstanding, Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">3,408,452</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190701__20200630_zgonWtHQMhhe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">2.97</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190701__20200630_zb6pnYzQw5me" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20190701__20200630_zpxnGzbA5Kcj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Intrinsic Value, Outstanding Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">3,721,339</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190701__20200630_zV6UOIH7z6Vk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Granted"><span style="font: 10pt Times New Roman, Times, Serif">766,455</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190701__20200630_zdgegZ1GCfD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">4.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20190701__20200630_zrmWHtXT5Hj1" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1_pp0p0_c20190701__20200630_zwgsJc589S68" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">182,328</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190701__20200630_zURj1yMlbtCk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1684">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190701__20200630_zRQQfwNqGdac" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1686">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20190701__20200630_zr6YdUFVAcdf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(82,314</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190701__20200630_zbXw88DiA1R4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">3.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20190701__20200630_zxVytULeCqll" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">9.6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pp0p0_c20190701__20200630_zEZsUrGn3rm8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(53,977</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20190701__20200630_z1IbJvB1Hbu6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options Outstanding, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">4,092,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20190701__20200630_zc58sM56YRMa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20190701__20200630_zmh6DS7UC7M7" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20190701__20200630_zGrw86flRq0e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">5,553,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20200630_zfHGkGxGtIx9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3,581,514</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20200630_zN5CkBFFF8Qa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3.06</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20190701__20200630_zBTTKP84nEO4" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20200630_zVGOEEuPWHBe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">5,365,512</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted Average</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Remaining</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Exercise</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Contractual</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Intrinsic</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at July 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20210630_zF5UdzkY22u8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,092,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20210630_zAP3TXyA6qrc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zC1bYpUqg1Yj" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20200701__20210630_zhtU6cOFUhSi" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,553,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200701__20210630_zh04eihJR0wk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">766,419</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">4.66</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20200701__20210630_zL62TI7gdSG7" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.7</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1_c20200701__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">383,210</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200701__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1723">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1725">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200701__20210630_zMnIeZllGOlk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(118,102</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">4.28</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20200701__20210630_zIa7LdcIt2Sa" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">8.9</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(89,956</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20210630_zimv9e1SP6zg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,740,910</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20210630_zZC1wjoUBRUi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200701__20210630_z7jchJYb6QXb" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20200701__20210630_zw7rKpmOdoCe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,893,467</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20210630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">4,346,734</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zIQeu2jgTVKe" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20210630_zqAbPYyh6n3f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">7,659,692</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zzVf6GJOqzKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zdCQ1sXnRKq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s stock option-based expense for the years ended June 30, 2021 and 2020 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BD_zFkO7lAISp02" style="display: none">SCHEDULE OF STOCK OPTION-BASED EXPENSE</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20200701__20210630_zlLzKpzIKczb" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended<br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20190701__20200630_zzkej1TY9Dc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended<br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Stock option-based expense :</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_z6jHluS8GIel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Research and development expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,381,168</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,266,911</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_ze2cxzQeqTCf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">General and administrative expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">373,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">570,765</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zHJWH3GtMFag" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">477,561</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">293,226</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zBaGrZzEEYcc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cost of goods sold</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">526,156</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">236,825</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__custom--BoardOptionExpenseMember_zkJ1y4a68fkd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Board option expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">187,096</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">182,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_zBZ57ogxWDX6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,945,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,550,521</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zs9KmVjhYnk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended June 30, 2019, certain Company advisors received $<span id="xdx_905_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationGross_pn4n6_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_zFhsl72nawC8" title="Stock options granted during period value">0.31</span> million worth of Company stock options with an exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_z5c0X26F4DN7" title="Stock options exercise price per share">5.25</span>/share and a <span title="Stock options exercise period"><span title="P3Y"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dxL_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_zhd7feHWNkD8" title="Stock options exercise period::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1772">three</span></span></span></span>-year term, for potential services to be performed over a three-year period. Of the $<span id="xdx_901_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationGross_pn4n6_c20180701__20190630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--AdvisorsMember_zxvyDp8nPGd5">0.31</span> million, $<span id="xdx_900_eus-gaap--PrepaidExpenseCurrent_iI_pn4n6_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zFYMn9de9xU6" title="Prepaid expenses">0.06</span> million and $<span id="xdx_90A_eus-gaap--PrepaidExpenseCurrent_iI_pn4n6_c20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zoPFFYTUFcTh" title="Prepaid expenses">0.17</span> million was categorized as a prepaid expense at June 30, 2021 and 2020, respectively. During the years ended June 30, 2021 and 2020, the Company recognized approximately $<span id="xdx_909_eus-gaap--GeneralAndAdministrativeExpense_pp0p0_c20200701__20210630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zPo0H4qUstc6" title="General and administration expense"><span id="xdx_901_eus-gaap--GeneralAndAdministrativeExpense_pp0p0_c20190701__20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zGiNKWyHu7p" title="General and administration expense">116,000</span></span> for each period, as general and administration expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At June 30, 2021, total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn4n6_c20210630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zSRsB8Y77Ica" title="Unrecognized compensation expense to employees and vendors">1.50</span> million and is expected to be recognized over a weighted average period of <span title="Unrecognized compensation expenses recognition period"><span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20200701__20210630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_z0bk67bBMOok">1.1</span> years</span>. At June 30, 2020, total unrecognized compensation expense related to stock options was approximately $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn4n6_c20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zyhCtjhhGnRl" title="Unrecognized compensation expense to employees and vendors">1.62</span> million and was expected to be recognized over a weighted average period of <span title="Unrecognized compensation expenses recognition period"><span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20190701__20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_zNgi6KomobUf">1.02</span> years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The intrinsic value of stock options as of June 30, 2021 was computed using a fair market value of the common stock of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_c20200701__20210630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_pdd" title="Stock options intrinsic value per share">5.00</span>/share, as compared to $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_c20190701__20200630__us-gaap--PlanNameAxis__custom--TwoThousandSixteenEquityIncentivePlanMember_pdd" title="Stock options intrinsic value per share">4.50</span>/share as of June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 300000000 0.001 20000000 7580000 7580000 7040000.00 7040000.00 0 0 0 0 76900 1600 4.50 346000 7000 1912500 7.00 332000 74000 102000 28800 23700 134400 101500 13000 67000 20000 92000 5000000 910000 5000000 10000000 5260000 the share reserve will automatically increase on January 1 of each calendar year, for the period beginning on January 1, 2022 and ending on (and including) January 1, 2030 (each, an “Evergreen Date”) in an amount equal to five percent (5%) of the total number of shares of the Company’s common stock outstanding on December 31st immediately preceding the applicable Evergreen Date (the “Evergreen Increase”). <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zZqv7NLMNHpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B9_zLlaCSpE3wx3" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_49E_20200701__20210630_z7QUQdoNouti" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended <br/> June, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td> <td colspan="2" id="xdx_494_20190701__20200630_zzLuo4Q54s94" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none">Year Ended <br/> June, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif; display: none"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended <br/> June, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended <br/> June, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Weighted average expected terms (in years)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200701__20210630_zspDvciFoI22" title="Weighted average expected terms (in years)">5.3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20190701__20200630_zWSWHXshX9X3">5.3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_zXuuGdrPaJdc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Weighted average expected volatility</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">126.6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">117.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_zut77LN7OoL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Weighted average risk-free interest rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_zUK1YSx99LNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> </table> P5Y3M18D P5Y3M18D 1.266 1.173 0.005 0.014 0 0 2.94 2.70 <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z1ZnsxHyD366" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following is a summary of the Company’s stock option activity for the years ended June 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BD_zyZKqSw5FiGd" style="display: none">SUMMARY OF STOCK OPTION ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted Average</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Remaining</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Exercise</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Contractual</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Intrinsic</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at July 1, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190701__20200630_z3RUYUGiPrI5" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options Outstanding, Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">3,408,452</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190701__20200630_zgonWtHQMhhe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">2.97</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190701__20200630_zb6pnYzQw5me" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20190701__20200630_zpxnGzbA5Kcj" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Intrinsic Value, Outstanding Beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">3,721,339</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190701__20200630_zV6UOIH7z6Vk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Granted"><span style="font: 10pt Times New Roman, Times, Serif">766,455</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190701__20200630_zdgegZ1GCfD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">4.26</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20190701__20200630_zrmWHtXT5Hj1" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1_pp0p0_c20190701__20200630_zwgsJc589S68" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">182,328</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190701__20200630_zURj1yMlbtCk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1684">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190701__20200630_zRQQfwNqGdac" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1686">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20190701__20200630_zr6YdUFVAcdf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(82,314</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190701__20200630_zbXw88DiA1R4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">3.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20190701__20200630_zxVytULeCqll" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">9.6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pp0p0_c20190701__20200630_zEZsUrGn3rm8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(53,977</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20190701__20200630_z1IbJvB1Hbu6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options Outstanding, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">4,092,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20190701__20200630_zc58sM56YRMa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20190701__20200630_zmh6DS7UC7M7" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20190701__20200630_zGrw86flRq0e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">5,553,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20200630_zfHGkGxGtIx9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3,581,514</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20200630_zN5CkBFFF8Qa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3.06</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20190701__20200630_zBTTKP84nEO4" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20200630_zVGOEEuPWHBe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">5,365,512</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted Average</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Remaining</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Exercise</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Contractual</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Intrinsic</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Term (Yrs)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at July 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200701__20210630_zF5UdzkY22u8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,092,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200701__20210630_zAP3TXyA6qrc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3.19</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zC1bYpUqg1Yj" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning">8.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20200701__20210630_zhtU6cOFUhSi" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,553,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200701__20210630_zh04eihJR0wk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">766,419</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">4.66</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20200701__20210630_zL62TI7gdSG7" title="Weighted Average Remaining Contractual Term (Yrs), Options Granted">9.7</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1_c20200701__20210630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Granted"><span style="font: 10pt Times New Roman, Times, Serif">383,210</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Options Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200701__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1723">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Exercised"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1725">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Options Forfeited / Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200701__20210630_zMnIeZllGOlk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(118,102</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200701__20210630_pdd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">4.28</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm_dtY_c20200701__20210630_zIa7LdcIt2Sa" title="Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled">8.9</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Options Forfeited/Cancelled"><span style="font: 10pt Times New Roman, Times, Serif">(89,956</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200701__20210630_zimv9e1SP6zg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,740,910</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200701__20210630_zZC1wjoUBRUi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200701__20210630_z7jchJYb6QXb" title="Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending">8.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20200701__20210630_zw7rKpmOdoCe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,893,467</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20210630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">4,346,734</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630_pdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable, Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">3.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2_dtY_c20200701__20210630_zIQeu2jgTVKe" title="Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending">8.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_c20210630_zqAbPYyh6n3f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Exercisable Ending balance"><span style="font: 10pt Times New Roman, Times, Serif">7,659,692</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 3408452 2.97 P8Y6M 3721339 766455 4.26 P9Y6M 182328 82314 3.84 P9Y7M6D -53977 4092593 3.19 P8Y4M24D 5553916 3581514 3.06 P8Y3M18D 5365512 4092593 3.19 P8Y4M24D 5553916 766419 4.66 P9Y8M12D 383210 118102 4.28 P8Y10M24D -89956 4740910 3.40 P8Y6M 7893467 4346734 3.29 P8Y4M24D 7659692 <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zdCQ1sXnRKq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s stock option-based expense for the years ended June 30, 2021 and 2020 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8BD_zFkO7lAISp02" style="display: none">SCHEDULE OF STOCK OPTION-BASED EXPENSE</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20200701__20210630_zlLzKpzIKczb" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended<br/> June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20190701__20200630_zzkej1TY9Dc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Year Ended<br/> June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Stock option-based expense :</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_z6jHluS8GIel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Research and development expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,381,168</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,266,911</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_ze2cxzQeqTCf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">General and administrative expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">373,506</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">570,765</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zHJWH3GtMFag" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">477,561</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">293,226</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zBaGrZzEEYcc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cost of goods sold</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">526,156</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">236,825</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_hus-gaap--IncomeStatementLocationAxis__custom--BoardOptionExpenseMember_zkJ1y4a68fkd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Board option expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">187,096</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">182,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_pp0p0_zBZ57ogxWDX6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,945,487</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,550,521</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 1381168 1266911 373506 570765 477561 293226 526156 236825 187096 182794 2945487 2550521 310000 5.25 310000 60000.00 170000 116000 116000 1500000 P1Y1M6D 1620000 P1Y7D 5.00 4.50 <p id="xdx_800_eus-gaap--BusinessCombinationDisclosureTextBlock_z2wJ555RimI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 7. <span id="xdx_825_zheMbtIcIUCf">CONTINGENT ACQUISITION LIABILITY</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Early Adopter, LLC</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In connection with the Company’s April 2018 asset acquisition of Early Adopter.Com (“EA”), the Company expected to pay additional contingent amounts, based on EA’s annual revenues (“contingent performance bonus”) as measured and paid in each of the first three anniversary dates after the closing of the acquisition, paid by the issuance of the Company’s common stock at a fixed price of $<span id="xdx_901_eus-gaap--BusinessAcquisitionSharePrice_c20210630__us-gaap--BusinessAcquisitionAxis__custom--EarlyAdopterComMember_pdd" title="Business acqusition, share price">3.25</span>/share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At June 30, 2020, the total estimated contingent acquisition liability was approximately $<span id="xdx_907_eus-gaap--BusinessCombinationContingentConsiderationLiability_c20200630__us-gaap--BusinessAcquisitionAxis__custom--EarlyAdopterComMember_pp0p0" title="Contingent acquisition liability">47,000</span> due for the third anniversary, which is included in accrued liabilities. During the year ended June 30, 2021, the Company issued approximately <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200701__20210630__us-gaap--BusinessAcquisitionAxis__custom--EarlyAdopterComMember_pdd" title="Stock issued during peirod shares acquisitions">32,000</span> shares of common stock in final payment of all contingent liabilities related to the EA acquisition and recorded share-based expense of approximately $<span title="Stock option-based expense"><span id="xdx_908_eus-gaap--BusinessCombinationContingentConsiderationLiability_c20210630__us-gaap--BusinessAcquisitionAxis__custom--EarlyAdopterComMember_pp0p0" title="Contingent acquisition liability">96,800</span></span>. There are no further obligations relating to the EA acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Kabaq 3D Technologies, LLC</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s November 2016 acquisition of assets relating to the acquisition of Kabaq 3D Technologies, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met and the Company incurred $<span id="xdx_905_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_pp0p0_c20210801__20210831__us-gaap--BusinessAcquisitionAxis__custom--Kabaq3DTechnologiesLLCMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zQLQHeikCAGh" title="Additional acquisition cost">750,000</span> of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition expense on the Company’s statement of operations for the year ended June 30, 2021. At June 30, 2020, no expense was accrued because the likelihood of the Company going public and reaching the volume threshold was not probable at that time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>KreatAR, LLC</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s October 2016 acquisition of assets relating to the acquisitions of KreatAR, LLC (and related entity LocateAR) contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met. In connection therewith, the Company incurred $<span id="xdx_90A_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_pp0p0_c20210801__20210831__us-gaap--BusinessAcquisitionAxis__custom--KreatARLLCMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zy9a6pZL3bra">500,000</span> of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition expense on the Company’s statement of operations for the year ended June 30, 2021. At June 30, 2020, no expense was accrued because the likelihood of the Company going public and reaching the volume threshold was not probable at that time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 3.25 47000 32000 96800 750000 500000 <p id="xdx_808_eus-gaap--GoodwillDisclosureTextBlock_z3FY1kSHyBeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 8. <span id="xdx_823_zmlYSISGeOFj">GOODWILL</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Due to a significant decline in EA’s business, unsuccessful VR/AR product commercialization efforts and negative future growth prospects, the goodwill related to the EA acquisition was determined to be impaired and written down to $<span id="xdx_90C_eus-gaap--GoodwillImpairmentLoss_pp0p0_c20190701__20200630__us-gaap--BusinessAcquisitionAxis__custom--EarlyAdopterComMember_zfGEcIr7NVLb" title="Goodwill impairment">0</span> as of June 30, 2020. During the year ended June 30, 2020, general and administrative expense included approximately $<span id="xdx_904_eus-gaap--GoodwillImpairmentLoss_pp0p0_c20190701__20200630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zTJq0Reh1cya" title="Goodwill impairment">140,000</span> for the impairment of goodwill. The Company has no other goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0 140000 <p id="xdx_801_eus-gaap--DebtDisclosureTextBlock_zeTygY8WPSc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 9. <span id="xdx_821_zkghEa55fkkf">DEBT</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Convertible Promissory Notes 1</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended June 30, 2020, the Company raised $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z8zOvjgrEdlf" title="Proceeds from issuance of unsecured debt">1.33</span> million by the issuance of unsecured Convertible Promissory Notes with a <span id="xdx_90B_eus-gaap--DebtInstrumentTerm_dtYxL_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z3tmJbGRGY9g" title="Debt instrument term::XDX::3"><span style="-sec-ix-hidden: xdx2ixbrl1816">three</span></span>-year term (the “Note 1” or “Notes 1”), primarily from existing Company investors. The Notes 1 included participation by the Company’s executives and independent members of the Company’s Board in the amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__custom--ExecutivesAndIndependentMembersMember_zpMOtu79GNj9" title="Debt instrument face amount">0.2</span> million. The Note 1 holders received approximately <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_znQJvi7MU6i4" title="Shares issued">45,000</span> shares of common stock (at $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_c20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pdd" title="Share issued price per share">4.50</span>/share) in the aggregate, with a relative value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" title="Stock issued during period value">170,000</span> at the time of issuance. As of June 30, 2020, the remaining original issue discount on the Notes was approximately $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" title="Original issue discount on notes">149,000</span>, which was to be amortized over the remaining term of the Notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additional interest expense for the amortization of the original issue discount amounted to approximately $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--AdditionalInterestMember_zSUNV6Y5npkd" title="Original issue discount on notes">96,900</span> for the year ended June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 1 bore an interest rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zQNH6KYZt1cg" title="Debt instrument interest rate percentage">10</span>% per annum. The first two years of interest were prepaid with the issuance of the Company’s common stock (at $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_c20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--FirstTwoYearsOfInteresPrepaymentMember_pdd" title="Share issued price per share">4.50</span>/share), for an issuance of approximately <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--FirstTwoYearsOfInteresPrepaymentMember_z7MOR4ba0IU9" title="Shares issued">57,000</span> shares of common stock with a fair value of approximately $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--FirstTwoYearsOfInteresPrepaymentMember_pp0p0" title="Stock issued during period value">258,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 1 were convertible by a Note 1 holder at any time <span id="xdx_90E_eus-gaap--DebtInstrumentDescription_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember" title="Debt interest payment description">during the term into common stock of the Company at a fixed price of $4.50/share, or approximately <span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20190701__20200630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pdd" title="Debt conversion converted instrument shares">295,000</span> shares of common stock upon full conversion.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year ended June 30, 2021, Note 1 holders converted approximately $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn4n6_c20210101__20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zbO5a07jMSLi" title="Stock issued during period value">1.21</span> million of principal into approximately <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pn4n6_c20210101__20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zmLZsLgyskgk">0.30</span> million shares of common stock at a revised conversion price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pn4n6_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zKci430XQpuf">4.00</span>/share. The original contracted conversion price was $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--RangeAxis__srt--MaximumMember_pdd" title="Debt instrument conversion price per share">4.50</span>/share. In order to encourage early conversion, two years before the maturity of the Convertible Notes 1, the Company reduced the conversion price to $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--RangeAxis__srt--MinimumMember_zXIYEfqmQUH1" title="Debt instrument conversion price per share">4.00</span>/share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In addition to the reduced conversion price, the Note holders who converted received the <span id="xdx_909_eus-gaap--DebtInstrumentTerm_dtYxL_c20200701__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--ThirdYearInterestMember_zVHmY7e6MQxa" title="Debt instrument term::XDX::3"><span style="-sec-ix-hidden: xdx2ixbrl1850">third year</span></span> interest (<span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--ThirdYearInterestMember_zBOR71nRXZBh" title="Debt instrument interest rate percentage">10</span>%) on the Notes, totaling approximately $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200701__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--ThirdYearInterestMember_pp0p0" title="Stock issued during period value">122,000</span>, as additional consideration to convert early which was paid in the Company’s common stock, amounting to approximately <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--ThirdYearInterestMember_zGyihtyWmZm3" title="Shares issued">30,000</span> shares. In the aggregate, a loss of approximately $<span id="xdx_90E_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200701__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--ThirdYearInterestMember_pp0p0" title="Gain loss on debt">515,500</span> was recognized <span id="xdx_908_eus-gaap--DebtInstrumentDescription_c20200701__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--ThirdYearInterestMember" title="Debt interest payment description">during the year ended June 30, 2021, reflecting the reduction of the Notes conversion price from $4.50/share to $4.00/share, the issuance of Year 3 Interest (10%) paid in common stock (at $4.00/share instead of $4.50/share), and the write-off of the remaining related pre-paid interest and original issue discount expenses.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The holders of the remaining unconverted Convertible Notes 1, equating to approximately $<span id="xdx_902_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zJsLPAWsHJll" title="Convertible promissory notes">117,000</span> (net of original discount of approximately $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhqV98O3tHG9" title="Original issue discount on notes">8,000</span>) of outstanding principal at June 30, 2021, amended their Notes 1 to allow for auto conversion upon the Company’s potential IPO event at a conversion price of $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOUHPQCcQPG1" title="Debt instrument conversion price per share">4.25</span>/share. As per the amendment, the residual Notes 1 converted upon the IPO. See Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Convertible Promissory Notes 2</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In March 2021, the Company raised $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n6_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zoun0k2vWnxc" title="Proceeds from issuance of unsecured debt">1.475</span> million by the issuance of unsecured Convertible Promissory Notes with a <span id="xdx_901_eus-gaap--DebtInstrumentTerm_dtYxL_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z61eiH9Qes33" title="Debt instrument term::XDX::2"><span style="-sec-ix-hidden: xdx2ixbrl1870">two-year</span></span> term (the “Notes 2”), to several investors. The Notes 2 holders received approximately <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zSM4EWiP7AN9" title="Shares issued">44,000</span> shares of common stock (at $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zSgIFj4fRR7h" title="Share issued price per share">5.00</span>/share) in the aggregate, with a relative fair value of approximately $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zfZDw9rrRkfc" title="Stock issued during period value">192,000</span> at the time of issuance. Accordingly, the original issue discount on the Notes 2 will be amortized over its term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 2 bear an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--ThirdYearInterestMember_z9ExQAPlzh36">10</span>% per annum. The first year of interest was prepaid with the issuance of the Company’s common stock (at $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKLHPEXLcm" title="Debt instrument conversion price per share">5.00</span>/share), for an issuance of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--FristYearOfInterestPrepaymentMember_ze2IrXr3jsi4" title="Shares issued">29,500</span> shares of common stock with a fair value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--FristYearOfInterestPrepaymentMember_zZpfysWL3QFh" title="Stock issued during period value">147,500</span>. During the second year of the Notes 2, interest will be paid monthly in the Company’s common stock (at a fixed price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxycRQl7paE5">5.00</span>/share) on any unpaid principal outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Notes 2 are convertible by a note holder at any time during the term into common stock of the Company at a fixed price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zCrR2U4W9Xg6">5.00</span>/share, or <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zT056IoVXFLi" title="Debt conversion converted instrument shares">295,000</span> shares of common stock upon full conversion. Notes 2 have a maturity date of <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20210301__20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_ztyxilA4lBA6" title="Debt instrument maturity date">March 5, 2023</span>. All outstanding amounts at the time of the Company’s IPO automatically converted at $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--SecondYearOfNotesMember_zR1G4olX82ua" title="Share issued price per share">5.00</span>/share in the aggregate. Convertible Notes 2 totaled approximately $<span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_pn3n6_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--SecondYearOfNotesMember_zazdnxOFqHa4" title="Convertible promissory notes">1.313</span> million (net of original issue discount of approximately $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--StatementScenarioAxis__custom--SecondYearOfNotesMember_zNn2eVd9kGH6" title="Original issue discount on notes">162,000</span>) at June 30, 2021. The Notes 2 converted upon the IPO. See Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>SBA Paycheck Protection Program Loans/EIDL</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In May 2020, the Company received a Paycheck Protection Program 1 (“PPP1”) loan from the Small Business Administration (“SBA”) in the amount of $<span id="xdx_90F_eus-gaap--ProceedsFromBankDebt_pn4n6_c20200501__20200531__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramMember_zASm1TV1q6k9" title="Proceeds from debt">0.55</span> million. The Company utilized the PPP 1 loan proceeds in full towards payroll and rent in accordance with the SBA guidelines. Pursuant to SBA guidelines, the Company’s PPP1 loan was fully forgiven in February 2021. In conjunction with the PPP1 loan, the Company also received an Economic Injury Disaster Loan (“EIDL”) advance of $<span id="xdx_908_eus-gaap--ProceedsFromBankDebt_pn4n6_c20200501__20200531__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zkDuJUxw0yY4" title="Proceeds from debt">0.01</span> million. As per the SBA guidelines, EIDL advances do not need to be repaid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In February 2021, the Company received a second Paycheck Protection Program 2 (“PPP2”) loan in the amount of $<span id="xdx_90C_eus-gaap--ProceedsFromBankDebt_pn4n6_c20210201__20210228__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramMember_zjC9Xztbujsc" title="Proceeds from debt">0.62</span> million. Similar to the PPP1 loan, the Company expects to utilize the loan proceeds in full toward payroll and rent in accordance with SBA guidelines. The PPP2 loan bears a fixed interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210228__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramMember_zz1epOTXNvs8" title="Debt instrument interest rate percentage">1</span>% per annum and is due in <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDateDescription_c20210201__20210228__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramMember" title="Debt instrument maturity date, description">February 2026</span>. Pursuant to SBA guidelines, the Company expects to apply for full forgiveness of its PPP2 loan in fiscal year 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 1330000 200000 45000 4.50 170000 149000 96900 0.10 4.50 57000 258000 during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion. 295000 1210000 300000 4000000.00 4.50 4.00 0.10 122000 30000 515500 during the year ended June 30, 2021, reflecting the reduction of the Notes conversion price from $4.50/share to $4.00/share, the issuance of Year 3 Interest (10%) paid in common stock (at $4.00/share instead of $4.50/share), and the write-off of the remaining related pre-paid interest and original issue discount expenses. 117000 8000 4.25 1475000 44000 5.00 192000 0.10 5.00 29500 147500 5.00 5.00 295000 2023-03-05 5.00 1313000 162000 550000 10000.00 620000 0.01 February 2026 <p id="xdx_804_eus-gaap--IncomeTaxDisclosureTextBlock_z1EimbrL2EO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 10. <span id="xdx_82B_z2dBAYslkejk">PROVISION FOR INCOME TAXES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There was no current or deferred income tax provision for the years ended June 30, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zPIVajY6JSW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s deferred tax assets as of June 30, 2021 and 2020 consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BF_zUW49MXAdt0k" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net-operating loss carryforward</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20210630_zFfKAHWsZKNj" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Net-operating loss carryforward"><span style="font: 10pt Times New Roman, Times, Serif">3,923,012</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20200630_zib0uIBhanNk" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Net-operating loss carryforward"><span style="font: 10pt Times New Roman, Times, Serif">2,811,156</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Stock-based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--DeferredTaxAssetsStockbasedCompensation_iI_pp0p0_c20210630_zbvdj1fcVKHc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock-based compensation"><span style="font: 10pt Times New Roman, Times, Serif">536,265</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--DeferredTaxAssetsStockbasedCompensation_iI_pp0p0_c20200630_zzhOosbKc9Ed" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock-based compensation"><span style="font: 10pt Times New Roman, Times, Serif">348,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_c20210630_zC4GaGxvUcK4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font: 10pt Times New Roman, Times, Serif">4,459,277</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_c20200630_zTgTtFG0ee3f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font: 10pt Times New Roman, Times, Serif">3,159,169</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20210630_za38aSlI2Sm" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font: 10pt Times New Roman, Times, Serif">(4,459,277</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20200630_zddSAwcFcUsg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font: 10pt Times New Roman, Times, Serif">(3,159,169</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Deferred Tax Asset, Net</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20210630_zodT4cLZwPu7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Tax Asset, Net"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1927">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20200630_zN1PswzIEUIl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Tax Asset, Net"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1929">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zcG5fJGNumM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company maintains a valuation allowance on deferred tax assets due to the uncertainty regarding the ability to utilize these deferred tax assets in the future. At June 30, 2021, the Company had potential utilizable aggregate gross net operating loss carryforwards (“NOLs”) of approximately $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pn4n6_c20210630_zgUrltnDqlXh" title="Operating loss carry forwards, net">11.35</span> million. <span id="xdx_908_ecustom--OperatingLossCarryForwardsExpirationDateDescription_pn4n6_c20200701__20210630_zCA9q8w2SJ15" title="Operating loss carry forwards expiration date">NOLs for the periods ending June 30, 2018 and prior ($<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_pn4n6_c20180630_ztozArjWi2s8">2.86</span> million) begin to expire in 2037.</span> NOLs for the years ending June 30, 2021, 2020 and 2019 ($<span id="xdx_900_ecustom--NetOperatingLossCarryforwardsNoExpiration_pn4n6_c20200701__20210630_zOIfQyeF829f">8.49</span> million), in accordance with changes to the U.S. Internal Revenue Code, have no expiration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Section 382 of the U.S. Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. The Company has not completed a Section 382 analysis of the NOL carryforwards. Consequently, the Company’s NOL carryforwards may be subject to annual limitations under Section 382.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. As a result of the uncertainly in the realization of the Company’s deferred tax assets, the Company has provided a valuation allowance for the full amount of the deferred tax assets at June 30, 2021 and June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s valuation allowance during the years ended June 30, 2021 and 2020 increased by approximately $<span id="xdx_906_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn4n6_c20200701__20210630_zNP7QH2o42oj" title="Valuation allowance">1.30</span> million and $<span id="xdx_904_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn4n6_c20190701__20200630_zxtnyP6muYnf" title="Valuation allowance">1.00</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zXJ9qRNLl67a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B7_zqhRPBZaBU38">SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Year Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Year Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Statutory Federal Income Tax Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_uPure_c20200701__20210630_zGuPiL7nuWXf" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font: 10pt Times New Roman, Times, Serif">(21.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_uPure_c20190701__20200630_zKRWiNMNrNJk" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font: 10pt Times New Roman, Times, Serif">(21.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">State and Local Taxes, Net of Federal Tax Benefit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20200701__20210630_zKbaIJ4qTOya" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State and Local Taxes, Net of Federal Tax Benefit"><span style="font: 10pt Times New Roman, Times, Serif">(13.56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20190701__20200630_zdbbsnr9nHDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State and Local Taxes, Net of Federal Tax Benefit"><span style="font: 10pt Times New Roman, Times, Serif">(13.56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Stock Based Compensation Expense (ISO)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp_c20200701__20210630_zXgwAnyZ3oK3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font: 10pt Times New Roman, Times, Serif">13.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp_c20190701__20200630_zjilZ0eAQ4he" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font: 10pt Times New Roman, Times, Serif">14.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Change in Valuation Allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20200701__20210630_zxNnVWuweWsg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in Valuation Allowance"><span style="font: 10pt Times New Roman, Times, Serif">21.36</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20190701__20200630_zN15iQgiD1xc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in Valuation Allowance"><span style="font: 10pt Times New Roman, Times, Serif">20.06</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Income Taxes Provision (Benefit)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20200701__20210630_zq89hq0HnzBk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font: 10pt Times New Roman, Times, Serif">0.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20190701__20200630_z1aJ0ydhCe3k" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font: 10pt Times New Roman, Times, Serif">0.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AD_zOnYWEE0vVwa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon completion of its 2021 U.S. income tax return in 2022, the Company may identify additional remeasurement adjustments. The Company will continue to assess its provision for income taxes as future guidance is issued, but do not currently anticipate significant revisions will be necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zPIVajY6JSW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s deferred tax assets as of June 30, 2021 and 2020 consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BF_zUW49MXAdt0k" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Net-operating loss carryforward</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20210630_zFfKAHWsZKNj" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Net-operating loss carryforward"><span style="font: 10pt Times New Roman, Times, Serif">3,923,012</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20200630_zib0uIBhanNk" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Net-operating loss carryforward"><span style="font: 10pt Times New Roman, Times, Serif">2,811,156</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Stock-based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_ecustom--DeferredTaxAssetsStockbasedCompensation_iI_pp0p0_c20210630_zbvdj1fcVKHc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock-based compensation"><span style="font: 10pt Times New Roman, Times, Serif">536,265</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--DeferredTaxAssetsStockbasedCompensation_iI_pp0p0_c20200630_zzhOosbKc9Ed" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock-based compensation"><span style="font: 10pt Times New Roman, Times, Serif">348,013</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_c20210630_zC4GaGxvUcK4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font: 10pt Times New Roman, Times, Serif">4,459,277</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_c20200630_zTgTtFG0ee3f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font: 10pt Times New Roman, Times, Serif">3,159,169</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Valuation allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20210630_za38aSlI2Sm" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font: 10pt Times New Roman, Times, Serif">(4,459,277</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20200630_zddSAwcFcUsg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font: 10pt Times New Roman, Times, Serif">(3,159,169</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Deferred Tax Asset, Net</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20210630_zodT4cLZwPu7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Tax Asset, Net"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1927">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20200630_zN1PswzIEUIl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Tax Asset, Net"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1929">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 3923012 2811156 536265 348013 4459277 3159169 4459277 3159169 11350000 NOLs for the periods ending June 30, 2018 and prior ($2.86 million) begin to expire in 2037. 2860000 8490000 1300000 1000000.00 <p id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zXJ9qRNLl67a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span id="xdx_8B7_zqhRPBZaBU38">SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Year Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">For the Year Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">June 30, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Statutory Federal Income Tax Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_uPure_c20200701__20210630_zGuPiL7nuWXf" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font: 10pt Times New Roman, Times, Serif">(21.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_uPure_c20190701__20200630_zKRWiNMNrNJk" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Statutory Federal Income Tax Rate"><span style="font: 10pt Times New Roman, Times, Serif">(21.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">State and Local Taxes, Net of Federal Tax Benefit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20200701__20210630_zKbaIJ4qTOya" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State and Local Taxes, Net of Federal Tax Benefit"><span style="font: 10pt Times New Roman, Times, Serif">(13.56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20190701__20200630_zdbbsnr9nHDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State and Local Taxes, Net of Federal Tax Benefit"><span style="font: 10pt Times New Roman, Times, Serif">(13.56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Stock Based Compensation Expense (ISO)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp_c20200701__20210630_zXgwAnyZ3oK3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font: 10pt Times New Roman, Times, Serif">13.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp_c20190701__20200630_zjilZ0eAQ4he" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock Based Compensation Expense (ISO)"><span style="font: 10pt Times New Roman, Times, Serif">14.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Change in Valuation Allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20200701__20210630_zxNnVWuweWsg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in Valuation Allowance"><span style="font: 10pt Times New Roman, Times, Serif">21.36</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20190701__20200630_zN15iQgiD1xc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in Valuation Allowance"><span style="font: 10pt Times New Roman, Times, Serif">20.06</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Income Taxes Provision (Benefit)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20200701__20210630_zq89hq0HnzBk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font: 10pt Times New Roman, Times, Serif">0.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20190701__20200630_z1aJ0ydhCe3k" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Income Taxes Provision (Benefit)"><span style="font: 10pt Times New Roman, Times, Serif">0.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 0.2100 0.2100 -0.1356 -0.1356 0.1320 0.1450 0.2136 0.2006 0.00 0.00 <p id="xdx_80C_ecustom--ForeignOperationsTextBlock_zk6F9WdIJY22" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 11. <span id="xdx_826_zvN8Up6lmWEe">FOREIGN OPERATIONS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In March 2021, the Company established Glimpse Turkey to support the operations of Kabaq 3D Technologies (dba QReal). Operations consist primarily of 3D modeler and artist employees. Glimpse Turkey has no revenue, long-term obligations or operating leases and all salaries are denominated in US dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In August 2021, the Company completed an asset acquisition which included certain assets, as defined, in Australia. See Note 13.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zrhEUkar0gw7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 12. <span id="xdx_82E_zlK2uGQnA4Fd">COMMITMENTS AND CONTINGENCIES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Operating Lease</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company entered into a <span id="xdx_909_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20210630_zylgEXgmyET1" title="Lease term">2</span>-year lease commencing <span id="xdx_902_ecustom--LeaseCommencingDate_c20200701__20210630_zqjhjXM6LwR9" title="Lease commencing date">January 1, 2020</span> and ending on <span id="xdx_909_eus-gaap--LeaseExpirationDate1_c20200701__20210630_z6naBxFWWuBj" title="Lease Expiration Date">December 31, 2021</span>. To secure the new lease, the Company paid a $<span id="xdx_90B_eus-gaap--SecurityDeposit_iI_pp0p0_c20210630_zGdNb3nYX558" title="Security deposit">75,000 </span>security deposit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Rent expense was approximately $<span id="xdx_900_eus-gaap--LeaseAndRentalExpense_pp0p0_c20200701__20210630_zn8m1hdLsh55" title="Rent expense">296,000</span> and $<span id="xdx_901_eus-gaap--LeaseAndRentalExpense_pp0p0_c20190701__20200630_z4J6tm1ymnp3" title="Rent expense">247,000</span> for the years ended June 30, 2021 and 2020, respectively. There is approximately $<span id="xdx_901_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20210630__us-gaap--AwardDateAxis__custom--JulyAndDecemberTwoThousandTwentyOneMember_zqeuGTjXg69h" title="Lease payments">180,000</span> due on the lease for the July-December 2021 period, prior to any potential discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Officers’ Employment Agreements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In May 2021, the Company entered into employment agreements with its three corporate officers. The agreements provide for base salary (including increases linked to Company revenue thresholds), performance bonus, incentive bonus (including those based on capital raising thresholds), equity incentives, benefits and severance (including confidentiality and non-compete). The employment agreements will continue until terminated by either the Company or the respective officers. The Company accrued approximately $<span id="xdx_90C_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20210630_znVv8BUTDsRc" title="Accrued bonuses">426,000</span> of bonuses at June 30, 2021 related to these agreements resulting from the IPO and other met thresholds, as defined. The statement of operations for the year ended June 30, 2021 (the year the employment agreements were executed) includes salary, stock option and the aforementioned bonus expenses for the three officers of approximately $<span id="xdx_90D_ecustom--BonusExpenses_pn4n6_c20200701__20210630__srt--TitleOfIndividualAxis__custom--ThreeOfficersMember_zIhoXQDvCjw4" title="Bonus expenses">1.03</span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Potential Future Distributions Upon Divestiture or Sale</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Upon a divestiture or sale of a subsidiary company, the Company is contractually obligated to distribute up to <span id="xdx_900_ecustom--MaximumDistributionPercentageOfNetProceedsFromDivestiture_dp_uPure_c20200701__20210630_zaXxGzFsUrX4" title="Maximum distribution percentage of net proceeds from divestiture">10</span>% of the net proceeds from such divestiture or sale to the senior management team of the divested subsidiary company. Currently, there were no active discussions pertaining to a potential divestiture or sale of any of the Company’s subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>COVID-19</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s business and operations have been adversely affected by the COVID-19 pandemic, as have the markets in which our customers operate. The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From March 2020 through June 2021, the Company had required substantially all of its employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit the Company’s ability to operate its business effectively. Commencing July 2021, the Company has tentatively required employees to return to the office several days a week.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company continues to closely monitor the situation and the effects on its business and operations. The Company does not yet know the full extent of potential impacts on its business and operations. Given the uncertainty, the Company cannot reasonably estimate the impact on its future results of operations, cash flows or financial condition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> P2Y 2020-01-01 2021-12-31 75000 296000 247000 180000 426000 1030000.00 0.10 <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_z5ZsG6fjvKMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">NOTE 13. <span id="xdx_827_z6g7wElQN0X6">SUBSEQUENT EVENTS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Initial Public Offering (“IPO”)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1 ,2021, the Company completed an IPO of common stock on the NASDAQ under the symbol “VRAR”, at a price of $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20210702__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhd9gNL0bbB4" title="Sale of stock, price per share">7.00</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company sold approximately <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn4n6_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmdyw8PFjMO9" title="Shares issued">1.91</span> million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn4n6_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJ9fGmsFo34j" title="Proceeds from issuance of common stock">11.82</span> million. Professional fees and listing expenses of approximately $<span id="xdx_901_ecustom--ProfessionalFeesAndListingExpenses_pn4n6_c20200701__20210630__us-gaap--FairValueByLiabilityClassAxis__custom--PreOfferingCostsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAgcSQsBWxO9" title="Professional fees and listing expenses">0.47</span> million were included in pre-offering costs, of which $<span id="xdx_902_ecustom--ProfessionalFeesAndListingExpenses_pn3n6_c20200701__20210630__us-gaap--FairValueByLiabilityClassAxis__us-gaap--AccountsPayableMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zpoyM3wzxLZ9" title="Professional fees and listing expenses">0.309</span> million was included in accounts payable on the balance sheet at June 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1H0uCLQQpM3" title="Number of warrants to purchase"> 87,500</span> shares of common stock at $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDSbE4Tat5Gg" title="Number of warrants to purchase per share">7.00</span> per share. The warrant cannot be exercised prior to December 30, 2021, and expires in <span id="xdx_902_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dxL_c20200701__20210630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zHq7MtifZgF6" title="Warrants expires date::XDX::2026-06-30"><span style="-sec-ix-hidden: xdx2ixbrl2003">June 2026</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As stated in Note 9, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through issuance of <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWMsDT45MMG6" title="Conversion of stock, shares issued">324,150</span> shares of commons stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">THE GLIMPSE GROUP, INC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">JUNE 30, 2021 AND 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_892_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zNjpxxEU11x1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following is a condensed balance sheet reflecting the proforma effect of the IPO on the June 30, 2021 balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">  <span id="xdx_8B8_zp6qJ0c0eIkl" style="display: none">SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As Reported at <br/> June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Proforma for IPO</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20210630_z96FWttORoea" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Cash and cash equivalents"><span style="font: 10pt Times New Roman, Times, Serif">1,771,929</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zqQ9TXO7NLjg" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Cash and cash equivalents"><span style="font: 10pt Times New Roman, Times, Serif">13,728,429</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--OtherAssetsCurrent_iI_c20210630_z2FOBI7xcEKl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other current assets"><span style="font: 10pt Times New Roman, Times, Serif">1,406,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--OtherAssetsCurrent_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zdUs55cZShV8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other current assets"><span style="font: 10pt Times New Roman, Times, Serif">833,296</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20210630_zoPPLKusSiii" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zowRcRkZkFSc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--Assets_iI_c20210630_zuVbuAZZzfs5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font: 10pt Times New Roman, Times, Serif">3,221,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Assets_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zqTN4PJzPD3b" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font: 10pt Times New Roman, Times, Serif">14,603,897</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--LiabilitiesCurrent_iI_c20210630_zNXIrYs2Twl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total current liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,339,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--LiabilitiesCurrent_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_z8U0SoeGJW0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total current liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,004,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Convertible promissory notes, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_c20210630_znsgDafXDoui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory notes, net"><span style="font: 10pt Times New Roman, Times, Serif">1,429,953</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_z5Qmr6eJfUea" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory notes, net"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Other long term liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--OtherLiabilitiesNoncurrent_iI_c20210630_zwPwPyMCIUo7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other long term liability"><span style="font: 10pt Times New Roman, Times, Serif">623,828</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OtherLiabilitiesNoncurrent_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zlaeKFmKdaek" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other long term liability"><span style="font: 10pt Times New Roman, Times, Serif">623,828</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Total liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--Liabilities_iI_c20210630_zYjuaOXWm0Fa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities"><span style="font: 10pt Times New Roman, Times, Serif">4,392,818</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--Liabilities_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zIt43kLy5a44" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,627,865</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Total stockholders’ equity (deficit)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--StockholdersEquity_iI_c20210630_zB0qUDNKefTh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,171,778</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zMonyE07PgF7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total stockholders' equity (deficit)"><span style="font: 10pt Times New Roman, Times, Serif">11,976,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total liabilities and stockholders’ equity (deficit)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--LiabilitiesAndStockholdersEquity_iI_c20210630_zQIhK5uUwY9h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,221,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--LiabilitiesAndStockholdersEquity_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zWETKh1JHwa4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities and stockholders' equity (deficit)"><span style="font: 10pt Times New Roman, Times, Serif">14,603,897</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_zn5SgZ8HARd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>ASSET ACQUISTION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC, completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services. Over time, the acquisition may facilitate the Company’s endeavors in the Architecture, Engineering and Construction (“AEC”) market segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Initial consideration for the purchase is $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pn4n6_c20210801__20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z543E8kf5Ved" title="Purchase of assets consideration value">0.75</span> million payable in Company common stock. In August 2021, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_pid_c20210801__20210831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zn4NUvll0nVh" title="Common stock purchase price">77,264</span> shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company is currently determining its purchase price allocation between customer list, intellectual property and goodwill.</span></p> 7.00 1910000 11820000 470000 309000 87500 7.00 324150 <p id="xdx_892_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zNjpxxEU11x1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following is a condensed balance sheet reflecting the proforma effect of the IPO on the June 30, 2021 balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">  <span id="xdx_8B8_zp6qJ0c0eIkl" style="display: none">SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">As Reported at <br/> June 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Proforma for IPO</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20210630_z96FWttORoea" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Cash and cash equivalents"><span style="font: 10pt Times New Roman, Times, Serif">1,771,929</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zqQ9TXO7NLjg" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Cash and cash equivalents"><span style="font: 10pt Times New Roman, Times, Serif">13,728,429</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Other current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--OtherAssetsCurrent_iI_c20210630_z2FOBI7xcEKl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other current assets"><span style="font: 10pt Times New Roman, Times, Serif">1,406,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--OtherAssetsCurrent_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zdUs55cZShV8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other current assets"><span style="font: 10pt Times New Roman, Times, Serif">833,296</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20210630_zoPPLKusSiii" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zowRcRkZkFSc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--Assets_iI_c20210630_zuVbuAZZzfs5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font: 10pt Times New Roman, Times, Serif">3,221,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--Assets_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zqTN4PJzPD3b" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font: 10pt Times New Roman, Times, Serif">14,603,897</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--LiabilitiesCurrent_iI_c20210630_zNXIrYs2Twl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total current liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,339,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--LiabilitiesCurrent_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_z8U0SoeGJW0j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total current liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,004,037</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Convertible promissory notes, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_c20210630_znsgDafXDoui" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory notes, net"><span style="font: 10pt Times New Roman, Times, Serif">1,429,953</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_z5Qmr6eJfUea" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible promissory notes, net"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2029">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Other long term liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--OtherLiabilitiesNoncurrent_iI_c20210630_zwPwPyMCIUo7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other long term liability"><span style="font: 10pt Times New Roman, Times, Serif">623,828</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--OtherLiabilitiesNoncurrent_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zlaeKFmKdaek" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other long term liability"><span style="font: 10pt Times New Roman, Times, Serif">623,828</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Total liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--Liabilities_iI_c20210630_zYjuaOXWm0Fa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities"><span style="font: 10pt Times New Roman, Times, Serif">4,392,818</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--Liabilities_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zIt43kLy5a44" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities"><span style="font: 10pt Times New Roman, Times, Serif">2,627,865</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Total stockholders’ equity (deficit)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--StockholdersEquity_iI_c20210630_zB0qUDNKefTh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,171,778</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--StockholdersEquity_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zMonyE07PgF7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total stockholders' equity (deficit)"><span style="font: 10pt Times New Roman, Times, Serif">11,976,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total liabilities and stockholders’ equity (deficit)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--LiabilitiesAndStockholdersEquity_iI_c20210630_zQIhK5uUwY9h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,221,040</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--LiabilitiesAndStockholdersEquity_iI_c20210630__srt--StatementScenarioAxis__srt--ProFormaMember_zWETKh1JHwa4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities and stockholders' equity (deficit)"><span style="font: 10pt Times New Roman, Times, Serif">14,603,897</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> </table> 1771929 13728429 1406939 833296 42172 42172 3221040 14603897 2339037 2004037 1429953 623828 623828 4392818 2627865 -1171778 11976032 3221040 14603897 750000 77264 XML 19 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover
3 Months Ended
Sep. 30, 2021
Cover [Abstract]  
Document Type S-1
Amendment Flag false
Entity Registrant Name THE GLIMPSE GROUP, INC.
Entity Central Index Key 0001854445
Entity Tax Identification Number 81-2958271
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 15 West 38th St
Entity Address, Address Line Two 9th Fl
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10018
City Area Code 917
Local Phone Number 292-2685
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false

XML 20 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
ASSETS      
Cash and cash equivalents $ 12,567,632 $ 1,771,929 $ 1,034,846
Accounts receivable 599,879 626,244 214,673
Deferred costs 45,981 29,512 237,745
Pre-offering costs 470,136
Prepaid expenses and other current assets 533,782 281,047 468,747
Total current assets 13,747,274 3,178,868 1,956,011
Other assets 80,000  
Equipment, net 53,513 42,172 41,224
Intangible assets, net 479,167  
Goodwill 250,000 (0) 0
Total assets 14,609,954 3,221,040 1,997,235
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)      
Accounts payable 112,687 381,510 121,508
Accrued liabilities 136,975 168,745 118,634
Accrued bonuses 288,388 440,357
Accrued legacy acquisition expense 500,000 1,250,000
Deferred revenue 114,055 98,425 330,362
Total current liabilities 1,152,105 2,339,037 570,504
Long term liabilities      
Paycheck Protection Program (PPP 1) loan 548,885
Paycheck Protection Program (PPP 2) loan 623,828 623,828
Convertible promissory notes, net 1,429,953 1,183,535
Total liabilities 1,775,933 4,392,818 2,302,924
Commitments and contingencies  
Stockholders’ Equity (Deficit)      
 Preferred Stock, par value $0.001 per share, 20 million shares  authorized; 0 shares issued and outstanding
 Common Stock, par value $0.001 per share, 300 million shares  authorized; 7,579,285 and 7,035,771 issued and outstanding 10,292 7,580 7,036
 Additional paid-in capital 36,595,898 20,936,050 15,710,996
 Accumulated deficit (23,772,169) (22,115,408) (16,023,721)
Total stockholders’ deficit 12,834,021 (1,171,778) (305,689)
 Total liabilities and stockholders’ deficit $ 14,609,954 $ 3,221,040 $ 1,997,235
XML 21 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Statement of Financial Position [Abstract]      
Preferred stock, par value $ 0.001 $ 0.001 $ 0.001
Preferred stock, shares authorized 20,000,000 20,000,000 20,000,000
Preferred stock, shares issued 0 0 0
Preferred stock, shares outstanding 0 0 0
Common stock, par value $ 0.001 $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000 300,000,000
Common stock, shares issued 10,291,638 7,579,285 7,035,771
Common stock, shares outstanding 10,291,638 7,579,285 7,035,771
XML 22 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue        
Total Revenue $ 1,022,533 $ 259,927 $ 3,421,495 $ 1,945,315
Cost of goods sold 145,387 137,124 1,461,210 1,137,193
Gross Profit 877,146 122,803 1,960,285 808,122
Operating expenses:        
Research and development expenses 989,384 736,750 3,183,055 2,430,752
General and administrative expenses 779,729 335,998 2,220,811 1,835,147
Sales and marketing expenses 504,687 289,476 1,267,088 1,462,701
Total operating expenses 2,273,800 1,362,224 6,670,954 5,728,600
Net loss from operations before other income (expense) (1,396,654) (1,239,421) (4,710,669) (4,920,478)
Other income (expense)        
 Forgiveness of Paycheck Protection Program (PPP1) loan 548,885
 Other income 10,000 10,000
 Interest income 19,623 534 6,202 8,583
 Interest expense (48,437) (180,641) (81,455)
 Loss on conversion of convertible notes (279,730) (515,464)
 Legacy acquisition expense (1,250,000)
Total other expense, net (260,107) (37,903) (1,381,018) (72,872)
Net Loss $ (1,656,761) $ (1,277,324) $ (6,091,687) $ (4,993,350)
Basic and diluted net loss per share $ (0.17) $ (0.18) $ (0.84) $ (0.72)
Weighted-average shares used to compute basic and diluted net loss per share 9,967,821 7,039,928 7,259,249 6,923,506
Software Sercices [Member]        
Revenue        
Total Revenue $ 804,718 $ 187,652 $ 3,082,528 $ 1,777,447
Software License [Member]        
Revenue        
Total Revenue $ 217,815 $ 72,275 $ 338,967 $ 167,868
XML 23 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jun. 30, 2019 $ 6,861 $ 12,497,228 $ (11,030,371) $ 1,473,718
Beginning Balance, Shares at Jun. 30, 2019 6,860,246      
Sales of common stock to investors $ 1 6,999 7,000
Sales of common stock to investors, Shares 1,556      
Common stock issued to vendors for compensation $ 24 101,475 $ 101,499
Common stock issued to vendors for compensation, Shares 23,681      
Common stock issued for exercise of options, shares      
Stock option-based compensation expense 2,288,258 $ 2,288,258
Stock option-based board of directors expense 167,055 167,055
Net loss (4,993,350) (4,993,350)
Ending balance, value at Jun. 30, 2020 $ 7,036 15,710,996 (16,023,721) (305,689)
Ending Balance, Shares at Jun. 30, 2020 7,035,771      
Common stock issued to convertible promissory note holders for prepaid interest $ 57 257,837 257,894
Common stock issued to convertible promissory note holders for prepaid interest, Shares 57,234      
Common stock issued to convertible promissory note holders as additional consideration $ 45 173,726 173,771
Common stock issued to convertible promissory note holders as additional consideration, Shares 44,506      
Common stock issued to satisfy contingent liability $ 20 91,735 91,755
Common stock issued to satisfy contingent liability, Shares 20,390      
Common stock issued to employees as compensation $ 28 126,683 126,711
Common stock issued to employees as compensation, Shares 28,158      
Sales of common stock to investors $ 2 10,818 10,820
Sales of common stock to investors, Shares 2,423      
Common stock issued to vendors for compensation $ 7 29,993 $ 30,000
Common stock issued to vendors for compensation, Shares 6,667      
Common stock issued for exercise of options, shares      
Stock option-based compensation expense 772,635 $ 772,635
Stock option-based board of directors expense 41,532 41,532
Net loss (1,277,324) (1,277,324)
Ending balance, value at Sep. 30, 2020 $ 7,045 16,565,974 (17,301,045) (728,026)
Ending Balance, Shares at Sep. 30, 2020 7,044,861      
Beginning balance, value at Jun. 30, 2020 $ 7,036 15,710,996 (16,023,721) (305,689)
Beginning Balance, Shares at Jun. 30, 2020 7,035,771      
Sales of common stock to investors $ 77 345,933 346,010
Sales of common stock to investors, Shares 76,891      
Common stock issued for convertible note conversion $ 332 1,486,727 1,487,059
Common stock issued for convertible note conversion, Shares 332,063      
Common stock issued to vendors for compensation $ 29 134,387 $ 134,416
Common stock issued to vendors for compensation, Shares 28,822      
Common stock issued for exercise of options, shares      
Stock option-based compensation expense 2,576,058 $ 2,576,058
Stock option-based board of directors expense 182,223 182,223
Net loss (6,091,687) (6,091,687)
Ending balance, value at Jun. 30, 2021 $ 7,580 20,936,050 (22,115,408) (1,171,778)
Ending Balance, Shares at Jun. 30, 2021 7,579,285      
Common stock issued to convertible promissory note holders for prepaid interest $ 30 147,471 147,501
Common stock issued to convertible promissory note holders for prepaid interest, Shares 29,500      
Common stock issued to convertible promissory note holders as additional consideration $ 44 192,347 192,391
Common stock issued to convertible promissory note holders as additional consideration, Shares 44,250      
Common stock issued to satisfy contingent liability $ 13 67,162 67,175
Common stock issued to satisfy contingent liability, Shares 13,435      
Common stock issued to employees for compensation $ 19 92,746 92,765
Common stock issued to employees for compensation, Shares 18,553      
Common stock issued in Initial Public Offering, net $ 1,913 11,819,451 11,821,364
Common stock issued in Initial Public Offering net, shares 1,912,500      
Common stock issued for convertible note conversion $ 324 1,605,852 1,606,176
Common stock issued for convertible note conversion, Shares 324,150      
Common stock issued for acquisition $ 77 749,923 750,000
Common stock issued for acquisition, shares 77,264      
Common stock issued for legacy acquisition obligation $ 375 749,625 750,000
Common stock issued for legacy acquisition obligation, shares 375,000      
Common stock issued to vendors for compensation $ 6 65,389 65,395
Common stock issued to vendors for compensation, Shares 6,045      
Common stock issued for exercise of options $ 17 45,683 $ 45,700
Common stock issued for exercise of options, shares 17,394     392,394
Stock option-based compensation expense 536,524 $ 536,524
Stock option-based board of directors expense 87,401 87,401
Net loss (1,656,761) (1,656,761)
Ending balance, value at Sep. 30, 2021 $ 10,292 $ 36,595,898 $ (23,772,169) $ 12,834,021
Ending Balance, Shares at Sep. 30, 2021 10,291,638      
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended 61 Months Ended
Jul. 02, 2021
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Cash flows from operating activities:            
Net loss   $ (1,656,761) $ (1,277,324) $ (6,091,687) $ (4,993,350)  
Adjustments to reconcile net loss to net cash used in operating activities:            
Amortization and depreciation   27,718 5,907      
Depreciation   27,054 20,222  
Amortization of paid-in kind common stock interest on convertible notes   54,039 180,642 81,456  
Impairment of goodwill   139,754  
Stock option based compensation for employees and board of directors   653,615 689,813 2,945,487 2,550,521  
Issuance of common stock to vendors as compensation   62,034 15,000 134,416 101,499  
Issuance of common stock to employees to satisfy contingent liability   92,765 91,755  
Issuance of common stock for additional cost to satisfy contingent liability   20,217 39,311  
Loss on conversion of convertible notes   279,730 515,464  
Forgiveness of Paycheck Protection Program (PPP 1) loan   (548,885)  
Changes in operating assets and liabilities:            
Accounts receivable   26,365 135,460 (411,571) (86,805)  
Pre-offering costs   470,136      
Prepaid expenses and other current assets   (381,856) (81,909) (25,933) (52,058)  
Deferred costs   17,185 124,155 136,925 14,164  
Other assets   (80,000)      
Accounts payable   (268,823) (52,343) 260,002 79,183  
Accrued liabilities   (31,770) (18,680) 97,068 (72,360)  
Accrued bonus   (151,969) (6,000) 440,357  
Accrued legacy acquisition expense   1,250,000  
Deferred revenue   15,630 499,650 (231,937) 62,433  
Net cash used in operating activities   (1,053,136) (160,542) (1,209,616) (2,024,275)  
Cash flow from investing activities:            
Purchases of equipment   (18,225) (15,004) (28,003) (32,660)  
Net cash used in investing activities   (18,225) (15,004) (28,003) (32,660)  
Cash flows from financing activities:            
Proceeds from initial public offering, net $ 11,800,000 11,821,364      
Proceeds from issuance of common equity to investors   10,820 346,010 7,000 $ 1,820,000
Proceeds from exercise of stock options   45,700      
Net cash provided by financing activities   11,867,064 10,820 1,974,702 1,888,385  
Net change in cash and cash equivalents   10,795,703 (164,726) 737,083 (168,550)  
Cash and cash equivalents, beginning of year $ 1,771,929 1,771,929 1,034,846 1,034,846 1,203,396  
Cash and cash equivalents, end of period   12,567,632 870,120 1,771,929 1,034,846 $ 1,771,929
Non-cash Investing and Financing activities:            
Issuance of common stock for satisfaction of contingent liability   750,000 46,958 87,400  
Conversion of convertible promissory notes 1 into common stock   1,606,176 1,487,059  
Issuance of warrants in connection with initial public offering   522,360      
Issuance of common stock for satisfaction of legacy acquisition liability   $ 750,000      
Proceeds from Paycheck Protection Program (PPP 1) loan       548,885  
Proceeds from Paycheck Protection Program (PPP 2) loan       623,828  
Proceeds from convertible promissory notes 1       1,332,500  
Proceeds from convertible promissory notes 2       1,475,000  
Pre-offering costs incurred       (470,136)  
Non-cash Investing and Financing activities:            
Forgiveness of Paycheck Protection Program (PPP 1) loan       548,885  
Common stock issued to convertible Note 2 holders as additional consideration       192,347  
Common stock issued to convertible Note 1 holders as additional consideration       173,771  
Common stock issued for interest paid-in kind on convertible notes       $ 147,471 $ 257,894  
XML 25 R7.htm IDEA: XBRL DOCUMENT v3.21.2
DESCRIPTION OF BUSINESS
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
DESCRIPTION OF BUSINESS

NOTE 1. DESCRIPTION OF BUSINESS

 

The Glimpse Group, Inc. (“Glimpse”) is a Virtual (VR) and Augmented (AR) Reality company, comprised of a diversified portfolio of VR and AR software and services companies. Glimpse’s ten wholly-owned operating subsidiaries (“Subsidiary Companies” or “Subsidiaries”) are: Adept Reality, LLC (dba Adept XR Learning), Kabaq 3D Technologies, LLC (dba QReal), KreatAR, LLC (dba PostReality), D6 VR, LLC, Immersive Health Group, LLC, Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), Early Adopter, LLC, and MotionZone, LLC (dba AUGGD) and one subsidiary in Turkey, Glimpse Group Yazılım ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”). In addition, the Company has one inactive subsidiary company, In-It VR, LLC (dba Mezmos), and with the operating Subsidiaries collectively comprise the “Company” or “Glimpse”. Glimpse was incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016.

 

A new subsidiary company was established in October 2021. See Note 11.

 

Glimpse’s robust VR/AR ecosystem, collaborative environment and business model simplify the many challenges faced by companies in an emerging industry. Glimpse cultivates and manages business operations while providing a strong network of professional relationships, thereby allowing the subsidiary company entrepreneurs to maximize their time and resources in pursuit of mission-critical endeavors, reducing time to market, optimizing costs, improving product quality and leveraging joint go-to-market strategies, while simultaneously providing investors an opportunity to invest directly into the VR/AR industry via a diversified platform.

 

The Company completed an initial public offering (“IPO”) of its common stock on the Nasdaq Capital Market Exchange (“Nasdaq”) on July 1, 2021, under the ticker VRAR. See Note 7.

 

On November 2, 2021 the Company completed a securities purchase agreement (“SPA”) for the sale of additional common stock to certain institutional investors. See Note 11.

 

NOTE 1. DESCRIPTION OF BUSINESS

 

The Glimpse Group, Inc. (“Glimpse”) is a Virtual (VR) and Augmented (AR) Reality company, comprised of a diversified portfolio of VR and AR software and services companies. Glimpse’s nine wholly-owned operating subsidiaries (“Subsidiary Companies” or “Subsidiaries”) are: Adept Reality, LLC (dba Adept XR Learning), Kabaq 3D Technologies, LLC (dba QReal), KreatAR, LLC (dba PostReality), D6 VR, LLC, Immersive Health Group, LLC, Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), and Early Adopter, LLC and one subsidiary in Turkey, Glimpse Group Yazilim ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”). In addition, the Company has two inactive subsidiary companies: In-It VR, LLC (dba Mezmos) and MotionZone, LLC (collectively, the “Company” or “Glimpse”). Glimpse was incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016.

 

Glimpse’s robust VR/AR ecosystem, collaborative environment and business model simplify the many challenges faced by companies in an emerging industry. Glimpse cultivates and manages business operations while providing a strong network of professional relationships, thereby allowing the subsidiary company entrepreneurs to maximize their time and resources in pursuit of mission-critical endeavors, reducing time to market, optimizing costs, improving product quality and leveraging joint go-to-market strategies, while simultaneously providing investors an opportunity to invest directly into the VR/AR industry via a diversified platform.

 

The Company completed an initial public offering (“IPO”) of its common stock on the Nasdaq Capital Market Exchange (“Nasdaq”) on July 1, 2021, under the ticker VRAR. See Note 13.

 

Summary of Glimpse’s Active Subsidiary Companies:

 

Kabaq 3D Technologies, LLC (dba QReal): Creating and displaying photorealistic 3D, AR, interactive digital models.

 

Adept Reality, LLC (dba Adept XR Learning): VR/AR corporate training solutions.

 

KreatAR, LLC (dba PostReality): AR presentation tools for design, creation and collaboration.

 

D6 VR, LLC: VR/AR data-analysis and collaboration for financial services and other data intensive industries.

 

Immersive Health Group, LLC (IHG): VR/AR solutions for the healthcare industry.

 

Foretell Studios, LLC (dba Foretell Reality): Social VR multi-person spaces, collaboration and group interaction for enterprise and support groups.

 

Number 9, LLC (dba Pagoni VR): VR/AR broadcasting solutions and environments for events, education, media and entertainment.

 

Early Adopter, LLC (EA): AR/VR solutions for K-12 education.

 

Glimpse Group Yazilim ve ARGE Ticaret Anonim Şirketi (“Glimpse Turkey”): primarily develops and creates 3D models for QReal

 

XML 26 R8.htm IDEA: XBRL DOCUMENT v3.21.2
LIQUIDITY AND CAPITAL RESOURCES
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Liquidity And Capital Resources    
LIQUIDITY AND CAPITAL RESOURCES

NOTE 2. LIQUIDITY AND CAPITAL RESOURCES

 

The Company incurred a loss of $1.66 million during the three months ended September 30, 2021, compared to a loss of $1.28 million during the three months ended September 30, 2020. The loss was incurred as the Company funded operational expenses, primarily research and development, general and administrative, and sales and marketing costs.

 

On July 1, 2021 the Company completed an IPO in which, as a result of the sale of its common shares at $7.00 per share, it raised approximately $13.4 million in gross proceeds and $11.8 million in net proceeds after fees and expenses. See Note 7. Furthermore, on November 2, 2021 the Company completed a SPA whereby it sold additional common shares that resulted in approximately $13.6 million in net proceeds after fees and expenses. See Note 11.

 

The Company expects to continue to generate net losses for the foreseeable future as it makes investments to grow its business. Management believes that the Company’s existing balances of cash and cash equivalents, which are approximately $26 million following the SPA (see Note 11), will be sufficient to meet its anticipated cash requirements for at least twelve months from the date that these financial statements are issued. However, should the Company’s current cash and cash equivalents not be sufficient to support the development of its business to the point at which it has positive cash flows from operations, the Company plans to meet its future needs for additional capital through equity and/or debt financings. Equity financings may include sales of common stock. Such financing may not be available on terms favorable to the Company or at all. If the Company is unable to obtain adequate financing or financing on terms satisfactory to it when required, the Company’s ability to continue to support its business growth, scale its infrastructure, develop product enhancements and to respond to business challenges could be significantly impaired.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

NOTE 2. LIQUIDITY AND CAPITAL RESOURCES

 

The Company incurred a loss of $6.09 million during the year ended June 30, 2021, compared to a loss of $4.99 million during the year ended June 30, 2020. The loss was incurred as the Company funded operational expenses, primarily research and development, general and administrative, sales and marketing, and to satisfy legacy acquisitions costs.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Net cash used in operating activities was $1.21 million during the year ended June 30, 2021, compared to $2.02 million during the year ended June 30, 2020. The Company has raised approximately $8.88 million through the issuance of common share and convertible debt financings since inception through June 30, 2021, of which approximately $1.82 million was raised during the year ended June 30, 2021 from the sale of common stock as disclosed in Note 6 and the issuance of convertible promissory notes as disclosed in Note 9.

 

The combination of operating losses since inception, cash expected to be used in operating activities in the future, uncertain conditions relating to additional capital raises and continued revenue growth had created uncertainty about the Company’s ability to continue as a going concern.

 

The Company had $1.77 million of cash as of June 30, 2021 compared to $1.03 million as of June 30, 2020. On July 1, 2021 the Company completed an IPO through Nasdaq in which, as a result of the sale of its common shares at $7.00 per share, it raised approximately $13.4 million in gross proceeds and $11.8 million in net proceeds after fees and expenses. See Note 13.

 

The Company generated $3.42 million of revenues during the year ended June 30, 2021, compared to $1.95 million during the year ended June 30, 2020. In addition, as disclosed in Note 9, during the year ended June 30, 2020 the Company received a $0.549 million Paycheck Protection Program 1 (“PPP 1”) loan and an additional $0.624 million Paycheck Protection Program 2 (“PPP 2”) loan in February 2021.

 

As of the date that this financial statement was issued, the Company’s cash position was approximately $13 million, contracted revenue backlog to be collected over the short term exceeded $1.5 million and the Company’s shares were traded on Nasdaq post its July 1, 2021 IPO. As such, the Company believes that it is sufficiently funded to meet its operational plan and future obligations beyond the 12-month period from the date that these financial statements were issued.

 

Given the above, doubt about the company’s ability to continue as a going concern was alleviated and the accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern.

 

While Management believes it will be able to continue to grow the Company’s revenue base, there is no assurance. In parallel, Management continually monitors its capital structure and operating plans and evaluates various potential funding alternatives that may be needed in order to finance the Company’s research and development activities, general and administrative expenses and growth strategy. These alternatives include raising funds through public equity or debt markets. Although there is no assurance that, if needed, the Company will be successful with its fundraising initiatives, the Company has been successful historically in raising equity capital and Management believes that its Nasdaq listing significantly increases its ability to access capital going forward.

 

XML 27 R9.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Accounting Policies [Abstract]    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2021 and the results of operations and cash flows for the three months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the three months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2022 or for any subsequent periods. The consolidated balance sheet at June 30, 2021 has been derived from the audited consolidated financial statements at that date.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations.

 

These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended June 30, 2021.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Accounting Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options, cost of goods sold and allocation of the purchase price of assets relating to business combinations.

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash and deposits in bank checking accounts with immediate access and cash equivalents that represent highly liquid investments.

 

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of September 30, 2021 and June 30, 2021 no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Customer Concentration and Credit Risk

 

Two customers accounted for approximately 70% (56% and 14%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2021. Four different customers accounted for approximately 53% (19%, 13%, 11% and 10%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2020.

 

One customer accounted for approximately 76% of the Company’s accounts receivable at September 30, 2021. The same customer, and along with a different customer, accounted for approximately 71% (57% and 14%, respectively) of the Company’s accounts receivable at June 30, 2021.

 

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

 

Equipment, net

 

Equipment is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.

 

The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.

 

Business Combinations

 

The results of a business acquired in a business combination are included in the Company’s consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business generally being recorded at their estimated fair values as of the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill.

 

The Company performs valuations of assets acquired and liabilities assumed and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired and liabilities assumed may require management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenues, costs and cash flows.

 

Intangibles, net

 

Intangibles represent the allocation of a portion of an asset acquisition purchase price (see Note 4). Intangibles are stated at allocated cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the related assets.

 

Goodwill

 

The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded goodwill related to an asset acquisition, see Note 4.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.

 

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
     
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured.

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue for the three months ended September 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.

 

Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

Timing of Revenue

 

The timing of revenue recognition for the three months ended September 30, 2021 and 2020 was as follows:

 

       
   For the Three Months Ended 
   September 30, 
   2021   2020 
Products transferred at a point in time  $955,751   $193,175 
Products and services transferred over time   66,782    66,752 
Total Revenue  $1,022,533   $259,927 

 

Remaining Performance Obligations

 

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.

 

For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

 

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.

 

For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.

 

For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Deferred revenue is comprised mainly of software project contract performance obligations not completed.

 

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of September 30, 2021, the Company had approximately $1.20 million in unfulfilled performance obligations.

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for the Company since its IPO. Prior to its IPO, expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the three months ended September 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.

 

Earnings Per Share

 

Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s financial statements.

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Accounting Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options and cost of goods sold.

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash and deposits in bank checking accounts or money market funds with immediate access.

 

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
     
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company adopted the new accounting standard, Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, (“ASC 606”) beginning on July 1, 2020 using the modified retrospective method for all open contracts and related amendments. The adoption did not result in an adjustment to the accumulated deficit as of June 30, 2020. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods. The adoption of ASC 606 did not have a material impact on reported sales to customers and net earnings (losses).

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue for the years ended June 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.

 

Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

As detailed in the Company’s Consolidated Statement of Operations, the following is a disaggregation of the Company’s revenue by major source for the years ended June 30, 2021 and 2020:

 

   For the Years Ended 
   June 30, 
   2021   2020 
Software Services  $3,082,528   $1,777,447 
Software License and Software as a Service   338,967    167,868 
Total Revenue  $3,421,495   $1,945,315 

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Timing of Revenue

 

As the Company began adopting ASC 606 in July 2020, the timing of revenue recognition for periods prior to the adoption is not required:

 

   For the Year Ended 
   June 30, 2021 
Products transferred at a point in time  $2,967,586 
Products and services transferred over time   453,909 
Total Revenue  $3,421,495 

 

Remaining Performance Obligations

 

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.

 

For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

 

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.

 

For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.

 

For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

 

Deferred revenue is comprised mainly of software project contract performance obligations not completed.

 

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of June 30, 2021, the Company had approximately $1.23 million in unfulfilled performance obligations.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Prior to the adoption of ASC 606 at July 1, 2020, the Company’s revenue recognition was as follows:

 

Software Service Revenue

 

The Company generates software related revenues from services performed for: Virtual and Augmented Reality projects, consulting retainers, and ongoing website maintenance and support. Software service revenue generated from Virtual and Augmented Reality projects is recognized after delivery of the project has occurred, when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured. Any unrecognized portion of project revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets. Deferred costs include cash and equity based payroll costs, and may include payments to vendors. Software service revenue generated from consulting retainers is typically billed in advance for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, services have been performed, and collection is reasonably assured. Software service revenue generated from ongoing website maintenance and support services is typically billed in arrears for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured.

 

Software License and Software as a Service Revenue

 

The Company derives revenue from software as-a-service subscriptions and software licenses. Upon delivery of the software to customers, revenue is recognized ratably over the term of the contract or arrangement. The unrecognized portion of this revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets.

 

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of June 30, 2021 and June 30, 2020 no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

Customer Concentration and Credit Risk

 

Two customers accounted for approximately 49% (26% and 23%, respectively) of the Company’s total gross revenues during the year ended June 30, 2021. One different customer accounted for approximately 13% of the Company’s total gross revenues during the year ended June 30, 2020.

 

Two customers accounted for approximately 71% (57% and 14%, respectively) of the Company’s accounts receivable at June 30, 2021. Four different customers accounted for approximately 96% (35%, 35%, 14% and 12%, respectively) of the Company’s accounts receivable at June 30, 2020.

 

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

 

Equipment, net

 

Equipment is stated at cost less accumulated depreciation (see Note 4). Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.

 

The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.

 

The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the years ended June 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.

 

Goodwill

 

The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded a goodwill impairment during the fiscal year ended June 30, 2020 (see Note 8). There was no Goodwill at June 30, 2021 and 2020.

 

Earnings Per Share

 

Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.

 

Recently Issued Pronouncements

 

Leases

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (Topic 842). The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company does not expect to adopt this standard prior to July 1, 2022. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Financial Instruments – Credit Losses

 

In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates (ASC 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

XML 28 R10.htm IDEA: XBRL DOCUMENT v3.21.2
ASSET ACQUISTION
3 Months Ended
Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]  
ASSET ACQUISTION

NOTE 4. ASSET ACQUISTION

 

In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC (dba AUGGD), completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services. Over time, the acquisition may facilitate the Company’s endeavors in the Architecture, Engineering and Construction (“AEC”) market segments.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Initial consideration for the purchase was $0.75 million payable in Company common stock. In August 2021, the Company issued 77,264 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company recorded the purchase price allocation as follows:

 

   As of September 30, 2021
   Value ($)   Useful Life
(Years)
Intangible Assets        
Customer Relationships  $250,000   3
Technology   250,000   3
Less: Accumulated Amortization   (20,833)   
Intangible Assets, net  $479,167    
         
Goodwill  $250,000   N/A

 

The goodwill recognized in connection with the acquisition is primarily attributable to new markets access and is expected to be deductible for tax purposes.

 

The results of operations of AUGGD have been included in the Company’s consolidated financial statements from the date of acquisition and did not have a material impact on the Company’s consolidated financial statements.

 

XML 29 R11.htm IDEA: XBRL DOCUMENT v3.21.2
CONTINGENT ACQUISITION LIABILITY
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Business Combination and Asset Acquisition [Abstract]    
CONTINGENT ACQUISITION LIABILITY

NOTE 5. CONTINGENT ACQUISITION LIABILITY

 

Kabaq 3D Technologies, LLC

 

The Company’s November 2016 acquisition of assets relating to the acquisition of Kabaq 3D Technologies, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met and the Company incurred $750,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition liability on the Company’s balance sheet at June 30, 2021. This obligation was satisfied in August 2021 through the issuance of common stock in settlement of 375,000 stock options at $2.00 per share.

 

KreatAR, LLC

 

The Company’s October 2016 acquisition of assets relating to the acquisitions of KreatAR, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met. In connection therewith, the Company incurred $500,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition liability on the Company’s balance sheet at June 30, 2021.

 

NOTE 7. CONTINGENT ACQUISITION LIABILITY

 

Early Adopter, LLC

 

In connection with the Company’s April 2018 asset acquisition of Early Adopter.Com (“EA”), the Company expected to pay additional contingent amounts, based on EA’s annual revenues (“contingent performance bonus”) as measured and paid in each of the first three anniversary dates after the closing of the acquisition, paid by the issuance of the Company’s common stock at a fixed price of $3.25/share.

 

At June 30, 2020, the total estimated contingent acquisition liability was approximately $47,000 due for the third anniversary, which is included in accrued liabilities. During the year ended June 30, 2021, the Company issued approximately 32,000 shares of common stock in final payment of all contingent liabilities related to the EA acquisition and recorded share-based expense of approximately $96,800. There are no further obligations relating to the EA acquisition.

 

Kabaq 3D Technologies, LLC

 

The Company’s November 2016 acquisition of assets relating to the acquisition of Kabaq 3D Technologies, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met and the Company incurred $750,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition expense on the Company’s statement of operations for the year ended June 30, 2021. At June 30, 2020, no expense was accrued because the likelihood of the Company going public and reaching the volume threshold was not probable at that time.

 

KreatAR, LLC

 

The Company’s October 2016 acquisition of assets relating to the acquisitions of KreatAR, LLC (and related entity LocateAR) contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met. In connection therewith, the Company incurred $500,000 of additional acquisition cost. In accordance with GAAP, the cost has been accrued as legacy acquisition expense on the Company’s statement of operations for the year ended June 30, 2021. At June 30, 2020, no expense was accrued because the likelihood of the Company going public and reaching the volume threshold was not probable at that time.

 

XML 30 R12.htm IDEA: XBRL DOCUMENT v3.21.2
DEBT
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Debt Disclosure [Abstract]    
DEBT

NOTE 6. DEBT

 

Convertible Promissory Notes 1

 

In December 2019 the Company raised $1.33 million by the issuance of unsecured Convertible Promissory Notes with a three-year term (the “Note 1” or “Notes 1”), primarily from existing Company investors.

 

The Notes 1 bore an interest rate of 10% per annum.

 

The Notes 1 were convertible by a Note 1 holder at any time during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Interest expense on the Notes 1 was approximately $48,500 for the three months ended September 30, 2020, representing amortization of the original issue discount and prepaid interest for the period.

 

Primarily in January 2021, Note 1 holders converted approximately $1.21 million of principal into approximately 0.30 million shares of common stock at a revised (to encourage early conversion) conversion price of $4.00/share.

 

The holders of the remaining unconverted Notes 1, equating to approximately $117,000 (net of original discount of approximately $8,000) of outstanding principal at June 30, 2021, amended their Notes 1 to allow for auto conversion upon the Company’s potential IPO event at a conversion price of $4.25/share. As per the amendment, the residual Notes 1 converted upon the IPO and no further obligations existed. See Note 7.

 

The Company recorded a loss on conversion of the remaining Notes 1 of approximately $18,000 at time of the IPO, representing unamortized original issue discount and prepaid interest.

 

Convertible Promissory Notes 2

 

In March 2021, the Company raised $1.48 million by the issuance of unsecured Convertible Promissory Notes with a two-year term (the “Notes 2”), to several investors.

 

The Notes 2 bore an interest rate of 10% per annum.

 

The Notes 2 were convertible by a note holder at any time during the term into common stock of the Company at a fixed price of $5.00/share, or 295,000 shares of common stock upon full conversion. Notes 2 had a maturity date of March 5, 2023. All outstanding amounts at the time of the Company’s IPO automatically converted at $5.00/share in the aggregate. Convertible Notes 2 totaled approximately $1.313 million (net of original issue discount of approximately $162,000) at June 30, 2021. The Notes 2 converted upon the IPO and no further obligations existed. See Note 7.

 

The Company recorded a loss on conversion of the Notes 2 of approximately $262,000 at time of the IPO, representing unamortized original issue discount and prepaid interest.

 

NOTE 9. DEBT

 

Convertible Promissory Notes 1

 

During the year ended June 30, 2020, the Company raised $1.33 million by the issuance of unsecured Convertible Promissory Notes with a three-year term (the “Note 1” or “Notes 1”), primarily from existing Company investors. The Notes 1 included participation by the Company’s executives and independent members of the Company’s Board in the amount of $0.2 million. The Note 1 holders received approximately 45,000 shares of common stock (at $4.50/share) in the aggregate, with a relative value of $170,000 at the time of issuance. As of June 30, 2020, the remaining original issue discount on the Notes was approximately $149,000, which was to be amortized over the remaining term of the Notes.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Additional interest expense for the amortization of the original issue discount amounted to approximately $96,900 for the year ended June 30, 2020.

 

The Notes 1 bore an interest rate of 10% per annum. The first two years of interest were prepaid with the issuance of the Company’s common stock (at $4.50/share), for an issuance of approximately 57,000 shares of common stock with a fair value of approximately $258,000.

 

The Notes 1 were convertible by a Note 1 holder at any time during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion.

 

During the year ended June 30, 2021, Note 1 holders converted approximately $1.21 million of principal into approximately 0.30 million shares of common stock at a revised conversion price of $4.00/share. The original contracted conversion price was $4.50/share. In order to encourage early conversion, two years before the maturity of the Convertible Notes 1, the Company reduced the conversion price to $4.00/share.

 

In addition to the reduced conversion price, the Note holders who converted received the third year interest (10%) on the Notes, totaling approximately $122,000, as additional consideration to convert early which was paid in the Company’s common stock, amounting to approximately 30,000 shares. In the aggregate, a loss of approximately $515,500 was recognized during the year ended June 30, 2021, reflecting the reduction of the Notes conversion price from $4.50/share to $4.00/share, the issuance of Year 3 Interest (10%) paid in common stock (at $4.00/share instead of $4.50/share), and the write-off of the remaining related pre-paid interest and original issue discount expenses.

 

The holders of the remaining unconverted Convertible Notes 1, equating to approximately $117,000 (net of original discount of approximately $8,000) of outstanding principal at June 30, 2021, amended their Notes 1 to allow for auto conversion upon the Company’s potential IPO event at a conversion price of $4.25/share. As per the amendment, the residual Notes 1 converted upon the IPO. See Note 13.

 

Convertible Promissory Notes 2

 

In March 2021, the Company raised $1.475 million by the issuance of unsecured Convertible Promissory Notes with a two-year term (the “Notes 2”), to several investors. The Notes 2 holders received approximately 44,000 shares of common stock (at $5.00/share) in the aggregate, with a relative fair value of approximately $192,000 at the time of issuance. Accordingly, the original issue discount on the Notes 2 will be amortized over its term.

 

The Notes 2 bear an interest rate of 10% per annum. The first year of interest was prepaid with the issuance of the Company’s common stock (at $5.00/share), for an issuance of 29,500 shares of common stock with a fair value of $147,500. During the second year of the Notes 2, interest will be paid monthly in the Company’s common stock (at a fixed price of $5.00/share) on any unpaid principal outstanding.

 

The Notes 2 are convertible by a note holder at any time during the term into common stock of the Company at a fixed price of $5.00/share, or 295,000 shares of common stock upon full conversion. Notes 2 have a maturity date of March 5, 2023. All outstanding amounts at the time of the Company’s IPO automatically converted at $5.00/share in the aggregate. Convertible Notes 2 totaled approximately $1.313 million (net of original issue discount of approximately $162,000) at June 30, 2021. The Notes 2 converted upon the IPO. See Note 13.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

SBA Paycheck Protection Program Loans/EIDL

 

In May 2020, the Company received a Paycheck Protection Program 1 (“PPP1”) loan from the Small Business Administration (“SBA”) in the amount of $0.55 million. The Company utilized the PPP 1 loan proceeds in full towards payroll and rent in accordance with the SBA guidelines. Pursuant to SBA guidelines, the Company’s PPP1 loan was fully forgiven in February 2021. In conjunction with the PPP1 loan, the Company also received an Economic Injury Disaster Loan (“EIDL”) advance of $0.01 million. As per the SBA guidelines, EIDL advances do not need to be repaid.

 

In February 2021, the Company received a second Paycheck Protection Program 2 (“PPP2”) loan in the amount of $0.62 million. Similar to the PPP1 loan, the Company expects to utilize the loan proceeds in full toward payroll and rent in accordance with SBA guidelines. The PPP2 loan bears a fixed interest rate of 1% per annum and is due in February 2026. Pursuant to SBA guidelines, the Company expects to apply for full forgiveness of its PPP2 loan in fiscal year 2022.

 

XML 31 R13.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Equity [Abstract]    
EQUITY

NOTE 7. EQUITY

 

Initial Public Offering (“IPO”)

 

On July 1 ,2021, the Company completed an IPO of common stock on the Nasdaq under the symbol “VRAR”, at a price of $7.00 per share.

 

The Company sold approximately 1.91 million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million.

 

In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase 87,500 shares of common stock at $7.00 per share. The warrant cannot be exercised prior to December 30, 2021, and expires in June 2026. The warrant is valued at approximately $520,000 based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 129% expected volatility, 0.87% risk-free rate and 0% expected dividend yield.

 

As stated in Note 6, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through the issuance of 324,150 shares of common stock. A loss of approximately $280,000 was recorded on this conversion at the time of the IPO.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Common Stock Issued

 

Common stock sold to Investors

 

During the three months ended September 30, 2021, the Company sold approximately 1.91 million shares of common stock to investors at the IPO at a price of $7.00 per share, for total net proceeds of approximately $11.82 million.

 

During the three months ended September 30, 2020, the Company sold approximately 2,400 shares of common stock to investors at a price of $4.50 per share, for total net proceeds of approximately $10,800.

 

Common stock issued to Investors

 

During the three months ended September 30, 2021, in connection with the conversion of convertible promissory notes and in conjunction with the IPO, the Company issued 324,150 shares of common stock (see Note 6).

 

Common stock issued for Acquisition

 

During the three months ended September 30, 2021 the Company issued approximately 77,000 shares of common stock, valued at $0.75 million, as consideration for the acquisition of certain assets (see Note 4).

 

Common stock issued for Legacy Acquisition Obligation

 

During the three months ended September 30, 2021 the Company issued 375,000 shares of common stock to satisfy a legacy acquisition obligation of $750,000 (see Note 5). This was accomplished by settling outstanding stock options the acquiree had been granted at $2.00 per share.

 

Common stock issued to Vendors

 

During the three months ended September 30, 2021 and 2020, the Company issued approximately 6,000 and 6,700 shares of common stock, respectively, to various vendors for services performed and recorded share-based compensation of approximately $65,000 and $30,000, respectively (of which approximately $3,000 and $15,000 was unrecognized in the periods, respectively).

 

Common stock issued for Exercise of options

 

During the three months ended September 30, 2021, the Company issued approximately 17,000 shares of common stock upon exercise of the respective option grants, and realized cash proceeds of approximately $46,000.

 

Employee Stock-Based Compensation

 

The Company’s 2016 Equity Incentive Plan (the “Plan”), as amended, has 10 million common shares reserved for issuance. As of September 30, 2021, there were 5.64 million shares available for issuance under the Plan.

 

The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table: 

 

   Three Months Ended
September 30, 2021
   Three Months Ended
September 30, 2020
 
Weighted average expected terms (in years)   5.4    5.1 
Weighted average expected volatility   146.1%   117.3%
Weighted average risk-free interest rate   0.9%   0.3%
Expected dividend yield   0.0%   0.0%

 

The grant date fair value, for options granted during the three months ended September 30, 2021 and 2020 was approximately $0.61 million and $0.40 million, respectively.

 

The following is a summary of the Company’s stock option activity for the three months ended September 30, 2021 and 2020:

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2021   4,740,910   $3.40    8.5   $7,893,467 
Options Granted   94,666    7.11    9.9    423,923 
Options Exercised   (392,394)   2.14    7.2    (3,720,795)
Options Forfeited / Cancelled   (82,838)   4.61    9.5    (563,393)
Outstanding at September 30, 2021   4,360,344   $3.58    8.6   $16,283,017 
Exercisable at September 30, 2021   4,143,324   $3.47    8.5   $15,852,955 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2020   4,092,593   $3.19    8.4   $5,553,916 
Options Granted   108,324    4.50    9.9    - 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (16,809)   4.33    9.4    (2,828)
Outstanding at September 30, 2020   4,184,108   $3.22    8.4   $5,469,339 
Exercisable at September 30, 2020   3,840,479   $3.14    8.4   $5,337,626 

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

The Company’s stock option-based expense for the three months ended September 30, 2021 and 2020 consisted of the following:

 

SCHEDULE OF STOCK OPTION-BASED EXPENSE 

   Three Months Ended
September 30, 2021
   Three Months Ended
September 30, 2020
 
Stock option-based expense :          
Research and development expenses  $347,597   $403,912 
General and administrative expenses   66,643    98,163 
Sales and marketing expenses   127,992    99,300 
Cost of goods sold   22,764    45,687 
Board option expense   88,619    42,751 
Total  $653,615   $689,813 

 

During the year ended June 30, 2019, certain Company advisors received approximately $320,000 worth of Company stock options with an exercise price of $5.25/share and a three-year term, for potential services to be performed over a three-year period. Of the $320,000, $29,000 and $58,000 was categorized as a prepaid expense at September 30, 2021 and June 30, 2021, respectively. During the three months ended September 30, 2021 and 2020, the Company recognized approximately $29,000 for each period, as general and administration expense.

 

At September 30, 2021, total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $1.06 million and is expected to be recognized over a weighted average period of 1.85 years. At September 30, 2020, total unrecognized compensation expense related to stock options was approximately $1.19 million and was recognized over a weighted average period of 0.83 years.

 

The intrinsic value of stock options at September 30, 2021 was computed using a fair market value of the common stock of $7.29/share, as compared to $4.50/share at September 30, 2020.

 

NOTE 6. EQUITY

 

Common Stock and Preferred Stock

 

As of June 30, 2021, the Company had authorized 300 million shares of common stock, $0.001 par value per share and 20 million shares of preferred stock; 7.58 million and 7.04 million shares of common stock were issued and outstanding as of June 30, 2021 and 2020, respectively. 0 shares of preferred stock were issued and outstanding as of June 30, 2021 and 2020, respectively.

 

Sale of Common Stock

 

Common stock sold to Investors

 

During the years ended June 30, 2021 and 2020, the Company sold approximately 76,900 and 1,600 shares of common stock to investors at a price of $4.50/share, for total proceeds of approximately $346,000 and $7,000, respectively.

 

On July 1, 2021 the Company sold 1,912,500 shares of common stock in an initial public offering at a price of $7.00/share. See Note 13.

 

Common stock issued to Investors

 

During the year ended June 30, 2021, in connection with the conversion of convertible promissory notes the Company issued approximately 332,000 shares of common stock (see Note 9).

 

During the years ended June 30, 2021 and 2020, in connection with the issuance of convertible promissory notes, the Company issued approximately 74,000 and 102,000 shares of common stock, respectively (see Note 9).

 

Common stock issued to Vendors

 

During the years ended June 30, 2021 and 2020, the Company issued approximately 28,800 and 23,700 shares of common stock, respectively, to various vendors for services performed and recorded share-based compensation of approximately $134,400 and $101,500, respectively.

 

Common stock issued to satisfy Contingent Liabilities

 

During the year ended June 30, 2021 the Company issued approximately 13,000 shares of common stock to satisfy a contingent liability related to a prior acquisition with a fair market value of approximately $67,000 (see Note 7).

 

During the year ended June 30, 2020 the Company issued approximately 20,000 shares of common stock to satisfy a contingent liability related to a prior acquisition with a fair market value of approximately $92,000 (see Note 7).

 

Employee Stock-Based Compensation

 

In October 2016, the Company’s Board of Directors and its stockholders adopted The Glimpse Group, Inc. 2016 Equity Incentive Plan (the “Plan”).

 

Under the Plan, the Company grants stock options at exercise prices generally equal to the fair value of the common stock on the grant date. These options generally expire ten years after the grant date and vest, depending on the optionee, over a varying period of continuous service following the vesting commencement date of such option (ranging from zero to three years), unless the optionee’s continuous service with the Company is terminated earlier. Stock-based compensation expense is recognized evenly over the requisite service period.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The Plan is administered by the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), who determine the recipients and the terms of the awards granted, subject to the approval of the Company’s Board of Directors. The Plan provides that awards granted may be options, restricted stock, restricted stock units or other stock based awards (collectively the “Awards”). Stock option awards may be either incentive stock options or nonqualified options. The Awards may be granted to eligible employees, directors, service providers, consultants and advisers.

 

As of June 30, 2020 an aggregate of up to 5 million shares of common stock were reserved for issuance under the Plan, with 0.91 million available for issuance.

 

In January and April 2021, the Company amended its 2016 Equity Incentive Plan (the “Plan”), increasing the amount of common shares reserved for issuance from 5 million to 10 million. As of June 30, 2021, there were 5.26 million shares available for issuance under the Plan.

 

In addition, the share reserve will automatically increase on January 1 of each calendar year, for the period beginning on January 1, 2022 and ending on (and including) January 1, 2030 (each, an “Evergreen Date”) in an amount equal to five percent (5%) of the total number of shares of the Company’s common stock outstanding on December 31st immediately preceding the applicable Evergreen Date (the “Evergreen Increase”). Notwithstanding the foregoing, the Board may act prior to the Evergreen Date of a given year to provide that there will be no Evergreen Increase for such year, or that the Evergreen Increase for such year will be a lesser number of shares of the Company’s common stock than would otherwise occur pursuant to the aforementioned. Any shares of stock delivered under the Plan shall consist of authorized and unissued shares or treasury shares. There were no other significant changes to the incentive plan.

 

The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.

 

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table:

 

       
   Year Ended
June, 2021
   Year Ended
June, 2020
 
Weighted average expected terms (in years)   5.3    5.3 
Weighted average expected volatility   126.6%   117.3%
Weighted average risk-free interest rate   0.5%   1.4%
Expected dividend yield   0%   0%

 

The grant date fair value, for options granted during the year ended June 30, 2021 was approximately $2.94 million.

 

The grant date fair value, for options granted during the year ended June 30, 2020 was approximately $2.70 million.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The following is a summary of the Company’s stock option activity for the years ended June 30, 2021 and 2020:

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2019   3,408,452   $2.97    8.5   $3,721,339 
Options Granted   766,455    4.26    9.5    182,328 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (82,314)   3.84    9.6    (53,977)
Outstanding at June 30, 2020   4,092,593   $3.19    8.4   $5,553,916 
Exercisable at June 30, 2020   3,581,514   $3.06    8.3   $5,365,512 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2020   4,092,593   $3.19    8.4   $5,553,916 
Options Granted   766,419    4.66    9.7    383,210 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (118,102)   4.28    8.9    (89,956)
Outstanding at June 30, 2021   4,740,910   $3.40    8.5   $7,893,467 
Exercisable at June 30, 2021   4,346,734   $3.29    8.4   $7,659,692 

 

The Company’s stock option-based expense for the years ended June 30, 2021 and 2020 consisted of the following:

 

   Year Ended
June 30, 2021
   Year Ended
June 30, 2020
 
Stock option-based expense :          
Research and development expenses  $1,381,168   $1,266,911 
General and administrative expenses  $373,506    570,765 
Sales and marketing expenses  $477,561    293,226 
Cost of goods sold  $526,156    236,825 
Board option expense  $187,096    182,794 
Total  $2,945,487   $2,550,521 
           

 

During the year ended June 30, 2019, certain Company advisors received $0.31 million worth of Company stock options with an exercise price of $5.25/share and a three-year term, for potential services to be performed over a three-year period. Of the $0.31 million, $0.06 million and $0.17 million was categorized as a prepaid expense at June 30, 2021 and 2020, respectively. During the years ended June 30, 2021 and 2020, the Company recognized approximately $116,000 for each period, as general and administration expense.

 

At June 30, 2021, total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $1.50 million and is expected to be recognized over a weighted average period of 1.1 years. At June 30, 2020, total unrecognized compensation expense related to stock options was approximately $1.62 million and was expected to be recognized over a weighted average period of 1.02 years.

 

The intrinsic value of stock options as of June 30, 2021 was computed using a fair market value of the common stock of $5.00/share, as compared to $4.50/share as of June 30, 2020.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

XML 32 R14.htm IDEA: XBRL DOCUMENT v3.21.2
EARNINGS PER SHARE
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Earnings Per Share [Abstract]    
EARNINGS PER SHARE

NOTE 8. EARNINGS PER SHARE

 

The following table presents the computation of basic and diluted net loss per common share:

 

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE 

   Three Months Ended September 30, 2021   Three Months Ended September 30, 2020 
Numerator:          
Net loss  $(1,656,761)  $(1,277,324)
Denominator:          
Weighted-average common shares outstanding
for basic and diluted net loss per share
   9,967,821    7,039,928 
Basic and diluted net loss per share  $(0.17)  $(0.18)

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

 

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES 

   At September 30, 2021   At September 30, 2020 
Stock Options   4,360,344    4,184,108 
Warrants   87,500    - 
Convertible Notes   -    296,111 
Total   4,447,844    4,480,219 

 

NOTE 5. EARNINGS PER SHARE

 

The following table presents the computation of basic and diluted net loss per common share:

 

       
   Year Ended
June 30, 2021
   Year Ended
June 30, 2020
 
Numerator:          
Net loss  $(6,091,687)  $(4,993,350)
Denominator:          
Weighted-average common shares outstanding for basic and diluted net loss per share   7,259,249    6,923,506 
Basic and diluted net loss per share  $(0.84)  $(0.72)

 

Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

 

 

   At
June 30, 2021
   At
June 30, 2020
 
Stock Options   4,740,910    4,092,593 
Convertible Notes   324,150    296,111 
Total   5,065,060    4,388,704 

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

XML 33 R15.htm IDEA: XBRL DOCUMENT v3.21.2
PROVISION FOR INCOME TAXES
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Income Tax Disclosure [Abstract]    
PROVISION FOR INCOME TAXES

NOTE 9. PROVISION FOR INCOME TAXES

 

There was no current or deferred income tax provision for the three months ended September 30, 2021 and 2020.

 

The Company’s deferred tax assets as of September 30 2021 and 2020 consist of the following:

 

   As of September 30,   As of September 30, 
   2021   2020 
Deferred tax assets:          
Net-operating loss carryforward  $4,269,910   $2,961,194 
Stock-based compensation   586,042    394,742 
Total Deferred Tax Assets   4,855,952    3,355,936 
Valuation allowance   (4,855,952)   (3,355,936)
Deferred Tax Asset, Net  $-   $- 

 

The Company maintains a valuation allowance on deferred tax assets due to the uncertainty regarding the ability to utilize these deferred tax assets in the future. At September 30, 2021, the Company had potential utilizable aggregate gross net operating loss carryforwards (“NOLs”) of approximately $12.35 million. NOLs for the periods ending June 30, 2018 and prior in the amount of approximately $2.86 million begin to expire in 2037. NOLs subsequent to June 30, 2018 have no expiration.

 

Section 382 of the U.S. Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. The Company has not completed a Section 382 analysis of the NOL carryforwards. Consequently, the Company’s NOL carryforwards may be subject to annual limitations under Section 382.

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. As a result of the uncertainly in the realization of the Company’s deferred tax assets, the Company has provided a valuation allowance for the full amount of the deferred tax assets at September 30, 2021 and September 30, 2020.

 

The Company’s valuation allowance during the three months ended September 30, 2021 and 2020 increased by approximately $0.40 million and $0.20 million, respectively.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:

 

SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE

   For the Three Months Ended September 30,   For the Three Months Ended September 30, 
   2021   2020 
Statutory Federal Income Tax Rate   21.00%   21.00%
State and Local Taxes, Net of Federal Tax Benefit   (13.56)%   (13.56)%
Stock Based Compensation Expense (ISO)   10.61%   19.15%
Change in Valuation Allowance   (18.05)%   (26.59)%
Income Taxes Provision (Benefit)   0.00    0.00 

 

Upon completion of its 2021 U.S. income tax return in 2022, the Company may identify additional remeasurement adjustments. The Company will continue to assess its provision for income taxes as future guidance is issued, but does not currently anticipate significant revisions will be necessary.

 

NOTE 10. PROVISION FOR INCOME TAXES

 

There was no current or deferred income tax provision for the years ended June 30, 2021 and 2020.

 

The Company’s deferred tax assets as of June 30, 2021 and 2020 consist of the following:

 

   As of   As of 
   June 30, 2021   June 30, 2020 
Deferred tax assets:          
Net-operating loss carryforward  $3,923,012   $2,811,156 
Stock-based compensation   536,265    348,013 
Total Deferred Tax Assets   4,459,277    3,159,169 
Valuation allowance   (4,459,277)   (3,159,169)
Deferred Tax Asset, Net  $-   $- 

 

The Company maintains a valuation allowance on deferred tax assets due to the uncertainty regarding the ability to utilize these deferred tax assets in the future. At June 30, 2021, the Company had potential utilizable aggregate gross net operating loss carryforwards (“NOLs”) of approximately $11.35 million. NOLs for the periods ending June 30, 2018 and prior ($2.86 million) begin to expire in 2037. NOLs for the years ending June 30, 2021, 2020 and 2019 ($8.49 million), in accordance with changes to the U.S. Internal Revenue Code, have no expiration.

 

Section 382 of the U.S. Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. The Company has not completed a Section 382 analysis of the NOL carryforwards. Consequently, the Company’s NOL carryforwards may be subject to annual limitations under Section 382.

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. As a result of the uncertainly in the realization of the Company’s deferred tax assets, the Company has provided a valuation allowance for the full amount of the deferred tax assets at June 30, 2021 and June 30, 2020.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The Company’s valuation allowance during the years ended June 30, 2021 and 2020 increased by approximately $1.30 million and $1.00 million, respectively.

 

The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:

SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE 

   For the Year Ended   For the Year Ended 
   June 30, 2021   June 30, 2020 
Statutory Federal Income Tax Rate   (21.00)%   (21.00)%
State and Local Taxes, Net of Federal Tax Benefit   (13.56)%   (13.56)%
Stock Based Compensation Expense (ISO)   13.20%   14.50%
Change in Valuation Allowance   21.36%   20.06%
Income Taxes Provision (Benefit)   0.00    0.00 

 

Upon completion of its 2021 U.S. income tax return in 2022, the Company may identify additional remeasurement adjustments. The Company will continue to assess its provision for income taxes as future guidance is issued, but do not currently anticipate significant revisions will be necessary.

 

XML 34 R16.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]    
COMMITMENTS AND CONTINGENCIES

NOTE 10. COMMITMENTS AND CONTINGENCIES

 

Operating Lease

 

The Company has an office space lease expiring, as amended, on December 31, 2022. To secure the initial lease, the Company paid a $75,000 security deposit.

 

Rent expense was approximately $86,000 and $72,000 for the three months ended September 30, 2021 and 2020, respectively. There is approximately $309,000 due on the lease for the October 2021-September 2022 period and approximately $75,000 due thereafter for the remaining lease term.

 

Potential Future Distributions Upon Divestiture or Sale

 

Upon a divestiture or sale of a subsidiary company, the Company is contractually obligated to distribute up to 10% of the net proceeds from such divestiture or sale to the senior management team of the divested subsidiary company. Currently, there were no active discussions pertaining to a potential divestiture or sale of any of the Company’s subsidiaries.

 

COVID-19

 

The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.

 

From March 2020 through June 2021, the Company had required substantially all of its employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit the Company’s ability to operate its business effectively. Commencing July 2021, the Company has tentatively required employees to return to the office several days a week.

 

We continue to closely monitor the situation and the effects on our business and operations. While uncertainty remains, given the current state of the pandemic, our expected revenue growth and current cash balance, we do not expect the impact of COVID-19 on our business and operations to worsen going forward.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

NOTE 12. COMMITMENTS AND CONTINGENCIES

 

Operating Lease

 

The Company entered into a 2-year lease commencing January 1, 2020 and ending on December 31, 2021. To secure the new lease, the Company paid a $75,000 security deposit.

 

Rent expense was approximately $296,000 and $247,000 for the years ended June 30, 2021 and 2020, respectively. There is approximately $180,000 due on the lease for the July-December 2021 period, prior to any potential discounts.

 

Officers’ Employment Agreements

 

In May 2021, the Company entered into employment agreements with its three corporate officers. The agreements provide for base salary (including increases linked to Company revenue thresholds), performance bonus, incentive bonus (including those based on capital raising thresholds), equity incentives, benefits and severance (including confidentiality and non-compete). The employment agreements will continue until terminated by either the Company or the respective officers. The Company accrued approximately $426,000 of bonuses at June 30, 2021 related to these agreements resulting from the IPO and other met thresholds, as defined. The statement of operations for the year ended June 30, 2021 (the year the employment agreements were executed) includes salary, stock option and the aforementioned bonus expenses for the three officers of approximately $1.03 million.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Potential Future Distributions Upon Divestiture or Sale

 

Upon a divestiture or sale of a subsidiary company, the Company is contractually obligated to distribute up to 10% of the net proceeds from such divestiture or sale to the senior management team of the divested subsidiary company. Currently, there were no active discussions pertaining to a potential divestiture or sale of any of the Company’s subsidiaries.

 

COVID-19

 

The Company’s business and operations have been adversely affected by the COVID-19 pandemic, as have the markets in which our customers operate. The COVID-19 pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.

 

From March 2020 through June 2021, the Company had required substantially all of its employees to work remotely to minimize the risk of the virus. While working remotely has proven to be effective to this point, it may eventually inhibit the Company’s ability to operate its business effectively. Commencing July 2021, the Company has tentatively required employees to return to the office several days a week.

 

The Company continues to closely monitor the situation and the effects on its business and operations. The Company does not yet know the full extent of potential impacts on its business and operations. Given the uncertainty, the Company cannot reasonably estimate the impact on its future results of operations, cash flows or financial condition.

 

XML 35 R17.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Subsequent Events [Abstract]    
SUBSEQUENT EVENTS

NOTE 11. SUBSEQUENT EVENTS

 

ASSET ACQUISTION

 

In October 2021, the Company, through its newly formed and wholly owned subsidiary company, XR Terra, LLC, completed an acquisition of certain assets, as defined, from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming.

 

Initial consideration for the purchase is $0.60 million payable 50% in Company common stock and 50% in cash. In October 2021, the Company paid $0.30 million cash and issued 33,877 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through September 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company is currently determining its purchase price allocation between customer list, intellectual property and goodwill.

 

SECURITIES PURCHASE AGREEMENT (“SPA”)

 

In November 2021, the Company entered into a SPA to sell $15.0 million worth of its common stock and warrants to certain institutional investors in a private placement.

 

Under the terms of the SPA, the Company sold 1.50 million shares of its common stock and warrants to purchase 0.75 million shares of common stock. The warrants have an exercise price of $14.68 per share. The warrants will expire five years from the date they can be exercised. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The gross proceeds to the Company from the registered direct offering were approximately $13.6 million after deducting the placement agent’s fees and other estimated offering expenses.

NOTE 13. SUBSEQUENT EVENTS

 

Initial Public Offering (“IPO”)

 

On July 1 ,2021, the Company completed an IPO of common stock on the NASDAQ under the symbol “VRAR”, at a price of $7.00 per share.

 

The Company sold approximately 1.91 million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million. Professional fees and listing expenses of approximately $0.47 million were included in pre-offering costs, of which $0.309 million was included in accounts payable on the balance sheet at June 30, 2021.

 

In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase 87,500 shares of common stock at $7.00 per share. The warrant cannot be exercised prior to December 30, 2021, and expires in June 2026.

 

As stated in Note 9, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through issuance of 324,150 shares of commons stock.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The following is a condensed balance sheet reflecting the proforma effect of the IPO on the June 30, 2021 balance sheet.

  

   As Reported at
June 30, 2021
   Proforma for IPO 
Cash and cash equivalents  $1,771,929   $13,728,429 
Other current assets   1,406,939    833,296 
Equipment, net   42,172    42,172 
Total assets  $3,221,040   $14,603,897 
           
Total current liabilities  $2,339,037   $2,004,037 
Convertible promissory notes, net   1,429,953    - 
Other long term liability   623,828    623,828 
Total liabilities   4,392,818    2,627,865 
Total stockholders’ equity (deficit)   (1,171,778)   11,976,032 
Total liabilities and stockholders’ equity (deficit)  $3,221,040   $14,603,897 

 

ASSET ACQUISTION

 

In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC, completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd, an Australia based company providing augmented reality software and services. Over time, the acquisition may facilitate the Company’s endeavors in the Architecture, Engineering and Construction (“AEC”) market segments.

 

Initial consideration for the purchase is $0.75 million payable in Company common stock. In August 2021, the Company issued 77,264 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, which is not expected at this time. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company is currently determining its purchase price allocation between customer list, intellectual property and goodwill.

XML 36 R18.htm IDEA: XBRL DOCUMENT v3.21.2
EQUIPMENT, NET
12 Months Ended
Jun. 30, 2021
Property, Plant and Equipment [Abstract]  
EQUIPMENT, NET

NOTE 4. EQUIPMENT, NET

 

Equipment, primarily comprised of computers and hardware, consisted of the following:

 

      Useful Life (Years)      Useful Life (Years) 
   As of June 30, 2021   As of June 30, 2020 
   Value ($)   Useful Life (Years)   Value ($)   Useful Life (Years) 
Equipment  $96,963    3   $105,239    3 
Less: accumulated depreciation   (54,791)        (64,015)     
Balance  $42,172        $41,224      

 

Depreciation expense was $27,054 and $20,222 during the years ended June 30, 2021 and 2020, respectively.

 

XML 37 R19.htm IDEA: XBRL DOCUMENT v3.21.2
GOODWILL
12 Months Ended
Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL

NOTE 8. GOODWILL

 

Due to a significant decline in EA’s business, unsuccessful VR/AR product commercialization efforts and negative future growth prospects, the goodwill related to the EA acquisition was determined to be impaired and written down to $0 as of June 30, 2020. During the year ended June 30, 2020, general and administrative expense included approximately $140,000 for the impairment of goodwill. The Company has no other goodwill.

 

XML 38 R20.htm IDEA: XBRL DOCUMENT v3.21.2
FOREIGN OPERATIONS
12 Months Ended
Jun. 30, 2021
Foreign Operations  
FOREIGN OPERATIONS

NOTE 11. FOREIGN OPERATIONS

 

In March 2021, the Company established Glimpse Turkey to support the operations of Kabaq 3D Technologies (dba QReal). Operations consist primarily of 3D modeler and artist employees. Glimpse Turkey has no revenue, long-term obligations or operating leases and all salaries are denominated in US dollars.

 

In August 2021, the Company completed an asset acquisition which included certain assets, as defined, in Australia. See Note 13.

 

XML 39 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Accounting Policies [Abstract]    
Basis of presentation

Basis of presentation

 

The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2021 and the results of operations and cash flows for the three months ended September 30, 2021 and 2020. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the three months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2022 or for any subsequent periods. The consolidated balance sheet at June 30, 2021 has been derived from the audited consolidated financial statements at that date.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations.

 

These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended June 30, 2021.

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Principles of Consolidation

Principles of Consolidation

 

The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Accounting Estimates

Use of Accounting Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options, cost of goods sold and allocation of the purchase price of assets relating to business combinations.

 

Use of Accounting Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options and cost of goods sold.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash and deposits in bank checking accounts with immediate access and cash equivalents that represent highly liquid investments.

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash and deposits in bank checking accounts or money market funds with immediate access.

 

Accounts Receivable

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of September 30, 2021 and June 30, 2021 no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of June 30, 2021 and June 30, 2020 no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

Customer Concentration and Credit Risk

Customer Concentration and Credit Risk

 

Two customers accounted for approximately 70% (56% and 14%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2021. Four different customers accounted for approximately 53% (19%, 13%, 11% and 10%, respectively) of the Company’s total gross revenues during the three months ended September 30, 2020.

 

One customer accounted for approximately 76% of the Company’s accounts receivable at September 30, 2021. The same customer, and along with a different customer, accounted for approximately 71% (57% and 14%, respectively) of the Company’s accounts receivable at June 30, 2021.

 

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

 

Customer Concentration and Credit Risk

 

Two customers accounted for approximately 49% (26% and 23%, respectively) of the Company’s total gross revenues during the year ended June 30, 2021. One different customer accounted for approximately 13% of the Company’s total gross revenues during the year ended June 30, 2020.

 

Two customers accounted for approximately 71% (57% and 14%, respectively) of the Company’s accounts receivable at June 30, 2021. Four different customers accounted for approximately 96% (35%, 35%, 14% and 12%, respectively) of the Company’s accounts receivable at June 30, 2020.

 

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

 

Equipment, net

Equipment, net

 

Equipment is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.

 

The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.

 

Equipment, net

 

Equipment is stated at cost less accumulated depreciation (see Note 4). Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.

 

The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.

 

Business Combinations

Business Combinations

 

The results of a business acquired in a business combination are included in the Company’s consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business generally being recorded at their estimated fair values as of the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill.

 

The Company performs valuations of assets acquired and liabilities assumed and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired and liabilities assumed may require management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenues, costs and cash flows.

 

 
Intangibles, net

Intangibles, net

 

Intangibles represent the allocation of a portion of an asset acquisition purchase price (see Note 4). Intangibles are stated at allocated cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the related assets.

 

 
Goodwill

Goodwill

 

The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded goodwill related to an asset acquisition, see Note 4.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Goodwill

 

The Company reviews goodwill for impairment annually or more frequently if current circumstances or events indicate that the fair value may be less than its carrying value. The Company recorded a goodwill impairment during the fiscal year ended June 30, 2020 (see Note 8). There was no Goodwill at June 30, 2021 and 2020.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.

 

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s financial instruments, such as accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximates fair value due to its short-term nature and market rate of interest.

 

Revenue Recognition

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
     
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured.

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue for the three months ended September 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.

 

Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

Timing of Revenue

 

The timing of revenue recognition for the three months ended September 30, 2021 and 2020 was as follows:

 

       
   For the Three Months Ended 
   September 30, 
   2021   2020 
Products transferred at a point in time  $955,751   $193,175 
Products and services transferred over time   66,782    66,752 
Total Revenue  $1,022,533   $259,927 

 

Remaining Performance Obligations

 

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.

 

For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

 

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.

 

For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.

 

For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

Deferred revenue is comprised mainly of software project contract performance obligations not completed.

 

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of September 30, 2021, the Company had approximately $1.20 million in unfulfilled performance obligations.

 

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
     
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company adopted the new accounting standard, Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, (“ASC 606”) beginning on July 1, 2020 using the modified retrospective method for all open contracts and related amendments. The adoption did not result in an adjustment to the accumulated deficit as of June 30, 2020. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods. The adoption of ASC 606 did not have a material impact on reported sales to customers and net earnings (losses).

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer that obtains control of the product and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. Most of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct.

 

Any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheet. Deferred costs include cash and equity based payroll costs, and may include payments to vendors.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue for the years ended June 30, 2021 and 2020 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

Revenue for Software Services projects and solutions is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project.

 

Revenue for Software Services consulting services and website maintenance is recognized at the point of time in which the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License and SaaS is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

As detailed in the Company’s Consolidated Statement of Operations, the following is a disaggregation of the Company’s revenue by major source for the years ended June 30, 2021 and 2020:

 

   For the Years Ended 
   June 30, 
   2021   2020 
Software Services  $3,082,528   $1,777,447 
Software License and Software as a Service   338,967    167,868 
Total Revenue  $3,421,495   $1,945,315 

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Timing of Revenue

 

As the Company began adopting ASC 606 in July 2020, the timing of revenue recognition for periods prior to the adoption is not required:

 

   For the Year Ended 
   June 30, 2021 
Products transferred at a point in time  $2,967,586 
Products and services transferred over time   453,909 
Total Revenue  $3,421,495 

 

Remaining Performance Obligations

 

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company records a receivable when revenue is recognized prior to invoicing, or deferred revenue when revenue is recognized subsequent to invoicing.

 

For Software Services project contracts, the Company generally invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. In certain instances one contract may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these distinct projects as separate performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

 

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.

 

For Software License or SaaS contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied.

 

For multi-period Software License or SaaS contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License or SaaS contracts consist of providing clients with software designed by the Company. For Software License or SaaS contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

 

Deferred revenue is comprised mainly of software project contract performance obligations not completed.

 

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of June 30, 2021, the Company had approximately $1.23 million in unfulfilled performance obligations.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Prior to the adoption of ASC 606 at July 1, 2020, the Company’s revenue recognition was as follows:

 

Software Service Revenue

 

The Company generates software related revenues from services performed for: Virtual and Augmented Reality projects, consulting retainers, and ongoing website maintenance and support. Software service revenue generated from Virtual and Augmented Reality projects is recognized after delivery of the project has occurred, when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured. Any unrecognized portion of project revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets. Deferred costs include cash and equity based payroll costs, and may include payments to vendors. Software service revenue generated from consulting retainers is typically billed in advance for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, services have been performed, and collection is reasonably assured. Software service revenue generated from ongoing website maintenance and support services is typically billed in arrears for services performed and is recognized when persuasive evidence of an arrangement exists, the fee is fixed or determinable, and collection is reasonably assured.

 

Software License and Software as a Service Revenue

 

The Company derives revenue from software as-a-service subscriptions and software licenses. Upon delivery of the software to customers, revenue is recognized ratably over the term of the contract or arrangement. The unrecognized portion of this revenue and any corresponding unrecognized expenses are presented as deferred revenue and deferred costs, respectively, in the accompanying consolidated balance sheets.

 

Employee Stock-Based Compensation

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for the Company since its IPO. Prior to its IPO, expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Income Taxes

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2021 AND 2020

 

The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the three months ended September 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.

 

The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the years ended June 30, 2021 and 2020. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.

 

Earnings Per Share

Earnings Per Share

 

Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.

 

Earnings Per Share

 

Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options and convertible debt.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

Recently Issued Pronouncements

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the Company’s financial statements.

Recently Issued Pronouncements

 

Leases

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (Topic 842). The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company does not expect to adopt this standard prior to July 1, 2022. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Financial Instruments – Credit Losses

 

In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates (ASC 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2021 AND 2020

 

XML 40 R22.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Accounting Policies [Abstract]    
SCHEDULE OF TIMING REVENUE RECOGNITION

The timing of revenue recognition for the three months ended September 30, 2021 and 2020 was as follows:

 

       
   For the Three Months Ended 
   September 30, 
   2021   2020 
Products transferred at a point in time  $955,751   $193,175 
Products and services transferred over time   66,782    66,752 
Total Revenue  $1,022,533   $259,927 

As the Company began adopting ASC 606 in July 2020, the timing of revenue recognition for periods prior to the adoption is not required:

 

   For the Year Ended 
   June 30, 2021 
Products transferred at a point in time  $2,967,586 
Products and services transferred over time   453,909 
Total Revenue  $3,421,495 
SCHEDULE OF DISAGGREGATION OF REVENUE  

As detailed in the Company’s Consolidated Statement of Operations, the following is a disaggregation of the Company’s revenue by major source for the years ended June 30, 2021 and 2020:

 

   For the Years Ended 
   June 30, 
   2021   2020 
Software Services  $3,082,528   $1,777,447 
Software License and Software as a Service   338,967    167,868 
Total Revenue  $3,421,495   $1,945,315 
XML 41 R23.htm IDEA: XBRL DOCUMENT v3.21.2
ASSET ACQUISTION (Tables)
3 Months Ended
Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]  
SCHEDULE OF ASSET ACQUISITION

 

   As of September 30, 2021
   Value ($)   Useful Life
(Years)
Intangible Assets        
Customer Relationships  $250,000   3
Technology   250,000   3
Less: Accumulated Amortization   (20,833)   
Intangible Assets, net  $479,167    
         
Goodwill  $250,000   N/A
XML 42 R24.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY (Tables)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Equity [Abstract]    
SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table: 

 

   Three Months Ended
September 30, 2021
   Three Months Ended
September 30, 2020
 
Weighted average expected terms (in years)   5.4    5.1 
Weighted average expected volatility   146.1%   117.3%
Weighted average risk-free interest rate   0.9%   0.3%
Expected dividend yield   0.0%   0.0%

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table:

 

       
   Year Ended
June, 2021
   Year Ended
June, 2020
 
Weighted average expected terms (in years)   5.3    5.3 
Weighted average expected volatility   126.6%   117.3%
Weighted average risk-free interest rate   0.5%   1.4%
Expected dividend yield   0%   0%
SUMMARY OF STOCK OPTION ACTIVITY

The following is a summary of the Company’s stock option activity for the three months ended September 30, 2021 and 2020:

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2021   4,740,910   $3.40    8.5   $7,893,467 
Options Granted   94,666    7.11    9.9    423,923 
Options Exercised   (392,394)   2.14    7.2    (3,720,795)
Options Forfeited / Cancelled   (82,838)   4.61    9.5    (563,393)
Outstanding at September 30, 2021   4,360,344   $3.58    8.6   $16,283,017 
Exercisable at September 30, 2021   4,143,324   $3.47    8.5   $15,852,955 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2020   4,092,593   $3.19    8.4   $5,553,916 
Options Granted   108,324    4.50    9.9    - 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (16,809)   4.33    9.4    (2,828)
Outstanding at September 30, 2020   4,184,108   $3.22    8.4   $5,469,339 
Exercisable at September 30, 2020   3,840,479   $3.14    8.4   $5,337,626 

The following is a summary of the Company’s stock option activity for the years ended June 30, 2021 and 2020:

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2019   3,408,452   $2.97    8.5   $3,721,339 
Options Granted   766,455    4.26    9.5    182,328 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (82,314)   3.84    9.6    (53,977)
Outstanding at June 30, 2020   4,092,593   $3.19    8.4   $5,553,916 
Exercisable at June 30, 2020   3,581,514   $3.06    8.3   $5,365,512 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2020   4,092,593   $3.19    8.4   $5,553,916 
Options Granted   766,419    4.66    9.7    383,210 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (118,102)   4.28    8.9    (89,956)
Outstanding at June 30, 2021   4,740,910   $3.40    8.5   $7,893,467 
Exercisable at June 30, 2021   4,346,734   $3.29    8.4   $7,659,692 
SCHEDULE OF STOCK OPTION-BASED EXPENSE

The Company’s stock option-based expense for the three months ended September 30, 2021 and 2020 consisted of the following:

 

SCHEDULE OF STOCK OPTION-BASED EXPENSE 

   Three Months Ended
September 30, 2021
   Three Months Ended
September 30, 2020
 
Stock option-based expense :          
Research and development expenses  $347,597   $403,912 
General and administrative expenses   66,643    98,163 
Sales and marketing expenses   127,992    99,300 
Cost of goods sold   22,764    45,687 
Board option expense   88,619    42,751 
Total  $653,615   $689,813 

The Company’s stock option-based expense for the years ended June 30, 2021 and 2020 consisted of the following:

 

   Year Ended
June 30, 2021
   Year Ended
June 30, 2020
 
Stock option-based expense :          
Research and development expenses  $1,381,168   $1,266,911 
General and administrative expenses  $373,506    570,765 
Sales and marketing expenses  $477,561    293,226 
Cost of goods sold  $526,156    236,825 
Board option expense  $187,096    182,794 
Total  $2,945,487   $2,550,521 
           
XML 43 R25.htm IDEA: XBRL DOCUMENT v3.21.2
EARNINGS PER SHARE (Tables)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Earnings Per Share [Abstract]    
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE

The following table presents the computation of basic and diluted net loss per common share:

 

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE 

   Three Months Ended September 30, 2021   Three Months Ended September 30, 2020 
Numerator:          
Net loss  $(1,656,761)  $(1,277,324)
Denominator:          
Weighted-average common shares outstanding
for basic and diluted net loss per share
   9,967,821    7,039,928 
Basic and diluted net loss per share  $(0.17)  $(0.18)

The following table presents the computation of basic and diluted net loss per common share:

 

       
   Year Ended
June 30, 2021
   Year Ended
June 30, 2020
 
Numerator:          
Net loss  $(6,091,687)  $(4,993,350)
Denominator:          
Weighted-average common shares outstanding for basic and diluted net loss per share   7,259,249    6,923,506 
Basic and diluted net loss per share  $(0.84)  $(0.72)
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

 

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES 

   At September 30, 2021   At September 30, 2020 
Stock Options   4,360,344    4,184,108 
Warrants   87,500    - 
Convertible Notes   -    296,111 
Total   4,447,844    4,480,219 

Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

 

 

   At
June 30, 2021
   At
June 30, 2020
 
Stock Options   4,740,910    4,092,593 
Convertible Notes   324,150    296,111 
Total   5,065,060    4,388,704 
XML 44 R26.htm IDEA: XBRL DOCUMENT v3.21.2
PROVISION FOR INCOME TAXES (Tables)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Income Tax Disclosure [Abstract]    
SCHEDULE OF DEFERRED TAX ASSETS

The Company’s deferred tax assets as of September 30 2021 and 2020 consist of the following:

 

   As of September 30,   As of September 30, 
   2021   2020 
Deferred tax assets:          
Net-operating loss carryforward  $4,269,910   $2,961,194 
Stock-based compensation   586,042    394,742 
Total Deferred Tax Assets   4,855,952    3,355,936 
Valuation allowance   (4,855,952)   (3,355,936)
Deferred Tax Asset, Net  $-   $- 

The Company’s deferred tax assets as of June 30, 2021 and 2020 consist of the following:

 

   As of   As of 
   June 30, 2021   June 30, 2020 
Deferred tax assets:          
Net-operating loss carryforward  $3,923,012   $2,811,156 
Stock-based compensation   536,265    348,013 
Total Deferred Tax Assets   4,459,277    3,159,169 
Valuation allowance   (4,459,277)   (3,159,169)
Deferred Tax Asset, Net  $-   $- 
SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE

The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:

 

SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE

   For the Three Months Ended September 30,   For the Three Months Ended September 30, 
   2021   2020 
Statutory Federal Income Tax Rate   21.00%   21.00%
State and Local Taxes, Net of Federal Tax Benefit   (13.56)%   (13.56)%
Stock Based Compensation Expense (ISO)   10.61%   19.15%
Change in Valuation Allowance   (18.05)%   (26.59)%
Income Taxes Provision (Benefit)   0.00    0.00 

The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:

SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE 

   For the Year Ended   For the Year Ended 
   June 30, 2021   June 30, 2020 
Statutory Federal Income Tax Rate   (21.00)%   (21.00)%
State and Local Taxes, Net of Federal Tax Benefit   (13.56)%   (13.56)%
Stock Based Compensation Expense (ISO)   13.20%   14.50%
Change in Valuation Allowance   21.36%   20.06%
Income Taxes Provision (Benefit)   0.00    0.00 
XML 45 R27.htm IDEA: XBRL DOCUMENT v3.21.2
EQUIPMENT, NET (Tables)
12 Months Ended
Jun. 30, 2021
Property, Plant and Equipment [Abstract]  
SCHEDULE OF EQUIPMENT, NET

Equipment, primarily comprised of computers and hardware, consisted of the following:

 

      Useful Life (Years)      Useful Life (Years) 
   As of June 30, 2021   As of June 30, 2020 
   Value ($)   Useful Life (Years)   Value ($)   Useful Life (Years) 
Equipment  $96,963    3   $105,239    3 
Less: accumulated depreciation   (54,791)        (64,015)     
Balance  $42,172        $41,224      
XML 46 R28.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS (Tables)
12 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]  
SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT

The following is a condensed balance sheet reflecting the proforma effect of the IPO on the June 30, 2021 balance sheet.

  

   As Reported at
June 30, 2021
   Proforma for IPO 
Cash and cash equivalents  $1,771,929   $13,728,429 
Other current assets   1,406,939    833,296 
Equipment, net   42,172    42,172 
Total assets  $3,221,040   $14,603,897 
           
Total current liabilities  $2,339,037   $2,004,037 
Convertible promissory notes, net   1,429,953    - 
Other long term liability   623,828    623,828 
Total liabilities   4,392,818    2,627,865 
Total stockholders’ equity (deficit)   (1,171,778)   11,976,032 
Total liabilities and stockholders’ equity (deficit)  $3,221,040   $14,603,897 
XML 47 R29.htm IDEA: XBRL DOCUMENT v3.21.2
LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended 61 Months Ended
Nov. 02, 2021
Jul. 02, 2021
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Subsequent Event [Line Items]              
Net loss     $ 1,656,761 $ 1,277,324 $ 6,091,687 $ 4,993,350  
Share issued price per share   $ 7.00          
Gross proceeds from issuance initial public offering   $ 13,400,000          
Net proceeds from issuance initial public offering   $ 11,800,000 11,821,364      
Cash and Cash Equivalents, at Carrying Value     12,567,632   1,771,929 1,034,846 $ 1,771,929
Net cash used in operating activities         1,210,000    
Net cash used in operating activities     1,053,136 160,542 1,209,616 2,024,275  
Proceeds from issuance of common stock and convertible debt             8,880,000
Proceeds from issuance of common stock     10,820 346,010 7,000 1,820,000
Cash         1,770,000 1,030,000.00 1,770,000
Revenues     $ 1,022,533 $ 259,927 3,421,495 1,945,315  
Proceeds from PPP loan         548,885  
Cash position         13,000,000   $ 13,000,000
Contracted revenue backlog         $ 1,500,000    
Payment Protection Program One [Member]              
Subsequent Event [Line Items]              
Proceeds from PPP loan           549,000  
Payment Protection Program Two [Member]              
Subsequent Event [Line Items]              
Proceeds from PPP loan           $ 624,000  
Subsequent Event [Member]              
Subsequent Event [Line Items]              
Share issued price per share   $ 7.00          
Gross proceeds from issuance initial public offering   $ 13,400,000          
Net proceeds from issuance initial public offering $ 13,600,000 $ 11,800,000          
Cash and Cash Equivalents, at Carrying Value $ 26,000,000            
XML 48 R30.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF TIMING REVENUE RECOGNITION (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Disaggregation of Revenue [Line Items]        
Total revenue $ 1,022,533 $ 259,927 $ 3,421,495 $ 1,945,315
Transferred at Point in Time [Member]        
Disaggregation of Revenue [Line Items]        
Total revenue 955,751 193,175 2,967,586  
Transferred over Time [Member]        
Disaggregation of Revenue [Line Items]        
Total revenue $ 66,782 $ 66,752 $ 453,909  
XML 49 R31.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Product Information [Line Items]        
Allowance for doubtful accounts receivable $ 0   $ 0  
Unfulfilled performance obligations $ 1,200,000   $ 1,230,000  
Tax benefit settlement description greater than 50%   greater than 50%  
Goodwill $ 250,000   $ (0) $ 0
Two Customers [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage 70.00%   49.00%  
Two Customers [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage     71.00%  
Customer One [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage 56.00%   26.00%  
Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage     57.00%  
Customer Two [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage 14.00%   23.00%  
Customer Two [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage     14.00%  
Four Other Customers [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage   53.00%   96.00%
Other Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage   19.00%   35.00%
Other Customer Two [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage   13.00%   35.00%
Other Customer Three [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage   11.00%   14.00%
Other Customer Four [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage   10.00%   12.00%
One Customers [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage 76.00%      
Other Customers [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk percentage       13.00%
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF ASSET ACQUISITION (Details) - USD ($)
3 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Acquired Finite-Lived Intangible Assets [Line Items]    
Accumulated amortization $ (20,833)  
Intangible assets, net 479,167
Goodwill 250,000  
Customer Relationships [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Technology $ 250,000  
Intangible assets useful life (years) 3 years  
Technology-Based Intangible Assets [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Technology $ 250,000  
Intangible assets useful life (years) 3 years  
XML 51 R33.htm IDEA: XBRL DOCUMENT v3.21.2
ASSET ACQUISTION (Details Narrative)
$ in Thousands
1 Months Ended
Aug. 31, 2021
USD ($)
shares
Business Combination and Asset Acquisition [Abstract]  
Purchase of assets consideration value | $ $ 750
Common stock purchase price | shares 77,264
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.21.2
CONTINGENT ACQUISITION LIABILITY (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jul. 02, 2021
Aug. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Business Acquisition [Line Items]        
Shares issued 1,910,000      
Shares issued price per share $ 7.00      
Kabaq3D Technologies, LLC [Member]        
Business Acquisition [Line Items]        
Additional acquisition cost   $ 750,000    
Kabaq3D Technologies, LLC [Member] | Forecast [Member]        
Business Acquisition [Line Items]        
Additional acquisition cost   $ 750,000    
Kabaq3D Technologies, LLC [Member] | Equity Option [Member]        
Business Acquisition [Line Items]        
Shares issued   375,000    
Shares issued price per share   $ 2.00    
KreatAR LLC [Member]        
Business Acquisition [Line Items]        
Additional acquisition cost   $ 500,000    
KreatAR LLC [Member] | Forecast [Member]        
Business Acquisition [Line Items]        
Additional acquisition cost   $ 500,000    
Early Adopter.Com [Member]        
Business Acquisition [Line Items]        
Business acqusition, share price     $ 3.25  
Contingent acquisition liability     $ 96,800 $ 47,000
Stock issued during peirod shares acquisitions     32,000  
XML 53 R35.htm IDEA: XBRL DOCUMENT v3.21.2
DEBT (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 02, 2021
Jun. 30, 2021
Mar. 31, 2021
Feb. 28, 2021
Jan. 31, 2021
May 31, 2020
Dec. 31, 2019
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Short-term Debt [Line Items]                          
Stock issued during period value                 $ 10,820     $ 346,010 $ 7,000
Convertible promissory notes   $ 1,429,953               $ 1,429,953   1,429,953  
Loss on conversion of convertible notes               $ (279,730)     (515,464)
Share issued price per share $ 7.00                        
Shares issued 1,910,000                        
Gain loss on debt                   548,885
Proceeds from debt                       548,885
IPO [Member]                          
Short-term Debt [Line Items]                          
Debt conversion converted instrument shares               324,150          
Loss on conversion of convertible notes               $ 280,000          
Share issued price per share               $ 7.00          
Convertible Notes Payable [Member]                          
Short-term Debt [Line Items]                          
Proceeds from issuance of unsecured debt     $ 1,475,000       $ 1,330,000           $ 1,330,000
Debt instrument maturity date, description     two-year term       three-year            
Debt instrument interest rate percentage     10.00%       10.00%       10.00%   10.00%
Debt interest payment description             during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion           during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion.
Debt conversion converted instrument shares     295,000   300,000   295,000 324,150   300,000   332,000 295,000
Original issue discount on notes                         $ 149,000
Stock issued during period value     $ 192,000   $ 1,210,000         $ 1,210,000     $ 170,000
Debt instrument conversion price per share   $ 4,000,000.00     $ 4.00         $ 4,000,000.00   $ 4,000,000.00  
Convertible promissory notes   $ 117,000               $ 117,000   $ 117,000  
Debt instrument maturity date     Mar. 05, 2023                    
Share issued price per share     $ 5.00               $ 5.00   $ 4.50
Debt instrument term     2 years                   3 years
Shares issued     44,000                   45,000
Convertible Notes Payable [Member] | Maximum [Member]                          
Short-term Debt [Line Items]                          
Debt instrument conversion price per share     $ 4.50               4.50    
Convertible Notes Payable [Member] | Minimum [Member]                          
Short-term Debt [Line Items]                          
Debt instrument conversion price per share   $ 4.00               $ 4.00   $ 4.00  
Convertible Notes Payable [Member] | Executives And Independent Members [Member]                          
Short-term Debt [Line Items]                          
Debt instrument face amount                         $ 200,000
Convertible Notes Payable [Member] | IPO [Member]                          
Short-term Debt [Line Items]                          
Original issue discount on notes   $ 8,000               $ 8,000   $ 8,000  
Debt instrument conversion price per share   $ 4.25 $ 5.00             $ 4.25 $ 5.00 $ 4.25  
Loss on conversion of convertible notes   $ 18,000 $ 262,000                    
Convertible Notes Payable [Member] | Additional Interest [Member]                          
Short-term Debt [Line Items]                          
Original issue discount on notes                 $ 48,500       96,900
Convertible Notes Payable [Member] | Second Year Of Notes [Member]                          
Short-term Debt [Line Items]                          
Original issue discount on notes   162,000 162,000             $ 162,000 $ 162,000 $ 162,000  
Convertible promissory notes   $ 1,313,000 $ 1,313,000             $ 1,313,000 $ 1,313,000 $ 1,313,000  
Share issued price per share   $ 5.00 $ 5.00             $ 5.00 $ 5.00 $ 5.00  
Convertible Notes Payable [Member] | First Two Years Of Interes Prepayment [Member]                          
Short-term Debt [Line Items]                          
Stock issued during period value                         $ 258,000
Share issued price per share                         $ 4.50
Shares issued                         57,000
Convertible Notes Payable [Member] | Third Year Interest [Member]                          
Short-term Debt [Line Items]                          
Debt instrument interest rate percentage     10.00%               10.00%    
Debt interest payment description                     during the year ended June 30, 2021, reflecting the reduction of the Notes conversion price from $4.50/share to $4.00/share, the issuance of Year 3 Interest (10%) paid in common stock (at $4.00/share instead of $4.50/share), and the write-off of the remaining related pre-paid interest and original issue discount expenses.    
Stock issued during period value                     $ 122,000    
Debt instrument term                     3 years    
Shares issued                     30,000    
Gain loss on debt                     $ 515,500    
Convertible Notes Payable [Member] | Frist Year Of Interest Prepayment [Member]                          
Short-term Debt [Line Items]                          
Stock issued during period value     $ 147,500                    
Shares issued     29,500                    
Paycheck Protection Program [Member]                          
Short-term Debt [Line Items]                          
Debt instrument maturity date, description       February 2026                  
Debt instrument interest rate percentage       1.00%                  
Proceeds from debt       $ 620,000   $ 550,000              
Economic Injury Disaster Loan [Member]                          
Short-term Debt [Line Items]                          
Proceeds from debt           $ 10,000.00              
XML 54 R36.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Equity [Abstract]        
Weighted average expected terms (in years) 5 years 4 months 24 days 5 years 1 month 6 days 5 years 3 months 18 days 5 years 3 months 18 days
Weighted average expected volatility 146.10% 117.30% 126.60% 117.30%
Weighted average risk-free interest rate 0.90% 0.30% 0.50% 1.40%
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
XML 55 R37.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF STOCK OPTION ACTIVITY (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Equity [Abstract]        
Options Outstanding, Beginning balance 4,740,910 4,092,593 4,092,593 3,408,452
Weighted Average Exercise Price, Outstanding, Beginning balance $ 3.40 $ 3.19 $ 3.19 $ 2.97
Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning 8 years 6 months 8 years 4 months 24 days 8 years 4 months 24 days 8 years 6 months
Intrinsic Value, Outstanding Beginning balance $ 7,893,467 $ 5,553,916 $ 5,553,916 $ 3,721,339
Options, Granted 94,666 108,324 766,419 766,455
Weighted Average Exercise Price, Options Granted $ 7.11 $ 4.50 $ 4.66 $ 4.26
Weighted Average Remaining Contractual Term (Yrs), Options Granted 9 years 10 months 24 days 9 years 10 months 24 days 9 years 8 months 12 days 9 years 6 months
Intrinsic Value, Options Granted $ 423,923   $ 383,210 $ 182,328
Options, Exercised (392,394)
Weighted Average Exercise Price, Options Exercised $ 2.14
Weighted Average Remaining Contractual Term (Yrs), Options Exercised 7 years 2 months 12 days      
Intrinsic Value, Options Exercised $ (3,720,795)      
Options, Forfeited/Cancelled (82,838) (16,809) (118,102) (82,314)
Weighted Average Exercise Price, Options Forfeited/Cancelled $ 4.61 $ 4.33 $ 4.28 $ 3.84
Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled 9 years 6 months 9 years 4 months 24 days 8 years 10 months 24 days 9 years 7 months 6 days
Intrinsic Value, Options Forfeited/Cancelled $ (563,393) $ (2,828) $ 89,956 $ 53,977
Options Outstanding, Ending balance 4,360,344 4,184,108 4,740,910 4,092,593
Weighted Average Exercise Price, Outstanding, Ending balance $ 3.58 $ 3.22 $ 3.40 $ 3.19
Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending 8 years 7 months 6 days 8 years 4 months 24 days 8 years 6 months 8 years 4 months 24 days
Intrinsic Value, Outstanding Ending balance $ 16,283,017 $ 5,469,339 $ 7,893,467 $ 5,553,916
Options Exercisable, Ending balance 4,143,324 3,840,479 4,346,734 3,581,514
Weighted Average Exercise Price, Exercisable, Ending balance $ 3.47 $ 3.14 $ 3.29 $ 3.06
Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending 8 years 6 months 8 years 4 months 24 days 8 years 4 months 24 days 8 years 3 months 18 days
Intrinsic Value, Exercisable Ending balance $ 15,852,955 $ 5,337,626 $ 7,659,692 $ 5,365,512
Options, Exercised 392,394
Intrinsic Value, Options Forfeited/Cancelled $ 563,393 $ 2,828 $ (89,956) $ (53,977)
XML 56 R38.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF STOCK OPTION-BASED EXPENSE (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Total $ 653,615 $ 689,813 $ 2,945,487 $ 2,550,521
Research and Development Expense [Member]        
Total 347,597 403,912 1,381,168 1,266,911
General and Administrative Expense [Member]        
Total 66,643 98,163 373,506 570,765
Selling and Marketing Expense [Member]        
Total 127,992 99,300 477,561 293,226
Cost of Sales [Member]        
Total 22,764 45,687 526,156 236,825
Board Option Expense [Member]        
Total $ 88,619 $ 42,751 $ 187,096 $ 182,794
XML 57 R39.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 61 Months Ended
Jul. 02, 2021
Jun. 30, 2021
Mar. 31, 2021
Jan. 31, 2021
Dec. 31, 2019
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2021
Apr. 30, 2021
Subsidiary, Sale of Stock [Line Items]                          
Shares Issued, Price Per Share $ 7.00                        
Shares issued 1,910,000                        
Proceeds from Issuance or Sale of Equity $ 11,820,000                        
Warrant exercisable description           The warrant is valued at approximately $520,000 based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 129% expected volatility, 0.87% risk-free rate and 0% expected dividend yield.              
Loss on conversion of convertible notes           $ (279,730)   $ (515,464)      
Proceeds from sale of common stock           10,820   346,010 7,000   $ 1,820,000  
Stock issued during period value             $ 10,820   $ 346,010 $ 7,000      
Legacy acquisition obligation           $ 750,000              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price           $ 7.11 $ 4.50   $ 4.66 $ 4.26      
Options granted, fair value           610,000 400,000   2.94 2.70      
Stock options exercise price per share           $ 2.14        
General and administration expense           $ 779,729 $ 335,998   $ 2,220,811 $ 1,835,147      
Common stock shares authorized   300,000,000       300,000,000   300,000,000 300,000,000 300,000,000   300,000,000  
Common stock par value per share   $ 0.001       $ 0.001   $ 0.001 $ 0.001 $ 0.001   $ 0.001  
Preferred stock shares authorized   20,000,000       20,000,000   20,000,000 20,000,000 20,000,000   20,000,000  
Common stock shares issued   7,579,285       10,291,638   7,579,285 7,579,285 7,035,771   7,579,285  
Common stock shares outstanding   7,579,285       10,291,638   7,579,285 7,579,285 7,035,771   7,579,285  
Preferred stock shares issued   0       0   0 0 0   0  
Preferred stock shares outstanding   0       0   0 0 0   0  
Subsequent Event [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares Issued, Price Per Share $ 7.00                        
Shares issued 1,912,500                        
2016 Equity Incentive Plan [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock available for issuance   5,260,000       5,640,000   5,260,000 5,260,000 910,000   5,260,000  
Prepaid expenses   $ 58,000       $ 29,000   $ 58,000 $ 58,000 $ 170,000   $ 58,000  
General and administration expense           29,000     116,000 116,000      
Unrecognized compensation expense to employees and vendors   $ 1,500,000       $ 1,060,000.00 $ 1,190,000 $ 1,500,000 $ 1,500,000 $ 1,620,000   $ 1,500,000  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition           1 year 10 months 6 days 9 months 29 days   1 year 1 month 6 days 1 year 7 days      
Stock options intrinsic value per share           $ 7.29 $ 4.50   $ 5.00 $ 4.50      
2016 Equity Incentive Plan [Member] | Maximum [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Aggregate number of common stock shares reserved for future issuance           10,000,000       5,000,000     10,000,000
To Satisfy Contingent Liabilities [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued           17,000     13,000 20,000      
Stock issued during period value           $ 46,000     $ 67,000 $ 92,000      
Legacy Acquisition Obligation [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price           $ 2.00              
Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued             2,423   76,891 1,556      
Stock issued during period value             $ 2   $ 77 $ 1      
Common Stock [Member] | Acquisition [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued           77,000              
Stock issued during period value           $ 750,000              
Common Stock [Member] | Legacy Acquisition Obligation [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued           375,000              
Convertible Notes Payable [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares Issued, Price Per Share     $ 5.00             $ 4.50      
Shares issued     44,000             45,000      
Stock issued during period shares     295,000 300,000 295,000 324,150   300,000 332,000 295,000      
Stock issued during period value     $ 192,000 $ 1,210,000       $ 1,210,000   $ 170,000      
New Convertible Promissory Notes [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued                 74,000        
Convertible Promissory Notes [Member] [Default Label]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued                   102,000      
Investor [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares Issued, Price Per Share   $ 4.50       $ 7.00 $ 4.50 $ 4.50 $ 4.50     $ 4.50  
Shares issued           1,910,000 2,400   76,900 1,600      
Proceeds from sale of common stock           $ 11,820,000 $ 10,800   $ 346,000 $ 7,000      
Vendors [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock issued during period shares for services           6,000 6,700   28,800 23,700      
Share-based compensation expense           $ 65,000 $ 30,000   $ 134,400 $ 101,500      
Unrecognized Share based compensation           $ 3,000 $ 15,000            
Advisors [Member] | 2016 Equity Incentive Plan [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock options granted during period value                     $ 320,000    
Stock options exercise price per share                     $ 5.25    
Stock based compensation description                     three-year term, for potential services to be performed over a three-year    
Stock options granted during period value                     $ 310,000    
Stock options exercise period                     3 years    
Employees [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock based compensation description                 the share reserve will automatically increase on January 1 of each calendar year, for the period beginning on January 1, 2022 and ending on (and including) January 1, 2030 (each, an “Evergreen Date”) in an amount equal to five percent (5%) of the total number of shares of the Company’s common stock outstanding on December 31st immediately preceding the applicable Evergreen Date (the “Evergreen Increase”).        
IPO [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares Issued, Price Per Share           $ 7.00              
Stock issued during period shares for services           87,500              
Stock issued during period shares           324,150              
Loss on conversion of convertible notes           $ 280,000              
IPO [Member] | Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued                 1,910,000        
Proceeds from sale of common stock                 $ 11,820,000        
IPO [Member] | Convertible Notes Payable [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Loss on conversion of convertible notes   $ 18,000 $ 262,000                    
XML 58 R40.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Earnings Per Share [Abstract]        
Net loss $ (1,656,761) $ (1,277,324) $ (6,091,687) $ (4,993,350)
Weighted-average common shares outstanding for basic and diluted net loss per share 9,967,821 7,039,928 7,259,249 6,923,506
Basic and diluted net loss per share $ (0.17) $ (0.18) $ (0.84) $ (0.72)
XML 59 R41.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) - shares
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Potentially dilutive securities 4,447,844 4,480,219 5,065,060 4,388,704
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Potentially dilutive securities 4,360,344 4,184,108 4,740,910 4,092,593
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Potentially dilutive securities 87,500    
Convertible Debt Securities [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Potentially dilutive securities 296,111 324,150 296,111
XML 60 R42.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2020
Jun. 30, 2020
Income Tax Disclosure [Abstract]        
Net-operating loss carryforward $ 4,269,910 $ 3,923,012 $ 2,961,194 $ 2,811,156
Stock-based compensation 586,042 536,265 394,742 348,013
Total Deferred Tax Assets 4,855,952 4,459,277 3,355,936 3,159,169
Valuation allowance (4,855,952) (4,459,277) (3,355,936) (3,159,169)
Deferred Tax Asset, Net
XML 61 R43.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE (Details)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Tax Disclosure [Abstract]        
Statutory Federal Income Tax Rate 21.00% 21.00% 21.00% 21.00%
State and Local Taxes, Net of Federal Tax Benefit (13.56%) (13.56%) 13.56% 13.56%
Stock Based Compensation Expense (ISO) 10.61% 19.15% 13.20% 14.50%
Change in Valuation Allowance (18.05%) (26.59%) (21.36%) (20.06%)
Income Taxes Provision (Benefit) 0.00% 0.00% 0.00% 0.00%
Statutory Federal Income Tax Rate (21.00%) (21.00%) (21.00%) (21.00%)
State and Local Taxes, Net of Federal Tax Benefit 13.56% 13.56% (13.56%) (13.56%)
Change in Valuation Allowance 18.05% 26.59% 21.36% 20.06%
XML 62 R44.htm IDEA: XBRL DOCUMENT v3.21.2
PROVISION FOR INCOME TAXES (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2018
Income Tax Disclosure [Abstract]          
Operating loss carry forwards, net $ 12,350   $ 11,350   $ 2,860
Operating loss carry forwards expiration date NOLs for the periods ending June 30, 2018 and prior in the amount of approximately $2.86 million begin to expire in 2037   NOLs for the periods ending June 30, 2018 and prior ($2.86 million) begin to expire in 2037.    
Valuation allowance $ 400 $ 200 $ 1,300 $ 1,000  
Net operating loss carryforwards no expiration     $ 8,490    
XML 63 R45.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Lease Expiration Date Dec. 31, 2022   Dec. 31, 2021  
Security deposit $ 75,000   $ 75,000  
Rent expense $ 86,000 $ 72,000 $ 296,000 $ 247,000
Maximum distribution percentage of net proceeds from divestiture 10.00%   10.00%  
Lease term     2 years  
Lease commencing date     Jan. 01, 2020  
Accrued bonuses     $ 426,000  
Three Officers [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Bonus expenses     1,030,000.00  
October Two Thousand Twenty One To September Two Thousand Twenty Two [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Lease payments $ 309,000      
Lease payments due thereafter $ 75,000      
July And December Two Thousand Twenty One [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Lease payments     $ 180,000  
XML 64 R46.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended 61 Months Ended
Jul. 02, 2021
Nov. 30, 2021
Oct. 31, 2021
Aug. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Subsequent Event [Line Items]                  
Purchase of assets consideration value       $ 750,000          
Shares Issued, Price Per Share $ 7.00                
Shares issued 1,910,000                
Proceeds from issuance of common stock         $ 10,820 $ 346,010 $ 7,000 $ 1,820,000
Common stock purchase price       77,264          
Common Stock [Member]                  
Subsequent Event [Line Items]                  
Shares issued           2,423 76,891 1,556  
Conversion of stock, shares issued             324,150    
IPO [Member]                  
Subsequent Event [Line Items]                  
Number of warrants to purchase per share             $ 7.00   $ 7.00
Shares Issued, Price Per Share         $ 7.00        
Number of warrants to purchase             87,500   87,500
Warrants expires date             Jun. 30, 2026    
IPO [Member] | Pre Offering Costs [Member]                  
Subsequent Event [Line Items]                  
Professional fees and listing expenses             $ 470,000    
IPO [Member] | Accounts Payable [Member]                  
Subsequent Event [Line Items]                  
Professional fees and listing expenses             $ 309,000    
IPO [Member] | Common Stock [Member]                  
Subsequent Event [Line Items]                  
Shares issued             1,910,000    
Proceeds from issuance of common stock             $ 11,820,000    
Subsequent Event [Member]                  
Subsequent Event [Line Items]                  
Purchase of assets consideration value     $ 600,000 $ 750,000          
Stock purchase percentage     50.00%            
Stock Repurchased During Period, Value     $ 300,000            
Stock Repurchased During Period, Shares     33,877            
Shares Issued, Price Per Share $ 7.00                
Shares issued 1,912,500                
Common stock purchase price       77,264          
Subsequent Event [Member] | IPO [Member]                  
Subsequent Event [Line Items]                  
Sale of stock, price per share $ 7.00                
Subsequent Event [Member] | Securities Purchase Agreement [Member]                  
Subsequent Event [Line Items]                  
Proceeds from sale of stock   $ 15,000,000.0              
Sale of stock, shares   1,500,000              
Warrants to purchase shares   750,000              
Number of warrants to purchase per share   $ 14.68              
Warrants and Rights Outstanding, Term   5 years              
Shares Issued, Price Per Share   $ 10.00              
Proceeds from warrants exercise   $ 13,600,000              
XML 65 R47.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Product Information [Line Items]        
Total Revenue $ 1,022,533 $ 259,927 $ 3,421,495 $ 1,945,315
Software Sercices [Member]        
Product Information [Line Items]        
Total Revenue 804,718 187,652 3,082,528 1,777,447
SoftwareServicesMember        
Product Information [Line Items]        
Total Revenue       1,777,447
Software License and Software as a Service [Member]        
Product Information [Line Items]        
Total Revenue     338,967  
Software License [Member]        
Product Information [Line Items]        
Total Revenue $ 217,815 $ 72,275 $ 338,967 $ 167,868
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF EQUIPMENT, NET (Details) - USD ($)
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Sep. 30, 2021
Property, Plant and Equipment [Abstract]      
Equipment $ 96,963 $ 105,239  
Property, Plant and Equipment, Useful Life 3 years 3 years  
Less: accumulated depreciation $ (54,791) $ (64,015)  
Balance $ 42,172 $ 41,224 $ 53,513
XML 67 R49.htm IDEA: XBRL DOCUMENT v3.21.2
EQUIPMENT, NET (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 27,054 $ 20,222
XML 68 R50.htm IDEA: XBRL DOCUMENT v3.21.2
GOODWILL (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Goodwill [Line Items]        
Goodwill impairment $ 139,754
General and Administrative Expense [Member]        
Goodwill [Line Items]        
Goodwill impairment       140,000
Early Adopter.Com [Member]        
Goodwill [Line Items]        
Goodwill impairment       $ 0
XML 69 R51.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT (Details) - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Cash and cash equivalents $ 12,567,632 $ 1,771,929   $ 1,034,846  
Other current assets   1,406,939      
Property, Plant and Equipment, Net 53,513 42,172   41,224  
Total assets 14,609,954 3,221,040   1,997,235  
Total current liabilities 1,152,105 2,339,037   570,504  
Convertible promissory notes, net   1,429,953      
Other long term liability   623,828      
Total liabilities 1,775,933 4,392,818   2,302,924  
Total stockholders' equity (deficit) 12,834,021 (1,171,778) $ (728,026) (305,689) $ 1,473,718
Total liabilities and stockholders' equity (deficit) $ 14,609,954 3,221,040   $ 1,997,235  
Pro Forma [Member]          
Cash and cash equivalents   13,728,429      
Other current assets   833,296      
Property, Plant and Equipment, Net   42,172      
Total assets   14,603,897      
Total current liabilities   2,004,037      
Convertible promissory notes, net        
Other long term liability   623,828      
Total liabilities   2,627,865      
Total stockholders' equity (deficit)   11,976,032      
Total liabilities and stockholders' equity (deficit)   $ 14,603,897      
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 208 376 1 false 69 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://theglimpsegroup.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://theglimpsegroup.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://theglimpsegroup.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://theglimpsegroup.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) Sheet http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit Consolidated Statement of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://theglimpsegroup.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - DESCRIPTION OF BUSINESS Sheet http://theglimpsegroup.com/role/DescriptionOfBusiness DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 00000008 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES Sheet http://theglimpsegroup.com/role/LiquidityAndCapitalResources LIQUIDITY AND CAPITAL RESOURCES Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - ASSET ACQUISTION Sheet http://theglimpsegroup.com/role/AssetAcquistion ASSET ACQUISTION Notes 10 false false R11.htm 00000011 - Disclosure - CONTINGENT ACQUISITION LIABILITY Sheet http://theglimpsegroup.com/role/ContingentAcquisitionLiability CONTINGENT ACQUISITION LIABILITY Notes 11 false false R12.htm 00000012 - Disclosure - DEBT Sheet http://theglimpsegroup.com/role/Debt DEBT Notes 12 false false R13.htm 00000013 - Disclosure - EQUITY Sheet http://theglimpsegroup.com/role/Equity EQUITY Notes 13 false false R14.htm 00000014 - Disclosure - EARNINGS PER SHARE Sheet http://theglimpsegroup.com/role/EarningsPerShare EARNINGS PER SHARE Notes 14 false false R15.htm 00000015 - Disclosure - PROVISION FOR INCOME TAXES Sheet http://theglimpsegroup.com/role/ProvisionForIncomeTaxes PROVISION FOR INCOME TAXES Notes 15 false false R16.htm 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://theglimpsegroup.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 00000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://theglimpsegroup.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 00000018 - Disclosure - EQUIPMENT, NET Sheet http://theglimpsegroup.com/role/EquipmentNet EQUIPMENT, NET Notes 18 false false R19.htm 00000019 - Disclosure - GOODWILL Sheet http://theglimpsegroup.com/role/Goodwill GOODWILL Notes 19 false false R20.htm 00000020 - Disclosure - FOREIGN OPERATIONS Sheet http://theglimpsegroup.com/role/ForeignOperations FOREIGN OPERATIONS Notes 20 false false R21.htm 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 00000023 - Disclosure - ASSET ACQUISTION (Tables) Sheet http://theglimpsegroup.com/role/AssetAcquistionTables ASSET ACQUISTION (Tables) Tables http://theglimpsegroup.com/role/AssetAcquistion 23 false false R24.htm 00000024 - Disclosure - EQUITY (Tables) Sheet http://theglimpsegroup.com/role/EquityTables EQUITY (Tables) Tables http://theglimpsegroup.com/role/Equity 24 false false R25.htm 00000025 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://theglimpsegroup.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://theglimpsegroup.com/role/EarningsPerShare 25 false false R26.htm 00000026 - Disclosure - PROVISION FOR INCOME TAXES (Tables) Sheet http://theglimpsegroup.com/role/ProvisionForIncomeTaxesTables PROVISION FOR INCOME TAXES (Tables) Tables http://theglimpsegroup.com/role/ProvisionForIncomeTaxes 26 false false R27.htm 00000027 - Disclosure - EQUIPMENT, NET (Tables) Sheet http://theglimpsegroup.com/role/EquipmentNetTables EQUIPMENT, NET (Tables) Tables http://theglimpsegroup.com/role/EquipmentNet 27 false false R28.htm 00000028 - Disclosure - SUBSEQUENT EVENTS (Tables) Sheet http://theglimpsegroup.com/role/SubsequentEventsTables SUBSEQUENT EVENTS (Tables) Tables http://theglimpsegroup.com/role/SubsequentEvents 28 false false R29.htm 00000029 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) Sheet http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) Details http://theglimpsegroup.com/role/LiquidityAndCapitalResources 29 false false R30.htm 00000030 - Disclosure - SCHEDULE OF TIMING REVENUE RECOGNITION (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails SCHEDULE OF TIMING REVENUE RECOGNITION (Details) Details 30 false false R31.htm 00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 00000032 - Disclosure - SCHEDULE OF ASSET ACQUISITION (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails SCHEDULE OF ASSET ACQUISITION (Details) Details 32 false false R33.htm 00000033 - Disclosure - ASSET ACQUISTION (Details Narrative) Sheet http://theglimpsegroup.com/role/AssetAcquistionDetailsNarrative ASSET ACQUISTION (Details Narrative) Details http://theglimpsegroup.com/role/AssetAcquistionTables 33 false false R34.htm 00000034 - Disclosure - CONTINGENT ACQUISITION LIABILITY (Details Narrative) Sheet http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative CONTINGENT ACQUISITION LIABILITY (Details Narrative) Details http://theglimpsegroup.com/role/ContingentAcquisitionLiability 34 false false R35.htm 00000035 - Disclosure - DEBT (Details Narrative) Sheet http://theglimpsegroup.com/role/DebtDetailsNarrative DEBT (Details Narrative) Details http://theglimpsegroup.com/role/Debt 35 false false R36.htm 00000036 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfBlack-scholesOption-pricingModelAssumptionsDetails SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details) Details 36 false false R37.htm 00000037 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details) Sheet http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails SUMMARY OF STOCK OPTION ACTIVITY (Details) Details 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF STOCK OPTION-BASED EXPENSE (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails SCHEDULE OF STOCK OPTION-BASED EXPENSE (Details) Details 38 false false R39.htm 00000039 - Disclosure - EQUITY (Details Narrative) Sheet http://theglimpsegroup.com/role/EquityDetailsNarrative EQUITY (Details Narrative) Details http://theglimpsegroup.com/role/EquityTables 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details) Details 40 false false R41.htm 00000041 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details) Details 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfExpectedTaxExpenseBenefitBasedOnUsFederalStatutoryRateDetails SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE (Details) Details 43 false false R44.htm 00000044 - Disclosure - PROVISION FOR INCOME TAXES (Details Narrative) Sheet http://theglimpsegroup.com/role/ProvisionForIncomeTaxesDetailsNarrative PROVISION FOR INCOME TAXES (Details Narrative) Details http://theglimpsegroup.com/role/ProvisionForIncomeTaxesTables 44 false false R45.htm 00000045 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://theglimpsegroup.com/role/CommitmentsAndContingencies 45 false false R46.htm 00000046 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://theglimpsegroup.com/role/SubsequentEventsTables 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Details 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF EQUIPMENT, NET (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails SCHEDULE OF EQUIPMENT, NET (Details) Details 48 false false R49.htm 00000049 - Disclosure - EQUIPMENT, NET (Details Narrative) Sheet http://theglimpsegroup.com/role/EquipmentNetDetailsNarrative EQUIPMENT, NET (Details Narrative) Details http://theglimpsegroup.com/role/EquipmentNetTables 49 false false R50.htm 00000050 - Disclosure - GOODWILL (Details Narrative) Sheet http://theglimpsegroup.com/role/GoodwillDetailsNarrative GOODWILL (Details Narrative) Details http://theglimpsegroup.com/role/Goodwill 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT (Details) Sheet http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT (Details) Details 51 false false All Reports Book All Reports forms-1.htm ex21-1.htm ex23-1.htm ex5-1.htm ggic-20210930.xsd ggic-20210930_cal.xml ggic-20210930_def.xml ggic-20210930_lab.xml ggic-20210930_pre.xml forms-1_001.jpg forms-1_002.jpg forms-1_003.jpg image_002.jpg image_003.jpg image_004.jpg image_005.jpg http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 true true JSON 76 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "forms-1.htm": { "axisCustom": 0, "axisStandard": 21, "contextCount": 208, "dts": { "calculationLink": { "local": [ "ggic-20210930_cal.xml" ] }, "definitionLink": { "local": [ "ggic-20210930_def.xml" ] }, "inline": { "local": [ "forms-1.htm" ] }, "labelLink": { "local": [ "ggic-20210930_lab.xml" ] }, "presentationLink": { "local": [ "ggic-20210930_pre.xml" ] }, "schema": { "local": [ "ggic-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 503, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 89, "http://theglimpsegroup.com/20210930": 39, "http://xbrl.sec.gov/dei/2021": 2, "total": 130 }, "keyCustom": 60, "keyStandard": 316, "memberCustom": 44, "memberStandard": 25, "nsprefix": "GGIC", "nsuri": "http://theglimpsegroup.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "b", "span", "p", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://theglimpsegroup.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "b", "span", "p", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - ASSET ACQUISTION", "role": "http://theglimpsegroup.com/role/AssetAcquistion", "shortName": "ASSET ACQUISTION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CONTINGENT ACQUISITION LIABILITY", "role": "http://theglimpsegroup.com/role/ContingentAcquisitionLiability", "shortName": "CONTINGENT ACQUISITION LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - DEBT", "role": "http://theglimpsegroup.com/role/Debt", "shortName": "DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - EQUITY", "role": "http://theglimpsegroup.com/role/Equity", "shortName": "EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - EARNINGS PER SHARE", "role": "http://theglimpsegroup.com/role/EarningsPerShare", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - PROVISION FOR INCOME TAXES", "role": "http://theglimpsegroup.com/role/ProvisionForIncomeTaxes", "shortName": "PROVISION FOR INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://theglimpsegroup.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SUBSEQUENT EVENTS", "role": "http://theglimpsegroup.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - EQUIPMENT, NET", "role": "http://theglimpsegroup.com/role/EquipmentNet", "shortName": "EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - GOODWILL", "role": "http://theglimpsegroup.com/role/Goodwill", "shortName": "GOODWILL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "role": "http://theglimpsegroup.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "GGIC:ForeignOperationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - FOREIGN OPERATIONS", "role": "http://theglimpsegroup.com/role/ForeignOperations", "shortName": "FOREIGN OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "GGIC:ForeignOperationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "GGIC:ScheduleOfTimingRevenueRecognitionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "GGIC:ScheduleOfTimingRevenueRecognitionTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - ASSET ACQUISTION (Tables)", "role": "http://theglimpsegroup.com/role/AssetAcquistionTables", "shortName": "ASSET ACQUISTION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - EQUITY (Tables)", "role": "http://theglimpsegroup.com/role/EquityTables", "shortName": "EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - EARNINGS PER SHARE (Tables)", "role": "http://theglimpsegroup.com/role/EarningsPerShareTables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - PROVISION FOR INCOME TAXES (Tables)", "role": "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesTables", "shortName": "PROVISION FOR INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - EQUIPMENT, NET (Tables)", "role": "http://theglimpsegroup.com/role/EquipmentNetTables", "shortName": "EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SUBSEQUENT EVENTS (Tables)", "role": "http://theglimpsegroup.com/role/SubsequentEventsTables", "shortName": "SUBSEQUENT EVENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)", "role": "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "shortName": "LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "GGIC:LiquidityAndCapitalResourcesDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-012021-07-02", "decimals": "-5", "lang": null, "name": "GGIC:GrossProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - SCHEDULE OF TIMING REVENUE RECOGNITION (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails", "shortName": "SCHEDULE OF TIMING REVENUE RECOGNITION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "GGIC:ScheduleOfTimingRevenueRecognitionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-012021-09-30_us-gaap_TransferredAtPointInTimeMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SCHEDULE OF ASSET ACQUISITION (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails", "shortName": "SCHEDULE OF ASSET ACQUISITION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-08-012021-08-31", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - ASSET ACQUISTION (Details Narrative)", "role": "http://theglimpsegroup.com/role/AssetAcquistionDetailsNarrative", "shortName": "ASSET ACQUISTION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-012021-07-02", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - CONTINGENT ACQUISITION LIABILITY (Details Narrative)", "role": "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "shortName": "CONTINGENT ACQUISITION LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-08-012021-08-31_custom_Kabaq3DTechnologiesLLCMember", "decimals": "0", "lang": null, "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012020-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - DEBT (Details Narrative)", "role": "http://theglimpsegroup.com/role/DebtDetailsNarrative", "shortName": "DEBT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-03-012021-03-31_us-gaap_ConvertibleNotesPayableMember", "decimals": "-3", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfUnsecuredDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfBlack-scholesOption-pricingModelAssumptionsDetails", "shortName": "SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SUMMARY OF STOCK OPTION ACTIVITY (Details)", "role": "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails", "shortName": "SUMMARY OF STOCK OPTION ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2019-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeBenefitsAndShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF STOCK OPTION-BASED EXPENSE (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails", "shortName": "SCHEDULE OF STOCK OPTION-BASED EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-012021-09-30_us-gaap_ResearchAndDevelopmentExpenseMember", "decimals": "0", "lang": null, "name": "us-gaap:EmployeeBenefitsAndShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "p", "GGIC:LiquidityAndCapitalResourcesDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-07-02", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - EQUITY (Details Narrative)", "role": "http://theglimpsegroup.com/role/EquityDetailsNarrative", "shortName": "EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-012021-07-02", "decimals": "-4", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "role": "http://theglimpsegroup.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "shortName": "SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "shortName": "SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfDeferredTaxAssetsDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfExpectedTaxExpenseBenefitBasedOnUsFederalStatutoryRateDetails", "shortName": "SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "INF", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - PROVISION FOR INCOME TAXES (Details Narrative)", "role": "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesDetailsNarrative", "shortName": "PROVISION FOR INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseExpirationDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseExpirationDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-08-012021-08-31", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30_us-gaap_CommonStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:ConversionOfStockSharesIssued1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "shortName": "SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2019-07-012020-06-30_custom_SoftwareServicesMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF EQUIPMENT, NET (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails", "shortName": "SCHEDULE OF EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2020-07-012021-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - EQUIPMENT, NET (Details Narrative)", "role": "http://theglimpsegroup.com/role/EquipmentNetDetailsNarrative", "shortName": "EQUIPMENT, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2019-06-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)", "role": "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "shortName": "Consolidated Statement of Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2019-06-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2019-07-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - GOODWILL (Details Narrative)", "role": "http://theglimpsegroup.com/role/GoodwillDetailsNarrative", "shortName": "GOODWILL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2019-07-012020-06-30_us-gaap_GeneralAndAdministrativeExpenseMember", "decimals": "0", "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT (Details)", "role": "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails", "shortName": "SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "AsOf2021-06-30", "decimals": "0", "lang": null, "name": "us-gaap:OtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "role": "http://theglimpsegroup.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS", "role": "http://theglimpsegroup.com/role/DescriptionOfBusiness", "shortName": "DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "GGIC:LiquidityAndCapitalResourcesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES", "role": "http://theglimpsegroup.com/role/LiquidityAndCapitalResources", "shortName": "LIQUIDITY AND CAPITAL RESOURCES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "GGIC:LiquidityAndCapitalResourcesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "forms-1.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 69, "tag": { "GGIC_AccruedLegacyAcquisitionExpense": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued legacy acquisition expense.", "label": "Accrued legacy acquisition expense" } } }, "localname": "AccruedLegacyAcquisitionExpense", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "GGIC_AcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition [Member]" } } }, "localname": "AcquisitionMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_AdditionalInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Interest [Member]", "label": "Additional Interest [Member]" } } }, "localname": "AdditionalInterestMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_AdvisorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisors Member.", "label": "Advisors [Member]" } } }, "localname": "AdvisorsMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_BoardOptionExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board option expense member.", "label": "Board Option Expense [Member]" } } }, "localname": "BoardOptionExpenseMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails" ], "xbrltype": "domainItemType" }, "GGIC_BonusExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Bonus expenses.", "label": "Bonus expenses" } } }, "localname": "BonusExpenses", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_ChangeInAccruedLegacyAcquisitionExpense": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInAccruedLegacyAcquisitionExpense", "negatedLabel": "Accrued legacy acquisition expense" } } }, "localname": "ChangeInAccruedLegacyAcquisitionExpense", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedAsAdditionalConsiderationWithConvertibleNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock issued as additional consideration with convertible notes.", "label": "Common stock issued to convertible Note 2 holders as additional consideration" } } }, "localname": "CommonStockIssuedAsAdditionalConsiderationWithConvertibleNotes", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedForInterestPaidInKindOnConvertibleNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock issued for interest paid in kind on convertible notes.", "label": "Common stock issued for interest paid-in kind on convertible notes" } } }, "localname": "CommonStockIssuedForInterestPaidInKindOnConvertibleNotes", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedForLegacyAcquisitionObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued for legacy acquisition obligation" } } }, "localname": "CommonStockIssuedForLegacyAcquisitionObligation", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedForLegacyAcquisitionObligationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for legacy acquisition obligation, shares" } } }, "localname": "CommonStockIssuedForLegacyAcquisitionObligationShares", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "GGIC_CommonStockIssuedToConvertibleNote1HoldersAsAdditionalConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock issued to convertible note1 holders as additional consideration.", "label": "Common stock issued to convertible Note 1 holders as additional consideration" } } }, "localname": "CommonStockIssuedToConvertibleNote1HoldersAsAdditionalConsideration", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedToConvertiblePromissoryNoteHoldersForPrepaidInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued to convertible promissory note holders for prepaid interest" } } }, "localname": "CommonStockIssuedToConvertiblePromissoryNoteHoldersForPrepaidInterest", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedToConvertiblePromissoryNoteHoldersForPrepaidInterestShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to convertible promissory note holders for prepaid interest, Shares" } } }, "localname": "CommonStockIssuedToConvertiblePromissoryNoteHoldersForPrepaidInterestShares", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "GGIC_CommonStockIssuedToConvertiblePrommissoryNoteHoldersAsAdditionalConsideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued to convertible promissory note holders as additional consideration" } } }, "localname": "CommonStockIssuedToConvertiblePrommissoryNoteHoldersAsAdditionalConsideration", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedToConvertiblePrommissoryNoteHoldersAsAdditionalConsiderationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to convertible promissory note holders as additional consideration, Shares" } } }, "localname": "CommonStockIssuedToConvertiblePrommissoryNoteHoldersAsAdditionalConsiderationShares", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "GGIC_CommonStockIssuedToEmployeesAsCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued to employees as compensation" } } }, "localname": "CommonStockIssuedToEmployeesAsCompensation", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedToEmployeesAsCompensationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to employees as compensation, Shares" } } }, "localname": "CommonStockIssuedToEmployeesAsCompensationShares", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "GGIC_CommonStockIssuedToEmployeesForCompensationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to employees for compensation, Shares" } } }, "localname": "CommonStockIssuedToEmployeesForCompensationShares", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "GGIC_CommonStockIssuedToVendorsForCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued to vendors for compensation" } } }, "localname": "CommonStockIssuedToVendorsForCompensation", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "GGIC_CommonStockIssuedToVendorsForCompensationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued to vendors for compensation, Shares" } } }, "localname": "CommonStockIssuedToVendorsForCompensationShares", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "GGIC_ConversionOfConvertiblePromissoryNotesIntoCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conversion of convertible promissory notes 1 into common stock" } } }, "localname": "ConversionOfConvertiblePromissoryNotesIntoCommonStock", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_ConvertibleNotesPayablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Promissory Notes [Member]", "label": "Convertible Promissory Notes [Member] [Default Label]" } } }, "localname": "ConvertibleNotesPayablesMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_DeferredTaxAssetsStockbasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock-based compensation.", "label": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsStockbasedCompensation", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "GGIC_DisclosureForeignOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Operations" } } }, "localname": "DisclosureForeignOperationsAbstract", "nsuri": "http://theglimpsegroup.com/20210930", "xbrltype": "stringItemType" }, "GGIC_DisclosureLiquidityAndCapitalResourcesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity And Capital Resources" } } }, "localname": "DisclosureLiquidityAndCapitalResourcesAbstract", "nsuri": "http://theglimpsegroup.com/20210930", "xbrltype": "stringItemType" }, "GGIC_EarlyAdopterComMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Early Adopter.Com member.", "label": "Early Adopter.Com [Member]" } } }, "localname": "EarlyAdopterComMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/GoodwillDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_EconomicInjuryDisasterLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Economic Injury Disaster Loan [Member]", "label": "Economic Injury Disaster Loan [Member]" } } }, "localname": "EconomicInjuryDisasterLoanMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees [Member]", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_ExecutivesAndIndependentMembersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Executives and Independent Members [Member]", "label": "Executives And Independent Members [Member]" } } }, "localname": "ExecutivesAndIndependentMembersMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_FirstTwoYearsOfInteresPrepaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Two Years of Interest Prepayment [Member]", "label": "First Two Years Of Interes Prepayment [Member]" } } }, "localname": "FirstTwoYearsOfInteresPrepaymentMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_ForeignOperationsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign operations text block.", "label": "FOREIGN OPERATIONS" } } }, "localname": "ForeignOperationsTextBlock", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ForeignOperations" ], "xbrltype": "textBlockItemType" }, "GGIC_ForgivenessOfPaycheckProtectionProgramPppLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Forgiveness of Paycheck Protection Program PPP loan.", "label": "Forgiveness of Paycheck Protection Program (PPP 1) loan" } } }, "localname": "ForgivenessOfPaycheckProtectionProgramPppLoan", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_FourOtherCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Four other customer member.", "label": "Four Other Customers [Member]" } } }, "localname": "FourOtherCustomersMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_FristYearOfInterestPrepaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Year of Interest Prepayment [Member]", "label": "Frist Year Of Interest Prepayment [Member]" } } }, "localname": "FristYearOfInterestPrepaymentMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_GrossProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds from issuance initial public offering.", "label": "Gross proceeds from issuance initial public offering" } } }, "localname": "GrossProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_IncreaseDecreaseInAccruedBonus": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accrued bonus" } } }, "localname": "IncreaseDecreaseInAccruedBonus", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_IncreaseDecreaseInOtherAssets": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInOtherAssets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherAssets", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_IncreaseDecreaseInPreOfferingCosts": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInPreOfferingCosts", "negatedLabel": "Pre-offering costs" } } }, "localname": "IncreaseDecreaseInPreOfferingCosts", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_IssuanceOfCommonStockForAdditionalCostToSatisfyContingentLiability": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock for additional cost to satisfy contingent liability.", "label": "Issuance of common stock for additional cost to satisfy contingent liability" } } }, "localname": "IssuanceOfCommonStockForAdditionalCostToSatisfyContingentLiability", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_IssuanceOfCommonStockForSatisfactionOfLegacyAcquisitionLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of common stock for satisfaction of legacy acquisition liability" } } }, "localname": "IssuanceOfCommonStockForSatisfactionOfLegacyAcquisitionLiability", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_IssuanceOfCommonStockToEmployeeAsCompensationToSatisfyContingentLiability": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock to employee as compensation to satisfy contingent liability.", "label": "Issuance of common stock to employees to satisfy contingent liability" } } }, "localname": "IssuanceOfCommonStockToEmployeeAsCompensationToSatisfyContingentLiability", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_IssuanceOfWarrantsInConnectionWithInitialPublicOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Issuance of warrants in connection with initial public offering" } } }, "localname": "IssuanceOfWarrantsInConnectionWithInitialPublicOffering", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_JulyAndDecemberTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July-December 2021 [Member]", "label": "July And December Two Thousand Twenty One [Member]" } } }, "localname": "JulyAndDecemberTwoThousandTwentyOneMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_Kabaq3DTechnologiesLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kabaq3D Technologies, LLC member.", "label": "Kabaq3D Technologies, LLC [Member]" } } }, "localname": "Kabaq3DTechnologiesLLCMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_KreatARLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "KreatAR LLC member.", "label": "KreatAR LLC [Member]" } } }, "localname": "KreatARLLCMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_LeagacyAcquisitionObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Legacy acquisition obligation" } } }, "localname": "LeagacyAcquisitionObligation", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_LeaseCommencingDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease commencing date.", "label": "Lease commencing date" } } }, "localname": "LeaseCommencingDate", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "GGIC_LegacyAcquisitionObligationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Acquisition Obligation [Member]" } } }, "localname": "LegacyAcquisitionObligationMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_LesseeOperatingLeaseLiabilityPaymentsDueAfter": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lease payments due thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfter", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_LiquidityAndCapitalResourcesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity and capital resources disclosure text block.", "label": "LIQUIDITY AND CAPITAL RESOURCES" } } }, "localname": "LiquidityAndCapitalResourcesDisclosureTextBlock", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResources" ], "xbrltype": "textBlockItemType" }, "GGIC_LossOnConversionOfConvertibleNotes": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loss on conversion of convertible notes.", "label": "Loss on conversion of convertible notes", "negatedLabel": "Loss on conversion of convertible notes", "verboseLabel": "Loss on conversion of convertible notes" } } }, "localname": "LossOnConversionOfConvertibleNotes", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "GGIC_MaximumDistributionPercentageOfNetProceedsFromDivestiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum distribution percentage of net proceeds from divestiture.", "label": "Maximum distribution percentage of net proceeds from divestiture" } } }, "localname": "MaximumDistributionPercentageOfNetProceedsFromDivestiture", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "GGIC_NetCashProvidedByUsedInOperatingsActivities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "NetCashProvidedByUsedInOperatingsActivities", "negatedLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingsActivities", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_NetOperatingLossCarryforwardsNoExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net operating loss carryforwards no expiration.", "label": "Net operating loss carryforwards no expiration" } } }, "localname": "NetOperatingLossCarryforwardsNoExpiration", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_NewConvertibleNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Convertible Promissory Notes [Member]", "label": "New Convertible Promissory Notes [Member]" } } }, "localname": "NewConvertibleNotesPayableMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_OctoberTwoThousandTwentyOneToSeptemberTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October Two Thousand Twenty One To September Two Thousand Twenty Two [Member]" } } }, "localname": "OctoberTwoThousandTwentyOneToSeptemberTwoThousandTwentyTwoMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_OneCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Customers [Member]" } } }, "localname": "OneCustomersMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_OperatingLossCarryForwardsExpirationDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carry forwards expiration date.", "label": "Operating loss carry forwards expiration date" } } }, "localname": "OperatingLossCarryForwardsExpirationDateDescription", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "GGIC_OtherCustomerFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other customer four member.", "label": "Other Customer Four [Member]" } } }, "localname": "OtherCustomerFourMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_OtherCustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other customer one member.", "label": "Other Customer One [Member]" } } }, "localname": "OtherCustomerOneMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_OtherCustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other customer three member.", "label": "Other Customer Three [Member]" } } }, "localname": "OtherCustomerThreeMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_OtherCustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other customer two member.", "label": "Other Customer Two [Member]" } } }, "localname": "OtherCustomerTwoMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_OtherCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Customers [Member]", "label": "Other Customers [Member]" } } }, "localname": "OtherCustomersMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program [Member]", "label": "Paycheck Protection Program [Member]" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_PaycheckProtectionProgramPppLoan": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Paycheck Protection Program (PPP 2) loan" } } }, "localname": "PaycheckProtectionProgramPppLoan", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "GGIC_PaymentProtectionProgramOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payment protection program one member.", "label": "Payment Protection Program One [Member]" } } }, "localname": "PaymentProtectionProgramOneMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_PaymentProtectionProgramTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payment Protection Program Two Member.", "label": "Payment Protection Program Two [Member]" } } }, "localname": "PaymentProtectionProgramTwoMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_PreOfferingCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre Offering Costs [Member]", "label": "Pre Offering Costs [Member]" } } }, "localname": "PreOfferingCostsMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_PreofferingCosts": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Pre-offering costs" } } }, "localname": "PreofferingCosts", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "GGIC_PreofferingCostsIncurred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "PreofferingCostsIncurred", "negatedLabel": "Pre-offering costs incurred" } } }, "localname": "PreofferingCostsIncurred", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_ProceedsFromConvertibleDebtOne": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from convertible promissory notes 2" } } }, "localname": "ProceedsFromConvertibleDebtOne", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_ProceedsFromIssuanceOfCommonStockAndConvertibleDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of common stock and convertible debt.", "label": "Proceeds from issuance of common stock and convertible debt" } } }, "localname": "ProceedsFromIssuanceOfCommonStockAndConvertibleDebt", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_ProceedsFromPaycheckProtectionProgramPpp2Loan": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from Paycheck Protection Program (PPP 2) loan" } } }, "localname": "ProceedsFromPaycheckProtectionProgramPpp2Loan", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GGIC_ProfessionalFeesAndListingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Professional fees and listing expenses.", "label": "Professional fees and listing expenses" } } }, "localname": "ProfessionalFeesAndListingExpenses", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_ScheduleOfTimingRevenueRecognitionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TIMING REVENUE RECOGNITION" } } }, "localname": "ScheduleOfTimingRevenueRecognitionTableTextBlock", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "GGIC_SecondYearOfNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Year of Notes [Member]", "label": "Second Year Of Notes [Member]" } } }, "localname": "SecondYearOfNotesMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term.", "label": "Weighted Average Remaining Contractual Term (Yrs), Exercisable, Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedInPeriodFairValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedInPeriodFairValue1", "negatedLabel": "Intrinsic Value, Options Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedInPeriodFairValue1", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term (Yrs), Options Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intrinsic Value, Options Forfeited/Cancelled.", "label": "Intrinsic Value, Options Forfeited/Cancelled", "negatedLabel": "Intrinsic Value, Options Forfeited/Cancelled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited/Cancelled Weighted Average Remaining Contractual Term.", "label": "Weighted Average Remaining Contractual Term (Yrs), Options Forfeited/Cancelled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intrinsic Value, Options Granted.", "label": "Intrinsic Value, Options Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodFairValue1", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term.", "label": "Weighted Average Remaining Contractual Term (Yrs), Options Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "GGIC_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractua lTerm.", "label": "Weighted Average Remaining Contractual Term (Yrs), Outstanding Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "GGIC_SoftwareLicenseAndSoftwareServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software License and Software as a Service [Member]", "label": "Software License and Software as a Service [Member]" } } }, "localname": "SoftwareLicenseAndSoftwareServiceMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "GGIC_SoftwareLicenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software license member.", "label": "Software License [Member]" } } }, "localname": "SoftwareLicenseMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "GGIC_SoftwareSercicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software sercices member.", "label": "Software Sercices [Member]" } } }, "localname": "SoftwareSercicesMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "GGIC_SoftwareServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software Services [Member]", "label": "SoftwareServicesMember" } } }, "localname": "SoftwareServicesMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "GGIC_StockGrantedDuringPeriodValueSharebasedCompensationNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock options granted during period value" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationNet", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_StockIssuedDuringPeriodSharesInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued in Initial Public Offering net, shares" } } }, "localname": "StockIssuedDuringPeriodSharesInitialPublicOffering", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "GGIC_StockIssuedDuringPeriodValueInitialPublicOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued in Initial Public Offering, net" } } }, "localname": "StockIssuedDuringPeriodValueInitialPublicOffering", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "GGIC_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock options member.", "label": "Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "GGIC_ThirdYearInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Year Interest [Member]", "label": "Third Year Interest [Member]" } } }, "localname": "ThirdYearInterestMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_ThreeOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three Officers.", "label": "Three Officers [Member]" } } }, "localname": "ThreeOfficersMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_ToSatisfyContingentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "To Satisfy Contingent Liabilities Member.", "label": "To Satisfy Contingent Liabilities [Member]" } } }, "localname": "ToSatisfyContingentLiabilitiesMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_TwoCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Customers [Member]", "label": "Two Customers [Member]" } } }, "localname": "TwoCustomersMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_TwoThousandSixteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2016 Equity Incentive Plan Member.", "label": "2016 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandSixteenEquityIncentivePlanMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_UnfulfilledPerformanceObligations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "unfulfilled performance obligations.", "label": "Unfulfilled performance obligations" } } }, "localname": "UnfulfilledPerformanceObligations", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_UnrecognizedShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized Share based compensation" } } }, "localname": "UnrecognizedShareBasedCompensation", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GGIC_VendorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendors Member.", "label": "Vendors [Member]" } } }, "localname": "VendorsMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GGIC_WarrantExercisableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant exercisable description" } } }, "localname": "WarrantExercisableDescription", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "GGIC_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://theglimpsegroup.com/20210930", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r498", "r500", "r501" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://theglimpsegroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r137", "r273", "r277", "r470" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r212", "r247", "r286", "r289", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r468", "r471", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r212", "r247", "r286", "r289", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r468", "r471", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r137", "r273", "r277", "r470" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers." } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProFormaMember": { "auth_ref": [ "r98", "r196", "r406" ], "lang": { "en-us": { "role": { "documentation": "Information reported based on historical fact adjusted for potential activity. Includes, but is not limited to, information expected to be reported in future period for effect on historical fact. Excludes forecast information.", "label": "Pro Forma [Member]" } } }, "localname": "ProFormaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r135", "r273", "r275", "r443", "r467", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r135", "r273", "r275", "r443", "r467", "r469" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services." } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r212", "r247", "r283", "r286", "r289", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r468", "r471", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r212", "r247", "r283", "r286", "r289", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r468", "r471", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r94", "r287", "r512" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r94", "r98", "r287" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "SCHEDULE OF CONDENSED BALANCE SHEET REFLECTING PROFORMA EFFECT" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsTables" ], "xbrltype": "textBlockItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r94", "r98", "r196", "r287", "r406" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r138", "r400" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r31", "r403" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r3", "r19", "r139", "r140" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [ "r8", "r9", "r34" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrentAndNoncurrent": { "auth_ref": [ "r451", "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.", "label": "Accrued Bonuses", "verboseLabel": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r34" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r29", "r187" ], "calculation": { "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r319", "r403" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r86", "r87", "r88", "r316", "r317", "r318", "r367" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Stock option-based board of directors expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "Stock option-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r291", "r312", "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r145", "r156", "r158", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for doubtful accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r67", "r232", "r240", "r241", "r393" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of paid-in kind common stock interest on convertible notes" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Total Potentially dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contingent consideration in asset acquisition.", "label": "SCHEDULE OF ASSET ACQUISITION" } } }, "localname": "AssetAcquisitionContingentConsiderationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/AssetAcquistionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AssetAcquisitionTextBlock": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for asset acquisition.", "label": "ASSET ACQUISTION" } } }, "localname": "AssetAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/AssetAcquistion" ], "xbrltype": "textBlockItemType" }, "us-gaap_Assets": { "auth_ref": [ "r82", "r124", "r127", "r133", "r154", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r361", "r364", "r377", "r401", "r403", "r447", "r459" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r7", "r46", "r82", "r154", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r361", "r364", "r377", "r401", "r403" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r292", "r314" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r285", "r288" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/GoodwillDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r285", "r288", "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/GoodwillDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business acqusition, share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r355", "r356", "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Contingent acquisition liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "CONTINGENT ACQUISITION LIABILITY" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs which have been expensed.", "label": "Additional acquisition cost" } } }, "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r26", "r403", "r478", "r479" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r26", "r69" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "verboseLabel": "Cash and Cash Equivalents, at Carrying Value" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r11", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r64", "r69", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r64", "r382" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r26" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash position" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format.", "label": "Warrants expires date" } } }, "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Number of warrants to purchase per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Warrants to purchase shares" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Number of warrants to purchase" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r40", "r195", "r452", "r464" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r192", "r193", "r194", "r197", "r482" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Aggregate number of common stock shares reserved for future issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r86", "r87", "r367" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock par value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r18", "r260" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r18", "r403" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, par value $0.001 per share, 300 million shares \u00a0authorized; 7,579,285 and 7,035,771 issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r114", "r115", "r137", "r375", "r376", "r481" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r114", "r115", "r137", "r375", "r376", "r477", "r481" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r114", "r115", "r137", "r375", "r376", "r477", "r481" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r110", "r457" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Customer Concentration and Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r114", "r115", "r137", "r375", "r376" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r114", "r115", "r137", "r375", "r376", "r481" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r76", "r363" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contracted revenue backlog" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r71", "r72", "r73" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of stock, shares issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible promissory notes, net" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r16", "r449", "r460", "r480" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible promissory notes", "verboseLabel": "Convertible promissory notes, net" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r14", "r448", "r458", "r480" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r58", "r443" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r113", "r137" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r71", "r73" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt conversion converted instrument shares", "verboseLabel": "Stock issued during period shares" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r79", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r226", "r233", "r234", "r236", "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r81", "r84", "r209", "r210", "r211", "r212", "r213", "r214", "r216", "r222", "r223", "r224", "r225", "r227", "r228", "r229", "r230", "r231", "r232", "r238", "r239", "r240", "r241", "r394", "r448", "r449", "r458" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r211", "r237" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt instrument conversion price per share" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r14", "r16", "r261", "r448", "r449", "r456", "r458" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt interest payment description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r209", "r238", "r239", "r392", "r394", "r395" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r36", "r210" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instrument interest rate percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r37", "r212", "r369" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt instrument maturity date, description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r38", "r81", "r84", "r209", "r210", "r211", "r212", "r213", "r214", "r216", "r222", "r223", "r224", "r225", "r227", "r228", "r229", "r230", "r231", "r232", "r238", "r239", "r240", "r241", "r394" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt instrument term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r222", "r391", "r395" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Original issue discount on notes" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.", "label": "Deferred costs" } } }, "localname": "DeferredCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Total Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Asset, Net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r338", "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net-operating loss carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r67", "r185" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquipmentNetDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r67", "r123" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Amortization and depreciation" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r273", "r275", "r276", "r277", "r278", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATION OF REVENUE" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and diluted net loss per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r102", "r103", "r104", "r105" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Taxes Provision (Benefit)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfExpectedTaxExpenseBenefitBasedOnUsFederalStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r83", "r327", "r344" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory Federal Income Tax Rate", "negatedLabel": "Statutory Federal Income Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfExpectedTaxExpenseBenefitBasedOnUsFederalStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r327", "r344" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Change in Valuation Allowance", "negatedLabel": "Change in Valuation Allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfExpectedTaxExpenseBenefitBasedOnUsFederalStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [ "r322", "r327" ], "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Stock Based Compensation Expense (ISO)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfExpectedTaxExpenseBenefitBasedOnUsFederalStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r327", "r344" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State and Local Taxes, Net of Federal Tax Benefit", "negatedLabel": "State and Local Taxes, Net of Federal Tax Benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfExpectedTaxExpenseBenefitBasedOnUsFederalStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Stock option based compensation for employees and board of directors", "verboseLabel": "Total" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails", "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r313" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Unrecognized compensation expense to employees and vendors" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r50", "r51", "r52", "r86", "r87", "r88", "r90", "r95", "r97", "r106", "r155", "r260", "r262", "r316", "r317", "r318", "r341", "r342", "r367", "r383", "r384", "r385", "r386", "r387", "r388", "r472", "r473", "r474", "r517" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r371", "r372" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r373", "r374" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r149", "r150", "r151", "r152", "r153", "r157", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r235", "r258", "r366", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r504", "r505", "r506", "r507", "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Intangible assets useful life (years)" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r183" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.", "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r179", "r180", "r183", "r184", "r444", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r183", "r445" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Technology" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r179", "r182" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r183", "r444" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r378", "r379", "r380", "r381" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Legacy acquisition expense" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r67", "r242", "r243" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Forgiveness of Paycheck Protection Program (PPP1) loan", "negatedLabel": "Forgiveness of Paycheck Protection Program (PPP 1) loan", "verboseLabel": "Gain loss on debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r59" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses", "verboseLabel": "General and administration expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/GoodwillDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r170", "r172", "r403", "r446" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "GOODWILL" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r67", "r171", "r173", "r175" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Impairment of goodwill", "verboseLabel": "Goodwill impairment" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/GoodwillDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/GoodwillDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r57", "r82", "r124", "r126", "r129", "r132", "r134", "r154", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r377" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r189", "r191" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/GoodwillDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/GoodwillDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r83", "r328", "r330", "r336", "r343", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "PROVISION FOR INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ProvisionForIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r324", "r329" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Tax benefit settlement description" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r49", "r325", "r326", "r330", "r331", "r335", "r340" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r66" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r66" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r66" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredCharges": { "auth_ref": [ "r66" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.", "label": "Increase (Decrease) in Deferred Charges", "negatedLabel": "Deferred costs" } } }, "localname": "IncreaseDecreaseInDeferredCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r66" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "verboseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r66" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r77", "r182", "r440", "r441", "r442", "r444" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangibles, net" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r178", "r181" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "verboseLabel": "Goodwill" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r53", "r122", "r390", "r393", "r454" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest income" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r67" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of common stock to vendors as compensation" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease Expiration Date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r397" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r33", "r82", "r128", "r154", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r362", "r364", "r365", "r377", "r401", "r402" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r24", "r82", "r154", "r377", "r403", "r450", "r462" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Total liabilities and stockholders' equity (deficit)", "totalLabel": "Total liabilities and stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r35", "r82", "r154", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r362", "r364", "r365", "r377", "r401", "r402", "r403" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long term liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r38" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Paycheck Protection Program (PPP 1) loan" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r107", "r119" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "DESCRIPTION OF BUSINESS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r64" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r64" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flow from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r64", "r65", "r68" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r47", "r48", "r52", "r54", "r68", "r82", "r89", "r91", "r92", "r93", "r94", "r96", "r97", "r99", "r124", "r126", "r129", "r132", "r134", "r154", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r368", "r377", "r453", "r466" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "negatedLabel": "Net loss", "totalLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/StatementsOfCashFlows", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash Investing and Financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Non-cash Investing and Financing activities:" } } }, "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r60" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r124", "r126", "r129", "r132", "r134" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Net loss from operations before other income (expense)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r337" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carry forwards, net" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r44", "r403" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r30" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other long term liability" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r56" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r61" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r292", "r314" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r17", "r245" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r17", "r245" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued", "verboseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheetsParenthetical", "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r17", "r403" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, par value $0.001 per share, 20 million shares \u00a0authorized; 0 shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r6", "r168", "r169" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromBankDebt": { "auth_ref": [ "r63" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from bank borrowing during the year.", "label": "Proceeds from Paycheck Protection Program (PPP 1) loan", "terseLabel": "Proceeds from debt", "verboseLabel": "Proceeds from PPP loan" } } }, "localname": "ProceedsFromBankDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r63" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible promissory notes 1" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r62" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from initial public offering, net", "verboseLabel": "Net proceeds from issuance initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r62" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common equity to investors", "terseLabel": "Proceeds from sale of common stock", "verboseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/StatementsOfCashFlows", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": { "auth_ref": [ "r63" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.", "label": "Proceeds from issuance of unsecured debt" } } }, "localname": "ProceedsFromIssuanceOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r62", "r315" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from warrants exercise" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r190", "r483", "r484", "r485" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r28", "r186" ], "calculation": { "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r12", "r13", "r188", "r403", "r455", "r463" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Equipment, net", "totalLabel": "Balance", "verboseLabel": "Property, Plant and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails", "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r27", "r188", "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r12", "r188" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfEquipmentNetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r323", "r439", "r488" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r262", "r319", "r403", "r461", "r475", "r476" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r86", "r87", "r88", "r90", "r95", "r97", "r155", "r316", "r317", "r318", "r341", "r342", "r367", "r472", "r474" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r120", "r121", "r125", "r130", "r131", "r135", "r136", "r137", "r272", "r273", "r443" ], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total Revenue", "terseLabel": "Total revenue", "verboseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r78", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Proceeds from sale of stock" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of stock, shares" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of stock, price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r114", "r137" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF EXPECTED TAX EXPENSE (BENEFIT) BASED ON US FEDERAL STATUTORY RATE" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r174", "r176" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/GoodwillDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r301", "r303", "r305" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK OPTION-BASED EXPENSE" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r292", "r314" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r295", "r303", "r305" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "SUMMARY OF STOCK OPTION ACTIVITY" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://theglimpsegroup.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing expenses" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r290", "r293" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Stock based compensation description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average intrinsic value of award granted under share-based payment arrangement. Excludes share and unit options.", "label": "Stock options intrinsic value per share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfBlack-scholesOption-pricingModelAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Weighted average expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfBlack-scholesOption-pricingModelAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Weighted average risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfBlack-scholesOption-pricingModelAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Stock available for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Options Exercisable, Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted Average Exercise Price, Exercisable, Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Options, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Options granted, fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Options, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r314" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Intrinsic Value, Outstanding Ending balance", "periodStartLabel": "Intrinsic Value, Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r297", "r314" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options Outstanding, Ending balance", "periodStartLabel": "Options Outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Ending balance", "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Options Exercised", "verboseLabel": "Stock options exercise price per share" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price, Options Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Exercise Price, Options Granted", "verboseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r292", "r294" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Employee Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r308", "r320" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average expected terms (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfBlack-scholesOption-pricingModelAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r314" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Intrinsic Value, Exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Stock options exercise period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term (Yrs), Outstanding Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Stock purchase percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Share issued price per share", "terseLabel": "Shares Issued, Price Per Share", "verboseLabel": "Shares issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r75", "r85" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r43", "r50", "r51", "r52", "r86", "r87", "r88", "r90", "r95", "r97", "r106", "r155", "r260", "r262", "r316", "r317", "r318", "r341", "r342", "r367", "r383", "r384", "r385", "r386", "r387", "r388", "r472", "r473", "r474", "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails", "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r86", "r87", "r88", "r106", "r443" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails", "http://theglimpsegroup.com/role/ScheduleOfStockOption-basedExpenseDetails", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Stock options granted during period value" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r71", "r72", "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Issuance of common stock for satisfaction of contingent liability" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r17", "r18", "r262" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Common stock issued for acquisition, shares", "verboseLabel": "Stock issued during peirod shares acquisitions" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r42", "r227", "r260", "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Common stock issued for convertible note conversion, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock issued during period shares for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r17", "r18", "r260", "r262" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Sales of common stock to investors, Shares", "verboseLabel": "Shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative", "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Common stock issued to satisfy contingent liability, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Common stock purchase price" } } }, "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/AssetAcquistionDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r17", "r18", "r260", "r262", "r299" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Common stock issued for exercise of options, shares", "negatedLabel": "Options, Exercised", "verboseLabel": "Options, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit", "http://theglimpsegroup.com/role/SummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r43", "r260", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Common stock issued for acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r43", "r260", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Common stock issued for convertible note conversion" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r17", "r18", "r260", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Sales of common stock to investors", "verboseLabel": "Stock issued during period value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Common stock issued to satisfy contingent liability" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Purchase of assets consideration value" } } }, "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/AssetAcquistionDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Common stock issued to employees for compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r43", "r260", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Common stock issued for exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r17", "r18", "r260", "r262" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r17", "r18", "r260", "r262" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r18", "r22", "r23", "r82", "r147", "r154", "r377", "r403" ], "calculation": { "http://theglimpsegroup.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Total stockholders' equity (deficit)", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets", "http://theglimpsegroup.com/role/ScheduleOfCondensedBalanceSheetReflectingProformaEffectDetails", "http://theglimpsegroup.com/role/StatementOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r80", "r246", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r259", "r262", "r263" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r389", "r405" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r389", "r405" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r389", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r389", "r405" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/LiquidityAndCapitalResourcesDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r404", "r407" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/DebtDetailsNarrative", "http://theglimpsegroup.com/role/EquityDetailsNarrative", "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfAssetAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r273", "r280" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r273", "r280" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time." } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r141", "r142", "r143", "r144", "r146", "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfTimingRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r149", "r150", "r151", "r152", "r153", "r235", "r258", "r366", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r504", "r505", "r506", "r507", "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ContingentAcquisitionLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r108", "r109", "r111", "r112", "r116", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Accounting Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ProvisionForIncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted-average shares used to compute basic and diluted net loss per share", "verboseLabel": "Weighted-average common shares outstanding for basic and diluted net loss per share" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://theglimpsegroup.com/role/ScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails", "http://theglimpsegroup.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r197": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r263": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r282": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r348": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492" }, "r359": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r407": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8,17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r489": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r490": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r491": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r492": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r493": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r494": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r495": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r496": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r497": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r498": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r499": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r500": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r501": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r502": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r503": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r504": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r505": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r506": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r507": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r508": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r509": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r510": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r511": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r512": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r513": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "i", "Publisher": "SEC", "Section": "3", "Subsection": "10" }, "r514": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r515": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r516": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" } }, "version": "2.1" } ZIP 77 0001493152-21-029915-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-029915-xbrl.zip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�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|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end